Index,Citation,Study type,Primary Report,Source,Group ID,Sub-group 1,Analytical Population,Comparison,Measure Domain,Measure Subdomain,"Measure, Binned","Measure, Cleaned","Measure, Reported",Sample Type,Time,Time Unit,"Time, weeks",n,Statistic,Unit,Value,SE,SD,Lower,Upper,Range Type,UNIT CONVERTED,Value CONVERTED,Value CONVERTED (bin),Value CONVERTED (bin 5),Value CONVERTED (bin 10),SE CONVERTED,SD CONVERTED,LOWER CONVERTED,UPPER CONVERTED,Conversion Method
1,Wang 2020,Intervention,NCT01235832,Methods section,Avocado diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,43,Average,g/d,136,,,,,NA,g/d,136,136,135,130,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,45,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section,Lower-fat diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,43,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section,Moderate-fat diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,42,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,45,Mean,Years,45,1.98,13.3,21,70,"min,max",years,45,45,45,40,1.98265,13.3,21,70,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,45,Mean,kg/m^2,28.2,0.36,2.4,25,35,"min,max",kg/m^2,28.2,28,25,20,0.357771,2.4,25,35,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,Asian,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,Asian,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,Caucasian and non-Hispanic,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,Caucasian and non-Hispanic,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,45,Count,Count,18,,,,,NA,Count,18,18,15,10,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,45,Percentage,%,40,,,,,NA,%,40,40,40,40,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,45,Count,Count,27,,,,,NA,Count,27,27,25,20,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Methods section Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,45,Percentage,%,60,,,,,NA,%,60,60,60,60,,,,,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Avocado Diet,NA,PP,Within,Outcome,Immune,ICAM-1,ICAM-1,ICAM1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Avocado Diet,NA,PP,Within,Outcome,Immune,IL-1b,IL-1b,IL1B,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Avocado Diet,NA,PP,Within,Outcome,Immune,MCP-1,MCP-1,MCP1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Avocado Diet,NA,PP,Within,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Immune,ICAM-1,ICAM-1,ICAM1,Blood,2,weeks,2,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Immune,IL-1b,IL-1b,IL1B,Blood,2,weeks,2,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Immune,MCP-1,MCP-1,MCP1,Blood,2,weeks,2,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,2,weeks,2,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Lower-Fat diet,NA,PP,Within,Outcome,Immune,ICAM-1,ICAM-1,ICAM1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Lower-Fat diet,NA,PP,Within,Outcome,Immune,IL-1b,IL-1b,IL1B,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Lower-Fat diet,NA,PP,Within,Outcome,Immune,MCP-1,MCP-1,MCP1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Lower-Fat diet,NA,PP,Within,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Moderate-Fat diet,NA,PP,Within,Outcome,Immune,ICAM-1,ICAM-1,ICAM1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Moderate-Fat diet,NA,PP,Within,Outcome,Immune,IL-1b,IL-1b,IL1B,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Moderate-Fat diet,NA,PP,Within,Outcome,Immune,MCP-1,MCP-1,MCP1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Supplemental Table 3,Moderate-Fat diet,NA,PP,Within,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,5,weeks,5,21,Mean,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,SD,"relative mRNA expression, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,43,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,43,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Lutein & zeaxanthin,NA,,NA,,43,Absolute value,ug/d,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,α-tocopherol,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Carotenoids,α-carotene,α-carotene,α-carotene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Avocado Diet,NA,PP,Summary,Dietary,Carotenoids,β-carotene,β-carotene,β-carotene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,45,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,45,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Lutein & zeaxanthin,NA,,NA,,45,Absolute value,ug/d,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,45,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,"Total fat, MUFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,"Total fat, PUFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,"Total fat, SFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,45,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,α-tocopherol,NA,,NA,,45,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Carotenoids,α-carotene,α-carotene,α-carotene,NA,,NA,,45,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Carotenoids,β-carotene,β-carotene,β-carotene,NA,,NA,,45,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,43,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,43,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Lutein & zeaxanthin,NA,,NA,,43,Absolute value,ug/d,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,α-tocopherol,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Carotenoids,α-carotene,α-carotene,α-carotene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Lower-Fat diet,NA,PP,Summary,Dietary,Carotenoids,β-carotene,β-carotene,β-carotene,NA,,NA,,43,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,42,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,42,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Lutein & zeaxanthin,NA,,NA,,42,Absolute value,ug/d,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,42,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,42,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,α-tocopherol,NA,,NA,,42,Absolute value,ug,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Carotenoids,α-carotene,α-carotene,α-carotene,NA,,NA,,42,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 1,Moderate-Fat diet,NA,PP,Summary,Dietary,Carotenoids,β-carotene,β-carotene,β-carotene,NA,,NA,,42,Absolute value,ug,NA,NA,NA,NA,NA,NA,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Antioxidation,Isoprostane,Isoprostane,Isoprostane,Blood,5,weeks,5,43,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,oxLDL,Blood,5,weeks,5,43,Mean,U/L,NA,NA,NA,NA,NA,SD,U/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinol,Retinol,Retinol,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,α-carotene,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol,α-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,β-carotene,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,γ-tocopherol,γ-tocopherol,γ-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Avocado Diet,NA,PP,Summary,Outcome,Nutrient bioavailability,δ-tocopherol,δ-tocopherol,δ-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Antioxidation,Isoprostane,Isoprostane,Isoprostane,Blood,2,weeks,2,45,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,oxLDL,Blood,2,weeks,2,45,Mean,U/L,NA,NA,NA,NA,NA,SD,U/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,Retinol,Retinol,Retinol,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,α-carotene,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol,α-tocopherol,Blood,2,weeks,2,45,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,β-carotene,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,γ-tocopherol,γ-tocopherol,γ-tocopherol,Blood,2,weeks,2,45,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Baseline Average American Diet,NA,ITT,Summary,Outcome,Nutrient bioavailability,δ-tocopherol,δ-tocopherol,δ-tocopherol,Blood,2,weeks,2,45,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Antioxidation,Isoprostane,Isoprostane,Isoprostane,Blood,5,weeks,5,43,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,oxLDL,Blood,5,weeks,5,43,Mean,U/L,NA,NA,NA,NA,NA,SD,U/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinol,Retinol,Retinol,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,α-carotene,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol,α-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,β-carotene,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,γ-tocopherol,γ-tocopherol,γ-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Lower-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,δ-tocopherol,δ-tocopherol,δ-tocopherol,Blood,5,weeks,5,43,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Antioxidation,Isoprostane,Isoprostane,Isoprostane,Blood,5,weeks,5,42,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,oxLDL,Blood,5,weeks,5,42,Mean,U/L,NA,NA,NA,NA,NA,SD,U/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinol,Retinol,Retinol,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,α-carotene,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol,α-tocopherol,Blood,5,weeks,5,42,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,β-carotene,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,γ-tocopherol,γ-tocopherol,γ-tocopherol,Blood,5,weeks,5,42,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 2,Moderate-Fat diet,NA,PP,Summary,Outcome,Nutrient bioavailability,δ-tocopherol,δ-tocopherol,δ-tocopherol,Blood,5,weeks,5,42,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Avocado Diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ester transfer protein,Cholesterol ester transfer protein,CETP,Blood,5,weeks,5,43,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Avocado Diet,NA,PP,Within,Outcome,Lipids,Lecithin cholesterol acyltransferase,Lecithin cholesterol acyltransferase,LCAT,Blood,5,weeks,5,43,Mean,% change,NA,NA,NA,NA,NA,SD,% change,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Avocado Diet,NA,PP,Summary,Outcome,Lipids,Phosopholipid transfer protein,Phosopholipid transfer protein,PLTP,Blood,5,weeks,5,43,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ester transfer protein,Cholesterol ester transfer protein,CETP,Blood,2,weeks,2,45,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Lecithin cholesterol acyltransferase,Lecithin cholesterol acyltransferase,LCAT,Blood,2,weeks,2,45,Mean,% change,NA,NA,NA,NA,NA,SD,% change,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Phosopholipid transfer protein,Phosopholipid transfer protein,PLTP,Blood,2,weeks,2,45,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Lower-Fat diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ester transfer protein,Cholesterol ester transfer protein,CETP,Blood,5,weeks,5,43,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Lower-Fat diet,NA,PP,Within,Outcome,Lipids,Lecithin cholesterol acyltransferase,Lecithin cholesterol acyltransferase,LCAT,Blood,5,weeks,5,43,Mean,% change,NA,NA,NA,NA,NA,SD,% change,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Lower-Fat diet,NA,PP,Summary,Outcome,Lipids,Phosopholipid transfer protein,Phosopholipid transfer protein,PLTP,Blood,5,weeks,5,43,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Moderate-Fat diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ester transfer protein,Cholesterol ester transfer protein,CETP,Blood,5,weeks,5,42,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Moderate-Fat diet,NA,PP,Within,Outcome,Lipids,Lecithin cholesterol acyltransferase,Lecithin cholesterol acyltransferase,LCAT,Blood,5,weeks,5,42,Mean,% change,NA,NA,NA,NA,NA,SD,% change,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3,Moderate-Fat diet,NA,PP,Summary,Outcome,Lipids,Phosopholipid transfer protein,Phosopholipid transfer protein,PLTP,Blood,5,weeks,5,42,Mean,pmol/(µL·h),NA,NA,NA,NA,NA,SD,pmol/(µL·h),NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Immune,CRP,hsCRP,hsCRP,NA,,NA,,45,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,45,Mean,mg/dL,48.7,1.8,12.1,36.6,60.8,SD,mg/dL,48.7,48,45,40,1.80376,12.1,36.6,60.8,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,45,Median,µIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,45,Mean,mg/dL,128.1,3.89,26.1,102,154.2,SD,mg/dL,128.1,128,125,120,3.89076,26.1,102,154.2,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,TC,NA,,NA,,45,Mean,mg/dL,199.9,4.83,32.4,167.5,232.3,SD,mg/dL,199.9,199,195,190,4.82991,32.4,167.5,232.3,NA
1,Wang 2020,Intervention,NCT01235832,Table 3 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,TG,NA,,NA,,45,Mean,mg/dL,114,5.9,39.6,74.4,153.6,SD,mg/dL,114,114,110,110,5.90322,39.6,74.4,153.6,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk < 5%,ASCVD 10yr risk < 5%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk 10-20%,ASCVD 10yr risk 10-20%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk 5-10%,ASCVD 10yr risk 5-10%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 10-30%,ASCVD lifetime risk 10-30%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 30-50%,ASCVD lifetime risk 30-50%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 5-10%,ASCVD lifetime risk 5-10%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 0","MetS risk factors, 0",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 1-2","MetS risk factors, 1-2",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
1,Wang 2020,Intervention,NCT01235832,Table 4 Wang 2015,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 3-4","MetS risk factors, 3-4",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Avocado added,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 3h,Glucose AUC 3hrs,Blood,,NA,,7,Mean,min x mg/dl,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Avocado added,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 3h,Insulin AUC 3hrs,Blood,,NA,,7,Mean,min x uIU/ml,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Avocado inclusive,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 3h,Glucose AUC 3hrs,Blood,,NA,,9,Mean,min x mg/dl,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Avocado inclusive,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 3h,Insulin AUC 3hrs,Blood,,NA,,9,Mean,min x uIU/ml,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 3h,Glucose AUC 3hrs,Blood,,NA,,10,Mean,min x mg/dl,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 1,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 3h,Insulin AUC 3hrs,Blood,,NA,,10,Mean,min x uIU/ml,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 5h,Desire AUC 5hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 5h,Fullness AUC 5hrs,NA,,NA,,7,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 5h,Hungry AUC 5hrs,NA,,NA,,7,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 5h,How much AUC 5hrs,NA,,NA,,7,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 5h,Satisfied AUC 5hrs,NA,,NA,,7,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 5h,Desire AUC 5hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 5h,Fullness AUC 5hrs,NA,,NA,,9,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 5h,Hungry AUC 5hrs,NA,,NA,,9,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 5h,How much AUC 5hrs,NA,,NA,,9,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 5h,Satisfied AUC 5hrs,NA,,NA,,9,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 5h,Desire AUC 5hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 5h,Fullness AUC 5hrs,NA,,NA,,10,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Control,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 5h,Hungry AUC 5hrs,NA,,NA,,10,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 5h,How much AUC 5hrs,NA,,NA,,10,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Figure 2,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 5h,Satisfied AUC 5hrs,NA,,NA,,10,Mean,min x mm,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,26,Mean,years,40.8,2.16,11,29.8,51.8,SD,years,40.8,40,40,40,2.15728,11,29.8,51.8,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,26,Mean,kg/m^2,28.1,0.47,2.4,25.7,30.5,SD,kg/m^2,28.1,28,25,20,0.470679,2.4,25.7,30.5,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,26,Count,Count,16,,,,,NA,Count,16,16,15,10,,,,,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,26,Percentage,%,61.5385,,,,,NA,%,61.5385,61,60,60,,,,,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,26,Count,Count,10,,,,,NA,Count,10,10,10,10,,,,,NA
2,Wien 2013,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,26,Percentage,%,38.4615,,,,,NA,%,38.4615,38,35,30,,,,,NA
2,Wien 2013,Intervention,NCT01271829,Results section,Avocado added,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,67.5,,,50,90,"min,max",g/test meal,67.5,67,65,60,,,50,90,NA
2,Wien 2013,Intervention,NCT01271829,Results section,Avocado inclusive,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,67.5,,,50,90,"min,max",g/test meal,67.5,67,65,60,,,50,90,NA
2,Wien 2013,Intervention,NCT01271829,Results section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 3h,Desire question AUC 3hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 3h,Fullness question AUC 3hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 3h,Hunger question AUC 3hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 3h,Intake question AUC 3hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 3h,Satisfaction question AUC 3hrs,NA,,NA,,7,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 3h,Desire question AUC 3hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 3h,Fullness question AUC 3hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 3h,Hunger question AUC 3hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 3h,Intake question AUC 3hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 3h,Satisfaction question AUC 3hrs,NA,,NA,,9,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question AUC 3h,Desire question AUC 3hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question AUC 3h,Fullness question AUC 3hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Control,NA,PP,Summary,Outcome,Satiety,Hunger question,Hunger question AUC 3h,Hunger question AUC 3hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question AUC 3h,Intake question AUC 3hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
2,Wien 2013,Intervention,NCT01271829,Table 2,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question AUC 3h,Satisfaction question AUC 3hrs,NA,,NA,,10,Mean,mm x min,NA,NA,NA,NA,NA,SD,mm per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 2,Control,NA,PP,Summary,Outcome,Microbiome,Faith phylogenetic diversity,Faith phylogenetic diversity,Faith phylogenetic diversity,Fecal,12,weeks,12,54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 2,Treatment,NA,PP,Summary,Outcome,Microbiome,Faith phylogenetic diversity,Faith phylogenetic diversity,Faith phylogenetic diversity,Fecal,12,weeks,12,55,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,54,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Treatment,Female,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,36,Absolute value,g/d,140,,,,,NA,g/d,140,140,140,140,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Treatment,Male,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,19,Absolute value,g/d,175,,,,,NA,g/d,175,175,175,170,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Control,NA,ITT,Summary,Outcome,Fecal acids,Acetate,Acetate,Acetate,Fecal,12,weeks,12,78,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Control,NA,ITT,Summary,Outcome,Fecal acids,Butyrate,Butyrate,Butyrate,Fecal,12,weeks,12,78,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Control,NA,ITT,Summary,Outcome,Fecal acids,Propionate,Propionate,Propionate,Fecal,12,weeks,12,78,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Control,NA,ITT,Summary,Outcome,Fecal acids,Total SCFA,Total SCFA,Total SCFA,Fecal,12,weeks,12,78,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Treatment,NA,ITT,Summary,Outcome,Fecal acids,Acetate,Acetate,Acetate,Fecal,12,weeks,12,79,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Treatment,NA,ITT,Summary,Outcome,Fecal acids,Butyrate,Butyrate,Butyrate,Fecal,12,weeks,12,79,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Treatment,NA,ITT,Summary,Outcome,Fecal acids,Propionate,Propionate,Propionate,Fecal,12,weeks,12,79,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Fig 3,Treatment,NA,ITT,Summary,Outcome,Fecal acids,Total SCFA,Total SCFA,Total SCFA,Fecal,12,weeks,12,79,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Total CHO,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,12,weeks,12,78,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Total DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble Fiber,Insoluble DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble Fiber,Soluble DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Total PRO,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Control,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Total CHO,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,12,weeks,12,78,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Total DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble Fiber,Insoluble DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble Fiber,Soluble DF,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Total PRO,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supp Table 3,Treatment,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,12,weeks,12,78,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Chenodeoxycholic acid,Chenodeoxycholic acid,Chenodeoxycholic acid,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Cholic acid,Cholic acid,Cholic acid,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Deoxycholic acid,Deoxycholic acid,Deoxycholic acid,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Lithocholic acid,Lithocholic acid,Lithocholic acid,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Primary bile acid sum,Primary bile acid sum,Primary bile acid sum,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Secondary bile acid sum,Secondary bile acid sum,Secondary bile acid sum,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Control,NA,PP,Summary,Outcome,Bile acids,Total bile acid sum,Total bile acid sum,Total bile acid sum,Fecal,12,weeks,12,44,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Chenodeoxycholic acid,Chenodeoxycholic acid,Chenodeoxycholic acid,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Cholic acid,Cholic acid,Cholic acid,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Deoxycholic acid,Deoxycholic acid,Deoxycholic acid,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Lithocholic acid,Lithocholic acid,Lithocholic acid,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Primary bile acid sum,Primary bile acid sum,Primary bile acid sum,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Secondary bile acid sum,Secondary bile acid sum,Secondary bile acid sum,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 1,Treatment,NA,PP,Summary,Outcome,Bile acids,Total bile acid sum,Total bile acid sum,Total bile acid sum,Fecal,12,weeks,12,46,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Arachidic acid,Arachidic acid,Arachidic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Behenic acid,Behenic acid,Behenic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Lignoceric acid,Lignoceric acid,Lignoceric acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Palmitic acid,Palmitic acid,Palmitic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Stearic acid,Stearic acid,Stearic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,PP,Summary,Outcome,Fecal acids,Vaccenic acid,Vaccenic acid,Vaccenic acid,Fecal,12,weeks,12,19,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Arachidic acid,Arachidic acid,Arachidic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Behenic acid,Behenic acid,Behenic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Lignoceric acid,Lignoceric acid,Lignoceric acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Palmitic acid,Palmitic acid,Palmitic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Stearic acid,Stearic acid,Stearic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,NA,PP,Summary,Outcome,Fecal acids,Vaccenic acid,Vaccenic acid,Vaccenic acid,Fecal,12,weeks,12,27,Mean,mg/100mg dry feces,NA,NA,NA,NA,NA,SD,mg/100mg dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 4,Control,NA,ITT,Summary,Outcome,Microbiome,Gut microbiota,Fecal bacteria,Fecal bacteria,Fecal,12,weeks,12,78,NA,relative abundance,NA,NA,NA,NA,NA,NA,relative abundance,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 4,Treatment,NA,ITT,Summary,Outcome,Microbiome,Gut microbiota,Fecal bacteria,Fecal bacteria,Fecal,12,weeks,12,79,NA,relative abundance,NA,NA,NA,NA,NA,NA,relative abundance,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Chenodeoxycholic acid,Chenodeoxycholic acid,Chenodeoxycholic acid,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Cholic acid,Cholic acid,Cholic acid,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Deoxycholic acid,Deoxycholic acid,Deoxycholic acid,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Lithocholic acid,Lithocholic acid,Lithocholic acid,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Primary bile acid sum,Primary bile acid sum,Primary bile acid sum,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Secondary bile acid sum,Secondary bile acid sum,Secondary bile acid sum,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Control,NA,ITT,Summary,Outcome,Bile acids,Total bile acid sum,Total bile acid sum,Total bile acid sum,Fecal,12,weeks,12,62,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Chenodeoxycholic acid,Chenodeoxycholic acid,Chenodeoxycholic acid,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Cholic acid,Cholic acid,Cholic acid,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Deoxycholic acid,Deoxycholic acid,Deoxycholic acid,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Lithocholic acid,Lithocholic acid,Lithocholic acid,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Primary bile acid sum,Primary bile acid sum,Primary bile acid sum,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Secondary bile acid sum,Secondary bile acid sum,Secondary bile acid sum,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 5,Treatment,NA,ITT,Summary,Outcome,Bile acids,Total bile acid sum,Total bile acid sum,Total bile acid sum,Fecal,12,weeks,12,63,Mean,ug/g dry feces,NA,NA,NA,NA,NA,SD,μg/g dry feces,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,157,Mean,years,35,0.5,6.26,28.74,41.26,SD,years,35,35,35,30,0.5,6.26498,28.735,41.265,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,157,Mean,kg/m^2,32.8,0.5,6.26,26.54,39.06,SD,kg/m^2,32.8,32,30,30,0.5,6.26498,26.535,39.065,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,Subcutaneous abdominal adiposity,NA,,NA,,157,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Visceral adipose tissue,Visceral abdominal adiposity,NA,,NA,,157,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,157,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic identity,NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic identity,NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, African American",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, African American",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian or Alaskan Native",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian or Alaskan Native",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asia",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asia",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, Mixed race",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, Mixed race",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,157,Count,Count,100,,,,,NA,Count,100,100,100,100,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,157,Percentage,%,63.6943,,,,,NA,%,63.6943,63,60,60,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,157,Count,Count,57,,,,,NA,Count,57,57,55,50,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,157,Percentage,%,36.3057,,,,,NA,%,36.3057,36,35,30,,,,,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI, 30-34.9",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI, 30-34.9",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,"BMI, 35-39.9",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,"BMI, 35-39.9",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,"BMI, >=40",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,"BMI, >=40",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,157,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,157,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Total CHO,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,12,weeks,12,52,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total DF,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Insoluble Fiber,Insoluble DF,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Soluble Fiber,Soluble DF,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Total PRO,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,12,weeks,12,52,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Total CHO,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,12,weeks,12,54,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total DF,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fiber,Fiber,Insoluble Fiber,Insoluble DF,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fiber,Fiber,Soluble Fiber,Soluble DF,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Total PRO,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,NA,PP,Summary,Outcome,Microbiome,Gut microbiota,Fecal bacteria,Fecal bacteria,Fecal,12,weeks,12,54,NA,relative abundance,NA,NA,NA,NA,NA,NA,relative abundance,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,NA,PP,Summary,Outcome,Microbiome,Gut microbiota,Fecal bacteria,Fecal bacteria,Fecal,12,weeks,12,55,NA,relative abundance,NA,NA,NA,NA,NA,NA,relative abundance,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Acetate,Acetate,Acetate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Butyrate,Butyrate,Butyrate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Isobutyrate,Isobutyrate,Isobutyrate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Isovalerate,Isovalerate,Isovalerate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Propionate,Propionate,Propionate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,SCFA:BCFA,SCFA:BCFA,SCFA:BCFA,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Summed BCFAs,Summed BCFAs,Summed BCFAs,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Summed SCFAs,Summed SCFAs,Summed SCFAs,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Control,NA,PP,Summary,Outcome,Fecal acids,Valerate,Valerate,Valerate,Fecal,12,weeks,12,52,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Acetate,Acetate,Acetate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Butyrate,Butyrate,Butyrate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Isobutyrate,Isobutyrate,Isobutyrate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Isovalerate,Isovalerate,Isovalerate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Propionate,Propionate,Propionate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,SCFA:BCFA,SCFA:BCFA,SCFA:BCFA,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Summed BCFAs,Summed BCFAs,Summed BCFAs,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Summed SCFAs,Summed SCFAs,Summed SCFAs,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
3,Thompson 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 5,Treatment,NA,PP,Summary,Outcome,Fecal acids,Valerate,Valerate,Valerate,Fecal,12,weeks,12,54,Mean,umol/g,NA,NA,NA,NA,NA,SD,μmol/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 1,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters,Retinyl esters,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 1,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 1,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters,Retinyl esters,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 1,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters,Retinyl esters,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters,Retinyl esters,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 2,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,12,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Vitamin A conversion,Vitamin A conversion,Vitamin A conversion,Blood,,NA,,11,NA,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Figure 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Vitamin A conversion,Vitamin A conversion,Vitamin A conversion,Blood,,NA,,11,NA,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Methods section,Carrot + avo,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Absolute value,g per test meal,150,,,,,NA,g/test meal,150,150,150,150,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Methods section,Carrot alone,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Methods section,Sauce + avo,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,150,,,,,NA,g/test meal,150,150,150,150,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Methods section,Sauce alone,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Female,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,28.5,2.04,5,23.5,33.5,SD,years,28.5,28,25,20,2.04124,5,23.5,33.5,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Male,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,27.2,1.63,4,23.2,31.2,SD,years,27.2,27,25,20,1.63299,4,23.2,31.2,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Female,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,23.1,1.1,2.7,20.4,25.8,SD,kg/m^2,23.1,23,20,20,1.10227,2.7,20.4,25.8,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Male,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,25.3,0.98,2.4,22.9,27.7,SD,kg/m^2,25.3,25,25,20,0.979796,2.4,22.9,27.7,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,All,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,12,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,All,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,12,Percentage,%,50,,,,,NA,%,50,50,50,50,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,All,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,12,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,All,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,12,Percentage,%,50,,,,,NA,%,50,50,50,50,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Female,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Plasma TC,NA,,NA,,6,Mean,mg/dL,172,6.04,14.8,157.2,186.8,SD,mg/dL,172,172,170,170,6.04207,14.8,157.2,186.8,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Male,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Plasma TC,NA,,NA,,6,Mean,mg/dL,166,12.74,31.2,134.8,197.2,SD,mg/dL,166,166,165,160,12.7373,31.2,134.8,197.2,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Female,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma TG,NA,,NA,,6,Mean,mg/dL,59.2,12.17,29.8,29.4,89,SD,mg/dL,59.2,59,55,50,12.1658,29.8,29.4,89,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Carrot study,Male,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma TG,NA,,NA,,6,Mean,mg/dL,88.3,35.76,87.6,0.7,175.9,SD,mg/dL,88.3,88,85,80,35.7626,87.6,0.7,175.9,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Female,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,5,Mean,years,24.6,2.06,4.6,20,29.2,SD,years,24.6,24,20,20,2.05718,4.6,20,29.2,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Male,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,26.7,2.04,5,21.7,31.7,SD,years,26.7,26,25,20,2.04124,5,21.7,31.7,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Female,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,5,Mean,kg/m^2,22.4,1.48,3.3,19.1,25.7,SD,kg/m^2,22.4,22,20,20,1.4758,3.3,19.1,25.7,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Male,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,25.8,0.9,2.2,23.6,28,SD,kg/m^2,25.8,25,25,20,0.898146,2.2,23.6,28,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,All,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,11,Count,Count,5,,,,,NA,Count,5,5,5,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,All,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,11,Percentage,%,45.4545,,,,,NA,%,45.4545,45,45,40,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,All,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,11,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,All,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,11,Percentage,%,54.5455,,,,,NA,%,54.5455,54,50,50,,,,,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Female,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Plasma TC,NA,,NA,,5,Mean,mg/dL,167,11.05,24.7,142.3,191.7,SD,mg/dL,167,167,165,160,11.0462,24.7,142.3,191.7,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Male,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Plasma TC,NA,,NA,,6,Mean,mg/dL,151,10.98,26.9,124.1,177.9,SD,mg/dL,151,151,150,150,10.9819,26.9,124.1,177.9,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Female,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma TG,NA,,NA,,5,Mean,mg/dL,79.2,19.19,42.9,36.3,122.1,SD,mg/dL,79.2,79,75,70,19.1855,42.9,36.3,122.1,NA
4,Kopec 2014,Intervention,NCT01432210,Table 1,Sauce study,Male,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma TG,NA,,NA,,6,Mean,mg/dL,107,26.58,65.1,41.9,172.1,SD,mg/dL,107,107,105,100,26.577,65.1,41.9,172.1,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 12h,Lutein AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 12h,Lycopene AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Phylloquinone,Phylloquinone AUC 12h,Phylloquinone AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters AUC 12h,Retinyl esters AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 12h,α-carotene AUC 12hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol AUC 12h,α-tocopherol AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 12h,β-carotene AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 12h,Lutein AUC 12hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 12h,Lycopene AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Phylloquinone,Phylloquinone AUC 12h,Phylloquinone AUC 12hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters AUC 12h,Retinyl esters AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 12h,α-carotene AUC 12hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol AUC 12h,α-tocopherol AUC 12hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 3,Sauce alone,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 12h,β-carotene AUC 12hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 12h,Lutein AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 12h,Lycopene AUC 12hrs,Blood,,NA,,12,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Phylloquinone,Phylloquinone AUC 12h,Phylloquinone AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters AUC 12h,Retinyl esters AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 12h,α-carotene AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol AUC 12h,α-tocopherol AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot + avo,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 12h,β-carotene AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 12h,Lutein AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 12h,Lycopene AUC 12hrs,Blood,,NA,,12,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Phylloquinone,Phylloquinone AUC 12h,Phylloquinone AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,Retinyl esters,Retinyl esters AUC 12h,Retinyl esters AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 12h,α-carotene AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,α-tocopherol,α-tocopherol AUC 12h,α-tocopherol AUC 12hrs,Blood,,NA,,12,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
4,Kopec 2014,Intervention,NCT01432210,Table 4,Carrot alone,NA,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 12h,β-carotene AUC 12hrs,Blood,,NA,,12,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Methods section,Treatment,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Average,g/d,135,,,,,NA,g/d,135,135,135,130,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Dietary CHO,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Dietary fat,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Dietary lutein/zeaxanthin,NA,0,weeks,0,20,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,Dietary MUFA,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Dietary PRO,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,20,Mean,years,62.5,2.06,9.2,53.3,71.7,SD,years,62.5,62,60,60,2.05718,9.2,53.3,71.7,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,24.2,0.54,2.4,21.8,26.6,SD,kg/m^2,24.2,24,20,20,0.536656,2.4,21.8,26.6,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Education college or greater,NA,,NA,,20,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,"Sex, female",NA,,NA,,20,Percentage,%,55,,,,,NA,%,55,55,55,50,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,"Sex, male",NA,,NA,,20,Percentage,%,45,,,,,NA,%,45,45,45,40,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Dietary CHO,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Dietary fat,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Dietary,Carotenoids,Lutein & Zeaxanthin,Lutein & Zeaxanthin,Dietary lutein/zeaxanthin,NA,0,weeks,0,20,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,Dietary MUFA,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Dietary PRO,NA,0,weeks,0,20,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,20,Mean,years,63.3,2.48,11.1,52.2,74.4,SD,years,63.3,63,60,60,2.48204,11.1,52.2,74.4,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,24.1,0.69,3.1,21,27.2,SD,kg/m^2,24.1,24,20,20,0.693181,3.1,21,27.2,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Education college or greater,NA,,NA,,20,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,"Sex, female",NA,,NA,,20,Percentage,%,70,,,,,NA,%,70,70,70,70,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Table 2,Treatment,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,"Sex, male",NA,,NA,,20,Percentage,%,30,,,,,NA,%,30,30,30,30,,,,,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,3,months,12,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,6,months,24,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,0,weeks,0,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,3,months,12,19,Mean,mg/dL,56,3.21,14,42,70,SD,mg/dL,56,56,55,50,3.21182,14,42,70,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,6,months,24,19,Mean,mg/dL,57,4.13,18,39,75,SD,mg/dL,57,57,55,50,4.12948,18,39,75,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,0,weeks,0,19,Mean,mg/dL,58,3.67,16,42,74,SD,mg/dL,58,58,55,50,3.67065,16,42,74,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,3,months,12,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,6,months,24,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,0,weeks,0,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,3,months,12,19,Mean,mg/dL,137,8.49,37,100,174,SD,mg/dL,137,137,135,130,8.48838,37,100,174,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,6,months,24,19,Mean,mg/dL,137,10.32,45,92,182,SD,mg/dL,137,137,135,130,10.3237,45,92,182,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,0,weeks,0,19,Mean,mg/dL,132,8.49,37,95,169,SD,mg/dL,132,132,130,130,8.48838,37,95,169,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,3,months,12,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,6,months,24,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,0,weeks,0,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,3,months,12,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,6,months,24,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,0,weeks,0,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,3,months,12,19,Mean,mg/dL,209,9.64,42,167,251,SD,mg/dL,209,209,205,200,9.63546,42,167,251,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,6,months,24,19,Mean,mg/dL,205,12.39,54,151,259,SD,mg/dL,205,205,205,200,12.3884,54,151,259,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,0,weeks,0,19,Mean,mg/dL,200,10.55,46,154,246,SD,mg/dL,200,200,200,200,10.5531,46,154,246,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,19,Mean,mg/dL,94,19.27,84,10,178,SD,mg/dL,94,94,90,90,19.2709,84,10,178,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,19,Mean,mg/dL,93,13.31,58,35,151,SD,mg/dL,93,93,90,90,13.3061,58,35,151,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,19,Mean,mg/dL,84,12.62,55,29,139,SD,mg/dL,84,84,80,80,12.6179,55,29,139,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,3,months,12,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,6,months,24,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,0,weeks,0,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,3,months,12,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,6,months,24,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Control,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,0,weeks,0,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,3,months,12,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,6,months,24,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,CRP,Blood,0,weeks,0,19,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,3,months,12,19,Mean,mg/dL,61,5.28,23,38,84,SD,mg/dL,61,61,60,60,5.27656,23,38,84,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,6,months,24,19,Mean,mg/dL,61,5.05,22,39,83,SD,mg/dL,61,61,60,60,5.04715,22,39,83,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL,Blood,0,weeks,0,19,Mean,mg/dL,57,4.82,21,36,78,SD,mg/dL,57,57,55,50,4.81773,21,36,78,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,3,months,12,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,6,months,24,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Antioxidation,LDL ox lag time,LDL ox lag time,LDL ox lag time,Blood,0,weeks,0,19,Mean,min,NA,NA,NA,NA,NA,SD,min,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,3,months,12,19,Mean,mg/dL,135,8.49,37,98,172,SD,mg/dL,135,135,135,130,8.48838,37,98,172,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,6,months,24,19,Mean,mg/dL,131,5.74,25,106,156,SD,mg/dL,131,131,130,130,5.73539,25,106,156,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL,Blood,0,weeks,0,19,Mean,mg/dL,129,9.86,43,86,172,SD,mg/dL,129,129,125,120,9.86488,43,86,172,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,3,months,12,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,6,months,24,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,0,weeks,0,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,3,months,12,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,6,months,24,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,MPD,NA,0,weeks,0,20,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,3,months,12,19,Mean,mg/dL,224,12.85,56,168,280,SD,mg/dL,224,224,220,220,12.8473,56,168,280,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,6,months,24,19,Mean,mg/dL,209,9.86,43,166,252,SD,mg/dL,209,209,205,200,9.86488,43,166,252,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Cholesterol,Blood,0,weeks,0,19,Mean,mg/dL,219,11.93,52,167,271,SD,mg/dL,219,219,215,210,11.9296,52,167,271,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,19,Mean,mg/dL,99,18.81,82,17,181,SD,mg/dL,99,99,95,90,18.8121,82,17,181,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,19,Mean,mg/dL,79,13.08,57,22,136,SD,mg/dL,79,79,75,70,13.0767,57,22,136,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,19,Mean,mg/dL,86,14.68,64,22,150,SD,mg/dL,86,86,85,80,14.6826,64,22,150,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,3,months,12,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,6,months,24,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Nutrient bioavailability,Zeaxanthin,Zeaxanthin,Zeaxanthin,Blood,0,weeks,0,19,Mean,nmol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,3,months,12,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,6,months,24,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 3,Treatment,NA,ITT,Summary,Outcome,Immune,β-amyloid,β-amyloid,β-amyloid,Blood,0,weeks,0,19,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,3,months,12,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,6,months,24,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,0,weeks,0,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,3,months,12,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,6,months,24,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,0,weeks,0,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,3,months,12,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,6,months,24,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,0,weeks,0,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,3,months,12,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,6,months,24,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,0,weeks,0,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,3,months,12,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,6,months,24,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,0,weeks,0,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,3,months,12,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,6,months,24,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,0,weeks,0,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,3,months,12,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,6,months,24,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,0,weeks,0,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,3,months,12,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,6,months,24,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Control,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,0,weeks,0,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,3,months,12,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,6,months,24,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Choice reaction time,Choice reaction time,CRT,NA,0,weeks,0,20,Mean,msec,NA,NA,NA,NA,NA,SD,msec,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,3,months,12,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,6,months,24,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Delayed matching to sample,Delayed matching to sample,DMS,NA,0,weeks,0,20,Mean,% correct all delays,NA,NA,NA,NA,NA,SD,% correct all delays,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,3,months,12,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,6,months,24,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Paired associates learning,Paired associates learning,PAL,NA,0,weeks,0,20,Mean,total errors,NA,NA,NA,NA,NA,SD,total errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,3,months,12,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,6,months,24,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Rapid visual information processing,Rapid visual information processing,RVIP,NA,0,weeks,0,20,Mean,signal detection,NA,NA,NA,NA,NA,SD,signal detection,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,3,months,12,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,6,months,24,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span forward,Spatial span forward,SS Forward,NA,0,weeks,0,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,3,months,12,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,6,months,24,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial span reverse,Spatial span reverse,SS Reverse,NA,0,weeks,0,20,Mean,highest span,NA,NA,NA,NA,NA,SD,highest span,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,3,months,12,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,6,months,24,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Spatial working memory,Spatial working memory,SWM,NA,0,weeks,0,20,Mean,errors,NA,NA,NA,NA,NA,SD,errors,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,3,months,12,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,6,months,24,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
5,Scott 2017,Intervention,NCT01621646,Table 4,Treatment,NA,ITT,Summary,Outcome,Cognition,Stockings of Cambridge,Stockings of Cambridge,SOC,NA,0,weeks,0,20,Mean,nr completed in min moves,NA,NA,NA,NA,NA,SD,nr completed in min moves,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Control Meal,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,31,NA,mmol/L,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Control Meal,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,,NA,,31,NA,pmol/L,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Half Avocado Meal,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,31,NA,mmol/L,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Half Avocado Meal,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,,NA,,31,NA,pmol/L,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,31,NA,mmol/L,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,,NA,,31,NA,pmol/L,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 4,Control Meal,NA,PP,Summary,Outcome,CVD risk factors,Vasodilation,Flow-mediated vasodilation,Flow-mediated vasodilation,Plasma,,NA,,23,NA,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 4,Half Avocado Meal,NA,PP,Summary,Outcome,CVD risk factors,Vasodilation,Flow-mediated vasodilation,Flow-mediated vasodilation,Plasma,,NA,,23,NA,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Figure 4,Whole Avocado Meal,NA,PP,Summary,Outcome,CVD risk factors,Vasodilation,Flow-mediated vasodilation,Flow-mediated vasodilation,Plasma,,NA,,23,NA,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Methods section,Control meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
6,Park 2018,Intervention,NCT02479048,Methods section,Half avocado meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,68,,,,,NA,g/test meal,68,68,65,60,,,,,NA
6,Park 2018,Intervention,NCT02479048,Methods section,Whole avocado meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,136,,,,,NA,g/test meal,136,136,135,130,,,,,NA
6,Park 2018,Intervention,NCT02479048,Supplementary Figure 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL particle concentration,Blood,,NA,,31,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Supplementary Figure 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL particle concentration,Blood,,NA,,31,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,31,Mean,years,37.9,1.85,10.3,27.6,48.2,SD,years,37.9,37,35,30,1.84993,10.3,27.6,48.2,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,31,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,31,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,31,Mean,kg/m^2,29,0.43,2.4,26.6,31.4,SD,kg/m^2,29,29,25,20,0.431053,2.4,26.6,31.4,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Mid-point waist circumference,NA,,NA,,31,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Venous fasting glucose concentration,NA,,NA,,31,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Metabolic,Insulin,Fasting insulin,Venous fasting insulin concentration,NA,,NA,,31,Mean,pmol/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race/Ethnicity, African-American",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race/Ethnicity, African-American",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race/Ethnicity, Asian",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race/Ethnicity, Asian",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race/Ethnicity, Caucasian",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race/Ethnicity, Caucasian",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Race/Ethnicity, Hispanic",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Race/Ethnicity, Hispanic",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, Female",NA,,NA,,31,Count,Count,16,,,,,NA,Count,16,16,15,10,,,,,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, Female",NA,,NA,,31,Percentage,%,52,,,,,NA,%,52,52,50,50,,,,,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, Male",NA,,NA,,31,Count,Count,15,,,,,NA,Count,15,15,15,10,,,,,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, Male",NA,,NA,,31,Percentage,%,48,,,,,NA,%,48,48,45,40,,,,,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI Categories, Obese I",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI Categories, Obese I",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI Categories, Overweight",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 3,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI Categories, Overweight",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Large 6h","HDL Particle concentration, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Medium 6h","HDL Particle concentration, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Small 6h","HDL Particle concentration, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total 6h","HDL Particle concentration, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Large 6h","LDL Particle concentration, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Medium 6h","LDL Particle concentration, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Small 6h","LDL Particle concentration, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total 6h","LDL Particle concentration, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Large 6h","Chylomicron/VLDL Particle concentraction, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Medium 6h","Chylomicron/VLDL Particle concentraction, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Small 6h","Chylomicron/VLDL Particle concentraction, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Total 6h","Chylomicron/VLDL Particle concentraction, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, HDL 6h","Average Particle size, HDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, LDL 6h","Average Particle size, LDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Control Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, VLDL 6h","Average Particle size, VLDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Large 6h","HDL Particle concentration, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Medium 6h","HDL Particle concentration, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Small 6h","HDL Particle concentration, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total 6h","HDL Particle concentration, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Large 6h","LDL Particle concentration, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Medium 6h","LDL Particle concentration, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Small 6h","LDL Particle concentration, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total 6h","LDL Particle concentration, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Large 6h","Chylomicron/VLDL Particle concentraction, Large 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Medium 6h","Chylomicron/VLDL Particle concentraction, Medium 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Small 6h","Chylomicron/VLDL Particle concentraction, Small 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentraction, Total 6h","Chylomicron/VLDL Particle concentraction, Total 6h",Blood,,NA,,31,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, HDL 6h","Average Particle size, HDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, LDL 6h","Average Particle size, LDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
6,Park 2018,Intervention,NCT02479048,Table 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Lipids,Particle size,"Average Particle size, VLDL 6h","Average Particle size, VLDL 6h",Blood,,NA,,31,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Avocado diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,43,Average,g/d,136,,,,,NA,g/d,136,136,135,130,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,45,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,Asian,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,Asian,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,Caucasian and non-Hispanic,NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,Caucasian and non-Hispanic,NA,,NA,,45,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,45,Count,Count,18,,,,,NA,Count,18,18,15,10,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,45,Percentage,%,40,,,,,NA,%,40,40,40,40,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,45,Count,Count,27,,,,,NA,Count,27,27,25,20,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,45,Percentage,%,60,,,,,NA,%,60,60,60,60,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Lower-Fat,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,43,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Methods section,Moderate-Fat,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,42,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,43,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,43,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,"Total fat, MUFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,"Total fat, PUFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Avocado diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,"Total fat, SFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,45,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,"Total fat, MUFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,"Total fat, PUFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Baseline Average American Diet,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,"Total fat, SFA",NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,43,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,43,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,"Total fat, MUFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,"Total fat, PUFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Lower-Fat,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,"Total fat, SFA",NA,,NA,,43,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,42,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,42,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,"Total fat, MUFA",NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,"Total fat, PUFA",NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 1,Moderate-Fat,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,"Total fat, SFA",NA,,NA,,42,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,45,Mean,years,45,1.98,13.3,21,70,"min,max",years,45,45,45,40,1.98265,13.3,21,70,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,45,Mean,kg/m^2,28.2,0.36,2.4,25,35,"min,max",kg/m^2,28.2,28,25,20,0.357771,2.4,25,35,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Immune,CRP,hsCRP,hsCRP,NA,,NA,,45,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,45,Mean,mg/dL,48.7,1.8,12.1,36.6,60.8,SD,mg/dL,48.7,48,45,40,1.80376,12.1,36.6,60.8,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,45,Median,µIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,45,Mean,mg/dL,128.1,3.89,26.1,102,154.2,SD,mg/dL,128.1,128,125,120,3.89076,26.1,102,154.2,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,TC,NA,,NA,,45,Mean,mg/dL,199.9,4.83,32.4,167.5,232.3,SD,mg/dL,199.9,199,195,190,4.82991,32.4,167.5,232.3,NA
8,Wang 2015,Intervention,NCT01235832,Table 3,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,TG,NA,,NA,,45,Mean,mg/dL,114,5.9,39.6,74.4,153.6,SD,mg/dL,114,114,110,110,5.90322,39.6,74.4,153.6,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk < 5%,ASCVD 10yr risk < 5%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk 10-20%,ASCVD 10yr risk 10-20%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD 10yr risk 5-10%,ASCVD 10yr risk 5-10%,NA,,NA,,26,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 10-30%,ASCVD lifetime risk 10-30%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 30-50%,ASCVD lifetime risk 30-50%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Subject Characteristics,Health status,Cardiovascular diseases,ASCVD lifetime risk 5-10%,ASCVD lifetime risk 5-10%,NA,,NA,,39,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 0","MetS risk factors, 0",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 1-2","MetS risk factors, 1-2",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 4,Baseline Average American Diet,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,"MetS risk factors, 3-4","MetS risk factors, 3-4",NA,,NA,,45,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,"Apolipoproteins, ApoA1",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB,"Apolipoproteins, ApoB",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB:ApoA1,"Apolipoproteins, ApoB:ApoA1",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,Apolipoprotein A,"Cholesterol, LP(a)",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,5,weeks,5,43,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,5,weeks,5,43,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,"Lipoprotein ratios, LDL:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,TG:HDL-C,"Lipoprotein ratios, TG:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,"Lipoprotein ratios, TC:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,"Cholesterol, HDL-C",Blood,5,weeks,5,43,Mean,mg/dL,46.9,1.6,10.49,36.41,57.39,SD,mg/dL,46.9,46,45,40,1.6,10.4919,36.4081,57.3919,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA,Blood,5,weeks,5,43,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C,"Cholesterol, IDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,5,weeks,5,43,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,"Cholesterol, LDL-C",Blood,5,weeks,5,43,Mean,mg/dL,113.7,3.4,22.3,91.4,136,SD,mg/dL,113.7,113,110,110,3.4,22.2953,91.4047,135.995,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Non HDL-C,Non HDL-C,"Cholesterol, Non-HDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,5,weeks,5,43,Mean,mg/dL,182.2,4.3,28.2,154,210.4,SD,mg/dL,182.2,182,180,180,4.3,28.197,154.003,210.397,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,5,weeks,5,43,Mean,mg/dL,108.6,7.2,47.21,61.39,155.81,SD,mg/dL,108.6,108,105,100,7.2,47.2136,61.3864,155.814,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Avocado diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,"Cholesterol, VLDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,"Lipoprotein ratios, LDL:HDL-C",Blood,2,weeks,2,45,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,TG:HDL-C,"Lipoprotein ratios, TG:HDL-C",Blood,2,weeks,2,45,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,"Lipoprotein ratios, TC:HDL-C",Blood,2,weeks,2,45,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,2,weeks,2,45,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA,Blood,2,weeks,2,45,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,2,weeks,2,45,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,2,weeks,2,45,Mean,mg/dL,114,5.9,39.58,74.42,153.58,SD,mg/dL,114,114,110,110,5.9,39.5784,74.4216,153.578,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,"Apolipoproteins, ApoA1",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB,"Apolipoproteins, ApoB",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB:ApoA1,"Apolipoproteins, ApoB:ApoA1",Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,Apolipoprotein A,"Cholesterol, LP(a)",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,5,weeks,5,43,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,5,weeks,5,43,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,"Lipoprotein ratios, LDL:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,TG:HDL-C,"Lipoprotein ratios, TG:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,"Lipoprotein ratios, TC:HDL-C",Blood,5,weeks,5,43,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,5,weeks,5,43,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,"Cholesterol, HDL-C",Blood,5,weeks,5,43,Mean,mg/dL,44.8,1.5,9.84,34.96,54.64,SD,mg/dL,44.8,44,40,40,1.5,9.83616,34.9638,54.6362,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA,Blood,5,weeks,5,43,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C,"Cholesterol, IDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,5,weeks,5,43,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,"Cholesterol, LDL-C",Blood,5,weeks,5,43,Mean,mg/dL,120.5,4.2,27.54,92.96,148.04,SD,mg/dL,120.5,120,120,120,4.2,27.5412,92.9588,148.041,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Non HDL-C,Non HDL-C,"Cholesterol, Non-HDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,5,weeks,5,43,Mean,mg/dL,190.7,5.1,33.44,157.26,224.14,SD,mg/dL,190.7,190,190,190,5.1,33.4429,157.257,224.143,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,5,weeks,5,43,Mean,mg/dL,134.3,9.8,64.26,70.04,198.56,SD,mg/dL,134.3,134,130,130,9.8,64.2629,70.0371,198.563,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Lower-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,"Cholesterol, VLDL-C",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,"Apolipoproteins, ApoA1",Blood,5,weeks,5,42,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB,"Apolipoproteins, ApoB",Blood,5,weeks,5,42,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,ApoB:ApoA1,"Apolipoproteins, ApoB:ApoA1",Blood,5,weeks,5,42,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Apolipoprotein,Apolipoprotein A,"Cholesterol, LP(a)",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,5,weeks,5,42,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,5,weeks,5,42,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,"Lipoprotein ratios, LDL:HDL-C",Blood,5,weeks,5,42,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,TG:HDL-C,"Lipoprotein ratios, TG:HDL-C",Blood,5,weeks,5,42,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,"Lipoprotein ratios, TC:HDL-C",Blood,5,weeks,5,42,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,5,weeks,5,42,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,"Cholesterol, HDL-C",Blood,5,weeks,5,42,Mean,mg/dL,47.2,1.5,9.72,37.48,56.92,SD,mg/dL,47.2,47,45,40,1.5,9.72111,37.4789,56.9211,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA,Blood,5,weeks,5,42,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C,"Cholesterol, IDL-C",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,5,weeks,5,42,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,"Cholesterol, LDL-C",Blood,5,weeks,5,42,Mean,mg/dL,119,3.7,23.98,95.02,142.98,SD,mg/dL,119,119,115,110,3.7,23.9787,95.0213,142.979,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Non HDL-C,Non HDL-C,"Cholesterol, Non-HDL-C",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,5,weeks,5,42,Mean,mg/dL,188.7,4.4,28.52,160.18,217.22,SD,mg/dL,188.7,188,185,180,4.4,28.5153,160.185,217.215,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,5,weeks,5,42,Mean,mg/dL,111.1,5.8,37.59,73.51,148.69,SD,mg/dL,111.1,111,110,110,5.8,37.5883,73.5117,148.688,NA
8,Wang 2015,Intervention,NCT01235832,Table 5,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,"Cholesterol, VLDL-C",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large",HDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium",HDL-P Medium,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small",HDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total",HDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL-P,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Large",LDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Small",LDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total",LDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large",VLDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium",VLDL-P Medium,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small",VLDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total",VLDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size HDL,"Average particle size, HDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size LDL,"Average particle size, LDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Avocado diet,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size VLDL,"Average particle size, VLDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,"Apolipoproteins, ApoA1",Blood,2,weeks,2,45,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoB,"Apolipoproteins, ApoB",Blood,2,weeks,2,45,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoB:ApoA1,"Apolipoproteins, ApoB:ApoA1",Blood,2,weeks,2,45,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,Apolipoprotein A,"Cholesterol, LP(a)",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,2,weeks,2,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,2,weeks,2,45,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"Cholesterol, HDL-C",Blood,2,weeks,2,45,Mean,mg/dL,48.7,1.8,12.07,36.63,60.77,SD,mg/dL,48.7,48,45,40,1.8,12.0748,36.6252,60.7748,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,IDL-C,IDL-C,"Cholesterol, IDL-C",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,"Cholesterol, LDL-C",Blood,2,weeks,2,45,Mean,mg/dL,128.1,3.9,26.16,101.94,154.26,SD,mg/dL,128.1,128,125,120,3.9,26.162,101.938,154.262,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Non HDL-C,Non HDL-C,"Cholesterol, Non-HDL-C",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL-P,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Large",LDL-P Large,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Small",LDL-P Small,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total",LDL-P Total,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large",VLDL-P Large,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium",VLDL-P Medium,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small",VLDL-P Small,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total",VLDL-P Total,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle size,Average particle size HDL,"Average particle size, HDL",Blood,2,weeks,2,45,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle size,Average particle size LDL,"Average particle size, LDL",Blood,2,weeks,2,45,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle size,Average particle size VLDL,"Average particle size, VLDL",Blood,2,weeks,2,45,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,2,weeks,2,45,Mean,mg/dL,199.9,4.8,32.2,167.7,232.1,SD,mg/dL,199.9,199,195,190,4.8,32.1994,167.701,232.099,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,"Cholesterol, VLDL-C",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large",HDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium",HDL-P Medium,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small",HDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total",HDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL-P,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Large",LDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Small",LDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total",LDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large",VLDL-P Large,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium",VLDL-P Medium,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small",VLDL-P Small,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total",VLDL-P Total,Blood,5,weeks,5,43,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size HDL,"Average particle size, HDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size LDL,"Average particle size, LDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size VLDL,"Average particle size, VLDL",Blood,5,weeks,5,43,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large",HDL-P Large,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium",HDL-P Medium,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small",HDL-P Small,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total",HDL-P Total,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,IDL particle concentration,IDL-P,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Large",LDL-P Large,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Small",LDL-P Small,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total",LDL-P Total,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large",VLDL-P Large,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium",VLDL-P Medium,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small",VLDL-P Small,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total",VLDL-P Total,Blood,5,weeks,5,42,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size HDL,"Average particle size, HDL",Blood,5,weeks,5,42,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size LDL,"Average particle size, LDL",Blood,5,weeks,5,42,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 6,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Particle size,Average particle size VLDL,"Average particle size, VLDL",Blood,5,weeks,5,42,Mean,nm,NA,NA,NA,NA,NA,SD,nm,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL-C, HDL2",Blood,5,weeks,5,43,Mean,mg/dL,10.8,0.6,3.93,6.87,14.73,SD,mg/dL,10.8,10,10,10,0.6,3.93446,6.86554,14.7345,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C III,"HDL-C, HDL3",Blood,5,weeks,5,43,Mean,mg/dL,36,1,6.56,29.44,42.56,SD,mg/dL,36,36,35,30,1,6.55744,29.4426,42.5574,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C I,"IDL-C, IDL1",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C II,"IDL-C, IDL2",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I,"LDL-C, LDL1",Blood,5,weeks,5,43,Mean,mg/dL,17.9,1,6.56,11.34,24.46,SD,mg/dL,17.9,17,15,10,1,6.55744,11.3426,24.4574,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I+II,"LDL-C, LDL1+2",Blood,5,weeks,5,43,Mean,mg/dL,43.2,2.9,19.02,24.18,62.22,SD,mg/dL,43.2,43,40,40,2.9,19.0166,24.1834,62.2166,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL-C, LDL2",Blood,5,weeks,5,43,Mean,mg/dL,25.4,2.2,14.43,10.97,39.83,SD,mg/dL,25.4,25,25,20,2.2,14.4264,10.9736,39.8264,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III,"LDL-C, LDL3",Blood,5,weeks,5,43,Mean,mg/dL,40,2,13.11,26.89,53.11,SD,mg/dL,40,40,40,40,2,13.1149,26.8851,53.1149,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III+IV,"LDL-C, LDL3+4",Blood,5,weeks,5,43,Mean,mg/dL,50.5,3.1,20.33,30.17,70.83,SD,mg/dL,50.5,50,50,50,3.1,20.3281,30.1719,70.8281,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL-C, LDL4",Blood,5,weeks,5,43,Mean,mg/dL,10.5,1.3,8.52,1.98,19.02,SD,mg/dL,10.5,10,10,10,1.3,8.52467,1.97533,19.0247,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,Peak max time,LDL peak max time,LDL peak max time,Blood,5,weeks,5,43,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Remnant Lp,Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C I+II,"VLDL-C, VLDL1+2",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Avocado diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C III,"VLDL-C, VLDL3",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL-C, HDL2",Blood,2,weeks,2,45,Mean,mg/dL,11.6,0.7,4.7,6.9,16.3,SD,mg/dL,11.6,11,10,10,0.7,4.69574,6.90426,16.2957,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C III,"HDL-C, HDL3",Blood,2,weeks,2,45,Mean,mg/dL,36.9,1.1,7.38,29.52,44.28,SD,mg/dL,36.9,36,35,30,1.1,7.37902,29.521,44.279,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,IDL-C,IDL-C I,"IDL-C, IDL1",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,IDL-C,IDL-C II,"IDL-C, IDL2",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C I,"LDL-C, LDL1",Blood,2,weeks,2,45,Mean,mg/dL,21.3,1.2,8.05,13.25,29.35,SD,mg/dL,21.3,21,20,20,1.2,8.04984,13.2502,29.3498,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C I+II,"LDL-C, LDL1+2",Blood,2,weeks,2,45,Mean,mg/dL,51,2.8,18.78,32.22,69.78,SD,mg/dL,51,51,50,50,2.8,18.783,32.217,69.783,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL-C, LDL2",Blood,2,weeks,2,45,Mean,mg/dL,29.7,2,13.42,16.28,43.12,SD,mg/dL,29.7,29,25,20,2,13.4164,16.2836,43.1164,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C III,"LDL-C, LDL3",Blood,2,weeks,2,45,Mean,mg/dL,44.5,2.4,16.1,28.4,60.6,SD,mg/dL,44.5,44,40,40,2.4,16.0997,28.4003,60.5997,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C III+IV,"LDL-C, LDL3+4",Blood,2,weeks,2,45,Mean,mg/dL,55,3.3,22.14,32.86,77.14,SD,mg/dL,55,55,55,50,3.3,22.1371,32.8629,77.1371,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL-C, LDL4",Blood,2,weeks,2,45,Mean,mg/dL,10.4,1.3,8.72,1.68,19.12,SD,mg/dL,10.4,10,10,10,1.3,8.72067,1.67933,19.1207,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large",HDL-P Large,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium",HDL-P Medium,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small",HDL-P Small,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total",HDL-P Total,Blood,2,weeks,2,45,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,Peak max time,LDL peak max time,LDL peak max time,Blood,2,weeks,2,45,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Remnant Lp,Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C I+II,"VLDL-C, VLDL1+2",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Baseline Average American Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C III,"VLDL-C, VLDL3",Blood,2,weeks,2,45,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL-C, HDL2",Blood,5,weeks,5,43,Mean,mg/dL,10.5,0.6,3.93,6.57,14.43,SD,mg/dL,10.5,10,10,10,0.6,3.93446,6.56554,14.4345,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C III,"HDL-C, HDL3",Blood,5,weeks,5,43,Mean,mg/dL,34.2,0.9,5.9,28.3,40.1,SD,mg/dL,34.2,34,30,30,0.9,5.90169,28.2983,40.1017,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C I,"IDL-C, IDL1",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C II,"IDL-C, IDL2",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I,"LDL-C, LDL1",Blood,5,weeks,5,43,Mean,mg/dL,19.4,1.1,7.21,12.19,26.61,SD,mg/dL,19.4,19,15,10,1.1,7.21318,12.1868,26.6132,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I+II,"LDL-C, LDL1+2",Blood,5,weeks,5,43,Mean,mg/dL,44.1,3.3,21.64,22.46,65.74,SD,mg/dL,44.1,44,40,40,3.3,21.6395,22.4605,65.7395,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL-C, LDL2",Blood,5,weeks,5,43,Mean,mg/dL,24.7,2.5,16.39,8.31,41.09,SD,mg/dL,24.7,24,20,20,2.5,16.3936,8.3064,41.0936,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III,"LDL-C, LDL3",Blood,5,weeks,5,43,Mean,mg/dL,42.2,2.3,15.08,27.12,57.28,SD,mg/dL,42.2,42,40,40,2.3,15.0821,27.1179,57.2821,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III+IV,"LDL-C, LDL3+4",Blood,5,weeks,5,43,Mean,mg/dL,54.9,3.5,22.95,31.95,77.85,SD,mg/dL,54.9,54,50,50,3.5,22.951,31.949,77.851,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL-C, LDL4",Blood,5,weeks,5,43,Mean,mg/dL,12.6,1.6,10.49,2.11,23.09,SD,mg/dL,12.6,12,10,10,1.6,10.4919,2.1081,23.0919,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,Peak max time,LDL peak max time,LDL peak max time,Blood,5,weeks,5,43,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Remnant Lp,Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C I+II,"VLDL-C, VLDL1+2",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Lower-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C III,"VLDL-C, VLDL3",Blood,5,weeks,5,43,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL-C, HDL2",Blood,5,weeks,5,42,Mean,mg/dL,10.9,0.6,3.89,7.01,14.79,SD,mg/dL,10.9,10,10,10,0.6,3.88844,7.01156,14.7884,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C III,"HDL-C, HDL3",Blood,5,weeks,5,42,Mean,mg/dL,36.1,1,6.48,29.62,42.58,SD,mg/dL,36.1,36,35,30,1,6.48074,29.6193,42.5807,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C I,"IDL-C, IDL1",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,IDL-C,IDL-C II,"IDL-C, IDL2",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I,"LDL-C, LDL1",Blood,5,weeks,5,42,Mean,mg/dL,18.4,0.9,5.83,12.57,24.23,SD,mg/dL,18.4,18,15,10,0.9,5.83267,12.5673,24.2327,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C I+II,"LDL-C, LDL1+2",Blood,5,weeks,5,42,Mean,mg/dL,43.6,2.7,17.5,26.1,61.1,SD,mg/dL,43.6,43,40,40,2.7,17.498,26.102,61.098,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL-C, LDL2",Blood,5,weeks,5,42,Mean,mg/dL,25.2,2.1,13.61,11.59,38.81,SD,mg/dL,25.2,25,25,20,2.1,13.6096,11.5904,38.8096,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III,"LDL-C, LDL3",Blood,5,weeks,5,42,Mean,mg/dL,43.4,1.9,12.31,31.09,55.71,SD,mg/dL,43.4,43,40,40,1.9,12.3134,31.0866,55.7134,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C III+IV,"LDL-C, LDL3+4",Blood,5,weeks,5,42,Mean,mg/dL,54.6,3,19.44,35.16,74.04,SD,mg/dL,54.6,54,50,50,3,19.4422,35.1578,74.0422,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL-C, LDL4",Blood,5,weeks,5,42,Mean,mg/dL,11.2,1.4,9.07,2.13,20.27,SD,mg/dL,11.2,11,10,10,1.4,9.07304,2.12696,20.273,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,Peak max time,LDL peak max time,LDL peak max time,Blood,5,weeks,5,42,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Remnant Lp,Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C I+II,"VLDL-C, VLDL1+2",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 7,Moderate-Fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C III,"VLDL-C, VLDL3",Blood,5,weeks,5,42,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Avocado diet,40-69 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD 10-year risk,Estimated ASCVD 10-year risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Avocado diet,20-59 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD lifetime risk,Estimated ASCVD lifetime risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Baseline Average American Diet,40-69 years old participants,ITT,Summary,Outcome,CVD risk factors,CVD,Estimated ASCVD 10-year risk,Estimated ASCVD 10-year risk,NA,5,weeks,5,26,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Baseline Average American Diet,20-59 years old participants,ITT,Summary,Outcome,CVD risk factors,CVD,Estimated ASCVD lifetime risk,Estimated ASCVD lifetime risk,NA,5,weeks,5,39,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Lower-Fat,40-69 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD 10-year risk,Estimated ASCVD 10-year risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Lower-Fat,20-59 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD lifetime risk,Estimated ASCVD lifetime risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Moderate-Fat,40-69 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD 10-year risk,Estimated ASCVD 10-year risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
8,Wang 2015,Intervention,NCT01235832,Table 8,Moderate-Fat,20-59 years old participants,PP,Within,Outcome,CVD risk factors,CVD,Estimated ASCVD lifetime risk,Estimated ASCVD lifetime risk,NA,5,weeks,5,,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,47,Mean,kg/m^2,32.52,0.83,5.69,26.83,38.21,SD,kg/m^2,32.52,32,30,30,0.829972,5.69,26.83,38.21,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Whole body % fat,NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,12,weeks,12,47,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,Macular pigment optical density,NA,12,weeks,12,47,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Dietary patterns,Adherence,Consumption,Consumption,NA,,NA,,47,Mean,%,NA,NA,NA,NA,NA,"min,max",%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,47,Mean,years,34.6,0.83,5.7,25,45,"min,max",years,34.6,34,30,30,0.83143,5.7,25,45,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,47,Mean,kg/m^2,32.49,0.85,5.83,25,49.4,"min,max",kg/m^2,32.49,32,30,30,0.850393,5.83,25,49.4,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,Whole body % fat,NA,,NA,,47,Mean,%,NA,NA,NA,NA,NA,"min,max",%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Highest education, college",NA,,NA,,47,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Highest education, post-college",NA,,NA,,47,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,High school,"Highest education, high school",NA,,NA,,47,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Other,Intelligence quotient,Intelligence quotient,Intelligence quotient,NA,,NA,,47,Mean,IQ score,NA,NA,NA,NA,NA,"min,max",IQ score,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Carotenoids,Lutein,Lutein,Serum lutein,NA,,NA,,47,Mean,µmol/L,NA,NA,NA,NA,NA,"min,max",μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Other,Macular pigment optical density,Macular pigment optical density,Macular pigment optical density,NA,,NA,,47,Mean,d.u,NA,NA,NA,NA,NA,"min,max",d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,"Sex, F",NA,,NA,,47,Mean,%,48.9362,,,,,NA,%,48.9362,48,45,40,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avocado,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,"Sex, M",NA,,NA,,47,Mean,%,31.9149,,,,,NA,%,31.9149,31,30,30,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,37,Mean,kg/m^2,31.13,0.96,5.82,25.31,36.95,SD,kg/m^2,31.13,31,30,30,0.956802,5.82,25.31,36.95,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Whole body % fat,NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Blood,12,weeks,12,37,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Macular pigment optical density,Macular pigment optical density,Macular pigment optical density,NA,12,weeks,12,37,Mean,d.u,NA,NA,NA,NA,NA,SD,d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Dietary patterns,Adherence,Consumption,Consumption,NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,"min,max",%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,37,Mean,years,34,1.02,6.2,25,45,"min,max",years,34,34,30,30,1.01927,6.2,25,45,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,37,Mean,kg/m^2,31.31,0.9,5.49,25,46.57,"min,max",kg/m^2,31.31,31,30,30,0.90255,5.49,25,46.57,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,Whole body % fat,NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,"min,max",%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Highest education, college",NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Highest education, post-college",NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Education,High school,"Highest education, high school",NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Other,Intelligence quotient,Intelligence quotient,Intelligence quotient,NA,,NA,,37,Mean,IQ score,NA,NA,NA,NA,NA,"min,max",IQ score,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Carotenoids,Lutein,Lutein,Serum lutein,NA,,NA,,37,Mean,µmol/L,NA,NA,NA,NA,NA,"min,max",μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Other,Macular pigment optical density,Macular pigment optical density,Macular pigment optical density,NA,,NA,,37,Mean,d.u,NA,NA,NA,NA,NA,"min,max",d.u,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,"Sex, F",NA,,NA,,37,Mean,%,48.6486,,,,,NA,%,48.6486,48,45,40,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,"Sex, M",NA,,NA,,37,Mean,%,43.2432,,,,,NA,%,43.2432,43,40,40,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent accuracy","Flanker task, congruent accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent accuracy","Flanker task, congruent accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent RT","Flanker task, congruent RT",NA,0,weeks,0,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent RT","Flanker task, congruent RT",NA,12,weeks,12,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent accuracy","Flanker task, incongruent accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent accuracy","Flanker task, incongruent accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent RT","Flanker task, incongruent RT",NA,0,weeks,0,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent RT","Flanker task, incongruent RT",NA,12,weeks,12,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall accuaracy","Flanker task, overall accuaracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall accuaracy","Flanker task, overall accuaracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall RT","Flanker task, overall RT",NA,0,weeks,0,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall RT","Flanker task, overall RT",NA,12,weeks,12,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, trials","Flanker task, useable ERP trials",NA,0,weeks,0,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, trials","Flanker task, useable ERP trials",NA,12,weeks,12,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target accuracy","NoGo task, non-target accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target accuracy","NoGo task, non-target accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target RT","NoGo task, non-target RT",NA,0,weeks,0,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target RT","NoGo task, non-target RT",NA,12,weeks,12,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, overall accuracy","NoGo task, overall accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, overall accuracy","NoGo task, overall accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, target accuracy","NoGo task, target accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, target accuracy","NoGo task, target accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, usable ERP trials","NoGo task, usable ERP trials",NA,0,weeks,0,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, usable ERP trials","NoGo task, usable ERP trials",NA,12,weeks,12,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, non-target accuracy","Oddball task, non-target accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, non-target accuracy","Oddball task, non-target accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, overall accuracy","Oddball task, overall accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, overall accuracy","Oddball task, overall accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target accuracy","Oddball task, target accuracy",NA,0,weeks,0,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target accuracy","Oddball task, target accuracy",NA,12,weeks,12,47,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target RT","Oddball task, target RT",NA,0,weeks,0,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target RT","Oddball task, target RT",NA,12,weeks,12,47,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, trials","Oddball task, usable ERP trials",NA,0,weeks,0,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Avocado,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, trials","Oddball task, usable ERP trials",NA,12,weeks,12,47,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent accuracy","Flanker task, congruent accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent accuracy","Flanker task, congruent accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent RT","Flanker task, congruent RT",NA,0,weeks,0,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, congruent RT","Flanker task, congruent RT",NA,12,weeks,12,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent accuracy","Flanker task, incongruent accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent accuracy","Flanker task, incongruent accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent RT","Flanker task, incongruent RT",NA,0,weeks,0,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, incongruent RT","Flanker task, incongruent RT",NA,12,weeks,12,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall accuaracy","Flanker task, overall accuaracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall accuaracy","Flanker task, overall accuaracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall RT","Flanker task, overall RT",NA,0,weeks,0,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, overall RT","Flanker task, overall RT",NA,12,weeks,12,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, trials","Flanker task, useable ERP trials",NA,0,weeks,0,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Flanker task,"Flanker task, trials","Flanker task, useable ERP trials",NA,12,weeks,12,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target accuracy","NoGo task, non-target accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target accuracy","NoGo task, non-target accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target RT","NoGo task, non-target RT",NA,0,weeks,0,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, non-target RT","NoGo task, non-target RT",NA,12,weeks,12,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, overall accuracy","NoGo task, overall accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, overall accuracy","NoGo task, overall accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, target accuracy","NoGo task, target accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, target accuracy","NoGo task, target accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, usable ERP trials","NoGo task, usable ERP trials",NA,0,weeks,0,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,NoGo task,"NoGo task, usable ERP trials","NoGo task, usable ERP trials",NA,12,weeks,12,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, non-target accuracy","Oddball task, non-target accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, non-target accuracy","Oddball task, non-target accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, overall accuracy","Oddball task, overall accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, overall accuracy","Oddball task, overall accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target accuracy","Oddball task, target accuracy",NA,0,weeks,0,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target accuracy","Oddball task, target accuracy",NA,12,weeks,12,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target RT","Oddball task, target RT",NA,0,weeks,0,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, target RT","Oddball task, target RT",NA,12,weeks,12,37,Mean,ms,NA,NA,NA,NA,NA,SD,ms,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, trials","Oddball task, usable ERP trials",NA,0,weeks,0,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Outcome,Cognition,Oddball task,"Oddball task, trials","Oddball task, usable ERP trials",NA,12,weeks,12,37,Mean,Count,NA,NA,NA,NA,NA,SD,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table1,Avocado,Female,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,23,Absolute value,g/d,140,,,,,NA,g/d,140,140,140,140,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table1,Avocado,Male,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Absolute value,g/d,175,,,,,NA,g/d,175,175,175,170,,,,,NA
9,Edwards 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table1,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,37,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
11,Li 2013,Intervention,Li 2013,Fig 1a,Burger patty alone,NA,ITT,Summary,Outcome,CVD risk factors,Peripheral arterial tonometry,Peripheral arterial tonometry score 0h,Peripheral arterial tonometry score 0h,NA,0,weeks,0,11,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Fig 1a,Burger patty alone,NA,ITT,Summary,Outcome,CVD risk factors,Peripheral arterial tonometry,Peripheral arterial tonometry score 2h,Peripheral arterial tonometry score 2h,NA,,NA,,11,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Fig 1a,Burger patty with avocado,NA,ITT,Summary,Outcome,CVD risk factors,Peripheral arterial tonometry,Peripheral arterial tonometry score 0h,Peripheral arterial tonometry score 0h,NA,0,weeks,0,11,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Fig 1a,Burger patty with avocado,NA,ITT,Summary,Outcome,CVD risk factors,Peripheral arterial tonometry,Peripheral arterial tonometry score 2h,Peripheral arterial tonometry score 2h,NA,,NA,,11,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 2,Burger patty alone,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx,NOx,Serum,,NA,,11,NA,uM,NA,NA,NA,NA,NA,NA,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 2,Burger patty with avocado,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx,NOx,Serum,,NA,,11,NA,uM,NA,NA,NA,NA,NA,NA,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 3a,Burger patty alone,NA,ITT,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Serum,,NA,,9,NA,pg/ml,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 3a,Burger patty with avocado,NA,ITT,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Serum,,NA,,9,NA,pg/ml,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 3b,Burger patty alone,NA,ITT,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a,Serum,,NA,,9,NA,pg/ml,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 3b,Burger patty with avocado,NA,ITT,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a,Serum,,NA,,9,NA,pg/ml,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 4,Burger patty alone,NA,ITT,Summary,Outcome,Immune,IkBa,IkBa,IkBa,Blood,,NA,,9,NA,% of baseline,NA,NA,NA,NA,NA,NA,% of baseline,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 4,Burger patty with avocado,NA,ITT,Summary,Outcome,Immune,IkBa,IkBa,IkBa,Blood,,NA,,9,NA,% of baseline,NA,NA,NA,NA,NA,NA,% of baseline,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Figure 5,Burger patty alone,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,11,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
11,Li 2013,Intervention,Li 2013,Figure 5,Burger patty with avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,11,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
11,Li 2013,Intervention,Li 2013,Methods section,All subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,11,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
11,Li 2013,Intervention,Li 2013,Methods section,All subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,11,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
11,Li 2013,Intervention,Li 2013,Methods section,Burger patty alone,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
11,Li 2013,Intervention,Li 2013,Methods section,Burger patty with avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,68,,,,,NA,g/test meal,68,68,65,60,,,,,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,11,Mean,years,25.4,1.72,5.7,19.7,31.1,SD,years,25.4,25,25,20,1.71861,5.7,19.7,31.1,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,11,Mean,kg/m^2,23.9,0.69,2.3,21.6,26.2,SD,kg/m^2,23.9,23,20,20,0.693476,2.3,21.6,26.2,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, black",NA,,NA,,11,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, asian",NA,,NA,,11,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Caucasian",NA,,NA,,11,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
11,Li 2013,Intervention,Li 2013,Table 1,All subjects,NA,ITT,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, hispanic",NA,,NA,,11,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,26,Mean,years,40.8,2.16,11,29.8,51.8,SD,years,40.8,40,40,40,2.15728,11,29.8,51.8,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,26,Mean,kg/m^2,28.1,0.47,2.4,25.7,30.5,SD,kg/m^2,28.1,28,25,20,0.470679,2.4,25.7,30.5,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,26,Count,Count,16,,,,,NA,Count,16,16,15,10,,,,,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,26,Percentage,%,61.5385,,,,,NA,%,61.5385,61,60,60,,,,,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,26,Count,Count,10,,,,,NA,Count,10,10,10,10,,,,,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,26,Percentage,%,38.4615,,,,,NA,%,38.4615,38,35,30,,,,,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,Avocado added,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,67.5,,,50,90,"min,max",g/test meal,67.5,67,65,60,,,50,90,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,Avocado inclusive,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,67.5,,,50,90,"min,max",g/test meal,67.5,67,65,60,,,50,90,NA
12,Haddad 2018,Intervention,NCT01271829,Results section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,26,Average,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin .5h,Ghrelin .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 0h,Ghrelin 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 1h,Ghrelin 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 2h,Ghrelin 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 3h,Ghrelin 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GIP,GIP .5h,GIP .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GIP,GIP 0h,GIP 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GIP,GIP 1h,GIP 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GIP,GIP 2h,GIP 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GIP,GIP 3h,GIP 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 .5h,GLP-1 .5h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 0h,GLP-1 0h,Blood,0,weeks,0,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 1h,GLP-1 1h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 2h,GLP-1 2h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 3h,GLP-1 3h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,PYY,PYY .5h,PYY .5h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,PYY,PYY 0h,PYY 0h,Blood,0,weeks,0,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,PYY,PYY 1h,PYY 1h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,PYY,PYY 2h,PYY 2h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado added,NA,PP,Summary,Outcome,Satiety,PYY,PYY 3h,PYY 3h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin .5h,Ghrelin .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 0h,Ghrelin 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 1h,Ghrelin 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 2h,Ghrelin 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 3h,Ghrelin 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP .5h,GIP .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP 0h,GIP 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP 1h,GIP 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP 2h,GIP 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP 3h,GIP 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 .5h,GLP-1 .5h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 0h,GLP-1 0h,Blood,0,weeks,0,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 1h,GLP-1 1h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 2h,GLP-1 2h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 3h,GLP-1 3h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY .5h,PYY .5h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY 0h,PYY 0h,Blood,0,weeks,0,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY 1h,PYY 1h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY 2h,PYY 2h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY 3h,PYY 3h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin .5h,Ghrelin .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 0h,Ghrelin 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 1h,Ghrelin 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 2h,Ghrelin 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin 3h,Ghrelin 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP .5h,GIP .5h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP 0h,GIP 0h,Blood,0,weeks,0,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP 1h,GIP 1h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP 2h,GIP 2h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP 3h,GIP 3h,Blood,,NA,,26,Mean,pg/ml,NA,NA,NA,NA,NA,95%CI,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 .5h,GLP-1 .5h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 0h,GLP-1 0h,Blood,0,weeks,0,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 1h,GLP-1 1h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 2h,GLP-1 2h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 3h,GLP-1 3h,Blood,,NA,,26,Mean,pmol/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY .5h,PYY .5h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY 0h,PYY 0h,Blood,0,weeks,0,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY 1h,PYY 1h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY 2h,PYY 2h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 1,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY 3h,PYY 3h,Blood,,NA,,26,Mean,ng/L,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question .5h,Desire question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 0h,Desire question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 1h,Desire question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 2h,Desire question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 3h,Desire question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question .5h,Fullness question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 0h,Fullness question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 1h,Fullness question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 2h,Fullness question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 3h,Fullness question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question .5h,Intake question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 0h,Intake question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 1h,Intake question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 2h,Intake question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 3h,Intake question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question .5h,Satisfaction question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 0h,Satisfaction question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 1h,Satisfaction question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 2h,Satisfaction question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado added,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 3h,Satisfaction question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question .5h,Desire question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 0h,Desire question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 1h,Desire question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 2h,Desire question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 3h,Desire question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question .5h,Fullness question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 0h,Fullness question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 1h,Fullness question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 2h,Fullness question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 3h,Fullness question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question .5h,Intake question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 0h,Intake question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 1h,Intake question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 2h,Intake question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 3h,Intake question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question .5h,Satisfaction question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 0h,Satisfaction question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 1h,Satisfaction question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 2h,Satisfaction question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 3h,Satisfaction question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question .5h,Desire question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 0h,Desire question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 1h,Desire question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 2h,Desire question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Desire question,Desire question 3h,Desire question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question .5h,Fullness question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 0h,Fullness question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 1h,Fullness question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 2h,Fullness question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Fullness question,Fullness question 3h,Fullness question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question .5h,Intake question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 0h,Intake question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 1h,Intake question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 2h,Intake question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 3h,Intake question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question .5h,Satisfaction question .5h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 0h,Satisfaction question 0h,NA,0,weeks,0,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 1h,Satisfaction question 1h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 2h,Satisfaction question 2h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Supplementary Table 3,Control,NA,PP,Summary,Outcome,Satiety,Satisfaction question,Satisfaction question 3h,Satisfaction question 3h,NA,,NA,,26,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table 1 header,All,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,26,Absolute value,kcal/d,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado Added,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin AUC 3h,Ghrelin AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado Added,NA,PP,Summary,Outcome,Satiety,GIP,GIP AUC 3h,GIP AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado Added,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 AUC 3h,GLP-1 AUC 3h,Blood,,NA,,26,LSM,log pmol/L x min,NA,NA,NA,NA,NA,SD,log pmol/L per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado Added,NA,PP,Summary,Outcome,Satiety,PYY,PYY AUC 3h,PYY AUC 3h,Blood,,NA,,26,LSM,log ng/L x min,NA,NA,NA,NA,NA,SD,log ng/L per hour,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin AUC 3h,Ghrelin AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GIP,GIP AUC 3h,GIP AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 AUC 3h,GLP-1 AUC 3h,Blood,,NA,,26,LSM,log pmol/L x min,NA,NA,NA,NA,NA,SD,log pmol/L per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Avocado inclusive,NA,PP,Summary,Outcome,Satiety,PYY,PYY AUC 3h,PYY AUC 3h,Blood,,NA,,26,LSM,log ng/L x min,NA,NA,NA,NA,NA,SD,log ng/L per hour,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Control,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin AUC 3h,Ghrelin AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Control,NA,PP,Summary,Outcome,Satiety,GIP,GIP AUC 3h,GIP AUC 3h,Blood,,NA,,26,LSM,log pg/ml x min,NA,NA,NA,NA,NA,SD,log pg/ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Control,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 AUC 3h,GLP-1 AUC 3h,Blood,,NA,,26,LSM,log pmol/L x min,NA,NA,NA,NA,NA,SD,log pmol/L per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
12,Haddad 2018,Intervention,NCT01271829,Table S2,Control,NA,PP,Summary,Outcome,Satiety,PYY,PYY AUC 3h,PYY AUC 3h,Blood,,NA,,26,LSM,log ng/L x min,NA,NA,NA,NA,NA,SD,log ng/L per hour,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1a,Avo,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,8,NA,"mmol/L, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1a,Cream,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,10,NA,"mmol/L, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1a,Ice cream,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,10,NA,"mmol/L, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1a,Sugar,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,,NA,,11,NA,"mmol/L, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1b,Avo,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Plasma,,NA,,8,NA,"mmol/L, change-in",,,,,,NA,"mg/dl, change-in",,,,,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1b,Cream,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Plasma,,NA,,10,NA,"mmol/L, change-in",,,,,,NA,"mg/dl, change-in",,,,,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1b,Ice cream,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Plasma,,NA,,10,NA,"mmol/L, change-in",,,,,,NA,"mg/dl, change-in",,,,,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Figure 1b,Sugar,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Plasma,,NA,,11,NA,"mmol/L, change-in",,,,,,NA,"mg/dl, change-in",,,,,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2a,Avo,NA,PP,Within,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,Plasma,,NA,,8,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2a,Cream,NA,PP,Within,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,Plasma,,NA,,10,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2a,Ice cream,NA,PP,Within,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,Plasma,,NA,,10,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2a,Sugar,NA,PP,Within,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,Plasma,,NA,,11,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2b,Avo,NA,PP,Within,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,Plasma,,NA,,8,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2b,Cream,NA,PP,Within,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,Plasma,,NA,,10,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2b,Ice cream,NA,PP,Within,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,Plasma,,NA,,10,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Figure 2b,Sugar,NA,PP,Within,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,Plasma,,NA,,11,NA,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,Female,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,45.2,5.8,14.2,31,59.4,SD,years,45.2,45,45,40,5.79713,14.2,31,59.4,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,Male,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,5,Mean,years,62.4,5.63,12.6,49.8,75,SD,years,62.4,62,60,60,5.63489,12.6,49.8,75,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,11,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,11,Percentage,%,54.5455,,,,,NA,%,54.5455,54,50,50,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,11,Count,Count,5,,,,,NA,Count,5,5,5,0,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,11,Percentage,%,45.4545,,,,,NA,%,45.4545,45,45,40,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section;Table1,Avo,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,489,,,,,NA,g/test meal,489,489,485,480,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section;Table1,Cream,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section;Table1,Ice cream,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Methods section;Table1,Sugar,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,NA,,NA,,8,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b monocytes,CD11b monocytes,NA,,NA,,8,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b neurophils,CD11b neurophils,NA,,NA,,8,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Immune,CD66b,CD66b,CD66b,NA,,NA,,8,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,8,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,Blood,,NA,,8,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,NA,,NA,,8,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Antioxidation,Protein carbonyls,Protein carbonyls,Protein carbonyls,NA,,NA,,8,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,8,Mean,mmol/L,4.85,0.3,0.85,4,5.7,SD,mg/dL,187.549,187,185,180,11.6211,32.8695,154.68,220.419,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Avo,NA,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,8,Mean,mmol/L,1.37,0.27,0.77,0.6,2.14,SD,mg/dL,121.341,121,120,120,24.112,68.1989,53.142,189.54,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,NA,,NA,,10,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b monocytes,CD11b monocytes,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b neurophils,CD11b neurophils,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Immune,CD66b,CD66b,CD66b,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,10,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,Blood,,NA,,10,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,NA,,NA,,10,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Protein carbonyls,Protein carbonyls,Protein carbonyls,NA,,NA,,10,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,10,Mean,mmol/L,5.39,0.25,0.8,4.59,6.19,SD,mg/dL,208.431,208,205,200,9.78282,30.936,177.495,239.367,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Cream,NA,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,10,Mean,mmol/L,1.4,0.23,0.73,0.67,2.13,SD,mg/dL,123.998,123,120,120,20.4461,64.6561,59.3419,188.654,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,NA,,NA,,10,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b monocytes,CD11b monocytes,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Immune,CD11b,CD11b neurophils,CD11b neurophils,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Immune,CD66b,CD66b,CD66b,NA,,NA,,10,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,10,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,Blood,,NA,,10,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,NA,,NA,,10,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Antioxidation,Protein carbonyls,Protein carbonyls,Protein carbonyls,NA,,NA,,10,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,10,Mean,mmol/L,5.29,0.28,0.9,4.39,6.19,SD,mg/dL,204.564,204,200,200,11.0057,34.803,169.761,239.367,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Ice cream,NA,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,10,Mean,mmol/L,1.33,0.22,0.7,0.63,2.03,SD,mg/dL,117.798,117,115,110,19.6058,61.999,55.7991,179.797,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Antioxidation,Antioxidant capacity,Antioxidant capacity,Antioxidant capacity,NA,,NA,,11,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Immune,CD11b,CD11b monocytes,CD11b monocytes,NA,,NA,,11,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Immune,CD11b,CD11b neurophils,CD11b neurophils,NA,,NA,,11,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Immune,CD66b,CD66b,CD66b,NA,,NA,,11,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,11,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,Blood,,NA,,11,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Antioxidation,Malondialdehyde,Malondialdehyde,MDA,NA,,NA,,11,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Antioxidation,Protein carbonyls,Protein carbonyls,Protein carbonyls,NA,,NA,,11,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,11,Mean,mmol/L,5.22,0.32,1.06,4.16,6.28,SD,mg/dL,201.857,201,200,200,12.359,40.9902,160.867,242.848,NA
13,Khor 2014,Intervention,Khor 2014,Table 2,Sugar,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,11,Mean,mmol/L,1.13,0.18,0.6,0.53,1.73,SD,mg/dL,100.084,100,100,100,16.0229,53.142,46.9421,153.226,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 0h,CD11b neurophils,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 4h,CD11b neurophils,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 0h,CD66b,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Avo,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 4h,CD66b,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 0h,CD11b neurophils,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 4h,CD11b neurophils,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 0h,CD66b,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 4h,CD66b,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 0h,CD11b neurophils,Blood,0,weeks,0,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 4h,CD11b neurophils,Blood,,NA,,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 0h,CD66b,Blood,0,weeks,0,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Ice cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 4h,CD66b,Blood,,NA,,7,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 0h,CD11b neurophils,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD11b,CD11b neurophils 4h,CD11b neurophils,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 0h,CD66b,Blood,0,weeks,0,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 3,Sugar,NA,PP,Summary,Outcome,Immune,CD66b,CD66b 4h,CD66b,Blood,,NA,,9,Mean,MFI,NA,NA,NA,NA,NA,SD,MFI,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity AUC 4h,Antioxidant capacity AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Immune,CD66b,CD66b AUC 4h,CD66b AUC 4hrs,Blood,,NA,,7,Mean,MFI.h,NA,NA,NA,NA,NA,SD,MFI per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 4h,Glucose AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Immune,IL-6,IL-6 AUC 4h,IL-6 AUC 4hrs,Blood,,NA,,7,Mean,pg/ml.h,NA,NA,NA,NA,NA,SD,pg/ml per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde AUC 4h,MDA AUC 4hrs,Blood,,NA,,7,Mean,umol/L.h,NA,NA,NA,NA,NA,SD,μmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Antioxidation,Protein carbonyls,Protein carbonyls AUC 4h,Protein carbonyls AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Cholesterol AUC 4h,Cholesterol AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,408.6,6.16,16.3,392.3,424.9,SD,mmol/L per h,408.6,408,405,400,6.16082,16.3,392.3,424.9,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Avo,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides AUC 4h,Triglycerides AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,546.2,37.04,98,448.2,644.2,SD,mmol/L per h,546.2,546,545,540,37.0405,98,448.2,644.2,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity AUC 4h,Antioxidant capacity AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b AUC 4h,CD66b AUC 4hrs,Blood,,NA,,7,Mean,MFI.h,NA,NA,NA,NA,NA,SD,MFI per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 4h,Glucose AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Immune,IL-6,IL-6 AUC 4h,IL-6 AUC 4hrs,Blood,,NA,,7,Mean,pg/ml.h,NA,NA,NA,NA,NA,SD,pg/ml per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde AUC 4h,MDA AUC 4hrs,Blood,,NA,,7,Mean,umol/L.h,NA,NA,NA,NA,NA,SD,μmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Antioxidation,Protein carbonyls,Protein carbonyls AUC 4h,Protein carbonyls AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Cholesterol AUC 4h,Cholesterol AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,400.1,8.92,23.6,376.5,423.7,SD,mmol/L per h,400.1,400,400,400,8.91996,23.6,376.5,423.7,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Cream,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides AUC 4h,Triglycerides AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,530.1,51.86,137.2,392.9,667.3,SD,mmol/L per h,530.1,530,530,530,51.8567,137.2,392.9,667.3,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity AUC 4h,Antioxidant capacity AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Immune,CD66b,CD66b AUC 4h,CD66b AUC 4hrs,Blood,,NA,,7,Mean,MFI.h,NA,NA,NA,NA,NA,SD,MFI per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 4h,Glucose AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Immune,IL-6,IL-6 AUC 4h,IL-6 AUC 4hrs,Blood,,NA,,7,Mean,pg/ml.h,NA,NA,NA,NA,NA,SD,pg/ml per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde AUC 4h,MDA AUC 4hrs,Blood,,NA,,7,Mean,umol/L.h,NA,NA,NA,NA,NA,SD,μmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Antioxidation,Protein carbonyls,Protein carbonyls AUC 4h,Protein carbonyls AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Cholesterol AUC 4h,Cholesterol AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,385,5.06,13.4,371.6,398.4,SD,mmol/L per h,385,385,385,380,5.06472,13.4,371.6,398.4,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Ice cream,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides AUC 4h,Triglycerides AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,548.3,23.74,62.8,485.5,611.1,SD,mmol/L per h,548.3,548,545,540,23.7362,62.8,485.5,611.1,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Antioxidation,Antioxidant capacity,Antioxidant capacity AUC 4h,Antioxidant capacity AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Immune,CD66b,CD66b AUC 4h,CD66b AUC 4hrs,Blood,,NA,,7,Mean,MFI.h,NA,NA,NA,NA,NA,SD,MFI per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 4h,Glucose AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Immune,IL-6,IL-6 AUC 4h,IL-6 AUC 4hrs,Blood,,NA,,7,Mean,pg/ml.h,NA,NA,NA,NA,NA,SD,pg/ml per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Antioxidation,Malondialdehyde,Malondialdehyde AUC 4h,MDA AUC 4hrs,Blood,,NA,,7,Mean,umol/L.h,NA,NA,NA,NA,NA,SD,μmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Antioxidation,Protein carbonyls,Protein carbonyls AUC 4h,Protein carbonyls AUC 4hrs,Blood,,NA,,7,Mean,nmol/mg protein.h,NA,NA,NA,NA,NA,SD,nmol/mg protein per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Cholesterol AUC 4h,Cholesterol AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,394.2,3.06,8.1,386.1,402.3,SD,mmol/L per h,394.2,394,390,390,3.06151,8.1,386.1,402.3,NA
13,Khor 2014,Intervention,Khor 2014,Table 4,Sugar,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides AUC 4h,Triglycerides AUC 4hrs,Blood,,NA,,7,Mean,mmol/L.h,366.9,12.81,33.9,333,400.8,SD,mmol/L per h,366.9,366,365,360,12.813,33.9,333,400.8,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Avo,CC genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,0,weeks,0,23,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Avo,CC/TT genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,0,weeks,0,39,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Avo,CC genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,12,weeks,12,23,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Avo,CC/TT genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,12,weeks,12,39,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Control,CC genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,0,weeks,0,20,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Control,CC/TT genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,0,weeks,0,34,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Control,CC genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,12,weeks,12,20,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Fig 2,Control,CC/TT genotype,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol,  total",Blood,12,weeks,12,34,Mean,mg/dL,,,,,,SD,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1a,Avo,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,12,weeks,12,61,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1a,Control,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,12,weeks,12,54,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1b,Avo,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,12,weeks,12,61,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1b,Control,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,12,weeks,12,54,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1c,Avo,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,12,weeks,12,61,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Figure 1c,Control,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,12,weeks,12,54,NA,mg/dL,,,,,,NA,mg/dL,,,,,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section;Table1,Avo,Female,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,23,Absolute value,g/d,140,,,,,NA,g/d,140,140,140,140,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section;Table1,Avo,Male,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,38,Absolute value,g/d,175,,,,,NA,g/d,175,175,175,170,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section;Table1,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,54,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Energy,NA,0,weeks,0,61,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Energy,NA,12,weeks,12,61,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,12,weeks,12,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble fiber,Insoluble fiber,NA,0,weeks,0,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble fiber,Insoluble fiber,NA,12,weeks,12,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,0,weeks,0,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble fiber,Soluble fiber,NA,0,weeks,0,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble fiber,Soluble fiber,NA,12,weeks,12,61,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Avo,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,12,weeks,12,61,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Energy,NA,0,weeks,0,54,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Energy,NA,12,weeks,12,54,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble fiber,Insoluble fiber,NA,0,weeks,0,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Insoluble fiber,Insoluble fiber,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,0,weeks,0,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Pectins,Pectins,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble fiber,Soluble fiber,NA,0,weeks,0,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fiber,Fiber,Soluble fiber,Soluble fiber,NA,12,weeks,12,54,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,12,weeks,12,54,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,61,Mean,years,35.4,0.7,5.47,29.93,40.87,SD,years,35.4,35,35,30,0.7,5.46717,29.9328,40.8672,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,61,Mean,kg/m^2,33,0.9,7.03,25.97,40.03,SD,kg/m^2,33,33,30,30,0.9,7.02922,25.9708,40.0292,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,WB % fat,NA,,NA,,61,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Visceral adipose tissue,VAT mass,NA,,NA,,61,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,61,Mean,mg/dL,52,2,15.62,36.38,67.62,SD,mg/dL,52,52,50,50,2,15.6205,36.3795,67.6205,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,61,Count,Count,37,,,,,NA,Count,37,37,35,30,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,61,Count,Count,24,,,,,NA,Count,24,24,20,20,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,TC,NA,,NA,,61,Mean,mg/dL,184,4,31.24,152.76,215.24,SD,mg/dL,184,184,180,180,4,31.241,152.759,215.241,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Avo,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,TG,NA,,NA,,61,Mean,mg/dL,116,7,54.67,61.33,170.67,SD,mg/dL,116,116,115,110,7,54.6717,61.3283,170.672,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,54,Mean,years,36.1,0.9,6.61,29.49,42.71,SD,years,36.1,36,35,30,0.9,6.61362,29.4864,42.7136,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,54,Mean,kg/m^2,33.2,0.9,6.61,26.59,39.81,SD,kg/m^2,33.2,33,30,30,0.9,6.61362,26.5864,39.8136,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,WB% fat,NA,,NA,,54,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Visceral adipose tissue,VAT mass,NA,,NA,,54,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,54,Mean,mg/dL,55,2,14.7,40.3,69.7,SD,mg/dL,55,55,55,50,2,14.6969,40.3031,69.6969,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,54,Count,Count,36,,,,,NA,Count,36,36,35,30,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,54,Count,Count,18,,,,,NA,Count,18,18,15,10,,,,,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,TC,NA,,NA,,54,Mean,mg/dL,191,5,36.74,154.26,227.74,SD,mg/dL,191,191,190,190,5,36.7423,154.258,227.742,NA
14,Hannon 2020,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,TG,NA,,NA,,54,Mean,mg/dL,114,8,58.79,55.21,172.79,SD,mg/dL,114,114,110,110,8,58.7878,55.2122,172.788,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Diets section,All,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,61,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Diets section,All,Men,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,13,Absolute value,kJ,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Diets section,All,Women,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,48,Absolute value,kJ,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Diets section,All,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,61,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Diets section,All,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,61,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,61,Mean,years,40.8,1.14,8.94,31.86,49.74,SD,years,40.8,40,40,40,1.14465,8.94,31.86,49.74,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Arterial compliance,Arterial compliance,Arterial compliance,NA,,NA,,61,Mean,mL/mmHg,NA,NA,NA,NA,NA,SD,mL/mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,61,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,61,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,61,Mean,kg/m^2,31.9,0.5,3.9,28,35.8,SD,kg/m^2,31.9,31,30,30,0.499344,3.9,28,35.8,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,61,Mean,g/L,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,61,Mean,mM/L,1.1,0.04,0.31,0.79,1.41,SD,mg/dL,42.537,42,40,40,1.53487,11.9877,30.5493,54.5247,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,61,Mean,mM/L,3.45,0.14,1.12,2.33,4.57,SD,mg/dL,133.412,133,130,130,5.54533,43.3104,90.1011,176.722,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,61,Count,Count,48,,,,,NA,Count,48,48,45,40,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,61,Percentage,%,78.6885,,,,,NA,%,78.6885,78,75,70,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,61,Count,Count,13,,,,,NA,Count,13,13,10,10,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,61,Percentage,%,21.3115,,,,,NA,%,21.3115,21,20,20,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,61,Mean,mM/L,5.19,0.15,1.17,4.02,6.36,SD,mg/dL,200.697,200,200,200,5.79289,45.2439,155.453,245.941,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,All,NA,PP,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,61,Mean,mM/L,1.73,0.26,2.03,-0.3,3.76,SD,mg/dL,153.226,153,150,150,23.0207,179.797,-26.571,333.023,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,27,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Methods section,Experimental,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,28,Absolute value,g/d,200,,,,,NA,g/d,200,200,200,200,,,,,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Results section,All,NA,PP,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,0,weeks,0,61,Absolute value,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Results section,Control,NA,PP,Summary,Outcome,Physical activity,Physical activity,Physical activity,Physical activity,NA,0,weeks,0,61,Absolute value,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Results section,Experimental,NA,PP,Summary,Outcome,Physical activity,Physical activity,Physical activity,Physical activity,NA,0,weeks,0,61,Absolute value,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,27,Median,kg/m^2,30.9,,,28.9,33.6,IQR,kg/m^2,30.9,30,30,30,,,28.9,33.6,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,weeks,6,27,Median,kg/m^2,29.9,,,27.8,32.9,IQR,kg/m^2,29.9,29,25,20,,,27.8,32.9,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,0,weeks,0,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,6,weeks,6,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,27,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,6,weeks,6,27,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,28,Median,kg/m^2,31.6,,,29.4,34.9,IQR,kg/m^2,31.6,31,30,30,,,29.4,34.9,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,weeks,6,28,Median,kg/m^2,30.8,,,28.9,33.9,IQR,kg/m^2,30.8,30,30,30,,,28.9,33.9,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,0,weeks,0,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,6,weeks,6,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,28,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 3,Experimental,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,6,weeks,6,28,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic,Blood,0,weeks,0,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic,Blood,6,weeks,6,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,α-Linolenic,Blood,0,weeks,0,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,α-Linolenic,Blood,6,weeks,6,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic,Blood,0,weeks,0,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic,Blood,6,weeks,6,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic,Blood,0,weeks,0,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic,Blood,6,weeks,6,27,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic,Blood,0,weeks,0,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic,Blood,6,weeks,6,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic,Blood,0,weeks,0,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Control,NA,PP,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic,Blood,6,weeks,6,27,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic,Blood,0,weeks,0,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic,Blood,6,weeks,6,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,α-Linolenic,Blood,0,weeks,0,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,α-Linolenic,Blood,6,weeks,6,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic,Blood,0,weeks,0,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic,Blood,6,weeks,6,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic,Blood,0,weeks,0,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic,Blood,6,weeks,6,28,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic,Blood,0,weeks,0,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic,Blood,6,weeks,6,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic,Blood,0,weeks,0,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 4,Experimental,NA,PP,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic,Blood,6,weeks,6,28,Median,%,NA,NA,NA,NA,NA,IQR,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,27,Mean,mmol/L,1.1,,,0.98,1.21,95%CI,mg/dL,42.537,42,40,40,,,37.8966,46.7907,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,weeks,6,27,Mean,mmol/L,1.1,,,0.98,1.22,95%CI,mg/dL,42.537,42,40,40,,,37.8966,47.1774,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,27,Mean,mmol/L,3.47,,,3.08,3.86,95%CI,mg/dL,134.185,134,130,130,,,119.104,149.266,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,weeks,6,27,Mean,mmol/L,3.58,,,3.21,3.95,95%CI,mg/dL,138.439,138,135,130,,,124.131,152.747,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,27,Mean,mmol/L,5.16,,,4.75,5.57,95%CI,mg/dL,199.537,199,195,190,,,183.683,215.392,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,6,weeks,6,27,Mean,mmol/L,5.26,,,4.84,5.68,95%CI,mg/dL,203.404,203,200,200,,,187.163,219.646,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,27,Mean,mmol/L,1.31,,,0.97,1.65,95%CI,mg/dL,116.027,116,115,110,,,85.9129,146.14,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Control,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,weeks,6,27,Mean,mmol/L,1.28,,,0.95,1.61,95%CI,mg/dL,113.37,113,110,110,,,84.1415,142.598,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,28,Mean,mmol/L,1.11,,,0.95,1.26,95%CI,mg/dL,42.9237,42,40,40,,,36.7365,48.7242,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,weeks,6,28,Mean,mmol/L,1.1,,,0.97,1.23,95%CI,mg/dL,42.537,42,40,40,,,37.5099,47.5641,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,28,Mean,mmol/L,3.43,,,2.92,3.95,95%CI,mg/dL,132.638,132,130,130,,,112.916,152.747,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,weeks,6,28,Mean,mmol/L,3.5,,,2.96,4.04,95%CI,mg/dL,135.345,135,135,130,,,114.463,156.227,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,28,Mean,mmol/L,5.22,,,4.69,5.75,95%CI,mg/dL,201.857,201,200,200,,,181.362,222.353,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,6,weeks,6,28,Mean,mmol/L,5.33,,,4.76,5.9,95%CI,mg/dL,206.111,206,205,200,,,184.069,228.153,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,28,Mean,mmol/L,2.13,,,1.09,3.18,95%CI,mg/dL,188.654,188,185,180,,,96.5413,281.653,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 5,Experimental,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,weeks,6,28,Mean,mmol/L,1.88,,,1.26,2.49,95%CI,mg/dL,166.512,166,165,160,,,111.598,220.539,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Arterial compliance,Arterial compliance,Arterial compliance,NA,0,weeks,0,27,Mean,mL/mmHg,NA,NA,NA,NA,NA,95%CI,mL/mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Arterial compliance,Arterial compliance,Arterial compliance,NA,6,weeks,6,27,Mean,mL/mmHg,NA,NA,NA,NA,NA,95%CI,mL/mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,0,weeks,0,27,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,6,weeks,6,27,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,0,weeks,0,27,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,6,weeks,6,27,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,0,weeks,0,27,Mean,g/L,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Control,NA,PP,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,6,weeks,6,27,Mean,g/L,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Arterial compliance,Arterial compliance,Arterial compliance,NA,0,weeks,0,28,Mean,mL/mmHg,NA,NA,NA,NA,NA,95%CI,mL/mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Arterial compliance,Arterial compliance,Arterial compliance,NA,6,weeks,6,28,Mean,mL/mmHg,NA,NA,NA,NA,NA,95%CI,mL/mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,0,weeks,0,28,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,"Blood pressure, DBP",NA,6,weeks,6,28,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,0,weeks,0,28,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,"Blood pressure, SBP",NA,6,weeks,6,28,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,0,weeks,0,28,Mean,g/L,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
15,Pieterse 2005,Intervention,Pieterse 2005,Table 6,Experimental,NA,PP,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,6,weeks,6,28,Mean,g/L,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Abstract,Control meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
16,Zhu 2019,Intervention,NCT02479048,Abstract,Half avocado meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,68,,,,,NA,g/test meal,68,68,65,60,,,,,NA
16,Zhu 2019,Intervention,NCT02479048,Abstract,Whole avocado meal,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,g per test meal,136,,,,,NA,g/test meal,136,136,135,130,,,,,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Control meal,NA,PP,Within,Outcome,Satiety,Desire question,Desire question 6h,Desire to eat,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Control meal,NA,PP,Within,Outcome,Satiety,Fullness question,Fullness question 6h,Fullness,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Control meal,NA,PP,Within,Outcome,Satiety,Hunger question,Hunger question 6h,Hunger,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Control meal,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 6h,Prospective consumption,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Control meal,NA,PP,Within,Outcome,Satiety,Satisfaction question,Satisfaction question 6h,Satisfaction,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Half Avocado Meal,NA,PP,Within,Outcome,Satiety,Desire question,Desire question 6h,Desire to eat,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Half Avocado Meal,NA,PP,Within,Outcome,Satiety,Fullness question,Fullness question 6h,Fullness,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Half Avocado Meal,NA,PP,Within,Outcome,Satiety,Hunger question,Hunger question 6h,Hunger,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Half Avocado Meal,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 6h,Prospective consumption,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Half Avocado Meal,NA,PP,Within,Outcome,Satiety,Satisfaction question,Satisfaction question 6h,Satisfaction,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Whole Avocado Meal,NA,PP,Within,Outcome,Satiety,Desire question,Desire question 6h,Desire to eat,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Whole Avocado Meal,NA,PP,Within,Outcome,Satiety,Fullness question,Fullness question 6h,Fullness,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Whole Avocado Meal,NA,PP,Within,Outcome,Satiety,Hunger question,Hunger question 6h,Hunger,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,Intake question,Intake question 6h,Prospective consumption,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 3,Whole Avocado Meal,NA,PP,Within,Outcome,Satiety,Satisfaction question,Satisfaction question 6h,Satisfaction,NA,,NA,,31,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Control meal,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin,Total ghrelin,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Control meal,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1,GLP-1,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Control meal,NA,PP,Summary,Outcome,Satiety,PYY,PYY,PYY,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin,Total ghrelin,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1,GLP-1,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Fig 4,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,PYY,PYY,PYY,Blood,,NA,,31,NA,pg/mL,NA,NA,NA,NA,NA,NA,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,31,Mean,years,38,1.8,10,28,48,SD,years,38,38,35,30,1.79605,10,28,48,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,31,Mean,kg/m^2,29,0.36,2,27,31,SD,kg/m^2,29,29,25,20,0.359211,2,27,31,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Mid-point waist circumference,NA,,NA,,31,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race/Ethnicity, AA",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race/Ethnicity, AS",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race/Ethnicity, Cau",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Race/Ethnicity, His",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, Female",NA,,NA,,31,Percentage,%,51.6129,,,,,NA,%,51.6129,51,50,50,,,,,NA
16,Zhu 2019,Intervention,NCT02479048,Table 2,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, Male",NA,,NA,,31,Percentage,%,48.3871,,,,,NA,%,48.3871,48,45,40,,,,,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Control meal,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin AUC 6h,Ghrelin iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pg ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Control meal,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 AUC 6h,GLP iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pmol/L per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Control meal,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 6h,Insulin iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Control meal,NA,PP,Summary,Outcome,Satiety,PYY,PYY AUC 6h,PYY iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pg/mL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,Ghrelin,Ghrelin AUC 6h,Ghrelin iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pg ml per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,GLP-1,GLP-1 AUC 6h,GLP iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pmol/L per min,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 6h,Insulin iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3,Whole Avocado Meal,NA,PP,Summary,Outcome,Satiety,PYY,PYY AUC 6h,PYY iAUC 6hrs,Blood,,NA,,31,Mean,pg min·mL^-1,NA,NA,NA,NA,NA,SD,pg/mL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,31,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,31,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Venous fasting glucose concentration,NA,,NA,,31,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Metabolic,Insulin,Fasting insulin,Venous fasting insulin concentration,NA,,NA,,31,Mean,pmol/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI Categories, Obese I",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,"BMI Categories, Obese I",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI Categories, Overweight",NA,,NA,,31,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
16,Zhu 2019,Intervention,NCT02479048,Table 3 Park 2018,All,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI Categories, Overweight",NA,,NA,,31,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 1a,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene,Lycopene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 1a,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene,Lycopene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 1b,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 1b,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2a,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2a,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2a,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2a,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene,a-carotene,Plasma,,NA,,8,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2b,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2b,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2b,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2b,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene,b-carotene,Plasma,,NA,,8,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2c,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2c,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2c,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Plasma,,NA,,11,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Figure 2c,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein,Lutein,Plasma,,NA,,8,NA,nmol/L,NA,NA,NA,NA,NA,NA,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salad control,Study 2,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salad with 150g avocado,Study 2,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,150,,,,,NA,g/test meal,150,150,150,150,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salad with 24g avocado oil,Study 2,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salad with 75g avocado,Study 2,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,8,Absolute value,g per test meal,75,,,,,NA,g/test meal,75,75,75,70,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salsa control,Study 1,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Methods section,Salsa with 150g avocado,Study 1,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,11,Absolute value,g per test meal,150,,,,,NA,g/test meal,150,150,150,150,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 1,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,11,Count,Count,5,,,,,NA,Count,5,5,5,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 2,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,11,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 1,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,11,Percentage,%,45.4545,,,,,NA,%,45.4545,45,45,40,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 2,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,11,Percentage,%,54.5455,,,,,NA,%,54.5455,54,50,50,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 1,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,11,Count,Count,6,,,,,NA,Count,6,6,5,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 2,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,11,Count,Count,5,,,,,NA,Count,5,5,5,0,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 1,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,11,Percentage,%,54.5455,,,,,NA,%,54.5455,54,50,50,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,All,Study 2,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,11,Percentage,%,45.4545,,,,,NA,%,45.4545,45,45,40,,,,,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 1,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,28.7,2.1,5.14,23.56,33.84,SD,years,28.7,28,25,20,2.1,5.14393,23.5561,33.8439,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 2,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,5,Mean,years,27.2,2.7,6.04,21.16,33.24,SD,years,27.2,27,25,20,2.7,6.03738,21.1626,33.2374,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 1,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,26,1.6,3.92,22.08,29.92,SD,kg/m^2,26,26,25,20,1.6,3.91918,22.0808,29.9192,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 2,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,5,Mean,kg/m^2,26,1.7,3.8,22.2,29.8,SD,kg/m^2,26,26,25,20,1.7,3.80132,22.1987,29.8013,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 1,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,6,Mean,mmol/L,4.62,0.41,1,3.62,5.62,SD,mg/dL,178.655,178,175,170,15.8547,38.8359,139.819,217.491,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 2,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,5,Mean,mmol/L,4.07,0.41,0.92,3.15,4.99,SD,mg/dL,157.387,157,155,150,15.8547,35.4522,121.935,192.839,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 1,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Tricylglycerol,NA,,NA,,6,Mean,mmol/L,0.809,0.13,0.32,0.49,1.12,SD,mg/dL,71.6531,71,70,70,11.4255,27.9867,43.6664,99.6398,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Men,Study 2,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Tricylglycerol,NA,,NA,,5,Mean,mmol/L,0.926,0.15,0.34,0.59,1.26,SD,mg/dL,82.0158,82,80,80,13.3741,29.9053,52.1105,111.921,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 1,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,5,Mean,years,31,3,6.71,24.29,37.71,SD,years,31,31,30,30,3,6.7082,24.2918,37.7082,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 2,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,26.2,2.3,5.63,20.57,31.83,SD,years,26.2,26,25,20,2.3,5.63383,20.5662,31.8338,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 1,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,5,Mean,kg/m^2,22.5,1.2,2.68,19.82,25.18,SD,kg/m^2,22.5,22,20,20,1.2,2.68328,19.8167,25.1833,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 2,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,21.3,1,2.45,18.85,23.75,SD,kg/m^2,21.3,21,20,20,1,2.44949,18.8505,23.7495,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 1,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,5,Mean,mmol/L,4.66,0.42,0.94,3.72,5.6,SD,mg/dL,180.202,180,180,180,16.2414,36.3169,143.885,216.519,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 2,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,6,Mean,mmol/L,5.18,0.36,0.88,4.3,6.06,SD,mg/dL,200.311,200,200,200,13.9212,34.0998,166.211,234.41,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 1,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Tricylglycerol,NA,,NA,,5,Mean,mmol/L,0.703,0.13,0.28,0.42,0.99,SD,mg/dL,62.2647,62,60,60,11.2484,25.1522,37.1125,87.4169,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 1,Women,Study 2,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Tricylglycerol,NA,,NA,,6,Mean,mmol/L,0.964,0.28,0.68,0.28,1.65,SD,mg/dL,85.3815,85,85,80,24.711,60.5294,24.8521,145.911,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad control,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 150g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 24g avocado oil,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,8,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,8,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,8,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salad with 75g avocado,Study 2,PP,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,8,Mean,nmol·h/L,NA,NA,NA,NA,NA,SD,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa control,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lutein,Lutein AUC 9.5h,Lutein AUC 9.5hrs,Blood,,NA,,11,Mean,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,Lycopene,Lycopene AUC 9.5h,Lycopene AUC 9.5hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,α-carotene,α-carotene AUC 9.5h,α-Carotene AUC 9.5hrs,Blood,,NA,,11,NA,nmol·h/L,NA,NA,NA,NA,NA,NA,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
18,Unlu 2005,Intervention,Unlu 2005,Table 3,Salsa with 150g avocado,Study 1,ITT,Summary,Outcome,Nutrient bioavailability,β-carotene,β-carotene AUC 9.5h,β-Carotene AUC 9.5hrs,Blood,,NA,,11,Median,nmol·h/L,NA,NA,NA,NA,NA,IQR,nmol/l per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,15,Mean,years,48.53,1.65,6.4,37,58,"min,max",years,48.53,48,45,40,1.65247,6.4,37,58,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,15,Mean,kg,NA,NA,NA,NA,NA,"min,max",kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,15,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,Avo diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Average,avocado/d,1,,,0.5,1.5,"min,max",g/d,350,350,350,350,,,175,525,350g/avo
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,Low-fat diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Average,avocado/d,0,,,,,NA,g/d,0,0,0,0,,,,,350g/avo
19,Colquhoun 1992,Intervention,Colquhoun 1992,Methods section,Pre-entry diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Average,avocado/d,0,,,,,NA,g/d,0,0,0,0,,,,,350g/avo
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,ITT,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Dietary cholesterol,NA,,NA,,15,Mean,g/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,15,Mean,MJ,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,15,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,Planned,Summary,Dietary,Fatty acids,SFA,SFA,Saturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Avo diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,15,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,ITT,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Dietary cholesterol,NA,,NA,,15,Mean,g/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,15,Mean,MJ,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,15,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,Planned,Summary,Dietary,Fatty acids,SFA,SFA,Saturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Low-fat diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,15,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,ITT,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Dietary cholesterol,NA,,NA,,15,Mean,g/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,15,Mean,MJ,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,15,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,Planned,Summary,Dietary,Fatty acids,SFA,SFA,Saturates,NA,,NA,,15,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 1,Pre-entry diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,15,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,Apolipoprotein A-I,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoB,Apolipoprotein B,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL,Blood,3,weeks,3,15,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,weeks,3,15,Mean,mmol/L,1.68,0.01,0.03,1.65,1.71,SD,mg/dL,64.9656,64,60,60,0.299537,1.1601,63.8055,66.1257,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,weeks,3,15,Mean,mmol/L,3.51,0.01,0.05,3.46,3.56,SD,mg/dL,135.732,135,135,130,0.499228,1.9335,133.798,137.665,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,3,weeks,3,15,Mean,mmol/L,5.6,0.02,0.07,5.53,5.67,SD,mg/dL,216.552,216,215,210,0.698919,2.7069,213.845,219.259,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Avo diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,weeks,3,15,Mean,mmol/L,1.41,0.01,0.04,1.37,1.45,SD,mg/dL,124.884,124,120,120,0.914747,3.5428,121.341,128.426,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,Apolipoprotein A-I,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoB,Apolipoprotein B,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL,Blood,3,weeks,3,15,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,weeks,3,15,Mean,mmol/L,1.49,0.01,0.03,1.46,1.52,SD,mg/dL,57.6183,57,55,50,0.299537,1.1601,56.4582,58.7784,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,weeks,3,15,Mean,mmol/L,3.76,0.02,0.06,3.7,3.82,SD,mg/dL,145.399,145,145,140,0.599073,2.3202,143.079,147.719,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,3,weeks,3,15,Mean,mmol/L,5.8,0.02,0.08,5.72,5.88,SD,mg/dL,224.286,224,220,220,0.798764,3.0936,221.192,227.38,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Low-fat diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,weeks,3,15,Mean,mmol/L,1.42,0.02,0.06,1.36,1.48,SD,mg/dL,125.769,125,125,120,1.37212,5.3142,120.455,131.084,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoA1,Apolipoprotein A-I,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,Apolipoprotein,ApoB,Apolipoprotein B,Blood,3,weeks,3,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL,Blood,3,weeks,3,15,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,weeks,3,15,Mean,mmol/L,1.73,0.01,0.04,1.69,1.77,SD,mg/dL,66.8991,66,65,60,0.399382,1.5468,65.3523,68.4459,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,weeks,3,15,Mean,mmol/L,3.86,0.01,0.05,3.81,3.91,SD,mg/dL,149.266,149,145,140,0.499228,1.9335,147.333,151.2,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,3,weeks,3,15,Mean,mmol/L,6.1,0.02,0.06,6.04,6.16,SD,mg/dL,235.887,235,235,230,0.599073,2.3202,233.567,238.207,NA
19,Colquhoun 1992,Intervention,Colquhoun 1992,Table 3,Pre-entry diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,weeks,3,15,Mean,mmol/L,1.39,0.01,0.05,1.34,1.44,SD,mg/dL,123.112,123,120,120,1.14343,4.4285,118.684,127.541,NA
21,Utari 2020,Intervention,Utari 2020,Abstract,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,30,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
21,Utari 2020,Intervention,Utari 2020,Methods section,Avocado intervention,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,10,Absolute value,g/d,100,,,,,NA,g/d,100,100,100,100,,,,,NA
21,Utari 2020,Intervention,Utari 2020,Methods section,Combination Avocado/Guava intervention,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,10,Absolute value,g/d,100,,,,,NA,g/d,100,100,100,100,,,,,NA
21,Utari 2020,Intervention,Utari 2020,Methods section,Guava intervention,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,10,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
21,Utari 2020,Intervention,Utari 2020,Table 1,Avocado intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,0,weeks,0,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
21,Utari 2020,Intervention,Utari 2020,Table 1,Avocado intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,2,weeks,2,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
21,Utari 2020,Intervention,Utari 2020,Table 2,Guava intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,0,weeks,0,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
21,Utari 2020,Intervention,Utari 2020,Table 2,Guava intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,2,weeks,2,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
21,Utari 2020,Intervention,Utari 2020,Table 3,Combination avocado/guava intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,0,weeks,0,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
21,Utari 2020,Intervention,Utari 2020,Table 3,Combination avocado/guava intervention,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Hemoglobin,Blood,2,weeks,2,30,Mean,g/dL,NA,NA,NA,NA,NA,NA,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Dietary,Energy,Energy,Energy,Caloric intake,NA,,NA,,55407,Mean,kJ/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,55407,Mean,Years,55.9,0.06,13.7,42.2,69.6,SD,years,55.9,55,55,50,0.058202,13.7,42.2,69.6,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,"Dietary pattern, nonvegetarians",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,"Dietary pattern, vegetarians",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, >= college graduate",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, some college",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, <= high school",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,55407,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,Vigorous activity,NA,,NA,,55407,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, black",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Non-African American,"Race, non-black",NA,,NA,,55407,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, female",NA,,NA,,55407,Percentage,%,62.7,,,,,NA,%,62.7,62,60,60,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, male",NA,,NA,,55407,Percentage,%,37.3,,,,,NA,%,37.3,37,35,30,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Caloric intake,NA,,NA,,819,Mean,kJ/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,819,Mean,Years,58.1,0.48,13.8,44.3,71.9,SD,years,58.1,58,55,50,0.482211,13.8,44.3,71.9,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,"Dietary pattern, nonvegetarians",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,"Dietary pattern, vegetarians",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, >= college graduate",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, some college",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, <= high school",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,819,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,Vigorous activity,NA,,NA,,819,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, black",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Race,Race,Non-African American,"Race, non-black",NA,,NA,,819,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, female",NA,,NA,,819,Percentage,%,65.7,,,,,NA,%,65.7,65,65,60,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,High avocado intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, male",NA,,NA,,819,Percentage,%,34.3,,,,,NA,%,34.3,34,30,30,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Caloric intake,NA,,NA,,31346,Mean,kJ/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,31346,Mean,Years,56.1,0.08,13.5,42.6,69.6,SD,years,56.1,56,55,50,0.0762505,13.5,42.6,69.6,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,"Dietary pattern, nonvegetarians",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,"Dietary pattern, vegetarians",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, >= college graduate",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, some college",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, <= high school",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,31346,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,Vigorous activity,NA,,NA,,31346,Median,Hours/day,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, black",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Race,Race,Non-African American,"Race, non-black",NA,,NA,,31346,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, female",NA,,NA,,31346,Percentage,%,63.2,,,,,NA,%,63.2,63,60,60,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Low avocado intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, male",NA,,NA,,31346,Percentage,%,36.8,,,,,NA,%,36.8,36,35,30,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Caloric intake,NA,,NA,,23242,Mean,kJ/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,23242,Mean,Years,55.6,0.09,13.9,41.7,69.5,SD,years,55.6,55,55,50,0.0911755,13.9,41.7,69.5,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,"Dietary pattern, nonvegetarians",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,"Dietary pattern, vegetarians",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, >= college graduate",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, some college",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, <= high school",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,23242,Mean,Hours/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,Vigorous activity,NA,,NA,,23242,Mean,Hours/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, black",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Non-African American,"Race, non-black",NA,,NA,,23242,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,"Gender, female",NA,,NA,,23242,Percentage,%,62,,,,,NA,%,62,62,60,60,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,"Gender, male",NA,,NA,,23242,Percentage,%,38,,,,,NA,%,38,38,35,30,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,High avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,819,Mean,kg/m^2,24.7,,,24.4,25,95%CI,kg/m^2,24.7,24,20,20,,,24.4,25,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,High avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,819,Mean,kg/m^2,24.8,0.15,4.4,20.4,29.2,SD,kg/m^2,24.8,24,20,20,0.153748,4.4,20.4,29.2,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,High avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,819,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Low avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,31346,Mean,kg/m^2,26.1,,,26.1,26.8,95%CI,kg/m^2,26.1,26,25,20,,,26.1,26.8,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Low avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,31346,Mean,kg/m^2,26.1,0.03,4.5,21.6,30.6,SD,kg/m^2,26.1,26,25,20,0.0254168,4.5,21.6,30.6,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Low avocado intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,31346,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,23242,Mean,kg/m^2,27.2,,,27.1,27.2,95%CI,kg/m^2,27.2,27,25,20,,,27.1,27.2,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,23242,Mean,kg/m^2,27.3,0.03,4.8,22.5,32.1,SD,kg/m^2,27.3,27,25,20,0.0314851,4.8,22.5,32.1,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,23242,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Black,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.5,,,,,NA,"%, change-in",0.5,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-black,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.09,,,,,NA,"%, change-in",0.09,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-vegetarian,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.16,,,,,NA,"%, change-in",0.16,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Vegetarian,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.02,,,,,NA,"%, change-in",0.02,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,<60 years,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",1.09,,,,,NA,"%, change-in",1.09,1,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,>=60 years,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",-1.47,,,,,NA,"%, change-in",-1.47,-2,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,All,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.07,,,,,NA,"%, change-in",0.07,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI Normal,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.36,,,,,NA,"%, change-in",0.36,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OB,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",-1.03,,,,,NA,"%, change-in",-1.03,-2,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OW,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",-0.21,,,,,NA,"%, change-in",-0.21,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Female,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",0.16,,,,,NA,"%, change-in",0.16,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Male,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,Percentage,"%, change-in",-0.1,,,,,NA,"%, change-in",-0.1,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Black,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,-0.004,0.02,0.43,-0.43,0.43,SD,NA,-0.004,-1,-5,-10,0.015,0.429273,-0.433273,0.425273,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-black,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.01,0.01,0.17,-0.16,0.18,SD,NA,0.01,0,0,0,0.006,0.171709,-0.161709,0.181709,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-vegetarian,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.002,0.01,0.2,-0.2,0.2,SD,NA,0.002,0,0,0,0.007,0.200327,-0.198327,0.202327,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Vegetarian,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.002,0.01,0.23,-0.23,0.23,SD,NA,0.002,0,0,0,0.008,0.228945,-0.226945,0.230945,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,<60 years,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,-0.007,0.01,0.17,-0.18,0.16,SD,NA,-0.007,-1,-5,-10,0.006,0.171709,-0.178709,0.164709,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,>=60 years,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.022,0.01,0.23,-0.21,0.25,SD,NA,0.022,0,0,0,0.008,0.228945,-0.206945,0.250945,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,All,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.001,0.01,0.14,-0.14,0.14,SD,NA,0.001,0,0,0,0.005,0.143091,-0.142091,0.144091,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI Normal,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,-0.031,0.01,0.2,-0.23,0.17,SD,NA,-0.031,-1,-5,-10,0.007,0.200327,-0.231327,0.169327,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OB,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,-0.005,0.01,0.37,-0.38,0.37,SD,NA,-0.005,-1,-5,-10,0.013,0.372036,-0.377036,0.367036,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OW,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,-0.001,0.01,0.23,-0.23,0.23,SD,NA,-0.001,-1,-5,-10,0.008,0.228945,-0.229945,0.227945,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Female,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.001,0.01,0.2,-0.2,0.2,SD,NA,0.001,0,0,0,0.007,0.200327,-0.199327,0.201327,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Male,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,819,B Coefficient,NA,0.0001,0.01,0.2,-0.2,0.2,SD,NA,0.0001,0,0,0,0.007,0.200327,-0.200227,0.200427,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Black,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-black,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-vegetarian,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Vegetarian,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,<60 years,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,>=60 years,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,All,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI Normal,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OB,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OW,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Female,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Male,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Black,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-black,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Non-vegetarian,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Vegetarian,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,<60 years,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,>=60 years,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,All,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI Normal,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OB,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,BMI OW,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Female,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,High avocado intake,Male,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,819,B Coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Black,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",0.56,,,,,NA,"%, change-in",0.56,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Non-black,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-0.09,,,,,NA,"%, change-in",-0.09,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Non-vegetarian,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",0.11,,,,,NA,"%, change-in",0.11,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Vegetarian,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-0.06,,,,,NA,"%, change-in",-0.06,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,<60 years,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",1.22,,,,,NA,"%, change-in",1.22,1,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,>=60 years,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-1.86,,,,,NA,"%, change-in",-1.86,-2,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,All,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",0.05,,,,,NA,"%, change-in",0.05,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI Normal,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",0.9,,,,,NA,"%, change-in",0.9,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI OB,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-0.95,,,,,NA,"%, change-in",-0.95,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI OW,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-0.19,,,,,NA,"%, change-in",-0.19,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Female,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",0.14,,,,,NA,"%, change-in",0.14,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Male,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI change,NA,,NA,,23242,Percentage,"%, change-in",-0.1,,,,,NA,"%, change-in",-0.1,-1,-5,-10,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Black,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Non-black,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Non-vegetarian,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Vegetarian,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,<60 years,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,>=60 years,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,All,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI Normal,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI OB,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,BMI OW,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Female,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 3,Non-consumers,Male,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight change,NA,,NA,,23242,Percentage,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,High avocado intake,Adjusted,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,819,Odds ratio,NA,0.61,,,,,NA,NA,0.61,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,High avocado intake,Adjusted for baseline BMI,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,819,Odds ratio,NA,0.85,,,,,NA,NA,0.85,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,High avocado intake,Unadjusted,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,819,Odds ratio,NA,0.54,,,,,NA,NA,0.54,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,Low avocado intake,Adjusted,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,31346,Odds ratio,NA,0.89,,,,,NA,NA,0.89,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,Low avocado intake,Adjusted for baseline BMI,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,31346,Odds ratio,NA,0.93,,,,,NA,NA,0.93,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table 4,Low avocado intake,Unadjusted,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,31346,Odds ratio,NA,0.82,,,,,NA,NA,0.82,0,0,0,,,,,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,All,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,55407,Median,g/d,2.2,,,0.6,3.8,IQR,g/d,2.2,2,0,0,,,0.6,3.8,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,All,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,55407,Median,g/d E adjusted,1.6,,,-0.1,3.3,IQR,g/d E adjusted,1.6,1,0,0,,,-0.1,3.3,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,High avocado intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,819,Median,g/d,37.8,,,29.8,45.8,IQR,g/d,37.8,37,35,30,,,29.8,45.8,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,High avocado intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,819,Median,g/d E adjusted,34.9,,,28.9,40.9,IQR,g/d E adjusted,34.9,34,30,30,,,28.9,40.9,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,Low avocado intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31346,Median,g/d,2.3,,,1.1,3.5,IQR,g/d,2.3,2,0,0,,,1.1,3.5,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,Low avocado intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31346,Median,g/d E adjusted,2.8,,,1.15,4.45,IQR,g/d E adjusted,2.8,2,0,0,,,1.15,4.45,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,23242,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
23,Heskey 2019,Observation,Adventist Health Study (AHS-2),Table1,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,23242,Median,g/d E adjusted,0,,,0,0,IQR,g/d E adjusted,0,0,0,0,,,0,0,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,667,LSM,Years,46.2,1.4,36.16,10.04,82.36,SD,years,46.2,46,45,40,1.4,36.1569,10.0431,82.3569,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, moderate",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,"Physical activity, sedentary",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, vigorous",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,Poverty Index Ratio,"Poverty Index Ratio, mean",NA,,NA,,667,LSM,Ratio,NA,NA,NA,NA,NA,SD,Ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,"Poverty Index Ratio, <1.35%","Poverty Index Ratio, <1.35%",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, NHB",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, NHW",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, MA",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other Hispanic,"Ethnicity, OH",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, O",NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,% female,NA,,NA,,667,LSM,%,54.4,3,77.48,-23.08,131.88,SD,%,54.4,54,50,50,3,77.479,-23.079,131.879,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,% male,NA,,NA,,667,Percentage,%,45.5,,,,,NA,%,45.5,45,45,40,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoking current,NA,,NA,,667,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,29017,LSM,Years,46.6,0.3,51.1,-4.5,97.7,SD,years,46.6,46,45,40,0.3,51.1031,-4.50313,97.7031,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, moderate",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,"Physical activity, sedentary",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, vigorous",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,Poverty Index Ratio,"Poverty Index Ratio, mean",NA,,NA,,29017,LSM,Ratio,NA,NA,NA,NA,NA,SD,Ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,"Poverty Index Ratio, <1.35%","Poverty Index Ratio, <1.35%",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, NHB",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, NHW",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, MA",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other Hispanic,"Ethnicity, OH",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, O",NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,% female,NA,,NA,,29017,LSM,%,50.7,0.3,51.1,-0.4,101.8,SD,%,50.7,50,50,50,0.3,51.1031,-0.403131,101.803,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,% male,NA,,NA,,29017,Percentage,%,49.3,,,,,NA,%,49.3,49,45,40,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoking current,NA,,NA,,29017,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Copper,Copper,Copper,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,667,LSM,kcals,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary Fiber,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated Fatty Acids,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Phosphorus,Phosphorus,Phosphorus,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated Fatty Acids,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated Fatty Acids,NA,,NA,,667,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,,NA,,667,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B1,Thiamin,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B12,Vitamin B12,NA,,NA,,667,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B2,Riboflavin,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B3,Niacin,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B6,Vitamin B6,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Total Folate,NA,,NA,,667,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E as α-tocopherol,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Consumers,NA,NA,Summary,Dietary,Minerals,Zinc,Zinc,Zinc,NA,,NA,,667,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Copper,Copper,Copper,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,29017,LSM,kcals,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary Fiber,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated Fatty Acids,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Phosphorus,Phosphorus,Phosphorus,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated Fatty Acids,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated Fatty Acids,NA,,NA,,29017,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,,NA,,29017,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B1,Thiamin,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B12,Vitamin B12,NA,,NA,,29017,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B2,Riboflavin,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B3,Niacin,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B6,Vitamin B6,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Total Folate,NA,,NA,,29017,LSM,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E as α-tocopherol,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Zinc,Zinc,Zinc,NA,,NA,,29017,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Empty Calories",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Empty Calories",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Fatty Acid Ratio",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty Acid Ratio",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Refined Grains",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined Grains",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Seafood and Plant Protein",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and Plant Protein",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Total Protein Foods",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total Protein Foods",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Whole Fruit",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole Fruit",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Food groups,"HEI, Whole Grains",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole Grains",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Non-consumers,Outcome,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index,NA,,NA,,612,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index,NA,,NA,,612,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Empty Calories",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty Acid Ratio",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined Grains",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and Plant Protein",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total Protein Foods",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole Fruit",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole Grains",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 4,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index,NA,,NA,,26686,LSM,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,BP Diastolic,NA,,NA,,579,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,BP Diastolic,NA,,NA,,579,LSM,mmhg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,BP Systolic,NA,,NA,,580,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,BP Systolic,NA,,NA,,580,LSM,mmhg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,597,B Coefficient,NA,-1.21,,,,,NA,NA,-1.21,-2,-5,-10,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,597,LSM,kg/m^2,27.27,0.3,7.33,19.94,34.6,SD,kg/m^2,27.27,27,25,20,0.3,7.33008,19.9399,34.6001,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Body size,Waist circumference,Waist Circumference,NA,,NA,,588,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist Circumference,NA,,NA,,588,LSM,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,599,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,599,LSM,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Immune,CRP,CRP,C-reative protein,NA,,NA,,471,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Immune,CRP,CRP,C-reative protein,NA,,NA,,471,LSM,mg/dL,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Glycemia,Glucose,Glucose,"Glucose, plasma",NA,,NA,,305,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,"Glucose, plasma",NA,,NA,,305,LSM,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Glycemia,HbA1c,HbA1c,Glycohemoglobin,NA,,NA,,584,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,Glycohemoglobin,NA,,NA,,584,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,NA,,NA,,579,B Coefficient,NA,2.93,,,,,NA,NA,2.93,2,0,0,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,NA,,NA,,579,LSM,mg/dL,55.65,0.94,22.62,33.03,78.27,SD,mg/dL,55.65,55,55,50,0.94,22.6187,33.0313,78.2687,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,NA,,NA,,223,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,NA,,NA,,223,LSM,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Glycemia,Insulin,Insulin,Insulin,NA,,NA,,308,B Coefficient,uU/mL,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,NA,,NA,,308,LSM,uU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,NA,,NA,,298,B Coefficient,NA,4.3,,,,,NA,NA,4.3,4,0,0,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,NA,,NA,,298,LSM,mg/dL,120.77,3,51.79,68.98,172.56,SD,mg/dL,120.77,120,120,120,3,51.788,68.982,172.558,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Metabolic,Metabolic syndrome,"Risk factors, Metabolic Syndrome","Risk factors, Metabolic Syndrome",NA,,NA,,432,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Metabolic,Metabolic syndrome,"Risk factors, Metabolic Syndrome","Risk factors, Metabolic Syndrome",NA,,NA,,432,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,593,B Coefficient,NA,2.04,,,,,NA,NA,2.04,2,0,0,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,593,LSM,mg/dL,200.35,2.82,68.67,131.68,269.02,SD,mg/dL,200.35,200,200,200,2.82,68.6715,131.679,269.021,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Lipids,Triglycerides,Triglycerides,Triglyceride,NA,,NA,,304,B Coefficient,NA,-2.49,,,,,NA,NA,-2.49,-3,-5,-10,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglyceride,NA,,NA,,304,LSM,mg/dL,135.53,18.68,325.7,-190.17,461.23,SD,mg/dL,135.53,135,135,130,18.68,325.697,-190.167,461.227,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Lipids,Triglycerides,Triglycerides Elevated,"Risk factors, Triglycerides Elevated",NA,,NA,,349,B Coefficient,NA,-10,,,,,NA,NA,-10,-10,-10,-10,,,,,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides Elevated,"Risk factors, Triglycerides Elevated",NA,,NA,,349,LSM,%,28,4,74.73,-46.73,102.73,SD,%,28,28,25,20,4,74.7262,-46.7262,102.726,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Obese,"Risk factors, Obese",NA,,NA,,597,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Obese,"Risk factors, Obese",NA,,NA,,597,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Overweight,"Risk factors, Overweight",NA,,NA,,597,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Overweight,"Risk factors, Overweight",NA,,NA,,597,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Overweight or Obese,"Risk factors, Overweight or Obese",NA,,NA,,597,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Overweight or Obese,"Risk factors, Overweight or Obese",NA,,NA,,597,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Waist Circumference Elevated,"Risk factors, Waist Circumference Elevated",NA,,NA,,588,B Coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Waist Circumference Elevated,"Risk factors, Waist Circumference Elevated",NA,,NA,,588,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,BP Diastolic,NA,,NA,,25223,LSM,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,BP Systolic,NA,,NA,,25350,LSM,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,26183,LSM,kg/m^2,28.48,0.08,12.94,15.54,41.42,SD,kg/m^2,28.48,28,25,20,0.08,12.9449,15.5351,41.4249,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist Circumference,NA,,NA,,25675,LSM,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,26313,LSM,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Immune,CRP,CRP,C-reative protein,NA,,NA,,20906,LSM,mg/dL,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,"Glucose, plasma",NA,,NA,,12254,LSM,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,Glycohemoglobin,NA,,NA,,25129,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,NA,,NA,,24867,LSM,mg/dL,52.72,0.16,25.23,27.49,77.95,SD,mg/dL,52.72,52,50,50,0.16,25.2308,27.4892,77.9508,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,NA,,NA,,11384,LSM,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,NA,,NA,,12228,LSM,uU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,NA,,NA,,11736,LSM,mg/dL,116.47,0.46,49.83,66.64,166.3,SD,mg/dL,116.47,116,115,110,0.46,49.8331,66.6369,166.303,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Metabolic,Metabolic syndrome,"Risk factors, Metabolic Syndrome","Risk factors, Metabolic Syndrome",NA,,NA,,18669,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,25293,LSM,mg/dL,198.31,0.43,68.39,129.92,266.7,SD,mg/dL,198.31,198,195,190,0.43,68.3862,129.924,266.696,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglyceride,NA,,NA,,12145,LSM,mg/dL,138.01,1.53,168.61,-30.6,306.62,SD,mg/dL,138.01,138,135,130,1.53,168.613,-30.6027,306.623,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides Elevated,"Risk factors, Triglycerides Elevated",NA,,NA,,14754,LSM,%,39,1,121.47,-82.47,160.47,SD,%,39,39,35,30,1,121.466,-82.466,160.466,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Obese,"Risk factors, Obese",NA,,NA,,26183,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Overweight,"Risk factors, Overweight",NA,,NA,,26183,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Overweight or Obese,"Risk factors, Overweight or Obese",NA,,NA,,26183,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 5,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Weight incidence,Waist Circumference Elevated,"Risk factors, Waist Circumference Elevated",NA,,NA,,25675,LSM,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 6,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Obese,Obese,NA,,NA,,612,Odds ratio,NA,NA,NA,NA,NA,NA,99%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 6,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Overweight,Overweight,NA,,NA,,612,Odds ratio,NA,NA,NA,NA,NA,NA,99%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 6,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Overweight or obese,Overweight or obese,NA,,NA,,612,Odds ratio,NA,NA,NA,NA,NA,NA,99%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table 6,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Weight incidence,Waist circumference elevated,Waist circumference elevated,NA,,NA,,612,Odds ratio,NA,NA,NA,NA,NA,NA,99%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table1,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,667,LSM,g/d,75.8,3.8,98.14,,,SD,g/d,75.8,75,75,70,3.8,98.1401,0,173.94,NA
24,O'Neil 2017,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2012),Table1,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,29017,LSM,g/d,0,,,,,NA,g/d,0,0,0,0,0,0,,,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,347,Percentage,%,49.8559,,,,,NA,%,49.8559,49,45,40,,,,,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,347,Percentage,%,50.1441,,,,,NA,%,50.1441,50,50,50,,,,,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index 2005,NA,,NA,,347,LSM,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index 2005,NA,,NA,,17220,LSM,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,347,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Calories,NA,,NA,,347,LSM,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fats,NA,,NA,,347,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,347,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,347,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,,NA,,347,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,347,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,,NA,,347,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,347,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E as α-tocopherol,NA,,NA,,347,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin K,Vitamin K,Vitamin K,NA,,NA,,347,LSM,ug,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,17220,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Calories,NA,,NA,,17220,LSM,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fats,NA,,NA,,17220,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,17220,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,17220,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,,NA,,17220,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,17220,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,,NA,,17220,LSM,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,17220,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E as α-tocopherol,NA,,NA,,17220,LSM,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 3,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin K,Vitamin K,Vitamin K,NA,,NA,,17220,LSM,ug,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,347,LSM,kg/m^2,26.7,0.4,7.45,19.25,34.15,SD,kg/m^2,26.7,26,25,20,0.4,7.45117,19.2488,34.1512,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist Circumference,NA,,NA,,347,LSM,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,347,LSM,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,347,LSM,mg/dL,55,0.8,14.9,40.1,69.9,SD,mg/dL,55,55,55,50,0.8,14.9023,40.0977,69.9023,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,17220,LSM,kg/m^2,28.4,0.1,13.12,15.28,41.52,SD,kg/m^2,28.4,28,25,20,0.1,13.1225,15.2775,41.5225,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist Circumference,NA,,NA,,17220,LSM,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,17220,LSM,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table 4,Non-consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,17220,LSM,mg/dL,52.6,0.2,26.24,26.36,78.84,SD,mg/dL,52.6,52,50,50,0.2,26.245,26.355,78.845,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table1,Consumers,Female,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,173,LSM,g/d,66.7,7.3,96.02,,,SD,g/d,66.7,66,65,60,7.3,96.0165,0,162.717,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table1,Consumers,Male,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,174,LSM,g/d,75.3,6.3,83.1,,,SD,g/d,75.3,75,75,70,6.3,83.1027,0,158.403,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table1,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,347,LSM,g/d,70.1,5.4,100.59,,,SD,g/d,70.1,70,70,70,5.4,100.591,0,170.691,NA
25,Fulgoni 2013,Observation,National Health and Nutrition Examination Survey (NHANES 2001-2008),Table1,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,17220,LSM,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocado Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,12,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocado Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,12,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocado Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,12,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocadoless Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,13,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocadoless Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,13,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Diets section,Avocadoless Vegetarian Diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,13,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,"Diets section, estimated",All,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,13,Absolute value,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,13,Mean,years,55.8,2.91,10.5,45.3,66.3,SD,years,55.8,55,55,50,2.91218,10.5,45.3,66.3,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,13,Mean,kg/m^2,28.7,1.58,5.7,23,34.4,SD,kg/m^2,28.7,28,25,20,1.5809,5.7,23,34.4,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,13,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,13,Mean,mmol/L,1.37,0.06,0.22,1.15,1.59,SD,mg/dL,52.9779,52,50,50,2.35953,8.5074,44.4705,61.4853,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,13,Mean,mmol/L,4.53,0.2,0.72,3.81,5.25,SD,mg/dL,175.175,175,175,170,7.72209,27.8424,147.333,203.018,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Hispanic,Mexican,NA,,NA,,13,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,13,Count,Count,11,,,,,NA,Count,11,11,10,10,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,13,Count,Count,2,,,,,NA,Count,2,2,0,0,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,13,Mean,mmol/L,6.86,0.24,0.88,5.98,7.74,SD,mg/dL,265.276,265,265,260,9.43811,34.0296,231.247,299.306,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,13,Mean,mmol/L,2.08,0.17,0.62,1.46,2.7,SD,mg/dL,184.226,184,180,180,15.2302,54.9134,129.312,239.139,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,Avocado vegetarian diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,13,Average,% fat from avo,75,,,,,NA,g/d,348.571,348,345,340,,,,,"30kcal/kg = 2049.6 kcal, 30% E from fat, 75% fat E from avo, 14.7g avo fat in 100 g avo, 9kcal/g fat"
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,Avocadoless vegetarian diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,13,Average,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Methods section,Free diet with avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,13,Average,% fat from avo,,,,,,NA,g/d,348.571,348,345,340,,,,,Provided same amount as treatment group
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,"Methods section, estimated",All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,13,Percentage,%,84.6154,,,,,NA,%,84.6154,84,80,80,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,"Methods section, estimated",All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,13,Percentage,%,15.3846,,,,,NA,%,15.3846,15,15,10,,,,,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,4,weeks,4,12,Mean,kg/m^2,28.9,1.67,5.8,23.1,34.7,SD,kg/m^2,28.9,28,25,20,1.67432,5.8,23.1,34.7,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,12,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,12,Mean,mmol/L,1.05,0.05,0.17,0.88,1.22,SD,mg/dL,40.6035,40,40,40,1.89772,6.5739,34.0296,47.1774,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,12,Mean,mmol/L,4.27,0.15,0.51,3.76,4.78,SD,mg/dL,165.121,165,165,160,5.69316,19.7217,145.399,184.843,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,4,weeks,4,12,Mean,mmol/L,6.51,0.2,0.69,5.82,7.2,SD,mg/dL,251.742,251,250,250,7.70252,26.6823,225.059,278.424,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocado Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,12,Mean,mmol/L,2.58,0.27,0.92,1.66,3.5,SD,mg/dL,228.511,228,225,220,23.5225,81.4844,147.026,309.995,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,4,weeks,4,13,Mean,kg/m^2,28.4,1.58,5.7,22.7,34.1,SD,kg/m^2,28.4,28,25,20,1.5809,5.7,22.7,34.1,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,13,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,13,Mean,mmol/L,0.89,0.06,0.2,0.69,1.09,SD,mg/dL,34.4163,34,30,30,2.14503,7.734,26.6823,42.1503,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,13,Mean,mmol/L,4.53,0.37,1.32,3.21,5.85,SD,mg/dL,175.175,175,175,170,14.1572,51.0444,124.131,226.22,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,4,weeks,4,13,Mean,mmol/L,6.65,0.35,1.26,5.39,7.91,SD,mg/dL,257.156,257,255,250,13.5137,48.7242,208.431,305.88,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Avocadoless Vegetarian Diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,13,Mean,mmol/L,2.81,0.22,0.78,2.03,3.59,SD,mg/dL,248.882,248,245,240,19.1606,69.0846,179.797,317.966,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,4,weeks,4,13,Mean,kg/m^2,28.5,1.58,5.7,22.8,34.2,SD,kg/m^2,28.5,28,25,20,1.5809,5.7,22.8,34.2,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,13,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,13,Mean,mmol/L,1.03,0.04,0.16,0.87,1.19,SD,mg/dL,39.8301,39,35,30,1.71602,6.1872,33.6429,46.0173,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,13,Mean,mmol/L,5.19,0.21,0.76,4.43,5.95,SD,mg/dL,200.697,200,200,200,8.1511,29.3892,171.308,230.087,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,4,weeks,4,13,Mean,mmol/L,7.29,0.24,0.88,6.41,8.17,SD,mg/dL,281.904,281,280,280,9.43811,34.0296,247.875,315.934,NA
29,Carranza-Madrigal 1997,Intervention,Carranza-Madrigal 1997,Table 2,Free Diet with Avocado,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,13,Mean,mmol/L,2.66,0.32,1.17,1.49,3.83,SD,mg/dL,235.596,235,235,230,28.7409,103.627,131.969,339.223,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Estimated,All,NA,ITT,Summary,Subject Characteristics,Health status,Dyslipidemia,Mild hypercholesterolemic subjects,Mild hypercholesterolemic subjects,NA,,NA,,67,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Estimated,All,NA,ITT,Summary,Subject Characteristics,Health status,Healthy,Healthy subjects,Healthy subjects,NA,,NA,,67,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Avocado-enriched diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,45,Absolute value,g/d,300,,,,,NA,g/d,300,300,300,300,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Control diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,22,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Healthy subjects,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,30,Mean,years,22,,,18,30,"min,max",years,22,22,20,20,,,18,30,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Healthy subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,30,Count,Count,14,,,,,NA,Count,14,14,10,10,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Healthy subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,30,Percentage,%,46.6667,,,,,NA,%,46.6667,46,45,40,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Healthy subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,30,Count,Count,16,,,,,NA,Count,16,16,15,10,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Healthy subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,30,Percentage,%,53.3333,,,,,NA,%,53.3333,53,50,50,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Mild hypercholesterolemic subjects,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,37,Mean,years,52,,,35,65,"min,max",years,52,52,50,50,,,35,65,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Mild hypercholesterolemic subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,37,Count,Count,25,,,,,NA,Count,25,25,25,20,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Mild hypercholesterolemic subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,37,Percentage,%,67.5676,,,,,NA,%,67.5676,67,65,60,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Mild hypercholesterolemic subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,37,Count,Count,12,,,,,NA,Count,12,12,10,10,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Methods section,Mild hypercholesterolemic subjects,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,37,Percentage,%,32.4324,,,,,NA,%,32.4324,32,30,30,,,,,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fatty acids,All fatty acids,All fatty acids,All fatty acids,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,45,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,45,Absolute value,kcal/d,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Lipids,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fibers,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fatty acids,MUFA,MUFA,MFA,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,45,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fatty acids,PUFA,PUFA,PFA,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,45,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Avocado-enriched diet,NA,Planned,Summary,Dietary,Fatty acids,SFA:UFA,SFA:UFA,SFA:UFA,NA,,NA,,45,Absolute value,ratio,NA,NA,NA,NA,NA,NA,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fatty acids,All fatty acids,All fatty acids,All fatty acids,NA,,NA,,22,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,22,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,22,Absolute value,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,22,Absolute value,kcal/d,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Lipids,NA,,NA,,22,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fibers,NA,,NA,,22,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fatty acids,MUFA,MUFA,MFA,NA,,NA,,22,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,22,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fatty acids,PUFA,PUFA,PFA,NA,,NA,,22,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,22,Absolute value,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 1,Control diet,NA,Planned,Summary,Dietary,Fatty acids,SFA:UFA,SFA:UFA,SFA:UFA,NA,,NA,,22,Absolute value,ratio,NA,NA,NA,NA,NA,NA,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,15,Mean,mmol/L,0.75,0.06,0.23,0.52,0.98,SD,mg/dL,29.0025,29,25,20,2.29645,8.8941,20.1084,37.8966,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,15,Mean,mmol/L,1.16,0.07,0.28,0.88,1.44,SD,mg/dL,44.8572,44,40,40,2.79567,10.8276,34.0296,55.6848,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,15,Mean,mmol/L,1.26,0.11,0.41,0.85,1.67,SD,mg/dL,48.7242,48,45,40,4.09367,15.8547,32.8695,64.5789,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,1,weeks,1,15,Mean,mmol/L,0.8,0.04,0.15,0.65,0.95,SD,mg/dL,30.936,30,30,30,1.49768,5.8005,25.1355,36.7365,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,1,weeks,1,15,Mean,mmol/L,1.18,0.09,0.36,0.82,1.54,SD,mg/dL,45.6306,45,45,40,3.59444,13.9212,31.7094,59.5518,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,1,weeks,1,15,Mean,mmol/L,1.44,0.11,0.41,1.03,1.85,SD,mg/dL,55.6848,55,55,50,4.09367,15.8547,39.8301,71.5395,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,15,Mean,mmol/L,4.21,0.29,1.11,3.1,5.32,SD,mg/dL,162.801,162,160,160,11.0829,42.9237,119.877,205.724,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,15,Mean,mmol/L,2.53,0.23,0.9,1.63,3.43,SD,mg/dL,97.8351,97,95,90,8.9861,34.803,63.0321,132.638,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,15,Mean,mmol/L,4.11,0.19,0.72,3.39,4.83,SD,mg/dL,158.934,158,155,150,7.18888,27.8424,131.091,186.776,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,1,weeks,1,15,Mean,mmol/L,3.33,0.24,0.93,2.4,4.26,SD,mg/dL,128.771,128,125,120,9.28563,35.9631,92.808,164.734,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,1,weeks,1,15,Mean,mmol/L,1.91,0.2,0.77,1.14,2.68,SD,mg/dL,73.8597,73,70,70,7.6881,29.7759,44.0838,103.636,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,1,weeks,1,15,Mean,mmol/L,3.15,0.13,0.51,2.64,3.66,SD,mg/dL,121.811,121,120,120,5.09212,19.7217,102.089,141.532,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,15,Mean,mmol/L,6.62,0.39,1.52,5.1,8.14,SD,mg/dL,255.995,255,255,250,15.1765,58.7784,197.217,314.774,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,15,Mean,mmol/L,4.55,0.22,0.85,3.7,5.4,SD,mg/dL,175.948,175,175,170,8.48687,32.8695,143.079,208.818,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,15,Mean,mmol/L,7.96,0.28,1.08,6.88,9.04,SD,mg/dL,307.813,307,305,300,10.7833,41.7636,266.05,349.577,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,1,weeks,1,15,Mean,mmol/L,5.3,0.28,1.08,4.22,6.38,SD,mg/dL,204.951,204,200,200,10.7833,41.7636,163.187,246.715,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,1,weeks,1,15,Mean,mmol/L,3.8,0.18,0.69,3.11,4.49,SD,mg/dL,146.946,146,145,140,6.88934,26.6823,120.264,173.628,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,1,weeks,1,15,Mean,mmol/L,6.85,0.21,0.8,6.05,7.65,SD,mg/dL,264.889,264,260,260,7.98764,30.936,233.953,295.825,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,15,Mean,mmol/L,2.29,0.23,0.89,1.4,3.18,SD,mg/dL,202.825,202,200,200,20.3531,78.8273,123.998,281.653,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,15,Mean,mmol/L,1.02,0.09,0.36,0.66,1.38,SD,mg/dL,90.3414,90,90,90,8.23272,31.8852,58.4562,122.227,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,15,Mean,mmol/L,1.97,0.05,0.21,1.76,2.18,SD,mg/dL,174.483,174,170,170,4.80242,18.5997,155.883,193.083,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,1,weeks,1,15,Mean,mmol/L,1.87,0.15,0.6,1.27,2.47,SD,mg/dL,165.626,165,165,160,13.7212,53.142,112.484,218.768,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Healthy,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,1,weeks,1,15,Mean,mmol/L,0.85,0.1,0.38,0.47,1.23,SD,mg/dL,75.2845,75,75,70,8.6901,33.6566,41.6279,108.941,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Avocado-enriched diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,1,weeks,1,15,Mean,mmol/L,1.46,0.02,0.09,1.37,1.55,SD,mg/dL,129.312,129,125,120,2.05818,7.9713,121.341,137.284,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,15,Mean,mmol/L,1.03,0.04,0.17,0.86,1.2,SD,mg/dL,39.8301,39,35,30,1.69737,6.5739,33.2562,46.404,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,7,Mean,mmol/L,1,0.05,0.12,0.88,1.12,SD,mg/dL,38.67,38,35,30,1.75391,4.6404,34.0296,43.3104,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,1,weeks,1,15,Mean,mmol/L,1.03,0.04,0.17,0.86,1.2,SD,mg/dL,39.8301,39,35,30,1.69737,6.5739,33.2562,46.404,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,1,weeks,1,7,Mean,mmol/L,1.05,0.04,0.1,0.95,1.15,SD,mg/dL,40.6035,40,40,40,1.46159,3.867,36.7365,44.4705,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,15,Mean,mmol/L,2.14,0.2,0.77,1.37,2.91,SD,mg/dL,82.7538,82,80,80,7.6881,29.7759,52.9779,112.53,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,7,Mean,mmol/L,4.13,0.25,0.67,3.46,4.8,SD,mg/dL,159.707,159,155,150,9.79264,25.9089,133.798,185.616,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,1,weeks,1,15,Mean,mmol/L,2.37,0.17,0.64,1.73,3.01,SD,mg/dL,91.6479,91,90,90,6.39011,24.7488,66.8991,116.397,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,1,weeks,1,7,Mean,mmol/L,4.21,0.27,0.72,3.49,4.93,SD,mg/dL,162.801,162,160,160,10.5234,27.8424,134.958,190.643,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,15,Mean,mmol/L,4.13,0.19,0.74,3.39,4.87,SD,mg/dL,159.707,159,155,150,7.38857,28.6158,131.091,188.323,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,7,Mean,mmol/L,6.54,0.39,1.03,5.51,7.57,SD,mg/dL,252.902,252,250,250,15.0544,39.8301,213.072,292.732,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,1,weeks,1,15,Mean,mmol/L,4.7,0.25,0.95,3.75,5.65,SD,mg/dL,181.749,181,180,180,9.48532,36.7365,145.013,218.486,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,1,weeks,1,7,Mean,mmol/L,6.82,0.37,0.98,5.84,7.8,SD,mg/dL,263.729,263,260,260,14.3236,37.8966,225.833,301.626,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,15,Mean,mmol/L,1.21,0.04,0.15,1.06,1.36,SD,mg/dL,107.17,107,105,100,3.4303,13.2855,93.8842,120.455,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,7,Mean,mmol/L,2.42,0.25,0.67,1.75,3.09,SD,mg/dL,214.339,214,210,210,22.4291,59.3419,154.998,273.681,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Healthy,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,1,weeks,1,15,Mean,mmol/L,1.06,0.1,0.4,0.66,1.46,SD,mg/dL,93.8842,93,90,90,9.14747,35.428,58.4562,129.312,NA
30,Ledesma 1996,Intervention,Ledesma 1996,Table 2,Control diet,Non-diabetic,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,1,weeks,1,7,Mean,mmol/L,2.37,0.19,0.51,1.86,2.88,SD,mg/dL,209.911,209,205,200,17.0729,45.1707,164.74,255.082,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Estimated,Control diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,16,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Estimated,Low-saturated fat,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,16,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Estimated,Rich-monounsaturated fat diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,16,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,All,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,16,Absolute value,kcal/kg BW,NA,NA,NA,NA,NA,NA,kcal/kg BW,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,16,Mean,years,26,,,18,37,"min,max",years,26,26,25,20,,,18,37,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,16,Mean,kg/m^2,22.9,0.55,2.2,20.7,25.1,SD,kg/m^2,22.9,22,20,20,0.55,2.2,20.7,25.1,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,Plasma,,NA,,16,Mean,mmol/L,1.41,0.06,0.23,1.18,1.64,SD,mg/dL,54.5247,54,50,50,2.22352,8.8941,45.6306,63.4188,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,Plasma,,NA,,16,Mean,mmol/L,2.48,0.17,0.68,1.8,3.16,SD,mg/dL,95.9016,95,95,90,6.5739,26.2956,69.606,122.197,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,16,Count,Count,7,,,,,NA,Count,7,7,5,0,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,16,Percentage,%,43.75,,,,,NA,%,43.75,43,40,40,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,16,Count,Count,9,,,,,NA,Count,9,9,5,0,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,16,Percentage,%,56.25,,,,,NA,%,56.25,56,55,50,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total Cholesterol,Plasma,,NA,,16,Mean,mmol/L,4.15,0.17,0.68,2.59,5.45,"min,max",mg/dL,160.481,160,160,160,6.5739,26.2956,100.155,210.752,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods Section,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triacylglycerol,Plasma,,NA,,16,Mean,mmol/L,1.29,0.18,0.72,0.57,2.01,SD,mg/dL,114.255,114,110,110,15.9426,63.7704,50.4849,178.026,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Control diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Absolute value,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Free monounsaturated-enriched diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Absolute value,% fat from avo,75,,,,,NA,g/d,304.592,304,300,300,,,,,"30 kcal/kg = 1791 kcal, 30% E from fat, 75% fat E from avo, 14.7g avo fat in 100 g avo, 9kcal/g fat"
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Low-saturated fat,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Absolute value,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Low-saturated fat,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Low-saturated fat,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Lipids,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Low-saturated fat,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Rich-monounsaturated fat diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Absolute value,% fat from avo,75,,,,,NA,g/d,304.592,304,300,300,,,,,Provided same amount as treatment group
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Rich-monounsaturated fat diet,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Rich-monounsaturated fat diet,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Lipids,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Methods section,Rich-monounsaturated fat diet,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,2,weeks,2,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL:LDL+VLDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL:HDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,2,weeks,2,16,Mean,mmol/L,1.41,0.06,0.23,1.18,1.64,SD,mg/dL,54.5247,54,50,50,2.22352,8.8941,45.6306,63.4188,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,2,weeks,2,16,Mean,mmol/L,2.48,0.17,0.68,1.8,3.16,SD,mg/dL,95.9016,95,95,90,6.5739,26.2956,69.606,122.197,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,2,weeks,2,16,Mean,mmol/L,4.15,0.17,0.68,3.47,4.83,SD,mg/dL,160.481,160,160,160,6.5739,26.2956,134.185,186.776,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,2,weeks,2,16,Mean,mmol/L,1.29,0.18,0.72,0.57,2.01,SD,mg/dL,114.255,114,110,110,15.9426,63.7704,50.4849,178.026,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Control diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL cholesterol,Blood,2,weeks,2,16,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,2,weeks,2,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL:LDL+VLDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL:HDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,2,weeks,2,16,Mean,mmol/L,1.3,0.06,0.22,1.08,1.52,SD,mg/dL,50.271,50,50,50,2.12685,8.5074,41.7636,58.7784,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,2,weeks,2,16,Mean,mmol/L,2.68,0.16,0.63,2.05,3.31,SD,mg/dL,103.636,103,100,100,6.09053,24.3621,79.2735,127.998,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,2,weeks,2,16,Mean,mmol/L,4.23,0.16,0.64,3.59,4.87,SD,mg/dL,163.574,163,160,160,6.1872,24.7488,138.825,188.323,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,2,weeks,2,16,Mean,mmol/L,1.26,0.17,0.68,0.58,1.94,SD,mg/dL,111.598,111,110,110,15.0569,60.2276,51.3706,171.826,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Free monounsaturated-enriched diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL cholesterol,Blood,2,weeks,2,16,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,2,weeks,2,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL:LDL+VLDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL:HDL,Blood,2,weeks,2,16,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,2,weeks,2,16,Mean,mmol/L,1.29,0.07,0.26,1.03,1.55,SD,mg/dL,49.8843,49,45,40,2.51355,10.0542,39.8301,59.9385,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,2,weeks,2,16,Mean,mmol/L,2.29,0.17,0.67,1.62,2.96,SD,mg/dL,88.5543,88,85,80,6.47723,25.9089,62.6454,114.463,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,2,weeks,2,16,Mean,mmol/L,3.85,0.17,0.68,3.17,4.53,SD,mg/dL,148.88,148,145,140,6.5739,26.2956,122.584,175.175,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,2,weeks,2,16,Mean,mmol/L,1.38,0.18,0.72,0.66,2.1,SD,mg/dL,122.227,122,120,120,15.9426,63.7704,58.4562,185.997,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Low-saturated fat,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL cholesterol,Blood,2,weeks,2,16,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,2,weeks,2,15,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL:LDL+VLDL,Blood,2,weeks,2,15,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL:HDL,Blood,2,weeks,2,15,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,2,weeks,2,15,Mean,mmol/L,1.36,0.08,0.32,1.04,1.68,SD,mg/dL,52.5912,52,50,50,3.19506,12.3744,40.2168,64.9656,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,2,weeks,2,15,Mean,mmol/L,2.38,0.14,0.56,1.82,2.94,SD,mg/dL,92.0346,92,90,90,5.59135,21.6552,70.3794,113.69,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,2,weeks,2,15,Mean,mmol/L,4,0.16,0.62,3.38,4.62,SD,mg/dL,154.68,154,150,150,6.19042,23.9754,130.705,178.655,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,2,weeks,2,15,Mean,mmol/L,1.23,0.18,0.7,0.53,1.93,SD,mg/dL,108.941,108,105,100,16.0081,61.999,46.9421,170.94,NA
31,Alvizouri-Muñoz 1992,Intervention,Alvizouri-Muñoz 1992,Table 2,Rich-monounsaturated fat diet,NA,PP,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL cholesterol,Blood,2,weeks,2,15,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,53,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Treatment,Female,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,32,Absolute value,g/d,140,,,,,NA,g/d,140,140,140,140,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Methods section,Treatment,Male,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Absolute value,g/d,175,,,,,NA,g/d,175,175,175,170,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Results section,Control,NA,PP,Within,Dietary,Energy,Energy,Energy,Energy,NA,12,weeks,12,53,Mean,"kcal/d, change-in",NA,NA,NA,NA,NA,SD,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Results section,Control,NA,PP,Within,Outcome,Physical activity,Physical activity,Leisure time physical activity,Leisure time physical activity score,NA,12,weeks,12,53,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Results section,Treatment,NA,PP,Within,Dietary,Energy,Energy,Energy,Energy,NA,12,weeks,12,52,Mean,"kcal/d, change-in",NA,NA,NA,NA,NA,SD,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Results section,Treatment,NA,PP,Within,Outcome,Physical activity,Physical activity,Leisure time physical activity,Leisure time physical activity score,NA,12,weeks,12,52,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,52,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,27,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,52,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,27,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Anthropometry,Body fat,VS ratio,VS Ratio,NA,12,weeks,12,52,Mean,"ratio, change-in",NA,NA,NA,NA,NA,SD,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Anthropometry,Body fat,VS ratio,VS Ratio,NA,12,weeks,12,27,Mean,"ratio, change-in",NA,NA,NA,NA,NA,SD,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,34,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,19,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic Index,Blood,12,weeks,12,38,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic Index,Blood,12,weeks,12,22,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Female,ITT,Within,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Index,NA,12,weeks,12,33,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Control,Male,ITT,Within,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Index,NA,12,weeks,12,18,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,49,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,28,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,49,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,28,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Anthropometry,Body fat,VS ratio,VS Ratio,NA,12,weeks,12,49,Mean,"ratio, change-in",NA,NA,NA,NA,NA,SD,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Anthropometry,Body fat,VS ratio,VS Ratio,NA,12,weeks,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,SD,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,25,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,20,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic Index,Blood,12,weeks,12,29,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic Index,Blood,12,weeks,12,20,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Female,ITT,Within,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Index,NA,12,weeks,12,24,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Supplemental Table 2,Treatment,Male,ITT,Within,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Index,NA,12,weeks,12,19,Mean,"index, change-in",NA,NA,NA,NA,NA,SD,"index, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,53,Mean,years,34.2,0.82,6,28.2,40.2,SD,years,34.2,34,30,30,0.824163,6,28.2,40.2,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,53,Mean,kg/m^2,33,0.85,6.2,26.8,39.2,SD,kg/m^2,33,33,30,30,0.851635,6.2,26.8,39.2,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,53,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,53,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"$41,000-$70,000","Household income, $41,000-$70,000",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"$41,000-$70,000","Household income, $41,000-$70,000",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"<= $41,000","Household income, <= $41,000",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"<= $41,000","Household income, <= $41,000",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,">= $70,000","Household income, >= $70,000",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,">= $70,000","Household income, >= $70,000",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, black or africa american",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, black or africa american",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, american indian or alaska native",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, american indian or alaska native",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, asian",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, asian",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, white or caucasian",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, white or caucasian",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,Other and multiracial,NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,Other and multiracial,NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,BMI obesity class 1,NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,BMI obesity class 1,NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,BMI obesity class 2,NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,BMI obesity class 2,NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,BMI obesity class 3,NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,BMI obesity class 3,NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, overweight",NA,,NA,,53,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, overweight",NA,,NA,,53,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,52,Mean,years,34.9,0.8,5.8,29.1,40.7,SD,years,34.9,34,30,30,0.804315,5.8,29.1,40.7,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,52,Mean,kg/m^2,32.1,0.83,6,26.1,38.1,SD,kg/m^2,32.1,32,30,30,0.83205,6,26.1,38.1,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,52,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,52,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"$41,000-$70,000","Household income, $41,000-$70,000",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"$41,000-$70,000","Household income, $41,000-$70,000",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"<= $41,000","Household income, <= $41,000",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,"<= $41,000","Household income, <= $41,000",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,">= $70,000","Household income, >= $70,000",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Lifestyle,Household income,">= $70,000","Household income, >= $70,000",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, black or africa american",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, black or africa american",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, american indian or alaska native",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, american indian or alaska native",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, asian",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, asian",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, white or caucasian",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, white or caucasian",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,Other and multiracial,NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,Other and multiracial,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,BMI obesity class 1,NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I,BMI obesity class 1,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,BMI obesity class 2,NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese II,BMI obesity class 2,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,BMI obesity class 3,NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,BMI obesity class 3,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, overweight",NA,,NA,,52,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 2,Treatment,NA,PP,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, overweight",NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,34,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,19,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,34,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,19,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,0,weeks,0,34,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,0,weeks,0,19,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,34,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,19,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,0,weeks,0,34,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,0,weeks,0,19,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,34,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,19,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,0,weeks,0,34,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,0,weeks,0,19,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,12,weeks,12,34,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,12,weeks,12,19,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,34,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,19,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Female,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,12,weeks,12,34,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,Male,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,12,weeks,12,19,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,53,Percentage,%,64.1509,,,,,NA,%,64.1509,64,60,60,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,53,Percentage,%,35.8491,,,,,NA,%,35.8491,35,35,30,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,30,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,22,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,30,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,22,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,0,weeks,0,30,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,0,weeks,0,22,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,30,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Subcutaneous abdominal adipose tissue,SAAT,NA,12,weeks,12,22,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,0,weeks,0,30,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,0,weeks,0,22,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,30,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,VAT,NA,12,weeks,12,22,Mean,g,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,0,weeks,0,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,0,weeks,0,22,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,12,weeks,12,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body fat,VS ratio,VS ratio,NA,12,weeks,12,22,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,30,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,22,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Female,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,12,weeks,12,30,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,Male,PP,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,12,weeks,12,22,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,52,Percentage,%,57.6923,,,,,NA,%,57.6923,57,55,50,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 3,Treatment,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,52,Percentage,%,42.3077,,,,,NA,%,42.3077,42,40,40,,,,,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,0,weeks,0,21,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,0,weeks,0,13,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,12,weeks,12,21,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,12,weeks,12,13,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,21,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,13,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,21,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,13,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,0,weeks,0,21,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,0,weeks,0,13,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,12,weeks,12,21,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,12,weeks,12,13,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,0,weeks,0,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,0,weeks,0,13,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,12,weeks,12,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,12,weeks,12,13,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,0,weeks,0,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,0,weeks,0,13,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Female,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,12,weeks,12,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Control,Male,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,12,weeks,12,13,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,0,weeks,0,16,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,0,weeks,0,14,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,12,weeks,12,16,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Fasting glucose,Blood,12,weeks,12,14,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,16,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,14,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,16,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,14,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,0,weeks,0,16,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,0,weeks,0,14,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,12,weeks,12,16,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Fasting insulin,Blood,12,weeks,12,14,Mean,uIU/L,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,0,weeks,0,14,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,12,weeks,12,16,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,Blood,12,weeks,12,14,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,0,weeks,0,14,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Female,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,12,weeks,12,16,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
34,Khan 2021,Intervention,Persea americana for Total Health (PATH) Study (NCT02740439),Table 4,Treatment,Male,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda index,Blood,12,weeks,12,14,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,644,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,644,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,644,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,644,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,644,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,644,Mean,Years,50,0.15,3.8,46.2,53.8,SD,years,50,50,50,50,0.149741,3.8,46.2,53.8,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,644,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,644,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,644,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,644,Mean,mg/dL,53.3,0.51,12.9,40.4,66.2,SD,mg/dL,53.3,53,50,50,0.508331,12.9,40.4,66.2,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,644,Mean,mg/dL,111,1.02,25.9,85.1,136.9,SD,mg/dL,111,111,110,110,1.0206,25.9,85.1,136.9,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,644,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,644,Percentage,%,52,,,,,NA,%,52,52,50,50,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,644,Percentage,%,48,,,,,NA,%,48,48,45,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,644,Mean,mg/dL,94.2,2.27,57.5,36.7,151.7,SD,mg/dL,94.2,94,90,90,2.26582,57.5,36.7,151.7,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,644,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,646,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,646,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,646,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,646,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,646,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,646,Mean,Years,49,0.15,3.8,45.2,52.8,SD,years,49,49,45,40,0.149509,3.8,45.2,52.8,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,646,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,646,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,646,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,646,Mean,mg/dL,51.9,0.45,11.4,40.5,63.3,SD,mg/dL,51.9,51,50,50,0.448527,11.4,40.5,63.3,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,646,Mean,mg/dL,110,1,25.5,84.5,135.5,SD,mg/dL,110,110,110,110,1.00328,25.5,84.5,135.5,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,646,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,646,Percentage,%,60,,,,,NA,%,60,60,60,60,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,646,Percentage,%,40,,,,,NA,%,40,40,40,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,646,Mean,mg/dL,87,1.64,41.7,45.3,128.7,SD,mg/dL,87,87,85,80,1.64066,41.7,45.3,128.7,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q1 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,646,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,646,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,646,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,646,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,646,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,646,Mean,Years,51,0.14,3.5,47.5,54.5,SD,years,51,51,50,50,0.137706,3.5,47.5,54.5,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,646,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,646,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,646,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,646,Mean,mg/dL,53,0.51,13,40,66,SD,mg/dL,53,53,50,50,0.511478,13,40,66,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,646,Mean,mg/dL,111,1,25.3,85.7,136.3,SD,mg/dL,111,111,110,110,0.995415,25.3,85.7,136.3,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,646,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,646,Percentage,%,55,,,,,NA,%,55,55,55,50,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,646,Percentage,%,45,,,,,NA,%,45,45,45,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,646,Mean,mg/dL,93.5,2.44,62,31.5,155.5,SD,mg/dL,93.5,93,90,90,2.43936,62,31.5,155.5,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,646,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,647,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,647,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,647,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,647,Mean,Years,50,0.14,3.5,46.5,53.5,SD,years,50,50,50,50,0.137599,3.5,46.5,53.5,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,647,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,647,Mean,mg/dL,53.7,0.5,12.6,41.1,66.3,SD,mg/dL,53.7,53,50,50,0.495357,12.6,41.1,66.3,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,647,Mean,mg/dL,111,1.04,26.4,84.6,137.4,SD,mg/dL,111,111,110,110,1.03789,26.4,84.6,137.4,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,647,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,647,Percentage,%,57,,,,,NA,%,57,57,55,50,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,647,Percentage,%,43,,,,,NA,%,43,43,40,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,647,Mean,mg/dL,89,1.8,45.9,43.1,134.9,SD,mg/dL,89,89,85,80,1.80452,45.9,43.1,134.9,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q3 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,647,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,647,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,647,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,647,Mean,Years,50,0.14,3.6,46.4,53.6,SD,years,50,50,50,50,0.141531,3.6,46.4,53.6,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,647,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,647,Mean,mg/dL,54.3,0.5,12.8,41.5,67.1,SD,mg/dL,54.3,54,50,50,0.50322,12.8,41.5,67.1,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,647,Mean,mg/dL,110,0.99,25.2,84.8,135.2,SD,mg/dL,110,110,110,110,0.990714,25.2,84.8,135.2,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,647,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,647,Percentage,%,62,,,,,NA,%,62,62,60,60,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,647,Percentage,%,38,,,,,NA,%,38,38,35,30,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,647,Mean,mg/dL,88.8,1.88,47.9,40.9,136.7,SD,mg/dL,88.8,88,85,80,1.88314,47.9,40.9,136.7,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 fruit intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,647,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,647,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,647,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,647,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,647,Mean,Years,51,0.13,3.4,47.6,54.4,SD,years,51,51,50,50,0.133668,3.4,47.6,54.4,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,647,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,647,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,647,Mean,mg/dL,55.5,0.52,13.2,42.3,68.7,SD,mg/dL,55.5,55,55,50,0.518946,13.2,42.3,68.7,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,647,Mean,mg/dL,109,1.03,26.3,82.7,135.3,SD,mg/dL,109,109,105,100,1.03396,26.3,82.7,135.3,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,647,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,647,Percentage,%,55,,,,,NA,%,55,55,55,50,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,647,Percentage,%,45,,,,,NA,%,45,45,45,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,647,Mean,mg/dL,92.8,2.56,65.1,27.7,157.9,SD,mg/dL,92.8,92,90,90,2.55935,65.1,27.7,157.9,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Q5 veg intake,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,647,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,3231,Median,mL/d,NA,NA,NA,NA,NA,IQR,mL/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,3231,Mean,Thousand kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,3231,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Dietary,Carotenoids,Lycopene,Lycopene,Lycopene,NA,,NA,,3231,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Dietary,Carotenoids,β-carotene,β-carotene,b-carotene,NA,,NA,,3231,Mean,mg/d,NA,NA,NA,NA,NA,SD,μg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Age,Age,Age at Y25,Age at Y25,NA,,NA,,3231,Mean,Years,50,0.06,3.6,46.4,53.6,SD,years,50,50,50,50,0.0633336,3.6,46.4,53.6,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,DBP,NA,,NA,,3231,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,SBP,NA,,NA,,3231,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education attained at Y25, >= 16",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education attained at Y25, 12-15.9",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education attained at Y25, <12",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting blood glucose,NA,,NA,,3231,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,Plasma HDL-C,NA,,NA,,3231,Mean,mg/dL,53.6,0.23,12.8,40.8,66.4,SD,mg/dL,53.6,53,50,50,0.225186,12.8,40.8,66.4,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,Plasma LDL-C,NA,,NA,,3231,Mean,mg/dL,111,0.46,26,85,137,SD,mg/dL,111,111,110,110,0.457409,26,85,137,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,3231,Median,Exercise unit,NA,NA,NA,NA,NA,IQR,Exercise unit,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,3231,Percentage,%,56,,,,,NA,%,56,56,55,50,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,3231,Percentage,%,44,,,,,NA,%,44,44,40,40,,,,,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking status, current smoker",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking status, former smoker",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking status, never smoker",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Plasma triglycerides,NA,,NA,,3231,Mean,mg/dL,91.3,0.96,54.4,36.9,145.7,SD,mg/dL,91.3,91,90,90,0.957041,54.4,36.9,145.7,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, 18.5-24.9",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 1,Total,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,"BMI, <18.5",NA,,NA,,3231,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,542,Average,serving/d,0.02,,,0.01,0.04,"min,max",g/d,0.75,0,0,0,,,0.375,1.5,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 1,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 2,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 1,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 2,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 1,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 1,Model 2,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,542,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,537,Average,serving/d,0.105,,,0.04,0.17,"min,max",g/d,3.9375,3,0,0,,,1.5,6.375,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 1,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 2,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 1,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 2,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 1,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 2,Model 2,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,537,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,553,Average,serving/d,0.17,,,0.17,3,"min,max",g/d,6.375,6,5,0,,,6.375,3,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 1,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 2,NA,Non-consumers,Outcome,Cognition,DSST symbols,DSST symbols,DSST symbols,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 1,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 2,NA,Non-consumers,Outcome,Cognition,RAVLT words,RAVLT words,RAVLT words,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 1,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Avo and guacamole level 3,Model 2,NA,Non-consumers,Outcome,Cognition,Stroop test points,Stroop test points,Stroop test points,NA,,NA,,553,Mean difference,Score,NA,NA,NA,NA,NA,95%CI,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table 2,Nonconsumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1599,Average,serving/d,0,,,,,NA,g/d,0,0,0,0,,,,,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q1 fruit intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,644,Mean,serving/d,0.039,,0.13,,,SD,g/d,1.4625,1,0,0,,4.875,0,6.3375,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q1 veg intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,646,Mean,serving/d,0.011,,0.04,,,SD,g/d,0.4125,0,0,0,,1.3125,0,1.725,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q3 fruit intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,646,Mean,serving/d,0.11,,0.3,,,SD,g/d,4.125,4,0,0,,11.25,0,15.375,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q3 veg intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,647,Mean,serving/d,0.066,,0.12,,,SD,g/d,2.475,2,0,0,,4.5,0,6.975,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q5 fruit intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,647,Mean,serving/d,0.19,,0.44,,,SD,g/d,7.125,7,5,0,,16.5,0,23.625,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Q5 veg intake,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,647,Mean,serving/d,0.28,,0.51,,,SD,g/d,10.5,10,10,10,,19.125,0,29.625,1 serving=1/4 avo;37.5g/.25avo
35,Mao 2019,Observation,Coronary Artery Risk Development in Young Adults Study (CARDIA),Table1,Total,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,3231,Mean,serving/d,0.1,,0.27,,,SD,g/d,3.75,3,0,0,,10.125,0,13.875,1 serving=1/4 avo;37.5g/.25avo
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Estimated,Consumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,193,Average,g/d,125.224,16.35,227.15,,,SD,g/d,125.224,125,125,120,16.3504,227.147,0,352.371,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Consumer,NA,NA,Summary,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,187,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Consumer,NA,NA,Summary,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,188,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Consumer,NA,NA,Summary,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,188,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Consumer,NA,NA,Summary,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,192,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Consumer,NA,NA,Summary,Outcome,Cognition,Global cognition,Global cognition,Global cognition,NA,,NA,,185,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Non-consumer,NA,NA,Summary,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,2640,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Non-consumer,NA,NA,Summary,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,2652,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Non-consumer,NA,NA,Summary,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,2654,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Non-consumer,NA,NA,Summary,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,2573,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Fig 2,Non-consumer,NA,NA,Summary,Outcome,Cognition,Global cognition,Global cognition,Global cognition,NA,,NA,,2513,Mean,z-score,NA,NA,NA,NA,NA,95%CI,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Results section,Non-consumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,2693,Average,g/d,0,,,,,NA,g/d,0,0,0,0,0,0,,,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,2886,Mean,kcals/day,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,2886,Mean,Years,69.3,0.2,10.74,58.56,80.04,SD,years,69.3,69,65,60,0.2,10.7443,58.5557,80.0443,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,Alcohol drinker,Alcohol drinker,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,2886,Mean,kg/m^2,29.1,0.2,10.74,18.36,39.84,SD,kg/m^2,29.1,29,25,20,0.2,10.7443,18.3557,39.8443,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,CHD,Coronary heart disease,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,Stroke,Stroke,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Prediabetes or diabetes,Prediabetes or diabetes,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, College graduate or above",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,"Education, High school grad/GED",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,"Education, <9th grade",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, Some college or AA",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, 9-11th grade",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Divorced,"Marital status, Divorced",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Living with partner,"Marital status, Living with partner",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Married,"Marital status, Married",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Separated,"Marital status, Separated",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,"Marital status, Never married",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Widowed,"Marital status, Widowed",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Moderate","Work activity, Moderate",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Other","Work activity, Other",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Vigorous","Work activity, Vigorous",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Recreation activities, Moderate",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Recreation activities, Vigorous",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,Poverty Index Ratio,Family income to povery ratio,NA,,NA,,2886,Mean,Ratio,NA,NA,NA,NA,NA,SD,Ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, Non-hispanic black",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Race, Non-hispanic Asian",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Non-hispanic white",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, Mexican American",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,"Race, Other race-including multi-racial",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Other Hispanic,"Race, Other hispanic",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreation activities, Other","Recreation activities, Other",NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,2886,Percentage,%,53.8,,,,,NA,%,53.8,53,50,50,,,,,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,2886,Percentage,%,46.2,,,,,NA,%,46.2,46,45,40,,,,,
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,2886,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,Mediterranean Diet Score,NA,,NA,,2886,Mean,Score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,193,Mean,kcals/day,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,193,Mean,Score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,193,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,193,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,193,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,193,Mean,Years,67.9,0.5,6.95,60.95,74.85,SD,years,67.9,67,65,60,0.5,6.94622,60.9538,74.8462,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,Alcohol drinker,Alcohol drinker,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,193,Mean,kg/m^2,27.5,0.7,9.72,17.78,37.22,SD,kg/m^2,27.5,27,25,20,0.7,9.72471,17.7753,37.2247,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,CHD,Coronary heart disease,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,Stroke,Stroke,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Prediabetes or diabetes,Prediabetes or diabetes,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, College graduate or above",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,"Education, High school grad/GED",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,"Education, <9th grade",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, Some college or AA",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, 9-11th grade",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Divorced,"Marital status, Divorced",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Living with partner,"Marital status, Living with partner",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Married,"Marital status, Married",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Separated,"Marital status, Separated",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,"Marital status, Never married",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Widowed,"Marital status, Widowed",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Moderate","Work activity, Moderate",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Other","Work activity, Other",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Vigorous","Work activity, Vigorous",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Recreation activities, Moderate",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Recreation activities, Vigorous",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,Poverty Index Ratio,Family income to povery ratio,NA,,NA,,193,Mean,Ratio,NA,NA,NA,NA,NA,SD,Ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, Non-hispanic black",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Race, Non-hispanic Asian",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Non-hispanic white",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, Mexican American",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,"Race, Other race-including multi-racial",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Other Hispanic,"Race, Other hispanic",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreation activities, Other","Recreation activities, Other",NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,193,Percentage,%,62,,,,,NA,%,62,62,60,60,,,,,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,193,Percentage,%,38,,,,,NA,%,38,38,35,30,,,,,
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,193,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,Mediterranean Diet Score,NA,,NA,,193,Mean,Score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,2693,Mean,kcals/day,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,2693,Mean,Score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,2693,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,2693,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,2693,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,2693,Mean,Years,69.4,0.2,10.38,59.02,79.78,SD,years,69.4,69,65,60,0.2,10.3788,59.0212,79.7788,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,Alcohol drinker,Alcohol drinker,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,2693,Mean,kg/m^2,29.3,0.2,10.38,18.92,39.68,SD,kg/m^2,29.3,29,25,20,0.2,10.3788,18.9212,39.6788,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,CHD,Coronary heart disease,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Health status,Cardiovascular diseases,Stroke,Stroke,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Prediabetes or diabetes,Prediabetes or diabetes,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,"Education, College graduate or above",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,"Education, High school grad/GED",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,"Education, <9th grade",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, Some college or AA",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,"Education, 9-11th grade",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Divorced,"Marital status, Divorced",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Living with partner,"Marital status, Living with partner",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Married,"Marital status, Married",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Separated,"Marital status, Separated",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,"Marital status, Never married",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Marriage status,Widowed,"Marital status, Widowed",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Moderate","Work activity, Moderate",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Other","Work activity, Other",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, Vigorous","Work activity, Vigorous",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Recreation activities, Moderate",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Recreation activities, Vigorous",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Poverty Index Ratio,Poverty Index Ratio,Family income to povery ratio,NA,,NA,,2693,Mean,Ratio,NA,NA,NA,NA,NA,SD,Ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Race, Non-hispanic black",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Race, Non-hispanic Asian",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Non-hispanic white",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, Mexican American",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,"Race, Other race-including multi-racial",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Other Hispanic,"Race, Other hispanic",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreation activities, Other","Recreation activities, Other",NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,2693,Percentage,%,53.2,,,,,NA,%,53.2,53,50,50,,,,,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,2693,Percentage,%,46.8,,,,,NA,%,46.8,46,45,40,,,,,
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,2693,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table 1,Non-consumer,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,Mediterranean Diet Score,NA,,NA,,2693,Mean,Score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 1,NA,Non-consumer,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,2827,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 2,NA,Non-consumer,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,2608,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 3,NA,Non-consumer,Outcome,Cognition,Animal fluency test,Animal fluency test,Animal fluency test,NA,,NA,,2521,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 1,NA,Non-consumer,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,2840,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 2,NA,Non-consumer,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,2619,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 3,NA,Non-consumer,Outcome,Cognition,CERAD delayed recall,CERAD delayed recall,CERAD delayed recall,NA,,NA,,2531,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 1,NA,Non-consumer,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,2842,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 2,NA,Non-consumer,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,2621,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 3,NA,Non-consumer,Outcome,Cognition,CERAD immediate learning,CERAD immediate learning,CERAD immediate learning,NA,,NA,,2532,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 1,NA,Non-consumer,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,2765,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 2,NA,Non-consumer,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,2553,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 3,NA,Non-consumer,Outcome,Cognition,DSST symbols,DSST symbols,Digit symbol substitution test,NA,,NA,,2477,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 1,NA,Non-consumer,Outcome,Cognition,Global cognition,Global cognition,Global cognition,NA,,NA,,2698,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 2,NA,Non-consumer,Outcome,Cognition,Global cognition,Global cognition,Global cognition,NA,,NA,,2491,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
36,Cheng 2021,Observation,National Health and Nutrition Examination Survey (NHANES 2011-2014),Table S1,Consumer,Model 3,NA,Non-consumer,Outcome,Cognition,Global cognition,Global cognition,Global cognition,NA,,NA,,2417,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Results section,All,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12153,Mean,g/d,2.56,,,2.37,2.75,95%CI,g/d,2.56,2,0,0,,,2.37,2.75,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Results section,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1898,Mean,g/d,16.09,,,15.41,16.78,95%CI,g/d,16.09,16,15,10,,,15.41,16.78,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Results section,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,1898,B Coefficient,NA,-0.03,,,-0.04,-0.01,95%CI,NA,-0.03,-1,-5,-10,,,-0.04,-0.01,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Results section,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Results section,Consumers,NA,NA,Non-consumers,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,Adults,Adults 18-64 years,NA,,NA,,12153,Percentage,%,60.3308,,,,,NA,%,,,,,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,Children,Children 2-8 years,NA,,NA,,12153,Percentage,%,10.3102,,,,,NA,%,10.3102,10,10,10,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,Children,Children 9-13 years,NA,,NA,,12153,Percentage,%,6.47577,,,,,NA,%,6.47577,6,5,0,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,Older adults,Older adults 65+ years,NA,,NA,,12153,Percentage,%,17.3044,,,,,NA,%,17.3044,17,15,10,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,12153,Percentage,%,53.0815,,,,,NA,%,53.0815,53,50,50,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,12153,Percentage,%,46.9185,,,,,NA,%,46.9185,46,45,40,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree/Advanced diploma,NA,,NA,,1898,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 2,All,NA,NA,Summary,Subject Characteristics,Age,Age group,Adolescents,Children 14-17 years,NA,,NA,,12153,Percentage,%,5.57887,,,,,NA,%,5.57887,5,5,0,,,,,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,No non-school qualification,NA,,NA,,1898,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Post-graduate,Postgraduate/Graduate degree,NA,,NA,,1898,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,Certificate,NA,,NA,,1898,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Ca,NA,,NA,,1898,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,1898,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Mg,NA,,NA,,1898,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,1898,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,1898,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Na,NA,,NA,,1898,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,1898,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Ca,NA,,NA,,10255,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,10255,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Mg,NA,,NA,,10255,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,10255,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,10255,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Na,NA,,NA,,10255,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 3,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,10255,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Minerals,Calcium,Calcium,Ca,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Macronutrients,Fat,Fat,Total fats,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Minerals,Magnesium,Magnesium,Mg,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Minerals,Sodium,Sodium,Na,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table 4,Consumers,NA,NA,Non-consumers,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,1898,B Coefficient,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"14-17 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,322,Mean,g/d,1.65,,,0.88,2.42,95%CI,g/d,1.65,1,0,0,,,0.88,2.42,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"14-17 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,356,Mean,g/d,0.77,,,0.26,1.28,95%CI,g/d,0.77,0,0,0,,,0.26,1.28,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"2-8 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,628,Mean,g/d,0.85,,,0.35,1.36,95%CI,g/d,0.85,0,0,0,,,0.35,1.36,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"2-8 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,625,Mean,g/d,0.95,,,0.33,1.56,95%CI,g/d,0.95,0,0,0,,,0.33,1.56,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"9-13 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,395,Mean,g/d,0.77,,,0.32,1.23,95%CI,g/d,0.77,0,0,0,,,0.32,1.23,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"9-13 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,392,Mean,g/d,0.63,,,0.14,1.12,95%CI,g/d,0.63,0,0,0,,,0.14,1.12,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Adult, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,3913,Mean,g/d,3.7,,,3.37,4.04,95%CI,g/d,3.7,3,0,0,,,3.37,4.04,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Adult, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,3419,Mean,g/d,2.37,,,2.02,2.72,95%CI,g/d,2.37,2,0,0,,,2.02,2.72,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Older adults, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1193,Mean,g/d,3.38,,,2.78,3.99,95%CI,g/d,3.38,3,0,0,,,2.78,3.99,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Older adults, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,910,Mean,g/d,2.16,,,1.53,2.8,95%CI,g/d,2.16,2,0,0,,,1.53,2.8,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"14-17 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,322,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"14-17 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,356,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"2-8 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,628,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"2-8 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,625,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"9-13 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,395,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"9-13 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,392,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Adult, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,3913,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Adult, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,3419,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Older adults, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1193,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,All,"Older adults, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,910,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"14-17 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,34,Mean,g/d,16.94,,,12.86,21.01,95%CI,g/d,16.94,16,15,10,,,12.86,21.01,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"14-17 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Mean,g/d,16.35,,,10.22,22.47,95%CI,g/d,16.35,16,15,10,,,10.22,22.47,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"2-8 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,30,Mean,g/d,19.24,,,12.96,25.52,95%CI,g/d,19.24,19,15,10,,,12.96,25.52,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"2-8 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,25,Mean,g/d,19.07,,,11.02,27.12,95%CI,g/d,19.07,19,15,10,,,11.02,27.12,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"9-13 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,32,Mean,g/d,11.99,,,7.05,16.94,95%CI,g/d,11.99,11,10,10,,,7.05,16.94,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"9-13 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Mean,g/d,12.57,,,6.91,18.22,95%CI,g/d,12.57,12,10,10,,,6.91,18.22,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Adult, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,816,Mean,g/d,17.13,,,16.07,18.19,95%CI,g/d,17.13,17,15,10,,,16.07,18.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Adult, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,513,Mean,g/d,15.84,,,14.29,17.4,95%CI,g/d,15.84,15,15,10,,,14.29,17.4,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Older adults, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,265,Mean,g/d,14.03,,,12.28,15.78,95%CI,g/d,14.03,14,10,10,,,12.28,15.78,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Older adults, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,148,Mean,g/d,13.61,,,11.39,15.83,95%CI,g/d,13.61,13,10,10,,,11.39,15.83,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"14-17 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,34,Median,g/d,15.91,,,6.84,21.19,IQR,g/d,15.91,15,15,10,,,6.84,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"14-17 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Median,g/d,10.9,,,9.08,21.37,IQR,g/d,10.9,10,10,10,,,9.08,21.37,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"2-8 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,30,Median,g/d,18.18,,,9.8,27.4,IQR,g/d,18.18,18,15,10,,,9.8,27.4,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"2-8 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,25,Median,g/d,12.68,,,6.05,31.26,IQR,g/d,12.68,12,10,10,,,6.05,31.26,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"9-13 years, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,32,Median,g/d,6.84,,,5.16,21.19,IQR,g/d,6.84,6,5,0,,,5.16,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"9-13 years, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,15,Median,g/d,12.64,,,6.05,18.29,IQR,g/d,12.64,12,10,10,,,6.05,18.29,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Adult, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,816,Median,g/d,12.88,,,7.58,21.19,IQR,g/d,12.88,12,10,10,,,7.58,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Adult, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,513,Median,g/d,10.9,,,7.26,21.19,IQR,g/d,10.9,10,10,10,,,7.26,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Older adults, female",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,265,Median,g/d,10.78,,,6.84,21.19,IQR,g/d,10.78,10,10,10,,,6.84,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,Consumers,"Older adults, male",Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,148,Median,g/d,7.92,,,6.05,18.03,IQR,g/d,7.92,7,5,0,,,6.05,18.03,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, Bachelor degree",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,581,Mean,g/d,16.89,,,15.46,18.32,95%CI,g/d,16.89,16,15,10,,,15.46,18.32,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, Bachelor degree",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,581,Median,g/d,11.91,,,7.58,21.19,IQR,g/d,11.91,11,10,10,,,7.58,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, certificate",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,345,Mean,g/d,16,,,14.36,17.64,95%CI,g/d,16,16,15,10,,,14.36,17.64,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, certificate",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,345,Median,g/d,10.9,,,6.84,21.19,IQR,g/d,10.9,10,10,10,,,6.84,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, non-school qualification",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,642,Mean,g/d,15.5,,,14.32,16.69,95%CI,g/d,15.5,15,15,10,,,14.32,16.69,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, non-school qualification",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,642,Median,g/d,10.9,,,6.84,21.19,IQR,g/d,10.9,10,10,10,,,6.84,21.19,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, post-grad degree",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,197,Mean,g/d,16.27,,,13.43,19.1,95%CI,g/d,16.27,16,15,10,,,13.43,19.1,NA
37,Guan 2022,Observation,National Nutrition and Physical Activity Survey (NNPAS),Table1,"Education, post-grad degree",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,197,Median,g/d,11.32,,,6.84,21.19,IQR,g/d,11.32,11,10,10,,,6.84,21.19,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Annex,Avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Average,kcal from avocado,162,,,,,NA,g/d,101.25,101,100,100,,,,,240kcal/avo;150g/avo
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Annex,Donut,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Average,kcal from avocado,0,,,,,NA,g/d,0,0,0,0,,,,,240kcal/avo;150g/avo
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Annex,Fruit,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Average,kcal from avocado,0,,,,,NA,g/d,0,0,0,0,,,,,240kcal/avo;150g/avo
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Annex,Hamburger,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12,Average,kcal from avocado,0,,,,,NA,g/d,0,0,0,0,,,,,240kcal/avo;150g/avo
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 1,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 0h,Subjects with normal endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 4h,Subjects with normal endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 0h,Subjects with normal endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 4h,Subjects with normal endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 0h,Subjects with normal endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 4h,Subjects with normal endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 0h,Subjects with normal endothelial function,NA,0,weeks,0,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Subjects with normal endothelial function 4h,Subjects with normal endothelial function,NA,,NA,,16,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 0h,Endothelial function,NA,0,weeks,0,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Figure 3,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Endothelial function,Endothelial function 4h,Endothelial function,NA,,NA,,16,Mean,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,16,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,16,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,16,Mean,years,23.5,0.65,2.58,20.92,26.08,SD,years,23.5,23,20,20,0.645,2.58,20.92,26.08,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,16,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,16,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,16,Mean,kg/m^2,24.1,0.2,0.8,23.3,24.9,SD,kg/m^2,24.1,24,20,20,0.2,0.8,23.3,24.9,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Size,Size,NA,,NA,,16,Mean,m^2,NA,NA,NA,NA,NA,SD,m^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 0h,"Diameter of the brachial artery, post",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 4h,"Diameter of the brachial artery, post",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 0h,"Diameter of the brachial artery, pre",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Avocado,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 4h,"Diameter of the brachial artery, pre",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 0h,"Diameter of the brachial artery, post",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 4h,"Diameter of the brachial artery, post",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 0h,"Diameter of the brachial artery, pre",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Donut,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 4h,"Diameter of the brachial artery, pre",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 0h,"Diameter of the brachial artery, post",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 4h,"Diameter of the brachial artery, post",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 0h,"Diameter of the brachial artery, pre",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Fruit,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 4h,"Diameter of the brachial artery, pre",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 0h,"Diameter of the brachial artery, post",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery post 4h,"Diameter of the brachial artery, post",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 0h,"Diameter of the brachial artery, pre",NA,0,weeks,0,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
39,Prado-Zavala 2020,Intervention,Prado-Zavala 2020,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,Diameter of the brachial artery pre 4h,"Diameter of the brachial artery, pre",NA,,NA,,16,Mean,mm,NA,NA,NA,NA,NA,SD,mm,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Fig 1,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Distribution density,DQI distribution density,DQI distribution density,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Fig 1,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Distribution density,DQI distribution density,DQI distribution density,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Fig 2,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,Adequacy of intake,Adequacy of intake,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Fig 2,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,Adequacy of intake,Adequacy of intake,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Results section,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,319,Mean,g/wk,62,,,,,NA,g/d,8.85714,8,5,0,,,,,7d/wk
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,319,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,319,Mean,Years,15.2,0.1,1.7,13.5,16.9,SD,years,15.2,15,15,10,0.0951817,1.7,13.5,16.9,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,non-vegetarian,NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,non-vegetarian,NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,vegetarian,NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,vegetarian,NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, College","Father's education, College",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, College","Father's education, College",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, Graduate","Father's education, Graduate",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, Graduate","Father's education, Graduate",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, HS or less","Father's education, HS or less",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, HS or less","Father's education, HS or less",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,319,Median,Min/d,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, AA",NA,,NA,,319,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, AA",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, Caucasian",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, Caucasian",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Hispanic",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Hispanic",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, Other",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, Other",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,319,Absolute value,Count,188,,,,,NA,Count,188,188,185,180,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,319,Percentage,%,58.9,,,,,NA,%,58.9,58,55,50,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,319,Absolute value,Count,131,,,,,NA,Count,131,131,130,130,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,319,Percentage,%,41.1,,,,,NA,%,41.1,41,40,40,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, California","Site, California",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, California","Site, California",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, Michigan","Site, Michigan",NA,,NA,,319,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, Michigan","Site, Michigan",NA,,NA,,319,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Sleep,Sleep,Sleep,NA,,NA,,319,Mean,Hours,NA,NA,NA,NA,NA,SD,Hours,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,215,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,215,Mean,Years,14.8,0.12,1.8,13,16.6,SD,years,14.8,14,10,10,0.122759,1.8,13,16.6,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,non-vegetarian,NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Non-vegetarian,non-vegetarian,NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,vegetarian,NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Diet pattern,Vegetarian,vegetarian,NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, College","Father's education, College",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, College","Father's education, College",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, Graduate","Father's education, Graduate",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, Graduate","Father's education, Graduate",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, HS or less","Father's education, HS or less",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Father's education, HS or less","Father's education, HS or less",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,215,Median,Min/d,NA,NA,NA,NA,NA,IQR,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, AA",NA,,NA,,215,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, AA",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, Caucasian",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, Caucasian",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Hispanic",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Hispanic",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, Other",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Race,Other race,"Ethnicity, Other",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,215,Absolute value,Count,116,,,,,NA,Count,116,116,115,110,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,215,Percentage,%,54,,,,,NA,%,54,54,50,50,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,215,Absolute value,Count,99,,,,,NA,Count,99,99,95,90,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,215,Percentage,%,46,,,,,NA,%,46,46,45,40,,,,,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, California","Site, California",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, California","Site, California",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, Michigan","Site, Michigan",NA,,NA,,215,Absolute value,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Other,Site,"Site, Michigan","Site, Michigan",NA,,NA,,215,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 2,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Sleep,Sleep,Sleep,NA,,NA,,215,Mean,Hours,NA,NA,NA,NA,NA,SD,Hours,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, fatty acid ratio","Balance, fatty acid ratio",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, macronutrient ratio","Balance, macronutrient ratio",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, overall",Balance,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, dietary cholesterol","Moderation, dietary cholesterol",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, empty calorie foods intake","Moderation, empty calorie foods intake",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, overall",Moderation,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, saturated fat intake","Moderation, saturated fat intake",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, sodium intake","Moderation, sodium intake",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, total fat intake","Moderation, total fat intake",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Overall food group variety,Overall food group variety,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Variety,Variety,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Within-group variety for protein source,Within-group variety for protein source,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, calcium","Adequacy, calcium",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, fiber","Adequacy, fiber",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, fruit group","Adequacy, fruit group",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, grain group","Adequacy, grain group",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, iron","Adequacy, iron",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, overall",Adequacy,NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, protein","Adequacy, protein",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, vegetable group","Adequacy, vegetable group",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, vitamin C","Adequacy, vitamin C",NA,,NA,,319,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,DQI-I total,DQI-I total,NA,,NA,,319,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, fatty acid ratio","Balance, fatty acid ratio",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, macronutrient ratio","Balance, macronutrient ratio",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Balance,"Balance, overall",Balance,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, dietary cholesterol","Moderation, dietary cholesterol",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, empty calorie foods intake","Moderation, empty calorie foods intake",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, overall",Moderation,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, saturated fat intake","Moderation, saturated fat intake",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, sodium intake","Moderation, sodium intake",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,"Moderation, total fat intake","Moderation, total fat intake",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Overall food group variety,Overall food group variety,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Variety,Variety,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Diet Quality Index,Within-group variety for protein source,Within-group variety for protein source,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Calcium","Adequacy, Calcium",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Fiber","Adequacy, Fiber",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Fruit group","Adequacy, Fruit group",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Grain group","Adequacy, Grain group",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Iron","Adequacy, Iron",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, overall",Adequacy,NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, Protein","Adequacy, Protein",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, vegetable group","Adequacy, vegetable group",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Nutrient Adequacy,"Adequacy, vitamin C","Adequacy, vitamin C",NA,,NA,,215,Median,Score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,DQI-I total,DQI-I score,NA,,NA,,215,EMM,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 3,Non-consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,DQI-I total,DQI-I total,NA,,NA,,215,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Anthropometry,BMI,BMI z-score,BMI z-score,NA,,NA,,,EMM,z-score,-0.05,,,-0.23,0.13,95%CI,z-score,-0.05,-1,-5,-10,,,-0.23,0.13,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI z-score,BMI z-score,NA,,NA,,319,EMM,z-score,0.28,,,0.13,0.43,95%CI,z-score,0.28,0,0,0,,,0.13,0.43,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,,C:NC ratio,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,,C:NC ratio,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,,C:NC ratio,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,319,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,319,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,319,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Non-Consumers,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,,C:NC ratio,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,319,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist to height ratio,NA,,NA,,,C:NC ratio,Ratio,NA,NA,NA,NA,NA,95%CI,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist to height ratio,NA,,NA,,319,EMM,Ratio,NA,NA,NA,NA,NA,95%CI,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,NA,NA,Summary,Outcome,Dietary patterns,Total diet,DQI-I total,DQI-I score,NA,,NA,,319,EMM,Score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Consumers,All,NA,Non-Consumers,Outcome,Dietary patterns,Total diet,DQI-I total,DQI-I score,NA,,NA,,,EMM,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI z-score,BMI z-score,NA,,NA,,215,EMM,z-score,0.33,,,0.16,0.49,95%CI,z-score,0.33,0,0,0,,,0.16,0.49,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,215,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,215,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Body fat,% body fat,NA,,NA,,215,EMM,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Fat mass,Fat mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,All,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Female,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,Male,NA,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,,NA,,215,EMM,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 4,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist to height ratio,NA,,NA,,215,EMM,Ratio,NA,NA,NA,NA,NA,95%CI,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,319,EMM,kcal/d,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Mean difference,kcal/d,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Iron,Iron,Iron,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,,NA,,319,EMM,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Other,Protein,Animal protein,Animal protein,NA,,NA,,,Mean difference,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable Protein,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Other,Protein,Vegetable protein,Vegetable Protein,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Fatty acids,Trans fat,Trans fat,Trans fat,NA,,NA,,319,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Fatty acids,Trans fat,Trans fat,Trans fat,NA,,NA,,,Mean difference,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,319,EMM,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,,Mean difference,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,,NA,,319,EMM,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,,NA,,,Mean difference,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Summary,Dietary,Minerals,Zinc,Zinc,Zinc,NA,,NA,,319,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Consumers,NA,NA,Non-Consumers,Dietary,Minerals,Zinc,Zinc,Zinc,NA,,NA,,,Mean difference,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,215,EMM,kcal/d,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,,NA,,215,EMM,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable Protein,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,Trans fat,Trans fat,Trans fat,NA,,NA,,215,EMM,g/d,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Retinol,NA,,NA,,215,EMM,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,,NA,,215,EMM,mcg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table 5,Non-consumers,NA,NA,Summary,Dietary,Minerals,Zinc,Zinc,Zinc,NA,,NA,,215,EMM,mg/d,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table2,All,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,638,Median,g/d,4.8,,,0,8.4,IQR,g/d,4.8,4,0,0,,,0,8.4,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table2,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,319,Median,g/d,6.6,,,5.3,11.8,IQR,g/d,6.6,6,5,0,,,5.3,11.8,NA
40,Segovia-Siapco 2021,Observation,Teen Food and Development Study,Table2,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,215,Median,g/d,0,,,0,0,IQR,g/d,0,0,0,0,,,0,0,NA
42,Henning 2022,Intervention,NCT05102604,Methods section,All,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,41,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
42,Henning 2022,Intervention,NCT05102604,Methods section,Avo,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Absolute value,avocado/d,1,,,,,NA,g/d,150,150,150,150,,,,,150g/avo
42,Henning 2022,Intervention,NCT05102604,Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,19,Absolute value,avocado/d,0,,,,,NA,g/d,0,0,0,0,,,,,150g/avo
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,21,Mean,years,43.1,2.86,13.1,30,56.2,SD,years,43.1,43,40,40,2.85865,13.1,30,56.2,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,21,Mean,kg/m^2,30.9,1.51,6.9,24,37.8,SD,kg/m^2,30.9,30,30,30,1.5057,6.9,24,37.8,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,21,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,21,Mean,lbs,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, Black/AA",NA,,NA,,21,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, Black/AA",NA,,NA,,21,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,21,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,21,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, White",NA,,NA,,21,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, White",NA,,NA,,21,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Latino",NA,,NA,,21,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Latino",NA,,NA,,21,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Multi-racial,"Ethnicity, Mixed",NA,,NA,,21,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Race,Race,Multi-racial,"Ethnicity, Mixed",NA,,NA,,21,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Avo,NA,PP,Summary,Subject Characteristics,Other,Skin type,Skin type,Skin type,NA,,NA,,21,Mean,Fitzpatrick skin type,NA,NA,NA,NA,NA,SD,Fitzpatrick skin type,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,19,Mean,years,48.4,2.59,11.3,37.1,59.7,SD,years,48.4,48,45,40,2.5924,11.3,37.1,59.7,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,19,Mean,kg/m^2,31.6,1.47,6.4,25.2,38,SD,kg/m^2,31.6,31,30,30,1.46826,6.4,25.2,38,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,19,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,19,Mean,lbs,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, Black/AA",NA,,NA,,19,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Ethnicity, Black/AA",NA,,NA,,19,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,19,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Ethnicity, Asian",NA,,NA,,19,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, White",NA,,NA,,19,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Ethnicity, White",NA,,NA,,19,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Latino",NA,,NA,,19,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Ethnicity, Latino",NA,,NA,,19,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Multi-racial,"Ethnicity, Mixed",NA,,NA,,19,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Multi-racial,"Ethnicity, Mixed",NA,,NA,,19,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 1,Control,NA,PP,Summary,Subject Characteristics,Other,Skin type,Skin type,Skin type,NA,,NA,,19,Mean,Fitzpatrick skin type,NA,NA,NA,NA,NA,SD,Fitzpatrick skin type,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Dermalight dose,Dermalight dose,Skin,0,weeks,0,20,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Dermalight dose,Dermalight dose,Skin,8,weeks,8,20,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Exposure time,Exposure time,Skin,0,weeks,0,20,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Exposure time,Exposure time,Skin,8,weeks,8,20,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,Minimal erythema dose,Minimal erythema dose,Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,Minimal erythema dose,Minimal erythema dose,Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Dermalight dose,Dermalight dose,Skin,0,weeks,0,19,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Dermalight dose,Dermalight dose,Skin,8,weeks,8,19,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Exposure time,Exposure time,Skin,0,weeks,0,19,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Dermalight exposure,Exposure time,Exposure time,Skin,8,weeks,8,19,Mean,sec,NA,NA,NA,NA,NA,SD,sec,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Erythema,Minimal erythema dose,Minimal erythema dose,Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 2,Control,NA,PP,Summary,Outcome,Skin health,Erythema,Minimal erythema dose,Minimal erythema dose,Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, forehead","R0, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, forehead","R1, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, forehead","R2, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, forehead","R3, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, forehead","R4, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, forehead","R5, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, forehead","R6, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, forehead","R7, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, forehead","R8, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 3,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, forehead","R9, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Avo,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R0, under eye","R0, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R1, under eye","R1, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R2, under eye","R2, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R3, under eye","R3, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R4, under eye","R4, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R5, under eye","R5, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R6, under eye","R6, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R7, under eye","R7, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R8, under eye","R8, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 4,Control,NA,PP,Summary,Outcome,Skin health,Skin elasticity,"R9, under eye","R9, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,0,weeks,0,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,4,weeks,4,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Avo,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,8,weeks,8,20,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, forehead","Erythema, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Erythema,"Erythema, under eye","Erythema, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, forehead","Hydration, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Hydration,"Hydration, under eye","Hydration, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, forehead","Melanin, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Melanin,"Melanin, under eye","Melanin, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, forehead","Sebum, forehead",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,0,weeks,0,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,4,weeks,4,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
42,Henning 2022,Intervention,NCT05102604,Table 5,Control,NA,PP,Summary,Outcome,Skin health,Sebum,"Sebum, under eye","Sebum, under eye",Skin,8,weeks,8,19,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet plus Avocado,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet plus Avocado,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet plus Avocado,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet without Avocado,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet without Avocado,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Diet section,Restricted Diet without Avocado,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Estimated,All,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,16,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,16,Mean,years,58.4,2.51,10.05,48.35,68.45,SD,years,58.4,58,55,50,2.5125,10.05,48.35,68.45,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,16,Mean,kg/m^2,29.8,0.79,3.14,26.66,32.94,SD,kg/m^2,29.8,29,25,20,0.785,3.14,26.66,32.94,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,16,Count,Count,14,,,,,NA,Count,14,14,10,10,,,,,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,16,Percentage,%,87.5,,,,,NA,%,87.5,87,85,80,,,,,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,16,Count,Count,2,,,,,NA,Count,2,2,0,0,,,,,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,16,Percentage,%,12.5,,,,,NA,%,12.5,12,10,10,,,,,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods;Estimated,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods;Estimated,Restricted diet plus avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Average,g/d,225,,,200,250,"min,max",g/d,225,225,225,220,,,200,250,NA
43,Carranza 1995,Intervention,Carranza 1995,Methods;Estimated,Restricted diet without avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16,Average,g/d,0,,,0,0,"min,max",g/d,0,0,0,0,,,0,0,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Control,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,16,Mean,mg/dL,42.66,0.81,3.25,39.41,45.91,SD,mg/dL,42.66,42,40,40,0.8125,3.25,39.41,45.91,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,16,Mean,mg/dL,152.55,2.07,8.29,144.26,160.84,SD,mg/dL,152.55,152,150,150,2.0725,8.29,144.26,160.84,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,0,weeks,0,16,Mean,mg/dL,252.5,2.43,9.7,242.8,262.2,SD,mg/dL,252.5,252,250,250,2.425,9.7,242.8,262.2,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,16,Mean,mg/dL,305.2,8.59,34.35,270.85,339.55,SD,mg/dL,305.2,305,305,300,8.5875,34.35,270.85,339.55,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,16,Mean,mg/dL,50.21,0.68,2.7,47.51,52.91,SD,mg/dL,50.21,50,50,50,0.675,2.7,47.51,52.91,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,16,Mean,mg/dL,118.5,2.9,11.6,106.9,130.1,SD,mg/dL,118.5,118,115,110,2.9,11.6,106.9,130.1,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,4,weeks,4,16,Mean,mg/dL,221.7,3.55,14.2,207.5,235.9,SD,mg/dL,221.7,221,220,220,3.55,14.2,207.5,235.9,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,16,Mean,mg/dL,270.3,16.78,67.1,203.2,337.4,SD,mg/dL,270.3,270,270,270,16.775,67.1,203.2,337.4,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,16,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,16,Mean,mg/dL,46.92,0.44,1.75,45.17,48.67,SD,mg/dL,46.92,46,45,40,0.4375,1.75,45.17,48.67,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,16,Mean,mg/dL,113.5,2.9,11.6,101.9,125.1,SD,mg/dL,113.5,113,110,110,2.9,11.6,101.9,125.1,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,"Cholesterol, total",Blood,4,weeks,4,16,Mean,mg/dL,219,2.45,9.8,209.2,228.8,SD,mg/dL,219,219,215,210,2.45,9.8,209.2,228.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 1,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,16,Mean,mg/dL,330.05,12.13,48.5,281.55,378.55,SD,mg/dL,330.05,330,330,330,12.125,48.5,281.55,378.55,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C II,"HDL-C, II",Blood,,NA,,16,Mean,mg/dL,47.99,1.13,4.5,43.49,52.49,SD,mg/dL,47.99,47,45,40,1.125,4.5,43.49,52.49,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C IV,"HDL-C, IV",Blood,,NA,,16,Mean,mg/dL,37.33,0.5,2.01,35.32,39.34,SD,mg/dL,37.33,37,35,30,0.5025,2.01,35.32,39.34,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C II,"LDL-C, II",Blood,,NA,,16,Mean,mg/dL,180.3,1.77,7.08,173.22,187.38,SD,mg/dL,180.3,180,180,180,1.77,7.08,173.22,187.38,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C IV,"LDL-C, IV",Blood,,NA,,16,Mean,mg/dL,124.8,2.38,9.5,115.3,134.3,SD,mg/dL,124.8,124,120,120,2.375,9.5,115.3,134.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol II,"Total cholesterol, II",Blood,,NA,,16,Mean,mg/dL,271.1,2.68,10.7,260.4,281.8,SD,mg/dL,271.1,271,270,270,2.675,10.7,260.4,281.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol IV,"Total cholesterol, IV",Blood,,NA,,16,Mean,mg/dL,233.6,2.18,8.7,224.9,242.3,SD,mg/dL,233.6,233,230,230,2.175,8.7,224.9,242.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides II,"Triglycerides, II",NA,,NA,,16,Mean,mg/dL,214,6.93,27.7,186.3,241.7,SD,mg/dL,214,214,210,210,6.925,27.7,186.3,241.7,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides IV,"Triglycerides, IV",NA,,NA,,16,Mean,mg/dL,396.3,10.25,41,355.3,437.3,SD,mg/dL,396.3,396,395,390,10.25,41,355.3,437.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL cholesterol, II",Blood,0,weeks,0,16,Mean,mg/dL,47.99,1.13,4.5,43.49,52.49,SD,mg/dL,47.99,47,45,40,1.125,4.5,43.49,52.49,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIa,"HDL cholesterol, IIa",Blood,0,weeks,0,16,Mean,mg/dL,51.29,1.58,6.3,44.99,57.59,SD,mg/dL,51.29,51,50,50,1.575,6.3,44.99,57.59,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIb,"HDL cholesterol, IIb",Blood,0,weeks,0,16,Mean,mg/dL,42.48,1.43,5.7,36.78,48.18,SD,mg/dL,42.48,42,40,40,1.425,5.7,36.78,48.18,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IV,"HDL cholesterol, IV",Blood,0,weeks,0,16,Mean,mg/dL,37.33,0.5,2.01,35.32,39.34,SD,mg/dL,37.33,37,35,30,0.5025,2.01,35.32,39.34,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL cholesterol, II",Blood,0,weeks,0,16,Mean,mg/dL,180.3,1.77,7.08,173.22,187.38,SD,mg/dL,180.3,180,180,180,1.77,7.08,173.22,187.38,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIa,"LDL cholesterol, IIa",Blood,0,weeks,0,16,Mean,mg/dL,177.3,2.53,10.1,167.2,187.4,SD,mg/dL,177.3,177,175,170,2.525,10.1,167.2,187.4,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIb,"LDL cholesterol, IIb",Blood,0,weeks,0,16,Mean,mg/dL,185.4,2.55,10.2,175.2,195.6,SD,mg/dL,185.4,185,185,180,2.55,10.2,175.2,195.6,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL cholesterol, IV",Blood,0,weeks,0,16,Mean,mg/dL,124.8,2.38,9.5,115.3,134.3,SD,mg/dL,124.8,124,120,120,2.375,9.5,115.3,134.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol II,"Total Cholesterol, II",Blood,0,weeks,0,16,Mean,mg/dL,271.1,2.68,10.7,260.4,281.8,SD,mg/dL,271.1,271,270,270,2.675,10.7,260.4,281.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIa,"Total Cholesterol, IIa",Blood,0,weeks,0,16,Mean,mg/dL,260.8,3.48,13.9,246.9,274.7,SD,mg/dL,260.8,260,260,260,3.475,13.9,246.9,274.7,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIb,"Total Cholesterol, IIb",Blood,0,weeks,0,16,Mean,mg/dL,288.3,3.48,13.9,274.4,302.2,SD,mg/dL,288.3,288,285,280,3.475,13.9,274.4,302.2,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IV,"Total Cholesterol, IV",Blood,0,weeks,0,16,Mean,mg/dL,233.6,2.18,8.7,224.9,242.3,SD,mg/dL,233.6,233,230,230,2.175,8.7,224.9,242.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides II,"Triglycerides, II",Blood,0,weeks,0,16,Mean,mg/dL,214,6.93,27.7,186.3,241.7,SD,mg/dL,214,214,210,210,6.925,27.7,186.3,241.7,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIa,"Triglycerides, IIa",Blood,0,weeks,0,16,Mean,mg/dL,161.1,2.73,10.9,150.2,172,SD,mg/dL,161.1,161,160,160,2.725,10.9,150.2,172,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIb,"Triglycerides, IIb",Blood,0,weeks,0,16,Mean,mg/dL,302.06,6,24,278.06,326.06,SD,mg/dL,302.06,302,300,300,6,24,278.06,326.06,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Control,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IV,"Triglycerides, IV",Blood,0,weeks,0,16,Mean,mg/dL,396.3,10.25,41,355.3,437.3,SD,mg/dL,396.3,396,395,390,10.25,41,355.3,437.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,53.34,1.01,4.04,49.3,57.38,SD,mg/dL,53.34,53,50,50,1.01,4.04,49.3,57.38,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIa,"HDL cholesterol, IIa",Blood,4,weeks,4,16,Mean,mg/dL,58.17,1.53,6.1,52.07,64.27,SD,mg/dL,58.17,58,55,50,1.525,6.1,52.07,64.27,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIb,"HDL cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,50.63,0.68,2.7,47.93,53.33,SD,mg/dL,50.63,50,50,50,0.675,2.7,47.93,53.33,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IV,"HDL cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,45.08,0.35,1.4,43.68,46.48,SD,mg/dL,45.08,45,45,40,0.35,1.4,43.68,46.48,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,131.1,2.48,9.9,121.2,141,SD,mg/dL,131.1,131,130,130,2.475,9.9,121.2,141,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIa,"LDL cholesterol, IIa",Blood,4,weeks,4,16,Mean,mg/dL,120.07,2.58,10.3,109.77,130.37,SD,mg/dL,120.07,120,120,120,2.575,10.3,109.77,130.37,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIb,"LDL cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,149.5,4.33,17.3,132.2,166.8,SD,mg/dL,149.5,149,145,140,4.325,17.3,132.2,166.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,105.9,3.35,13.4,92.5,119.3,SD,mg/dL,105.9,105,105,100,3.35,13.4,92.5,119.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol II,"Total Cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,231.8,3.78,15.1,216.7,246.9,SD,mg/dL,231.8,231,230,230,3.775,15.1,216.7,246.9,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIa,"Total Cholesterol, IIa",Blood,4,weeks,4,16,Mean,mg/dL,211.1,3.33,13.3,197.8,224.4,SD,mg/dL,211.1,211,210,210,3.325,13.3,197.8,224.4,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIb,"Total Cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,266.4,3.58,14.3,252.1,280.7,SD,mg/dL,266.4,266,265,260,3.575,14.3,252.1,280.7,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IV,"Total Cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,211.6,3.33,13.3,198.3,224.9,SD,mg/dL,211.6,211,210,210,3.325,13.3,198.3,224.9,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides II,"Triglycerides, II",Blood,4,weeks,4,16,Mean,mg/dL,227.2,8.6,34.4,192.8,261.6,SD,mg/dL,227.2,227,225,220,8.6,34.4,192.8,261.6,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIa,"Triglycerides, IIa",Blood,4,weeks,4,16,Mean,mg/dL,164.5,5.58,22.3,142.2,186.8,SD,mg/dL,164.5,164,160,160,5.575,22.3,142.2,186.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIb,"Triglycerides, IIb",Blood,4,weeks,4,16,Mean,mg/dL,331.6,6.4,25.6,306,357.2,SD,mg/dL,331.6,331,330,330,6.4,25.6,306,357.2,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet plus Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IV,"Triglycerides, IV",Blood,4,weeks,4,16,Mean,mg/dL,313.4,8.18,32.7,280.7,346.1,SD,mg/dL,313.4,313,310,310,8.175,32.7,280.7,346.1,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C II,"HDL cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,48.46,0.58,2.3,46.16,50.76,SD,mg/dL,48.46,48,45,40,0.575,2.3,46.16,50.76,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIa,"HDL cholesterol, IIa",Blood,4,weeks,4,16,Mean,mg/dL,49.54,0.73,2.9,46.64,52.44,SD,mg/dL,49.54,49,45,40,0.725,2.9,46.64,52.44,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IIb,"HDL cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,45.75,1.05,4.2,41.55,49.95,SD,mg/dL,45.75,45,45,40,1.05,4.2,41.55,49.95,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C IV,"HDL cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,45.38,0.3,1.2,44.18,46.58,SD,mg/dL,45.38,45,45,40,0.3,1.2,44.18,46.58,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C II,"LDL cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,126.1,2.83,11.3,114.8,137.4,SD,mg/dL,126.1,126,125,120,2.825,11.3,114.8,137.4,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIa,"LDL cholesterol, IIa",Blood,4,weeks,4,16,Mean,mg/dL,129.6,3.78,15.1,114.5,144.7,SD,mg/dL,129.6,129,125,120,3.775,15.1,114.5,144.7,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IIb,"LDL cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,117.03,4.35,17.4,99.63,134.43,SD,mg/dL,117.03,117,115,110,4.35,17.4,99.63,134.43,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C IV,"LDL cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,100.9,2.98,11.9,89,112.8,SD,mg/dL,100.9,100,100,100,2.975,11.9,89,112.8,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol II,"Total Cholesterol, II",Blood,4,weeks,4,16,Mean,mg/dL,220.9,2.53,10.1,210.8,231,SD,mg/dL,220.9,220,220,220,2.525,10.1,210.8,231,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIa,"Total Cholesterol, Iia",Blood,4,weeks,4,16,Mean,mg/dL,214.9,3.35,13.4,201.5,228.3,SD,mg/dL,214.9,214,210,210,3.35,13.4,201.5,228.3,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IIb,"Total Cholesterol, IIb",Blood,4,weeks,4,16,Mean,mg/dL,235.8,1.65,6.6,229.2,242.4,SD,mg/dL,235.8,235,235,230,1.65,6.6,229.2,242.4,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol IV,"Total Cholesterol, IV",Blood,4,weeks,4,16,Mean,mg/dL,217.1,2.38,9.5,207.6,226.6,SD,mg/dL,217.1,217,215,210,2.375,9.5,207.6,226.6,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides II,"Triglycerides, II",Blood,4,weeks,4,16,Mean,mg/dL,243.4,10.93,43.7,199.7,287.1,SD,mg/dL,243.4,243,240,240,10.925,43.7,199.7,287.1,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIa,"Triglycerides, IIa",Blood,4,weeks,4,16,Mean,mg/dL,178.2,4.27,17.07,161.13,195.27,SD,mg/dL,178.2,178,175,170,4.2675,17.07,161.13,195.27,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IIb,"Triglycerides, IIb",Blood,4,weeks,4,16,Mean,mg/dL,406.6,2.1,8.4,398.2,415,SD,mg/dL,406.6,406,405,400,2.1,8.4,398.2,415,NA
43,Carranza 1995,Intervention,Carranza 1995,Table 3,Restricted Diet without Avocado,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides IV,"Triglycerides, IV",Blood,4,weeks,4,16,Mean,mg/dL,416.7,13.33,53.3,363.4,470,SD,mg/dL,416.7,416,415,410,13.325,53.3,363.4,470,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,All other plant oils,NA,All other plant oils,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Butter,NA,Butter,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Cheese,NA,Cheese,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Dairy foods,NA,Dairy foods,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Egg,NA,Egg,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Margarine,NA,Margarine,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Mayo,NA,Mayo,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Nuts,NA,Nuts,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Olive oil,NA,Olive oil,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Processed meats,NA,Processed meats,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Yogurt,NA,Yogurt,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,All other plant oils,NA,All other plant oils,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Butter,NA,Butter,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Cheese,NA,Cheese,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Dairy foods,NA,Dairy foods,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Egg,NA,Egg,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Margarine,NA,Margarine,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Mayo,NA,Mayo,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Nuts,NA,Nuts,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Olive oil,NA,Olive oil,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Processed meats,NA,Processed meats,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Yogurt,NA,Yogurt,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,All other plant oils,NA,All other plant oils,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Butter,NA,Butter,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Cheese,NA,Cheese,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Dairy foods,NA,Dairy foods,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Egg,NA,Egg,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Margarine,NA,Margarine,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Mayo,NA,Mayo,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Nuts,NA,Nuts,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Olive oil,NA,Olive oil,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Processed meats,NA,Processed meats,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Fig,Sub 1/2 serving avo,Yogurt,NA,Yogurt,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,41701,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,41701,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,904,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,904,Mean,Years,55.8,0.33,10,45.8,65.8,SD,years,55.8,55,55,50,0.332595,10,45.8,65.8,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,904,Mean,kg/m^2,25,0.11,3.4,21.6,28.4,SD,kg/m^2,25,25,25,20,0.113082,3.4,21.6,28.4,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,904,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,904,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=2/wk",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,904,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,1991,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,1991,Mean,Years,53.4,0.22,9.8,43.6,63.2,SD,years,53.4,53,50,50,0.219629,9.8,43.6,63.2,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,1991,Mean,kg/m^2,25.1,0.08,3.4,21.7,28.5,SD,kg/m^2,25.1,25,25,20,0.0761979,3.4,21.7,28.5,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,1991,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,1991,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1/wk",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,1991,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,9323,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,9323,Mean,Years,52.7,0.1,9.5,43.2,62.2,SD,years,52.7,52,50,50,0.0983888,9.5,43.2,62.2,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,9323,Mean,kg/m^2,25.3,0.03,3.3,22,28.6,SD,kg/m^2,25.3,25,25,20,0.0341772,3.3,22,28.6,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,9323,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,9323,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,9323,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,29483,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,29483,Mean,Years,52.8,0.05,9.4,43.4,62.2,SD,years,52.8,52,50,50,0.0547447,9.4,43.4,62.2,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,29483,Mean,kg/m^2,25.6,0.02,3.3,22.3,28.9,SD,kg/m^2,25.6,25,25,20,0.0192189,3.3,22.3,28.9,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,29483,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,29483,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,29483,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,NHS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,62225,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,761,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,761,Mean,Years,54.7,0.25,6.9,47.8,61.6,SD,years,54.7,54,50,50,0.250125,6.9,47.8,61.6,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,761,Mean,kg/m^2,24.6,0.17,4.7,19.9,29.3,SD,kg/m^2,24.6,24,20,20,0.170375,4.7,19.9,29.3,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,761,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,761,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=2/wk",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,761,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,1955,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,1955,Mean,Years,53.8,0.15,6.8,47,60.6,SD,years,53.8,53,50,50,0.153793,6.8,47,60.6,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,1955,Mean,kg/m^2,24.2,0.1,4.3,19.9,28.5,SD,kg/m^2,24.2,24,20,20,0.0972512,4.3,19.9,28.5,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,1955,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,1955,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1/wk",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,1955,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,8669,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,8669,Mean,Years,53.2,0.08,7.2,46,60.4,SD,years,53.2,53,50,50,0.07733,7.2,46,60.4,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,8669,Mean,kg/m^2,24.4,0.05,4.3,20.1,28.7,SD,kg/m^2,24.4,24,20,20,0.0461832,4.3,20.1,28.7,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,8669,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,8669,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/mth",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,8669,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,57401,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,57401,Mean,Years,52.3,0.03,7.1,45.2,59.4,SD,years,52.3,52,50,50,0.0296346,7.1,45.2,59.4,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,57401,Mean,kg/m^2,25.5,0.02,4.9,20.6,30.4,SD,kg/m^2,25.5,25,25,20,0.020452,4.9,20.6,30.4,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypertension,Hypertension,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of myocardial infarction,Family history of myocardial infarction,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Hispanic,"Ancestry, Hispanic only",NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other and Multi-racial,"Ancestry, All other ancestry including Hispanic",NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Other Caucasian,"Ancestry, Other Caucasian or Scandinavian",NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Heritage,Southern European,"Ancestry, Southern European or Mediterranean",NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Current menopausal hormone,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin supplement use,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,57401,Mean,MET-h/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,57401,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, Never or <=1/mth",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI,NA,,NA,,57401,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"Pooled, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Ancestry, All other including Hispanic",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1546,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Ancestry, Mediterranean and other Caucasian",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,12728,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Family history of myocardial infarction, no",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,8242,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Family history of myocardial infarction, yes",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,6032,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"AHEI, above median",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,6727,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"AHEI, below median",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,7547,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,Men,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,6661,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,Women,NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,7613,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"BMI, <25",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,7352,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"BMI, >=25",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,6922,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Age, <65",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,3496,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,Pooled,"Age, >=65",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,10778,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,904,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,12218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1991,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"HPFS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,9323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,761,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,11385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1955,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"NHS, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,8669,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, >=2/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,1665,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/2 serving increase/d",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,23603,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1/wk",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,3946,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Hemorragic stroke,Hemorragic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Age adjusted model 1,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Multivar model 2,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S5,"Pooled, 1-3/mth",Multivar model 3,NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Ischemic stroke,Ischemic stroke,NA,,NA,,17992,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,904,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,12218,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1991,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"HPFS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,9323,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,761,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,11385,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1955,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"NHS, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,8669,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, >=2/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,1665,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/2 serving increase/d","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,23603,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1/wk","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,3946,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CHD,CHD,CHD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,CVD,Total CVD,CVD,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table S9,"Pooled, 1-3/mth","Multivar model 3, MUFA-adjusted",NA,Never or <=1/mth,Outcome,CVD incidence,Stroke,Total stroke,Stroke,NA,,NA,,17992,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"HPFS, >=2/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,904,Categorical,g/d,38.8,,18.8,,,SD,g/d,38.8,38,35,30,,18.8,19,57.6,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"HPFS, 1/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1991,Categorical,g/d,10.7,,,,,NA,g/d,10.7,10,10,10,,,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"HPFS, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,9323,Categorical,g/d,5,,,,,NA,g/d,5,5,5,0,,0,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"HPFS, Never or <=1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,29483,Categorical,g/d,0,,,,,NA,g/d,0,0,0,0,,0,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"NHS, >=2/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,761,Categorical,g/d,37.6,,13.3,,,SD,g/d,37.6,37,35,30,,13.3,24.3,50.9,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"NHS, 1/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,1955,Categorical,g/d,10.7,,,,,NA,g/d,10.7,10,10,10,,0,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"NHS, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,8669,Categorical,g/d,5,,,,,NA,g/d,5,5,5,0,,0,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),Table1,"NHS, Never or <=1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,57401,Categorical,g/d,0,,,,,NA,g/d,0,0,0,0,,0,,,NA
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,1986,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,17.5,,46.2,,,SD,g/d,2.5,2,0,0,,6.6,0,9.1,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,1994,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,16.1,,45.5,,,SD,g/d,2.3,2,0,0,,6.5,0,8.8,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,1998,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,16.8,,51.1,,,SD,g/d,2.4,2,0,0,,7.3,0,9.7,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,2002,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,20.3,,62.3,,,SD,g/d,2.9,2,0,0,,8.9,0,11.8,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,2006,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,24.5,,63.7,,,SD,g/d,3.5,3,0,0,,9.1,0,12.6,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,2010,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,27.3,,74.2,,,SD,g/d,3.9,3,0,0,,10.6,0,14.5,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,HPFS,2014,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,32.2,,81.2,,,SD,g/d,4.6,4,0,0,,11.6,0,16.2,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,NHS,1986,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,9.1,,32.2,,,SD,g/d,1.3,1,0,0,,0,1.3,1.3,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,NHS,1994,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,8.4,,32.2,,,SD,g/d,1.2,1,0,0,,4.6,0,5.8,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,NHS,1998,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,8.4,,32.9,,,SD,g/d,1.2,1,0,0,,4.6,0,5.8,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,NHS,2006,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,14,,47.6,,,SD,g/d,2,2,0,0,,4.7,0,6.7,7d/wk
44,Pacheco 2022a,Observation,Nurses' Health Study (NHS 1986-2016);Health Professionals Follow-up Study (HPFS 1986-2016),TableS1;Results section,NHS,2010,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Mean,g/wk,16.1,,51.1,,,SD,g/d,2.3,2,0,0,,6.8,0,9.1,7d/wk
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Methods section;Table2,Avocado supplemented diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,455,Average,g/d,168,,,,,NA,g/d,168,168,165,160,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Methods section;Table2,Habitual diet,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,468,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,505,Mean,years,50.1,0.64,14.3,35.8,64.4,SD,years,50.1,50,50,50,0.636342,14.3,35.8,64.4,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,505,Mean,kg/m^2,32.9,0.24,5.3,27.6,38.2,SD,kg/m^2,32.9,32,30,30,0.235847,5.3,27.6,38.2,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,,NA,,505,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,,NA,,505,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, all",NA,,NA,,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,Men,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,,NA,,149,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,Women,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,,NA,,356,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,505,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,,NA,,505,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,505,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,Men,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,"HDL cholesterol, Men",NA,,NA,,505,Mean,mg/dL,44,0.4,9,35,53,SD,mg/dL,44,44,40,40,0.400495,9,35,53,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,Women,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,"HDL cholesterol, Women",NA,,NA,,505,Mean,mg/dL,55,0.58,13,42,68,SD,mg/dL,55,55,55,50,0.578492,13,42,68,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic or Latino,NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic or Latino,NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL cholesterol,NA,,NA,,505,Mean,mg/dL,110,1.51,34,76,144,SD,mg/dL,110,110,110,110,1.51298,34,76,144,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, Black",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, Black",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, multiple reported",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, multiple reported",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,"Race, no answer","Race, did not answer",NA,,NA,,505,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Race,Race,"Race, no answer","Race, did not answer",NA,,NA,,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,505,Count,Count,356,,,,,NA,Count,356,356,355,350,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,505,Percentage,%,70.5,,,,,NA,%,70.5,70,70,70,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,505,Count,Count,395,,,,,NA,Count,395,395,395,390,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,505,Percentage,%,29.5,,,,,NA,%,29.5,29,25,20,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,505,Mean,mg/dL,185,1.78,40,145,225,SD,mg/dL,185,185,185,180,1.77998,40,145,225,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglyceride,NA,,NA,,505,Median,mg/dL,106,,,79,145,IQR,mg/dL,106,106,105,100,,,79,145,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado supplemented diet,NA,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,NA,,NA,,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,503,Mean,years,50.4,0.62,13.8,36.6,64.2,SD,years,50.4,50,50,50,0.615312,13.8,36.6,64.2,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,503,Mean,kg/m^2,33.2,0.25,5.6,27.6,38.8,SD,kg/m^2,33.2,33,30,30,0.249692,5.6,27.6,38.8,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,,NA,,503,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,,NA,,503,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, all",NA,,NA,,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,Men,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,,NA,,129,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,Women,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,,NA,,374,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,503,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,,NA,,503,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,503,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,Men,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,"HDL cholesterol, Men",NA,,NA,,503,Mean,mg/dL,45,0.45,10,35,55,SD,mg/dL,45,45,45,40,0.445878,10,35,55,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,Women,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,"HDL cholesterol, Women",NA,,NA,,503,Mean,mg/dL,56,0.58,13,43,69,SD,mg/dL,56,56,55,50,0.579641,13,43,69,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic or Latino,NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic or Latino,NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL cholesterol,NA,,NA,,503,Mean,mg/dL,114,1.52,34,80,148,SD,mg/dL,114,114,110,110,1.51599,34,80,148,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, Black",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,"Race, Black",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,American Indian or Alaskan Native,"Race, American Indian",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, White",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, multiple reported",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Multi-racial,"Race, multiple reported",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,"Race, no answer","Race, did not answer",NA,,NA,,503,Count,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Race,Race,"Race, no answer","Race, did not answer",NA,,NA,,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,503,Count,Count,374,,,,,NA,Count,374,374,370,370,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,503,Percentage,%,74.4,,,,,NA,%,74.4,74,70,70,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,503,Count,Count,389,,,,,NA,Count,389,389,385,380,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,503,Percentage,%,26.6,,,,,NA,%,26.6,26,25,20,,,,,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,503,Mean,mg/dL,190,1.74,39,151,229,SD,mg/dL,190,190,190,190,1.73892,39,151,229,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglyceride,NA,,NA,,503,Median,mg/dL,104,,,73,145,IQR,mg/dL,104,104,100,100,,,73,145,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual Diet,NA,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,NA,,NA,,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,3,months,12,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,6,months,24,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,0,weeks,0,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,3,months,12,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,6,months,24,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,0,weeks,0,505,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,505,Mean,kg/m^2,33.1,0.24,5.5,27.6,38.6,SD,kg/m^2,33.1,33,30,30,0.244747,5.5,27.6,38.6,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,505,Mean,kg/m^2,33,0.24,5.5,27.5,38.5,SD,kg/m^2,33,33,30,30,0.244747,5.5,27.5,38.5,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,505,Mean,kg/m^2,32.9,0.24,5.3,27.6,38.2,SD,kg/m^2,32.9,32,30,30,0.235847,5.3,27.6,38.2,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,3,months,12,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,6,months,24,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,0,weeks,0,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,3,months,12,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,6,months,24,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,0,weeks,0,505,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,3,months,12,505,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,6,months,24,505,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,505,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,3,months,12,505,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,6,months,24,505,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,0,weeks,0,505,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,3,months,12,505,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,6,months,24,505,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,0,weeks,0,505,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,0,weeks,0,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,3,months,12,505,Mean,mg/dL,45,0.44,10,35,55,SD,mg/dL,45,45,45,40,0.444994,10,35,55,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,6,months,24,505,Mean,mg/dL,44,0.4,9,35,53,SD,mg/dL,44,44,40,40,0.400495,9,35,53,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,0,weeks,0,505,Mean,mg/dL,44,0.4,9,35,53,SD,mg/dL,44,44,40,40,0.400495,9,35,53,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,3,months,12,505,Mean,mg/dL,55,0.58,13,42,68,SD,mg/dL,55,55,55,50,0.578492,13,42,68,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,6,months,24,505,Mean,mg/dL,54,0.58,13,41,67,SD,mg/dL,54,54,50,50,0.578492,13,41,67,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,0,weeks,0,505,Mean,mg/dL,55,0.58,13,42,68,SD,mg/dL,55,55,55,50,0.578492,13,42,68,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,505,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,505,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,0,weeks,0,505,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,3,months,12,505,Mean,mg/dL,106,1.47,33,73,139,SD,mg/dL,106,106,105,100,1.46848,33,73,139,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,6,months,24,505,Mean,mg/dL,104,1.47,33,71,137,SD,mg/dL,104,104,100,100,1.46848,33,71,137,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,0,weeks,0,505,Mean,mg/dL,110,1.51,34,76,144,SD,mg/dL,110,110,110,110,1.51298,34,76,144,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,505,Mean,mg/dL,181,1.78,40,141,221,SD,mg/dL,181,181,180,180,1.77998,40,141,221,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,505,Mean,mg/dL,180,1.69,38,142,218,SD,mg/dL,180,180,180,180,1.69098,38,142,218,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,0,weeks,0,505,Mean,mg/dL,185,1.78,40,145,225,SD,mg/dL,185,185,185,180,1.77998,40,145,225,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,505,Median,mg/dL,102,,,73,144,IQR,mg/dL,102,102,100,100,,,73,144,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,505,Median,mg/dL,103,,,75,148,IQR,mg/dL,103,103,100,100,,,75,148,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,505,Median,mg/dL,106,,,79,145,IQR,mg/dL,106,106,105,100,,,79,145,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,3,months,12,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,6,months,24,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado supplemented diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,0,weeks,0,505,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,3,months,12,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,6,months,24,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,0,weeks,0,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,3,months,12,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,6,months,24,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,0,weeks,0,503,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,503,Mean,kg/m^2,33.3,0.25,5.7,27.6,39,SD,kg/m^2,33.3,33,30,30,0.25415,5.7,27.6,39,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,503,Mean,kg/m^2,33.2,0.25,5.6,27.6,38.8,SD,kg/m^2,33.2,33,30,30,0.249692,5.6,27.6,38.8,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,503,Mean,kg/m^2,33.2,0.25,5.6,27.6,38.8,SD,kg/m^2,33.2,33,30,30,0.249692,5.6,27.6,38.8,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,3,months,12,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,6,months,24,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, men",NA,0,weeks,0,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,3,months,12,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,6,months,24,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Anthropometry,Body size,Waist circumference,"Waist circumference, women",NA,0,weeks,0,503,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,3,months,12,503,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,6,months,24,503,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,0,weeks,0,503,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,3,months,12,503,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,6,months,24,503,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol:HDL-cholesterol,Blood,0,weeks,0,503,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,3,months,12,503,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,6,months,24,503,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Immune,CRP,hsCRP,High-sensitivity C-reactive protein,Blood,0,weeks,0,503,Median,mg/L,NA,NA,NA,NA,NA,IQR,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,0,weeks,0,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,3,months,12,503,Mean,mg/dL,46,0.49,11,35,57,SD,mg/dL,46,46,45,40,0.490466,11,35,57,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,6,months,24,503,Mean,mg/dL,46,0.49,11,35,57,SD,mg/dL,46,46,45,40,0.490466,11,35,57,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Men,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL cholesterol, men",Blood,0,weeks,0,503,Mean,mg/dL,45,0.45,10,35,55,SD,mg/dL,45,45,45,40,0.445878,10,35,55,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,3,months,12,503,Mean,mg/dL,56,0.54,12,44,68,SD,mg/dL,56,56,55,50,0.535054,12,44,68,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,6,months,24,503,Mean,mg/dL,56,0.58,13,43,69,SD,mg/dL,56,56,55,50,0.579641,13,43,69,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,Women,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,"HDL Cholesterol, women",Blood,0,weeks,0,503,Mean,mg/dL,56,0.58,13,43,69,SD,mg/dL,56,56,55,50,0.579641,13,43,69,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,503,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,503,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,0,weeks,0,503,Median,uIU/mL,NA,NA,NA,NA,NA,IQR,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,3,months,12,503,Mean,mg/dL,112,1.52,34,78,146,SD,mg/dL,112,112,110,110,1.51599,34,78,146,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,6,months,24,503,Mean,mg/dL,111,1.47,33,78,144,SD,mg/dL,111,111,110,110,1.4714,33,78,144,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,0,weeks,0,503,Mean,mg/dL,114,1.52,34,80,148,SD,mg/dL,114,114,110,110,1.51599,34,80,148,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,503,Mean,mg/dL,189,1.78,40,149,229,SD,mg/dL,189,189,185,180,1.78351,40,149,229,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,503,Mean,mg/dL,189,1.69,38,151,227,SD,mg/dL,189,189,185,180,1.69434,38,151,227,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,0,weeks,0,503,Mean,mg/dL,190,1.74,39,151,229,SD,mg/dL,190,190,190,190,1.73892,39,151,229,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,503,Median,mg/dL,105,,,76,149,IQR,mg/dL,105,105,105,100,,,76,149,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,503,Median,mg/dL,104,,,80,146,IQR,mg/dL,104,104,100,100,,,80,146,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,503,Median,mg/dL,104,,,73,145,IQR,mg/dL,104,104,100,100,,,73,145,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,3,months,12,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,6,months,24,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual Diet,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,Very LDL-cholesterol,Blood,0,weeks,0,503,Median,mg/dL,NA,NA,NA,NA,NA,IQR,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,0,weeks,0,504,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,8,weeks,8,490,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,16,weeks,16,479,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,26,weeks,26,472,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,0,weeks,0,504,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,8,weeks,8,490,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,16,weeks,16,479,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,26,weeks,26,472,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,504,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,504,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,8,weeks,8,490,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,8,weeks,8,490,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,16,weeks,16,479,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,16,weeks,16,479,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,26,weeks,26,472,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,26,weeks,26,472,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Animal Protein,Animal protein,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Animal Protein,Animal protein,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Animal Protein,Animal protein,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Animal Protein,Animal protein,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,504,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,504,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,8,weeks,8,490,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,8,weeks,8,490,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,16,weeks,16,479,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,16,weeks,16,479,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,26,weeks,26,472,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,26,weeks,26,472,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,0,weeks,0,504,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,0,weeks,0,503,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,8,weeks,8,486,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,16,weeks,16,487,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,26,weeks,26,480,Mean,mg/d,NA,NA,NA,NA,NA,NA,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,0,weeks,0,503,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,8,weeks,8,486,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,16,weeks,16,487,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,26,weeks,26,480,Mean,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,503,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,0,weeks,0,503,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,8,weeks,8,486,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,8,weeks,8,486,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,16,weeks,16,487,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,16,weeks,16,487,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,26,weeks,26,480,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,26,weeks,26,480,Mean,g/d,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-3 FA,Omega-3 FA,Omega-3 FA,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,Omega-6 FA,Omega-6 FA,Omega-6 FA,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Animal protein,Animal protein,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable protein,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,503,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,0,weeks,0,503,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,8,weeks,8,486,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,8,weeks,8,486,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,16,weeks,16,487,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,16,weeks,16,487,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,26,weeks,26,480,Mean,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,SFA,NA,26,weeks,26,480,Mean,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,NA,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,6,months,24,505,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,0,weeks,0,505,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,6,months,24,505,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado supplemented diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,0,weeks,0,505,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,6,months,24,503,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,0,weeks,0,503,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,6,months,24,503,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
46,Lichtenstein 2022,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual Diet,NA,ITT,Summary,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,0,weeks,0,503,Mean,L,NA,NA,NA,NA,NA,SD,g,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 3a,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Insulin Sensitivity Index,Blood,0,weeks,0,49,NA,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 3a,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Insulin Sensitivity Index,Blood,12,weeks,12,49,NA,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 3a,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Insulin Sensitivity Index,Blood,0,weeks,0,44,NA,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 3a,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,Matsuda Insulin Sensitivity Index,Blood,12,weeks,12,44,NA,index,NA,NA,NA,NA,NA,NA,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4a,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,0,weeks,0,49,NA,mg/dL,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4a,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,12,weeks,12,49,NA,mg/dL,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4a,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,0,weeks,0,44,NA,mg/dL,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4a,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose,Glucose,Plasma,12,weeks,12,44,NA,mg/dL,NA,NA,NA,NA,NA,NA,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4b,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,0,weeks,0,49,NA,uIU/mL,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4b,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,12,weeks,12,49,NA,uIU/mL,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4b,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,0,weeks,0,44,NA,uIU/mL,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Figure 4b,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin,Insulin,Plasma,12,weeks,12,44,NA,uIU/mL,NA,NA,NA,NA,NA,NA,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Methods section;STable2,Avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,49,Average,g/d,168,,,,,NA,g/d,168,168,165,160,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Methods section;STable2,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,44,Average,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,49,Mean,years,40.6,1.69,11.8,28.8,52.4,SD,years,40.6,40,40,40,1.68571,11.8,28.8,52.4,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,49,Mean,kg/m^2,32.3,0.56,3.9,28.4,36.2,SD,kg/m^2,32.3,32,30,30,0.557143,3.9,28.4,36.2,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist midpoint,NA,,NA,,49,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,49,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting plasma glucose,NA,,NA,,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,49,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Metabolic,Insulin,Fasting insulin,Fasting plasma insulin,NA,,NA,,49,Mean,µIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, AA",NA,,NA,,49,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,49,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Cau",NA,,NA,,49,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, His",NA,,NA,,49,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,49,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,49,Percentage,%,57.1429,,,,,NA,%,57.1429,57,55,50,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Avocado,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,49,Percentage,%,42.8571,,,,,NA,%,42.8571,42,40,40,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,44,Mean,years,42.7,1.88,12.5,30.2,55.2,SD,years,42.7,42,40,40,1.88445,12.5,30.2,55.2,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,44,Mean,kg/m^2,32.8,0.58,3.88,28.92,36.68,SD,kg/m^2,32.8,32,30,30,0.584932,3.88,28.92,36.68,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist midpoint,NA,,NA,,44,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,44,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting plasma glucose,NA,,NA,,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,44,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Metabolic,Insulin,Fasting insulin,Fasting plasma insulin,NA,,NA,,44,Mean,µIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,African-American,"Race, AA",NA,,NA,,44,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Asian,"Race, Asian",NA,,NA,,44,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Caucasian,"Race, Cau",NA,,NA,,44,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Hispanic,"Race, His",NA,,NA,,44,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Race,Race,Other race,"Race, Other",NA,,NA,,44,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,44,Percentage,%,59.0909,,,,,NA,%,59.0909,59,55,50,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Table 1,Control,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,44,Percentage,%,40.9091,,,,,NA,%,40.9091,40,40,40,,,,,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,1,months,4,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,2,months,8,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,1,months,4,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,2,months,8,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,3,months,12,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,1,months,4,49,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,2,months,8,49,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,3,months,12,49,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,1,months,4,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,2,months,8,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,1,months,4,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,2,months,8,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,1,months,4,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,2,months,8,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,3,months,12,49,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,1,months,4,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,2,months,8,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,3,months,12,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,1,months,4,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,2,months,8,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,1,months,4,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,2,months,8,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,3,months,12,49,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,1,months,4,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,2,months,8,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Avocado,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,49,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Cholesterol,Cholesterol,Cholesterol,Cholesterol,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,1,months,4,44,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,2,months,8,44,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,3,months,12,44,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fiber,Fiber,Fiber,Total dietary fiber,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,MUFA,MUFA,Total monounsaturated,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,PUFA,PUFA,Total polyunsaturated,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Fatty acids,SFA,SFA,Total saturated,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,1,months,4,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,2,months,8,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Other,Sugar,Sugar,Sugar,NA,3,months,12,44,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,1,months,4,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,2,months,8,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin A,Vitamin A,Vitamin A,NA,3,months,12,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,1,months,4,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,2,months,8,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,44,Mean,ug/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin C,Vitamin C,Vitamin C,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,1,months,4,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,2,months,8,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 2,Control,NA,PP,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,44,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,0,weeks,0,49,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,12,weeks,12,49,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,0,weeks,0,49,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,12,weeks,12,49,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,49,Mean,kg/m^2,32.2,0.56,3.91,28.29,36.11,SD,kg/m^2,32.2,32,30,30,0.558,3.906,28.294,36.106,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,49,Mean,kg/m^2,32.2,0.62,4.36,27.84,36.56,SD,kg/m^2,32.2,32,30,30,0.623,4.361,27.839,36.561,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,49,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,49,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,0,weeks,0,49,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,12,weeks,12,49,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,0,weeks,0,49,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,12,weeks,12,49,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,0,weeks,0,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,12,weeks,12,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 2h,Glucose AUC 2hrs,Blood,0,weeks,0,49,Mean,mg/dL.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 2h,Glucose AUC 2hrs,Blood,12,weeks,12,49,Mean,mg/dL.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose Cmax,Glucose Cmax,Blood,0,weeks,0,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose Cmax,Glucose Cmax,Blood,12,weeks,12,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,Blood,0,weeks,0,49,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,Blood,12,weeks,12,49,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,Blood,0,weeks,0,49,Mean,mg/dL,48.1,2.15,15.05,33.05,63.15,SD,mg/dL,48.1,48,45,40,2.15,15.05,33.05,63.15,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,Blood,12,weeks,12,49,Mean,mg/dL,48.4,2.07,14.49,33.91,62.89,SD,mg/dL,48.4,48,45,40,2.07,14.49,33.91,62.89,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,49,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,49,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-β,Blood,0,weeks,0,49,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-β,Blood,12,weeks,12,49,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,ICAM-1,ICAM-1,ICAM-1,Blood,0,weeks,0,49,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,ICAM-1,ICAM-1,ICAM-1,Blood,12,weeks,12,49,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,0,weeks,0,49,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,12,weeks,12,49,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,0,weeks,0,49,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,12,weeks,12,49,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 2h,Insulin AUC 2hrs,Blood,0,weeks,0,49,Mean,mg/dL x h,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 2h,Insulin AUC 2hrs,Blood,12,weeks,12,49,Mean,mg/dL x h,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin Cmax,Insulin Cmax,Blood,0,weeks,0,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin Cmax,Insulin Cmax,Blood,12,weeks,12,49,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,MISI,Blood,0,weeks,0,49,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,MISI,Blood,12,weeks,12,49,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,0,weeks,0,49,Mean,mg/dL,113,4.23,29.61,83.39,142.61,SD,mg/dL,113,113,110,110,4.23,29.61,83.39,142.61,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,12,weeks,12,49,Mean,mg/dL,112,3.92,27.44,84.56,139.44,SD,mg/dL,112,112,110,110,3.92,27.44,84.56,139.44,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,MCP-1,MCP-1,MCP-1,Blood,0,weeks,0,49,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,MCP-1,MCP-1,MCP-1,Blood,12,weeks,12,49,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,0,weeks,0,49,Mean,mg/dL,184,5.11,35.77,148.23,219.77,SD,mg/dL,184,184,180,180,5.11,35.77,148.23,219.77,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,12,weeks,12,49,Mean,mg/dL,182,4.74,33.18,148.82,215.18,SD,mg/dL,182,182,180,180,4.74,33.18,148.82,215.18,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,0,weeks,0,49,Mean,mg/dL,114,8.13,56.91,57.09,170.91,SD,mg/dL,114,114,110,110,8.13,56.91,57.09,170.91,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,12,weeks,12,49,Mean,mg/dL,120,10.9,76.3,43.7,196.3,SD,mg/dL,120,120,120,120,10.9,76.3,43.7,196.3,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,0,weeks,0,49,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Avocado,NA,PP,Summary,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,12,weeks,12,49,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,0,weeks,0,44,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,12,weeks,12,44,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,0,weeks,0,44,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,12,weeks,12,44,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,44,Mean,kg/m^2,32.8,0.59,3.93,28.87,36.73,SD,kg/m^2,32.8,32,30,30,0.592,3.92688,28.8731,36.7269,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,44,Mean,kg/m^2,32.9,0.62,4.12,28.78,37.02,SD,kg/m^2,32.9,32,30,30,0.621,4.11925,28.7808,37.0192,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,0,weeks,0,44,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Body fat,Fat,NA,12,weeks,12,44,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,0,weeks,0,44,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Anthropometry,Body fat,Fat-free mass,Fat-free mass,NA,12,weeks,12,44,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,0,weeks,0,44,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,12,weeks,12,44,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,0,weeks,0,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,12,weeks,12,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 2h,Glucose AUC 2hrs,Blood,0,weeks,0,44,Mean,mg/dL.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose AUC 2h,Glucose AUC 2hrs,Blood,12,weeks,12,44,Mean,mg/dL.h,NA,NA,NA,NA,NA,SD,mg/dL per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose Cmax,Glucose Cmax,Blood,0,weeks,0,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Glucose,Glucose Cmax,Glucose Cmax,Blood,12,weeks,12,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,Blood,0,weeks,0,44,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,Blood,12,weeks,12,44,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,Blood,0,weeks,0,44,Mean,mg/dL,45.4,2.06,13.66,31.74,59.06,SD,mg/dL,45.4,45,45,40,2.06,13.6645,31.7355,59.0645,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL cholesterol,Blood,12,weeks,12,44,Mean,mg/dL,47.1,2.25,14.92,32.18,62.02,SD,mg/dL,47.1,47,45,40,2.25,14.9248,32.1752,62.0248,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,0,weeks,0,44,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,12,weeks,12,44,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-β,Blood,0,weeks,0,44,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-β,Blood,12,weeks,12,44,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,ICAM-1,ICAM-1,ICAM-1,Blood,0,weeks,0,44,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,ICAM-1,ICAM-1,ICAM-1,Blood,12,weeks,12,44,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,0,weeks,0,44,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,12,weeks,12,44,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,0,weeks,0,44,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,12,weeks,12,44,Mean,uIU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 2h,Insulin AUC 2hrs,Blood,0,weeks,0,44,Mean,mg/dL x h,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin AUC 2h,Insulin AUC 2hrs,Blood,12,weeks,12,44,Mean,mg/dL x h,NA,NA,NA,NA,NA,SD,pmol/L per h,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin Cmax,Insulin Cmax,Blood,0,weeks,0,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Insulin Cmax,Insulin Cmax,Blood,12,weeks,12,44,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,MISI,Blood,0,weeks,0,44,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Glycemia,Insulin,Matsuda Insulin Sensitivity Index,MISI,Blood,12,weeks,12,44,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,0,weeks,0,44,Mean,mg/dL,110,3.93,26.07,83.93,136.07,SD,mg/dL,110,110,110,110,3.93,26.0687,83.9313,136.069,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL cholesterol,Blood,12,weeks,12,44,Mean,mg/dL,113,3.94,26.14,86.86,139.14,SD,mg/dL,113,113,110,110,3.94,26.135,86.865,139.135,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,MCP-1,MCP-1,MCP-1,Blood,0,weeks,0,44,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,MCP-1,MCP-1,MCP-1,Blood,12,weeks,12,44,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,0,weeks,0,44,Mean,mg/dL,177,5.03,33.37,143.63,210.37,SD,mg/dL,177,177,175,170,5.03,33.3652,143.635,210.365,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholestrol,Blood,12,weeks,12,44,Mean,mg/dL,181,4.44,29.45,151.55,210.45,SD,mg/dL,181,181,180,180,4.44,29.4516,151.548,210.452,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,0,weeks,0,44,Mean,mg/dL,111,8.88,58.9,52.1,169.9,SD,mg/dL,111,111,110,110,8.88,58.9033,52.0967,169.903,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Total triglycerides,Blood,12,weeks,12,44,Mean,mg/dL,107,7.58,50.28,56.72,157.28,SD,mg/dL,107,107,105,100,7.58,50.28,56.72,157.28,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,0,weeks,0,44,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 3,Control,NA,PP,Summary,Outcome,Immune,VCAM-1,VCAM-1,VCAM-1,Blood,12,weeks,12,44,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large","HDL particle concentration, Large",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large","HDL particle concentration, Large",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium","HDL particle concentration, medium",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium","HDL particle concentration, medium",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small","HDL particle concentration, Small",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small","HDL particle concentration, Small",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total","Average particle concentration, HDL",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total","Average particle concentration, HDL",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total","HDL particle concentration, Total",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total","HDL particle concentration, Total",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, IDL","LDL particle concentration, IDL",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, IDL","LDL particle concentration, IDL",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, large","LDL particle concentration, LDL, large",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, large","LDL particle concentration, LDL, large",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, small","LDL particle concentration, LDL, small",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, small","LDL particle concentration, LDL, small",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total","Average particle concentration, LDL",Blood,0,weeks,0,49,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total","Average particle concentration, LDL",Blood,12,weeks,12,49,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total","LDL particle concentration, Total",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total","LDL particle concentration, Total",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large","Chylomicron/VLDL particle concentration, Large",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large","Chylomicron/VLDL particle concentration, Large",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium","Chylomicron/VLDL particle concentration, Medium",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium","Chylomicron/VLDL particle concentration, Medium",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small","Chylomicron/VLDL particle concentration, Small",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small","Chylomicron/VLDL particle concentration, Small",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentration, Total","Average particle concentration, VLDL",Blood,0,weeks,0,49,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentration, Total","Average particle concentration, VLDL",Blood,12,weeks,12,49,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total","Chylomicron/VLDL particle concentration, Total",Blood,0,weeks,0,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Avocado,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total","Chylomicron/VLDL particle concentration, Total",Blood,12,weeks,12,49,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large","HDL particle concentration, Large",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Large","HDL particle concentration, Large",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium","HDL particle concentration, medium",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, medium","HDL particle concentration, medium",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small","HDL particle concentration, Small",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Small","HDL particle concentration, Small",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total","Average particle concentration, HDL",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL Particle concentration, Total","Average particle concentration, HDL",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total","HDL particle concentration, Total",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"HDL particle concentration, Total","HDL particle concentration, Total",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, IDL","LDL particle concentration, IDL",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, IDL","LDL particle concentration, IDL",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, large","LDL particle concentration, LDL, large",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, large","LDL particle concentration, LDL, large",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, small","LDL particle concentration, LDL, small",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, small","LDL particle concentration, LDL, small",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total","Average particle concentration, LDL",Blood,0,weeks,0,44,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL Particle concentration, Total","Average particle concentration, LDL",Blood,12,weeks,12,44,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total","LDL particle concentration, Total",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"LDL particle concentration, Total","LDL particle concentration, Total",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large","Chylomicron/VLDL particle concentration, Large",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Large","Chylomicron/VLDL particle concentration, Large",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium","Chylomicron/VLDL particle concentration, Medium",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Medium","Chylomicron/VLDL particle concentration, Medium",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small","Chylomicron/VLDL particle concentration, Small",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Small","Chylomicron/VLDL particle concentration, Small",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentration, Total","Average particle concentration, VLDL",Blood,0,weeks,0,44,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL Particle concentration, Total","Average particle concentration, VLDL",Blood,12,weeks,12,44,Mean,nm,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total","Chylomicron/VLDL particle concentration, Total",Blood,0,weeks,0,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
47,Zhang 2022,Intervention,NCT02695433,Table 4,Control,NA,PP,Summary,Outcome,Lipids,Particle concentration,"VLDL particle concentration, Total","Chylomicron/VLDL particle concentration, Total",Blood,12,weeks,12,44,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,High avocado allotment,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,35,Absolute value,avocado/wk/family,14,,,,,NA,g/d,300,300,300,300,,,,,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Low avocado allotment,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,37,Absolute value,avocado/wk/family,3,,,,,NA,g/d,64.2857,64,60,60,,,,,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Results section,High avocado allotment,Head of household,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,6,months,24,35,Mean,avocado/wk/head of household,5.4,,3.3,,,SD,g/d,115.714,115,115,110,,70.7143,45,186.429,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Results section,High avocado allotment,Head of household,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,0,weeks,0,35,Mean,avocado/wk/head of household,1.5,,1.7,,,SD,g/d,32.1429,32,30,30,,36.4286,0,68.5714,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Results section,Low avocado allotment,Head of household,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,6,months,24,37,Mean,avocado/wk/head of household,1.7,,1.7,,,SD,g/d,36.4286,36,35,30,,36.4286,0,72.8571,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Results section,Low avocado allotment,Head of household,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,0,weeks,0,37,Mean,avocado/wk/head of household,1.5,,1.4,,,SD,g/d,32.1429,32,30,30,,30,2.14286,62.1429,150g/avo;7d/wk
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,35,Mean,years,44.5,1.42,8.4,36.1,52.9,SD,years,44.5,44,40,40,1.41986,8.4,36.1,52.9,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,NA,,NA,,35,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,NA,,NA,,35,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,NA,,NA,,35,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,35,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,35,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,35,Mean,kg/m^2,30.5,1.05,6.2,24.3,36.7,SD,kg/m^2,30.5,30,30,30,1.04799,6.2,24.3,36.7,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,35,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Country of bith,"Country of birth, Mexico","Country of birth, Mexico",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Country of bith,"Country of birth, US or other","Country of birth, US or other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Immune,CRP,hsCRP,hsCRP,NA,,NA,,35,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,Diabetes/prediabetes status,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,"Education, other","Education, other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,No diploma,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Post-graduate,Master's degree or above,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Trade school or associate's degree,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Employed for wages,Employed for wages,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,"Employment, other","Employment, other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Homemaker,Homemaker,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Self-employed,Self-employed,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,NA,,NA,,35,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Central American,"Heritage, Central America",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Mexican,"Heritage, Mexico",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Total family income, <$30,000",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,">$30,000","Total family income, >$30,000",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"Family income, unknown","Total family income, unknown",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Married or cohabitation,Married or cohabitation,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,"Separated, divorced, or widowed","Separated, divorced, or widowed",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,Single,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,NAFLD fibrosis score,NAFLD fibrosis score,NA,,NA,,35,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate vigorous physical activity,NA,,NA,,35,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,35,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Years lived in US,Years lived in US,Years lived in US,NA,,NA,,35,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,37,Mean,years,46.5,1.86,11.3,35.2,57.8,SD,years,46.5,46,45,40,1.85771,11.3,35.2,57.8,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,NA,,NA,,37,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,NA,,NA,,37,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,NA,,NA,,37,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,37,Mean,kg/m^2,30.6,1,6.1,24.5,36.7,SD,kg/m^2,30.6,30,30,30,1.00283,6.1,24.5,36.7,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,37,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Country of bith,"Country of birth, Mexico","Country of birth, Mexico",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Country of bith,"Country of birth, US or other","Country of birth, US or other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Immune,CRP,hsCRP,hsCRP,NA,,NA,,37,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,Diabetes/prediabetes status,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,"Education, other","Education, other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,No diploma,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Post-graduate,Master's degree or above,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Trade school or associate's degree,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Employed for wages,Employed for wages,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,"Employment, other","Employment, other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Homemaker,Homemaker,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Self-employed,Self-employed,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,NA,,NA,,37,Mean,IU/L,NA,NA,NA,NA,NA,SD,IU/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Central American,"Heritage, Central America",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Mexican,"Heritage, Mexico",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Total family income, <$30,000",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,">$30,000","Total family income, >$30,000",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"Family income, unknown","Total family income, unknown",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Married or cohabitation,Married or cohabitation,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,"Separated, divorced, or widowed","Separated, divorced, or widowed",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,Single,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Health status,Metabolic syndrome,NAFLD fibrosis score,NAFLD fibrosis score,NA,,NA,,37,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate vigorous physical activity,NA,,NA,,37,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,37,Percentage,%,97.3,,,,,NA,%,97.3,97,95,90,,,,,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,37,Percentage,%,2.7,,,,,NA,%,2.7,2,0,0,,,,,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,NA,ITT,Summary,Subject Characteristics,Lifestyle,Years lived in US,Years lived in US,Years lived in US,NA,,NA,,37,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,31,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,31,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,31,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,20,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,20,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,20,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,20,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,20,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,20,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,20,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,20,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,19,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,18,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,19,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,18,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,16,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,16,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,19,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,18,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,19,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,18,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,19,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,18,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,16,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,16,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,35,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,31,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,31,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,37,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,31,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,31,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low avocado allotment,NA,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,31,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,20,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,20,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,20,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alanine aminotransferase,Alanine aminotransferase,Alanine aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Alkaline phosphatase,Alkaline phosphatase,Alkaline phosphatase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Aspartate aminotransferase,Aspartate aminotransferase,Aspartate aminotransferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,16,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Immune,CRP,hsCRP,hsCRP,Blood,6,months,24,15,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,16,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Gamma-glutamyl transferase,Blood,6,months,24,15,Mean,"IU/L, change-in",NA,NA,NA,NA,NA,95%CI,"IU/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,ITT,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,16,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
48,Pacheco 2022b,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Prediabetic,PP,Within,Outcome,Metabolic,NAFLD,NAFLD fibrosis score,NAFLD fibrosis score,NA,6,months,24,15,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Fig 1,Avocado substituted,Multivariable,NA,Butter,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,67383,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Fig 1,Avocado substituted,Multivariable,NA,Cream,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,67383,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Fig 1,Avocado substituted,Multivariable,NA,Margarine,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,67383,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Results section,Consumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,50391,Median,serving/wk,1,,,0.23,1,IQR,g/d,10.7143,10,10,10,,,2.46429,10.7143,1 serving=1/2avo=75 g;7d/wk
49,Monge 2023,Observation,Mexican Teachers' Cohort,Results section,Non-consumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16992,Median,serving/wk,0,,,,,NA,g/d,0,0,0,0,,,,,1 serving=1/2avo=75 g;7d/wk
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,17275,Categorical,1/2 avo/wk,1,,,,,NA,g/d,10.7143,10,10,10,,,,,1 serving = 75 g = 1/2 avo;7 d/wk
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,17275,Mean,Years,42.1,0.05,7.1,35,49.2,SD,years,42.1,42,40,40,0.0540193,7.1,35,49.2,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,17275,Mean,kg/m^2,26.9,0.03,4.3,22.6,31.2,SD,kg/m^2,26.9,26,25,20,0.0327159,4.3,22.6,31.2,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, other","Insurance, other",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, private","Insurance, private",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, social security","Insurance, social security",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Internet,Internet use,Internet use,NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Menopausal status unknown,"Menopausal status, unknown",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Postmenopausal,"Menopausal status, postmenopausal",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Premenopausal,"Menopausal status, premenopausal",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin intake,NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Low physical activity,"Physical activity, low",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, medium",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, high",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking, current smoker",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking, past smoker",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking, never smoker",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Smoking unkown,"Smoking, unknown",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index score,NA,,NA,,17275,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,BMI unknown,"BMI, unknown",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, normal",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, OB",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,1/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,17275,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16294,Categorical,1/2 avo/mo,2.5,,,2,3,"min,max",g/d,6.25,6,5,0,,,5,7.5,1 serving = 75 g = 1/2 avo;30 d/mo
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,16294,Mean,Years,41.4,0.06,7.1,34.3,48.5,SD,years,41.4,41,40,40,0.0556217,7.1,34.3,48.5,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,16294,Mean,kg/m^2,27,0.04,4.5,22.5,31.5,SD,kg/m^2,27,27,25,20,0.0352532,4.5,22.5,31.5,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, other","Insurance, other",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, private","Insurance, private",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, social security","Insurance, social security",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Internet,Internet use,Internet use,NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Menopausal status unknown,"Menopausal status, unknown",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Postmenopausal,"Menopausal status, postmenopausal",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Premenopausal,"Menopausal status, premenopausal",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin intake,NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Low physical activity,"Physical activity, low",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, medium",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, high",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking, current smoker",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking, past smoker",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking, never smoker",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Smoking unkown,"Smoking, unknown",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index score,NA,,NA,,16294,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,BMI unknown,"BMI, unknown",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, normal",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, OB",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-3/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,16294,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12700,Categorical,1/2 avo/wk,3,,,2,4,"min,max",g/d,32.1429,32,30,30,,,21.4286,42.8571,1 serving = 75 g = 1/2 avo;7 d/wk
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,12700,Mean,Years,42.7,0.06,7,35.7,49.7,SD,years,42.7,42,40,40,0.062115,7,35.7,49.7,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,12700,Mean,kg/m^2,26.6,0.04,4.3,22.3,30.9,SD,kg/m^2,26.6,26,25,20,0.0381563,4.3,22.3,30.9,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, other","Insurance, other",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, private","Insurance, private",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, social security","Insurance, social security",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Internet,Internet use,Internet use,NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Menopausal status unknown,"Menopausal status, unknown",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Postmenopausal,"Menopausal status, postmenopausal",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Premenopausal,"Menopausal status, premenopausal",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin intake,NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Low physical activity,"Physical activity, low",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, medium",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, high",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking, current smoker",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking, past smoker",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking, never smoker",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Smoking unkown,"Smoking, unknown",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index score,NA,,NA,,12700,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,BMI unknown,"BMI, unknown",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, normal",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, OB",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,2-4/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,12700,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,4122,Categorical,1/2 avo/wk,5,,,,,NA,g/d,53.5714,53,50,50,,,,,1 serving = 75 g = 1/2 avo;7 d/wk
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,4122,Mean,Years,43.1,0.11,7.3,35.8,50.4,SD,years,43.1,43,40,40,0.113702,7.3,35.8,50.4,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,4122,Mean,kg/m^2,26.5,0.07,4.3,22.2,30.8,SD,kg/m^2,26.5,26,25,20,0.0669753,4.3,22.2,30.8,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, other","Insurance, other",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, private","Insurance, private",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, social security","Insurance, social security",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Internet,Internet use,Internet use,NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Menopausal status unknown,"Menopausal status, unknown",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Postmenopausal,"Menopausal status, postmenopausal",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Premenopausal,"Menopausal status, premenopausal",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin intake,NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Low physical activity,"Physical activity, low",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, medium",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, high",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking, current smoker",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking, past smoker",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking, never smoker",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Smoking unkown,"Smoking, unknown",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index score,NA,,NA,,4122,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,BMI unknown,"BMI, unknown",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, normal",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, OB",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,5+/wk,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,4122,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,67383,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,16992,Categorical,1/2 avo/mo,0,,,,,NA,g/d,0,0,0,0,,,,,1 serving = 75 g = 1/2 avo;30 d/mo
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,16992,Mean,Years,41.5,0.05,7.1,34.4,48.6,SD,years,41.5,41,40,40,0.0544673,7.1,34.4,48.6,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,16992,Mean,kg/m^2,27.3,0.04,4.6,22.7,31.9,SD,kg/m^2,27.3,27,25,20,0.0352887,4.6,22.7,31.9,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Hypercholesterolemia,NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, other","Insurance, other",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, private","Insurance, private",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Insurance,"Insurance, social security","Insurance, social security",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Internet,Internet use,Internet use,NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Menopausal status unknown,"Menopausal status, unknown",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Postmenopausal,"Menopausal status, postmenopausal",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Health status,Menopause,Premenopausal,"Menopausal status, premenopausal",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin intake,NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Low physical activity,"Physical activity, low",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,"Physical activity, medium",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,"Physical activity, high",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,"Smoking, current smoker",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,"Smoking, past smoker",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,"Smoking, never smoker",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Smoking unkown,"Smoking, unknown",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",Healthy eating index score,NA,,NA,,16992,Mean,Score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,BMI unknown,"BMI, unknown",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, normal",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, OB",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 1,Never or <=1/month,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, OW",NA,,NA,,16992,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,BMI status,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,1/wk,Diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,17275,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,BMI status,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-3/month,Diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,16294,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,BMI status,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,2-4/wk,Diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,12700,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,BMI status,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table 2,5+/wk,Diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,4122,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,17275,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,17275,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,17275,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,17275,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,17275,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,1/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,17275,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,16294,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,16294,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,16294,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,16294,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-3/month,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,16294,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,12700,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,12700,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,12700,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,12700,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,2-4/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,12700,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,4122,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,4122,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,4122,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,4122,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,5+/wk,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,4122,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,16992,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,16992,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,16992,Mean,mg/d,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,16992,Mean,%kcal/d,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S1,Never or <=1/month,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,16992,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,1/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,1/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,2-3/month,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,2-3/month,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,2-4/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,2-4/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,5+/wk,Age adjusted,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S2,5+/wk,Multivariable,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,1/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,1/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,1/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,1/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-3/month,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-3/month,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-3/month,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-3/month,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-4/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-4/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-4/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,2-4/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,5+/wk,Healthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,5+/wk,Unhealthy diet,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,5+/wk,Unhealthy lifestyle,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
49,Monge 2023,Observation,Mexican Teachers' Cohort,Table S3,5+/wk,Without T2D,NA,Never or <=1/month,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Incident rate ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,3006,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5892,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5419,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,3006,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5625,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5191,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,3003,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5896,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5993,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,3006,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5892,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5419,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,3006,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,5892,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,5419,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,3003,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5886,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5411,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,3006,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5607,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5183,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,3006,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5607,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5183,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Diabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Normoglycemic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 2,Non-consumers,Prediabetic,NA,Summary,Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,,Mean,index,NA,NA,NA,NA,NA,95%CI,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,369,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1236,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1498,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,317,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1237,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1495,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,369,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1236,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1498,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,369,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,1236,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,1498,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,351,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1231,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1493,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,HOMA,HOMA-β,HOMA-B,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,95%CI,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated insulin",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, treated metformin",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Figure 3,Non-consumers,"Diabetic, untreated",NA,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,,Mean,mU/L,NA,NA,NA,NA,NA,95%CI,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Results section;Methods section,Consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,2256,Average,serving/d,0.36,,0.01,,,SD,g/d,18,18,15,10,,0.5,17.5,18.5,1 serving=50g
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Results section;Methods section,Non-consumers,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,12335,Average,serving/d,0,,,,,NA,g/d,0,0,0,0,,,,,1 serving=50g
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,2256,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Acculturation score,Acculturation score,Acculturation score,NA,,NA,,2256,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,2256,Mean,years,41.5,0.01,0.56,40.94,42.06,SD,years,41.5,41,40,40,0.0117901,0.56,40.94,42.06,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,2256,Mean,kg/m^2,28.6,0,0.02,28.58,28.62,SD,kg/m^2,28.6,28,25,20,0.000421076,0.02,28.58,28.62,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school diploma/GED,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,Greater than high school/GED,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,No high school diploma/GED,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Central American,Central American,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Cuban,Cuban,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Dominican,Dominican,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Mexican,Mexican,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,More than one heritage/other,More than one heritage/other,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Puerto Rican,Puerto Rican,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,South American,South American,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,2256,Mean,MET-min/day,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,2256,Percentage,%,62.59,,,,,NA,%,62.59,62,60,60,,,,,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,2256,Percentage,%,37.41,,,,,NA,%,37.41,37,35,30,,,,,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Non-smoker,NA,,NA,,2256,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,"Diet quality, aHEI total score",NA,,NA,,2256,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,12335,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Acculturation score,Acculturation score,Acculturation score,NA,,NA,,12335,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,12335,Mean,years,41.2,0,0.26,40.94,41.46,SD,years,41.2,41,40,40,0.00234101,0.26,40.94,41.46,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,12335,Mean,kg/m^2,29.5,0,0.09,29.41,29.59,SD,kg/m^2,29.5,29,25,20,0.000810351,0.09,29.41,29.59,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school diploma/GED,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,Greater than high school/GED,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,No high school diploma/GED,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Central American,Central American,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Cuban,Cuban,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Dominican,Dominican,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Mexican,Mexican,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,More than one heritage/other,More than one heritage/other,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,Puerto Rican,Puerto Rican,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Race,Heritage,South American,South American,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,12335,Mean,MET-min/day,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,12335,Percentage,%,60.15,,,,,NA,%,60.15,60,60,60,,,,,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,12335,Percentage,%,39.85,,,,,NA,%,39.85,39,35,30,,,,,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Non-smoker,NA,,NA,,12335,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,"Diet quality, aHEI total score",NA,,NA,,12335,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,317,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,317,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,317,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1237,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1237,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1237,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1495,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1495,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,1495,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5896,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5896,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5896,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,14536,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,14536,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,14536,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5993,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5993,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 2,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,5993,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5625,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5625,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5625,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,11991,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,11991,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,11991,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5191,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5191,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Glucose,Glucose 2h,2h OGTT glucose,NA,,NA,,5191,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,3006,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,369,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1236,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,1498,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5892,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,14555,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,HOMA,HOMA-β,HOMA-%B,NA,,NA,,5419,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Diabetic,NA,"Non-consumers, diabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,3003,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,351,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,351,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated insulin",NA,"Non-consumers, diabetic, treated, insulin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,351,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1231,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1231,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, treated metformin",NA,"Non-consumers, diabetic, treated, metformin",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1231,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1493,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1493,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,1493,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5886,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5886,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5886,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,14517,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,14517,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,14517,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5411,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5411,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,5411,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulin 2h,2h OGTT insulin,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,"Diabetic, untreated",NA,"Non-consumers, diabetic, untreated",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,989,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Normoglycemic,NA,"Non-consumers, normoglycemic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5607,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Overall population,NA,"Non-consumers, overall population",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,11966,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
50,Senn 2023,Observation,Hispanic Community Health Study/Study of Latinos (HCHS/SOL),Table 3,Consumers,Prediabetic,NA,"Non-consumers, prediabetic",Outcome,Glycemia,Insulin,Insulinogenic index,Insulinogenic index,NA,,NA,,5183,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Results section,Consumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,2182,Mean,serving/wk,0.81,,1.27,,,SD,g/d,5.78571,5,5,0,,9.07143,0,14.8571,1 serving=50g;7d/wk
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Results section,Nonconsumer,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,4038,Mean,serving/wk,0,,,,,NA,g/d,0,0,0,0,,,,,1 serving=50g;7d/wk
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,2182,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,2182,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,2182,Mean,years,60.74,0.22,10.29,50.45,71.03,SD,years,60.74,60,60,60,0.220287,10.29,50.45,71.03,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,2182,Mean,kg/m^2,28.23,0.11,5.24,22.99,33.47,SD,kg/m^2,28.23,28,25,20,0.112177,5.24,22.99,33.47,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Dysglycemia,Dysglycemia,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Normoglycemia,Normoglycemia,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated T2D,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated T2D,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,Completed high school/GED,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Grades 1-8,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,No schooling,No schooling,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Post-graduate,Graduate or professional school,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Some college, but no degree",NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,Grades 9-11,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Associate degree,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Technical school certificate,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","Income level, $25,000-$49,000",NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","Income level, <$25,000",NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000","Income level, >=$50,000",NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,2182,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,2182,Percentage,%,53.9,,,,,NA,%,53.9,53,50,50,,,,,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,2182,Percentage,%,46.1,,,,,NA,%,46.1,46,45,40,,,,,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Non-smoker,NA,,NA,,2182,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Consumer,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,"Diet quality, Mediterranean-style diet score",NA,,NA,,2182,Mean,score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,4038,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,4038,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,4038,Mean,years,63.1,0.16,10.15,52.95,73.25,SD,years,63.1,63,60,60,0.159729,10.15,52.95,73.25,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,4038,Mean,kg/m^2,28.21,0.09,5.48,22.73,33.69,SD,kg/m^2,28.21,28,25,20,0.0862377,5.48,22.73,33.69,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Dysglycemia,Dysglycemia,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Normoglycemia,Normoglycemia,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated T2D,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated T2D,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,Completed high school/GED,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Grades 1-8,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,No schooling,No schooling,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Post-graduate,Graduate or professional school,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Some college, but no degree",NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some high school,Grades 9-11,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Associate degree,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Technical school certificate,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","Income level, $25,000-$49,000",NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","Income level, <$25,000",NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000","Income level, >=$50,000",NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,4038,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,4038,Percentage,%,52.3,,,,,NA,%,52.3,52,50,50,,,,,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,4038,Percentage,%,47.8,,,,,NA,%,47.8,47,45,40,,,,,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Non-smoker,NA,,NA,,4038,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Nonconsumer,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,"Diet quality, Mediterranean-style diet score",NA,,NA,,4038,Mean,score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,855,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,4590,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,6220,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, treated",NA,"Nonconsumer, T2D, treated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,610,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,"Diabetes, untreated",NA,"Nonconsumer, T2D, untreated",Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,159,B coefficient,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,855,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,855,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Impaired fasting glucose,NA,"Nonconsumer, impaired fasting glucose",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,855,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,4590,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,4590,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,4590,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,6220,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,6220,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Diabetes incidence,T2D,Diabetes diagnosis,Incident T2D,NA,,NA,,6220,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 4,Consumer,"Diabetes, treated",NA,"Nonconsumer, Diabetes, treated",Outcome,Metabolic,Metabolomic biomarkers,Metabolomic biomarkers,Metabolomic biomarkers,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 4,Consumer,"Diabetes, untreated",NA,"Nonconsumer, Diabetes, untreated",Outcome,Metabolic,Metabolomic biomarkers,Metabolomic biomarkers,Metabolomic biomarkers,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 4,Consumer,Impaired fasting glucose,NA,"Nonconsumer, IFG",Outcome,Metabolic,Metabolomic biomarkers,Metabolomic biomarkers,Metabolomic biomarkers,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 4,Consumer,Normoglycemic,NA,"Nonconsumer, normoglycemia",Outcome,Metabolic,Metabolomic biomarkers,Metabolomic biomarkers,Metabolomic biomarkers,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51,Wood 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 4,Consumer,Overall population,NA,"Nonconsumer, overall population",Outcome,Metabolic,Metabolomic biomarkers,Metabolomic biomarkers,Metabolomic biomarkers,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,45289,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,45289,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,64.4,,11.3,53.1,75.7,SD,years,64.4,64,60,60,,11.3,53.1,75.7,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,26.2,,3.8,22.4,30,SD,kg/m^2,26.2,26,25,20,,3.8,22.4,30,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, <1/month",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,62.6,,11.2,51.4,73.8,SD,years,62.6,62,60,60,,11.2,51.4,73.8,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,25.8,,3.7,22.1,29.5,SD,kg/m^2,25.8,25,25,20,,3.7,22.1,29.5,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, >=1/week",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,62.5,,11.2,51.3,73.7,SD,years,62.5,62,60,60,,11.2,51.3,73.7,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,26,,3.8,22.2,29.8,SD,kg/m^2,26,26,25,20,,3.8,22.2,29.8,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"HPFS, 1-3/month",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,NHS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,67039,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,62.6,,10.3,52.3,72.9,SD,years,62.6,62,60,60,,10.3,52.3,72.9,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,28.9,,4.8,24.1,33.7,SD,kg/m^2,28.9,28,25,20,,4.8,24.1,33.7,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, <1/month",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,65.9,,9.8,56.1,75.7,SD,years,65.9,65,65,60,,9.8,56.1,75.7,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,24.7,,4.3,20.4,29,SD,kg/m^2,24.7,24,20,20,,4.3,20.4,29,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, >=1/week",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,,NA,,,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Mean,years,63.7,,9.8,53.9,73.5,SD,years,63.7,63,60,60,,9.8,53.9,73.5,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Mean,kg/m^2,25,,4.3,20.7,29.3,SD,kg/m^2,25,25,25,20,,4.3,20.7,29.3,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,,Mean,inches,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of cancer,Family history of cancer,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,Aspirin use,Aspirin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current",Postmenopausal hormone,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Mean,METs-h/week,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Colonoscopy or sigmoidoscopy,Colonoscopy or sigmoidoscopy,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,Mammogram,Mammogram,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,PSA screening in 1994,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current or former smoker,Ever smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 1,"NHS, 1-3/month",NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,AHEI,AHEI-2010,NA,,NA,,,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, >=1/week",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total Cancer,Total Cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"HPFS, 1-3/month",All,NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total Cancer,Total Cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total Cancer,Total Cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 2,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total Cancer,Total Cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",Diabetic,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",ER negative,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",ER positive,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",Mammogram,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",No mammogram,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",Non-diabetic,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",Post-menopause,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",PR negative,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",PR positive,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, >=1/week",Pre-menopause,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",All,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",Diabetic,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",ER negative,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",ER positive,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",Mammogram,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",No mammogram,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",Non-diabetic,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",Post-menopause,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",PR negative,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",PR positive,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table 3,"NHS, 1-3/month",Pre-menopause,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Total breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, >=1/week",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"HPFS, 1-3/month",Never or former smoker,NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, >=1/week",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Bladder cancer,Bladder cancer,Bladder cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Breast cancer,Breast cancer,Breast cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Endometrial cancer,Endometrial cancer,Endometrial cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Lung cancer,Lung cancer,Lung cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Melanoma,Melanoma,Melanoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,Non-Hodgkin lymphoma,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Ovarian cancer,Ovarian cancer,Ovarian cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Prostate cancer,Aggressive prostate cancer,Aggressive prostate cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S1,"NHS, 1-3/month",Never or former smoker,NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","Age, <65",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","Age, >=65",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","AHEI, <50",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","AHEI, >=50",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","BMI, <25",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, >=1/week","BMI, >=25",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","Age, <65",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","Age, >=65",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","AHEI, <50",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","AHEI, >=50",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","BMI, <25",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"HPFS, 1-3/month","BMI, >=25",NA,"HPFS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","Age, <65",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","Age, >=65",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","AHEI, <50",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","AHEI, >=50",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","BMI, <25",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, >=1/week","BMI, >=25",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","Age, <65",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","Age, >=65",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","AHEI, <50",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","AHEI, >=50",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","BMI, <25",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table S2,"NHS, 1-3/month","BMI, >=25",NA,"NHS, <1/month",Outcome,Cancer incidence,Total cancer,Total cancer,Total cancer,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"HPFS, <1/month",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/month,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving=75g;30d/mth
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"HPFS, >=1/week",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/wk,1,,,,,NA,g/d,10.7143,10,10,10,,,,,1 serving=75g;7d/wk
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"HPFS, 1-3/month",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/month,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving=75g;30d/mth
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"NHS, <1/month",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/month,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving=75g;30d/mth
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"NHS, >=1/week",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/wk,1,,,,,NA,g/d,10.7143,10,10,10,,,,,1 serving=75g;7d/wk
52,Ericsson 2022,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2016),Table1;Methods section,"NHS, 1-3/month",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,serving/month,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving=75g;30d/mth
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Abstract,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,14,Percentage,%,21.4286,,,,,NA,%,21.4286,21,20,20,,,,,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Abstract,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,14,Percentage,%,78.5714,,,,,NA,%,78.5714,78,75,70,,,,,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Methods section,Hamburger,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,14,Absolute value,g/test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Methods section,Hamburger + avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,14,Absolute value,g/test meal,68,,,,,NA,g/test meal,68,68,65,60,,,,,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,14,Mean,years,36,3.54,13.26,22.74,49.26,SD,years,36,36,35,30,3.54388,13.26,22.74,49.26,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,14,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,14,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,14,Mean,mg/dL,40.28,1.48,5.53,34.75,45.81,SD,mg/dL,40.28,40,40,40,1.47795,5.53,34.75,45.81,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,14,Mean,mg/dL,144.64,9.31,34.83,109.81,179.47,SD,mg/dL,144.64,144,140,140,9.30871,34.83,109.81,179.47,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Cholesterol,NA,,NA,,14,Mean,mg/dL,237.42,10.28,38.47,198.95,275.89,SD,mg/dL,237.42,237,235,230,10.2815,38.47,198.95,275.89,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,14,Mean,mg/dL,224.67,18.81,70.39,154.28,295.06,SD,mg/dL,224.67,224,220,220,18.8125,70.39,154.28,295.06,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b granulocytes 0h,CD11b granulocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b granulocytes 4h,CD11b granulocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11c,CD11c monocytes 0h,CD11c monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD11c,CD11c monocytes 4h,CD11c monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD18,CD18 granulocytes 0h,CD18 granulocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD18,CD18 granulocytes 4h,CD18 granulocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD18,CD18 monocytes 0h,CD18 monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Immune,CD18,CD18 monocytes 4h,CD18 monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,Expression of reactive oxygen,Expression of reactive oxygen 0h,Expression of reactive oxygen,Blood,0,weeks,0,14,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,Expression of reactive oxygen,Expression of reactive oxygen 4h,Expression of reactive oxygen,Blood,,NA,,14,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation 0h,Lipoperoxidation,Blood,0,weeks,0,14,Mean,TBARS nmol/mg,NA,NA,NA,NA,NA,SD,TBARS nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation 4h,Lipoperoxidation,Blood,,NA,,14,Mean,TBARS nmol/mg,NA,NA,NA,NA,NA,SD,TBARS nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx 0h,Nitric oxide,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx 4h,Nitric oxide,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation 0h,Flow-dependent vasodilation,Blood,0,weeks,0,14,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation 4h,Flow-dependent vasodilation,Blood,,NA,,14,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b granulocytes 0h,CD11b granulocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b granulocytes 4h,CD11b granulocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b monocytes 0h,CD11b monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11b,CD11b monocytes 4h,CD11b monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11c,CD11c monocytes 0h,CD11c monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD11c,CD11c monocytes 4h,CD11c monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD18,CD18 granulocytes 0h,CD18 granulocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD18,CD18 granulocytes 4h,CD18 granulocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD18,CD18 monocytes 0h,CD18 monocytes,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Immune,CD18,CD18 monocytes 4h,CD18 monocytes,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,Expression of reactive oxygen,Expression of reactive oxygen 0h,Expression of reactive oxygen,Blood,0,weeks,0,14,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,Expression of reactive oxygen,Expression of reactive oxygen 4h,Expression of reactive oxygen,Blood,,NA,,14,Mean,nmol/mg,NA,NA,NA,NA,NA,SD,nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation 0h,Lipoperoxidation,Blood,0,weeks,0,14,Mean,TBARS nmol/mg,NA,NA,NA,NA,NA,SD,TBARS nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation 4h,Lipoperoxidation,Blood,,NA,,14,Mean,TBARS nmol/mg,NA,NA,NA,NA,NA,SD,TBARS nmol/mg,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx 0h,Nitric oxide,Blood,0,weeks,0,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,Antioxidation,NOx,NOx 4h,Nitric oxide,Blood,,NA,,14,Mean,uM,NA,NA,NA,NA,NA,SD,μM,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation 0h,Flow-dependent vasodilation,Blood,0,weeks,0,14,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
53,Raya-Farias 2018,Intervention,Raya-Farias 2018,Table 2,Hamburger + avocado,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation 4h,Flow-dependent vasodilation,Blood,,NA,,14,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,High avocado,Adolescent only,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,18,Absolute value,avocado/wk/family,14,,,,,NA,g/d,300,300,300,300,,,,,150g/avo;7d/wk
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,High avocado,Children only,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,28,Absolute value,avocado/wk/family,14,,,,,NA,g/d,300,300,300,300,,,,,150g/avo;7d/wk
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Low avocado,Adolescent only,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,14,Absolute value,avocado/wk/family,3,,,,,NA,g/d,64.2857,64,60,60,,,,,150g/avo;7d/wk
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Low avocado,Children only,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,30,Absolute value,avocado/wk/family,3,,,,,NA,g/d,64.2857,64,60,60,,,,,150g/avo;7d/wk
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,18,Mean,years,15.6,0.33,1.4,14.2,17,SD,years,15.6,15,15,10,0.329983,1.4,14.2,17,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,28,Mean,years,9.4,0.42,2.2,7.2,11.6,SD,years,9.4,9,5,0,0.415761,2.2,7.2,11.6,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,18,Mean,kg/m^2,25.1,1.08,4.6,20.5,29.7,SD,kg/m^2,25.1,25,25,20,1.08423,4.6,20.5,29.7,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,28,Mean,kg/m^2,20.7,1.08,5.7,15,26.4,SD,kg/m^2,20.7,20,20,20,1.0772,5.7,15,26.4,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip circumference,NA,,NA,,18,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip circumference,NA,,NA,,28,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,18,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,28,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,,NA,,18,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,,NA,,28,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,,NA,,18,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,,NA,,28,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip circumference,NA,,NA,,18,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip circumference,NA,,NA,,28,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,18,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,28,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,18,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,28,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,18,Percentage,%,72.2,,,,,NA,%,72.2,72,70,70,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,28,Percentage,%,60.7,,,,,NA,%,60.7,60,60,60,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Adolescents only,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,18,Percentage,%,27.8,,,,,NA,%,27.8,27,25,20,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado,Children only,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,28,Percentage,%,39.3,,,,,NA,%,39.3,39,35,30,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,14,Mean,years,16,0.27,1,15,17,SD,years,16,16,15,10,0.267261,1,15,17,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,30,Mean,years,9,0.38,2.1,6.9,11.1,SD,years,9,9,5,0,0.383406,2.1,6.9,11.1,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,14,Mean,kg/m^2,23.2,1.52,5.7,17.5,28.9,SD,kg/m^2,23.2,23,20,20,1.52339,5.7,17.5,28.9,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,30,Mean,kg/m^2,18.6,0.58,3.2,15.4,21.8,SD,kg/m^2,18.6,18,15,10,0.584237,3.2,15.4,21.8,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip circumference,NA,,NA,,14,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip circumference,NA,,NA,,30,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,14,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,30,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,,NA,,14,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,,NA,,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,,NA,,14,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,,NA,,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip circumference,NA,,NA,,14,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip circumference,NA,,NA,,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,14,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,30,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,14,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,30,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,14,Percentage,%,69.2,,,,,NA,%,69.2,69,65,60,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,30,Percentage,%,40,,,,,NA,%,40,40,40,40,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Adolescents only,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,14,Percentage,%,30.8,,,,,NA,%,30.8,30,30,30,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado,Children only,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,30,Percentage,%,60,,,,,NA,%,60,60,60,60,,,,,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,18,Mean,"kg/m^2, change-in",0.08,,,-3.24,3.29,95%CI,"kg/m^2, change-in",0.08,0,0,0,,,-3.24,3.29,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,35,Mean,"kg/m^2, change-in",0.2,,,-2.15,2.55,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,-2.15,2.55,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,28,Mean,"kg/m^2, change-in",0.3,,,-2.87,3.46,95%CI,"kg/m^2, change-in",0.3,0,0,0,,,-2.87,3.46,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,18,Mean,"kg/m^2, change-in",0.91,,,-2.55,4.36,95%CI,"kg/m^2, change-in",0.91,0,0,0,,,-2.55,4.36,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,35,Mean,"kg/m^2, change-in",0.51,,,-1.89,2.92,95%CI,"kg/m^2, change-in",0.51,0,0,0,,,-1.89,2.92,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,28,Mean,"kg/m^2, change-in",0.23,,,-2.93,3.38,95%CI,"kg/m^2, change-in",0.23,0,0,0,,,-2.93,3.38,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,14,Mean,"kg/m^2, change-in",0.24,,,-4.03,4.51,95%CI,"kg/m^2, change-in",0.24,0,0,0,,,-4.03,4.51,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,37,Mean,"kg/m^2, change-in",0.2,,,-1.89,2.3,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,-1.89,2.3,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,30,Mean,"kg/m^2, change-in",0.19,,,-1.9,2.27,95%CI,"kg/m^2, change-in",0.19,0,0,0,,,-1.9,2.27,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,14,Mean,"kg/m^2, change-in",-0.08,,,-4.15,3.99,95%CI,"kg/m^2, change-in",-0.08,-1,-5,-10,,,-4.15,3.99,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,37,Mean,"kg/m^2, change-in",0.26,,,-1.8,2.31,95%CI,"kg/m^2, change-in",0.26,0,0,0,,,-1.8,2.31,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,30,Mean,"kg/m^2, change-in",0.42,,,-1.71,2.55,95%CI,"kg/m^2, change-in",0.42,0,0,0,,,-1.71,2.55,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,18,Mean,"kg/m^2, change-in",0.08,,,-0.43,0.58,95%CI,"kg/m^2, change-in",0.08,0,0,0,,,-0.43,0.58,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,35,Mean,"kg/m^2, change-in",0.2,,,-0.09,0.5,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,-0.09,0.5,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,28,Mean,"kg/m^2, change-in",0.3,,,-0.08,0.67,95%CI,"kg/m^2, change-in",0.3,0,0,0,,,-0.08,0.67,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,18,Mean,"kg/m^2, change-in",0.91,,,-0.4,2.21,95%CI,"kg/m^2, change-in",0.91,0,0,0,,,-0.4,2.21,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,35,Mean,"kg/m^2, change-in",0.51,,,-0.16,1.19,95%CI,"kg/m^2, change-in",0.51,0,0,0,,,-0.16,1.19,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,28,Mean,"kg/m^2, change-in",0.23,,,-0.5,0.95,95%CI,"kg/m^2, change-in",0.23,0,0,0,,,-0.5,0.95,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,14,Mean,"kg/m^2, change-in",0.24,,,-0.05,0.53,95%CI,"kg/m^2, change-in",0.24,0,0,0,,,-0.05,0.53,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,37,Mean,"kg/m^2, change-in",0.2,,,0.01,0.4,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,0.01,0.4,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,30,Mean,"kg/m^2, change-in",0.19,,,-0.07,0.45,95%CI,"kg/m^2, change-in",0.19,0,0,0,,,-0.07,0.45,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,14,Mean,"kg/m^2, change-in",-0.08,,,-0.48,0.32,95%CI,"kg/m^2, change-in",-0.08,-1,-5,-10,,,-0.48,0.32,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,37,Mean,"kg/m^2, change-in",0.26,,,0,0.52,95%CI,"kg/m^2, change-in",0.26,0,0,0,,,0,0.52,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,30,Mean,"kg/m^2, change-in",0.42,,,0.1,0.74,95%CI,"kg/m^2, change-in",0.42,0,0,0,,,0.1,0.74,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,18,Mean,"kg/m^2, change-in",0.08,,,-3.03,3.18,95%CI,"kg/m^2, change-in",0.08,0,0,0,,,-3.03,3.18,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,35,Mean,"kg/m^2, change-in",0.21,,,-1.99,2.4,95%CI,"kg/m^2, change-in",0.21,0,0,0,,,-1.99,2.4,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,28,Mean,"kg/m^2, change-in",0.31,,,-2.73,3.34,95%CI,"kg/m^2, change-in",0.31,0,0,0,,,-2.73,3.34,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,18,Mean,"kg/m^2, change-in",0.91,,,-2.54,4.35,95%CI,"kg/m^2, change-in",0.91,0,0,0,,,-2.54,4.35,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,35,Mean,"kg/m^2, change-in",0.52,,,-1.9,2.94,95%CI,"kg/m^2, change-in",0.52,0,0,0,,,-1.9,2.94,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,28,Mean,"kg/m^2, change-in",0.22,,,-2.59,3.03,95%CI,"kg/m^2, change-in",0.22,0,0,0,,,-2.59,3.03,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,18,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,28,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,18,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,35,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,28,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,18,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,35,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,High Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,28,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,14,Mean,"kg/m^2, change-in",0.24,,,-3.25,3.74,95%CI,"kg/m^2, change-in",0.24,0,0,0,,,-3.25,3.74,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,37,Mean,"kg/m^2, change-in",0.21,,,-2.03,2.45,95%CI,"kg/m^2, change-in",0.21,0,0,0,,,-2.03,2.45,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,30,Mean,"kg/m^2, change-in",0.2,,,-2.05,2.45,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,-2.05,2.45,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,14,Mean,"kg/m^2, change-in",-0.08,,,-4.21,4.05,95%CI,"kg/m^2, change-in",-0.08,-1,-5,-10,,,-4.21,4.05,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,37,Mean,"kg/m^2, change-in",0.24,,,-1.92,2.4,95%CI,"kg/m^2, change-in",0.24,0,0,0,,,-1.92,2.4,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,30,Mean,"kg/m^2, change-in",0.4,,,-1.81,2.61,95%CI,"kg/m^2, change-in",0.4,0,0,0,,,-1.81,2.61,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Hip circumference,Hip circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,14,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,30,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist circumference:Height,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Weight,Waist circumference:Weight,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,3,months,12,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,14,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,37,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body size,Waist:Hip circumference,Waist:Hip circumference,NA,6,months,24,30,Mean,"ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,3,months,12,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Adolescents only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,14,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children and adolescents,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,37,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
54,VanEvery 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 4,Low Avocado,Children only,ITT,Within,Outcome,Anthropometry,Body weight,Body weight,Body Weight,NA,6,months,24,30,Mean,"kg, change-in",NA,NA,NA,NA,NA,95%CI,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 1,1g,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation fasting,Flow-dependent vasodilation fasting,NA,0,weeks,0,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 1,2g,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation fasting,Flow-dependent vasodilation fasting,NA,0,weeks,0,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 1,Control,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation fasting,Flow-dependent vasodilation fasting,NA,0,weeks,0,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 2,1g,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation postprandial,Flow-dependent vasodilation postprandial,NA,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 2,2g,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation postprandial,Flow-dependent vasodilation postprandial,NA,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Figure 2,Control,NA,ITT,Summary,Outcome,CVD risk factors,Vasodilation,Flow-dependent vasodilation postprandial,Flow-dependent vasodilation postprandial,NA,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Methods section,1g,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Absolute value,g/kg/d,1,,22.2,,,SD,g/d,70.7,70,70,70,,22.2,48.5,92.9,2g/kg;kg=70.7
56,Carranza 2004,Intervention,Carranza 2004,Methods section,2g,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Absolute value,g/kg/d,2,,12.8,,,SD,g/d,140.4,140,140,140,,12.8,127.6,153.2,1g/kg;kg=70.2
56,Carranza 2004,Intervention,Carranza 2004,Methods section,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,20,Absolute value,g/kg/d,0,,,,,NA,g/d,0,0,0,0,,,,,0g/kg
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,20,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,20,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,29.1,0.91,4.09,25.01,33.19,SD,kg/m^2,29.1,29,25,20,0.914552,4.09,25.01,33.19,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,20,Mean,m,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,20,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Health status,Diabetes,Diabetes,T2D,NA,,NA,,20,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Health status,Dyslipidemia,Hypercholesterolemia,Arterial hypertension,NA,,NA,,20,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,CVD risk factors,Heart rate,Heart rate,Heart rate,NA,,NA,,20,Mean,beats/min,NA,NA,NA,NA,NA,SD,beats/min,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,20,Percentage,%,55,,,,,NA,%,55,55,55,50,,,,,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 1,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,20,Percentage,%,45,,,,,NA,%,45,45,45,40,,,,,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,28.8,0.87,3.9,24.9,32.7,SD,kg/m^2,28.8,28,25,20,0.872067,3.9,24.9,32.7,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,20,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL/HDL,NA,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol/HDL,Blood,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,20,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,20,Mean,mg/dL,42.8,0.51,2.3,40.5,45.1,SD,mg/dL,42.8,42,40,40,0.514296,2.3,40.5,45.1,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,20,Mean,mg/dL,107.4,5.9,26.4,81,133.8,SD,mg/dL,107.4,107,105,100,5.90322,26.4,81,133.8,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,20,Mean,mg/dL,195,6.86,30.7,164.3,225.7,SD,mg/dL,195,195,195,190,6.86473,30.7,164.3,225.7,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,1g,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,20,Mean,mg/dL,223,10.73,48,175,271,SD,mg/dL,223,223,220,220,10.7331,48,175,271,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,29.1,0.85,3.81,25.29,32.91,SD,kg/m^2,29.1,29,25,20,0.851942,3.81,25.29,32.91,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,20,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL/HDL,NA,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol/HDL,Blood,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,20,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,20,Mean,mg/dL,43.4,0.63,2.8,40.6,46.2,SD,mg/dL,43.4,43,40,40,0.626099,2.8,40.6,46.2,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,20,Mean,mg/dL,99.8,5.55,24.8,75,124.6,SD,mg/dL,99.8,99,95,90,5.54545,24.8,75,124.6,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,20,Mean,mg/dL,185,5.41,24.2,160.8,209.2,SD,mg/dL,185,185,185,180,5.41128,24.2,160.8,209.2,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,2g,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,20,Mean,mg/dL,207,10.02,44.8,162.2,251.8,SD,mg/dL,207,207,205,200,10.0176,44.8,162.2,251.8,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,20,Mean,kg/m^2,29.1,0.91,4.09,25.01,33.19,SD,kg/m^2,29.1,29,25,20,0.914552,4.09,25.01,33.19,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,20,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL/HDL,NA,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol/HDL,Blood,,NA,,20,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,20,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,20,Mean,mg/dL,32.7,0.78,3.5,29.2,36.2,SD,mg/dL,32.7,32,30,30,0.782624,3.5,29.2,36.2,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,20,Mean,mg/dL,124.7,9.06,40.5,84.2,165.2,SD,mg/dL,124.7,124,120,120,9.05608,40.5,84.2,165.2,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,20,Mean,mg/dL,201.3,7.16,32,169.3,233.3,SD,mg/dL,201.3,201,200,200,7.15542,32,169.3,233.3,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 2,Control,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,20,Mean,mg/dL,185,11.72,52.4,132.6,237.4,SD,mg/dL,185,185,185,180,11.717,52.4,132.6,237.4,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 3,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,1g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,2g,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidic acid,Arachidic acid,Arachidic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Arachidonic acid,Arachidonic acid,Arachidonic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Behenic acid,Behenic acid,Behenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Lauric acid,Lauric acid,Lauric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,Linolenic acid,Linolenic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Linolenic acid,y-linolenic acid,y-linolenic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Margaric acid,Margaric acid,Margaric acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Myristoleic acid,Myristoleic acid,Myristoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Palmitoleic acid,Palmitoleic acid,Palmitoleic acid,Serum,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 4,Control,NA,ITT,Summary,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Erythrocytes,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,1g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Platelet aggregation 30sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,1g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Platelet aggregation 60 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,1g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Platelet aggregation 90 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,2g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Platelet aggregation 30sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,2g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Platelet aggregation 60 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,2g,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Platelet aggregation 90 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Platelet aggregation 30sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Platelet aggregation 60 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 5,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Platelet aggregation 90 sec after stimulation with adenosine diphosphate,Blood,4,weeks,4,20,Mean,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,1g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after fasting endothelium stimulation","Brachial artery area, after fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,1g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before fasting endothelium stimulation","Brachial artery area, before fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,2g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after fasting endothelium stimulation","Brachial artery area, after fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,2g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before fasting endothelium stimulation","Brachial artery area, before fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,Control,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after fasting endothelium stimulation","Brachial artery area, after fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 6,Control,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before fasting endothelium stimulation","Brachial artery area, before fasting endothelium stimulation",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,1g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after stimulating postprandial endothelium","Brachial artery area, after stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,1g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before stimulating postprandial endothelium","Brachial artery area, before stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,2g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after stimulating postprandial endothelium","Brachial artery area, after stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,2g,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before stimulating postprandial endothelium","Brachial artery area, before stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,Control,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, after stimulating postprandial endothelium","Brachial artery area, after stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
56,Carranza 2004,Intervention,Carranza 2004,Table 7,Control,NA,ITT,Summary,Outcome,CVD risk factors,Brachial artery,"Brachial artery area, before stimulating postprandial endothelium","Brachial artery area, before stimulating postprandial endothelium",Blood,4,weeks,4,20,Mean,mm^2,NA,NA,NA,NA,NA,NA,mm^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Fig 2,High avocado allotment,NA,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Fig 2,Low avocado allotment,NA,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,,NA,,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,High avocado allotment,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,35,Absolute value,avocado/wk/family,14,,,,,NA,g/d,300,300,300,300,,,,,150g/avo;7d/wk
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Low avocado allotment,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,37,Absolute value,avocado/wk/family,3,,,,,NA,g/d,64.2857,64,60,60,,,,,150g/avo;7d/wk
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,35,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,0,weeks,0,35,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,35,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Other,Protein,Animal protein,Animal origin,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,35,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,0,weeks,0,35,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,0,weeks,0,35,Mean,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,0,weeks,0,35,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,0,weeks,0,35,Mean,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,0,weeks,0,35,Mean,IU,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,18,Mean,years,15.6,0.33,1.4,14.2,17,SD,years,15.6,15,15,10,0.329983,1.4,14.2,17,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Child,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,28,Mean,years,9.4,0.42,2.2,7.2,11.6,SD,years,9.4,9,5,0,0.415761,2.2,7.2,11.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,35,Mean,years,44.5,1.42,8.4,36.1,52.9,SD,years,44.5,44,40,40,1.41986,8.4,36.1,52.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,32,Mean,years,38,3.24,18.3,19.7,56.3,SD,years,38,38,35,30,3.23501,18.3,19.7,56.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of birth,"Country of birth, Mexico","Country of birth, Mexico",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of education,"Country where education completed, Mexico","Country where education completed, Mexico",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of education,"Country where education completed, US or other","Country where education completed, US or other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree or above,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,"Education, other","Education, other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,No diploma,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Trade school or associate's degree,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Employed for wages,Employed for wages,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,"Employment, other","Employment, other",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Homemaker,Homemaker,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Self-employed,Self-employed,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Average family size,NA,,NA,,35,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Heritage,Mexican,"Heritage, Mexican",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Family income, <$30,000/yr",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Married or cohabitation,Married or cohabitation,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,"Separated, divorced, or widowed","Separated, divorced, or widowed",NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,Single,NA,,NA,,35,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,18,Percentage,%,72.2,,,,,NA,%,72.2,72,70,70,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Child,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,28,Percentage,%,60.7,,,,,NA,%,60.7,60,60,60,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,35,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,32,Percentage,%,46.9,,,,,NA,%,46.9,46,45,40,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,18,Percentage,%,27.8,,,,,NA,%,27.8,27,25,20,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Child,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,28,Percentage,%,39.3,,,,,NA,%,39.3,39,35,30,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,32,Percentage,%,53.1,,,,,NA,%,53.1,53,50,50,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Family,ITT,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI 2015,NA,,NA,,35,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Years lived in US,Years lived in US,Years lived in US,NA,,NA,,35,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,37,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Energy,Energy,Energy,Total energy intake,NA,0,weeks,0,37,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,37,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Minerals,Iron,Iron,Iron,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,Monounsaturated fat,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Other,Protein,Animal protein,Animal origin,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,37,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,Polyunsaturated fat,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,0,weeks,0,37,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,0,weeks,0,37,Mean,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,0,weeks,0,37,Mean,mg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,0,weeks,0,37,Mean,mcg,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,0,weeks,0,37,Mean,IU,NA,NA,NA,NA,NA,SD,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,14,Mean,years,16,0.27,1,15,17,SD,years,16,16,15,10,0.267261,1,15,17,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,30,Mean,years,9,0.38,2.1,6.9,11.1,SD,years,9,9,5,0,0.383406,2.1,6.9,11.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,37,Mean,years,46.5,1.86,11.3,35.2,57.8,SD,years,46.5,46,45,40,1.85771,11.3,35.2,57.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,37,Mean,years,44.4,3.21,19.5,24.9,63.9,SD,years,44.4,44,40,40,3.20578,19.5,24.9,63.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of birth,"Country of birth, Mexico","Country of birth, Mexico",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of education,"Country where education completed, Mexico","Country where education completed, Mexico",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Country of education,"Country where education completed, US or other","Country where education completed, US or other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,College or higher,Bachelor's degree or above,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,"Education, other","Education, other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,No diploma,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Education,Trade school or associate's degree,Trade school or associate's degree,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Employed for wages,Employed for wages,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,"Employment, other","Employment, other",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Homemaker,Homemaker,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Employment,Self-employed,Self-employed,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Average family size,NA,,NA,,37,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Race,Heritage,Mexican,"Heritage, Mexican",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Family income, <$30,000/yr",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Married or cohabitation,Married or cohabitation,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,"Separated, divorced, or widowed","Separated, divorced, or widowed",NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Marriage status,Single,Single,NA,,NA,,37,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,14,Percentage,%,69.2,,,,,NA,%,69.2,69,65,60,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,30,Percentage,%,40,,,,,NA,%,40,40,40,40,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,37,Percentage,%,97.3,,,,,NA,%,97.3,97,95,90,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,37,Percentage,%,35.1,,,,,NA,%,35.1,35,35,30,,,,,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,14,Percentage,%,30.8,,,,,NA,%,30.8,30,30,30,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,30,Percentage,%,60,,,,,NA,%,60,60,60,60,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,37,Percentage,%,2.7,,,,,NA,%,2.7,2,0,0,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,37,Percentage,%,64.9,,,,,NA,%,64.9,64,60,60,,,,,
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Family,ITT,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI 2015,NA,,NA,,37,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lifestyle,Years lived in US,Years lived in US,Years lived in US,NA,,NA,,37,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,18,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Child,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,28,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,35,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,32,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,18,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Child,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,28,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,35,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,32,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,35,Mean,kg/m^2,30.5,1.05,6.2,24.3,36.7,SD,kg/m^2,30.5,30,30,30,1.04799,6.2,24.3,36.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,32,Mean,kg/m^2,28.6,1.22,6.9,21.7,35.5,SD,kg/m^2,28.6,28,25,20,1.21976,6.9,21.7,35.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Adolescent, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,13,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Adolescent, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,5,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Child, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,17,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Child, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,11,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Head of household, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,35,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Non-head of household, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,15,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,"Non-head of household, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,17,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,18,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Child,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,28,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,18,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,32,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Free fatty acids,Free fatty acids,Free fatty acids,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Free fatty acids,Free fatty acids,Free fatty acids,NA,,NA,,18,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,18,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,35,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,18,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,35,Mean,mg/dL,49.9,1.83,10.8,39.1,60.7,SD,mg/dL,49.9,49,45,40,1.82553,10.8,39.1,60.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,18,Mean,mg/dL,51.8,3.68,15.6,36.2,67.4,SD,mg/dL,51.8,51,50,50,3.67696,15.6,36.2,67.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,35,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,32,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,32,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,35,Mean,mg/dL,112.1,4.58,27.1,85,139.2,SD,mg/dL,112.1,112,110,110,4.58074,27.1,85,139.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,18,Mean,mg/dL,105.9,7.83,33.2,72.7,139.1,SD,mg/dL,105.9,105,105,100,7.82532,33.2,72.7,139.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,18,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Child,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,28,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,35,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,32,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,RBC magnesium,RBC magnesium,RBC magnesium,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,RBC magnesium,RBC magnesium,RBC magnesium,NA,,NA,,10,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,35,Mean,mg/dL,188.7,5.56,32.9,155.8,221.6,SD,mg/dL,188.7,188,185,180,5.56111,32.9,155.8,221.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,18,Mean,mg/dL,180.3,7.78,33,147.3,213.3,SD,mg/dL,180.3,180,180,180,7.77817,33,147.3,213.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,35,Mean,mg/dL,142.8,16.19,95.8,47,238.6,SD,mg/dL,142.8,142,140,140,16.1932,95.8,47,238.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,18,Mean,mg/dL,113.1,10.89,46.2,66.9,159.3,SD,mg/dL,113.1,113,110,110,10.8894,46.2,66.9,159.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,VLDL-C,NA,,NA,,35,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,High avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,VLDL-C,NA,,NA,,18,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,30,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,30,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,37,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,37,Mean,kg/m^2,30.6,1,6.1,24.5,36.7,SD,kg/m^2,30.6,30,30,30,1.00283,6.1,24.5,36.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,37,Mean,kg/m^2,31.7,1.02,6.2,25.5,37.9,SD,kg/m^2,31.7,31,30,30,1.01927,6.2,25.5,37.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Adolescent, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,9,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Adolescent, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,5,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Child, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,12,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Child, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,18,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Head of household, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,36,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Non-head of household, female",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,13,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,"Non-head of household, male",ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,24,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,14,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,30,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,37,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,37,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Free fatty acids,Free fatty acids,Free fatty acids,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Free fatty acids,Free fatty acids,Free fatty acids,NA,,NA,,23,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Glucose,Glucose,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,37,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Hemoglobin A1c,NA,,NA,,23,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,37,Mean,mg/dL,52.7,2.47,15,37.7,67.7,SD,mg/dL,52.7,52,50,50,2.46598,15,37.7,67.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,NA,,NA,,23,Mean,mg/dL,44.8,2.48,11.9,32.9,56.7,SD,mg/dL,44.8,44,40,40,2.48132,11.9,32.9,56.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,37,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,HOMA,HOMA-IR,HOMA-IR,NA,,NA,,23,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Insulin,Insulin,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,37,Mean,mg/dL,111.4,6.15,37.4,74,148.8,SD,mg/dL,111.4,111,110,110,6.14852,37.4,74,148.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,NA,,NA,,21,Mean,mg/dL,112.3,8.38,38.4,73.9,150.7,SD,mg/dL,112.3,112,110,110,8.37957,38.4,73.9,150.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Adolescent,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,14,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Child,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,30,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,37,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate-vigorous physical activity,Moderate-vigorous physical activity,NA,,NA,,37,Mean,min/wk,NA,NA,NA,NA,NA,SD,min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Metabolic,RBC magnesium,RBC magnesium,RBC magnesium,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Metabolic,RBC magnesium,RBC magnesium,RBC magnesium,NA,,NA,,7,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,37,Mean,mg/dL,189.2,6.71,40.8,148.4,230,SD,mg/dL,189.2,189,185,180,6.70748,40.8,148.4,230,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,NA,,NA,,23,Mean,mg/dL,185.5,8.24,39.5,146,225,SD,mg/dL,185.5,185,185,180,8.23632,39.5,146,225,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,37,Mean,mg/dL,138.5,21.45,130.5,8,269,SD,mg/dL,138.5,138,135,130,21.4541,130.5,8,269,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,NA,,NA,,23,Mean,mg/dL,163.8,22.73,109,54.8,272.8,SD,mg/dL,163.8,163,160,160,22.7281,109,54.8,272.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Head of household,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,VLDL-C,NA,,NA,,37,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Low avocado allotment,Non-head of household,ITT,Summary,Subject Characteristics,Lipids,VLDL-C,VLDL-C,VLDL-C,NA,,NA,,21,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,3,months,12,35,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,6,months,24,35,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,High avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,3,months,12,37,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,6,months,24,37,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 3,Low avocado allotment,Family,ITT,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,18,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,67,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,27,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,35,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,32,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,18,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,67,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,27,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,35,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,32,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,18,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,67,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,27,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,35,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,32,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,18,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,67,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,27,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,35,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,32,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,67,Mean,"kg/m^2, change-in",-0.1,,,-0.7,0.4,95%CI,"kg/m^2, change-in",-0.1,-1,-5,-10,,,-0.7,0.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,35,Mean,"kg/m^2, change-in",-0.1,,,-0.6,0.3,95%CI,"kg/m^2, change-in",-0.1,-1,-5,-10,,,-0.6,0.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,32,Mean,"kg/m^2, change-in",-0.1,,,-1.2,1,95%CI,"kg/m^2, change-in",-0.1,-1,-5,-10,,,-1.2,1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adults,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,67,Mean,"kg/m^2, change-in",-0.01,,,-0.7,0.7,95%CI,"kg/m^2, change-in",-0.01,-1,-5,-10,,,-0.7,0.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,35,Mean,"kg/m^2, change-in",0.1,,,-0.9,1.1,95%CI,"kg/m^2, change-in",0.1,0,0,0,,,-0.9,1.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Non-head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,32,Mean,"kg/m^2, change-in",0.2,,,-1.2,0.9,95%CI,"kg/m^2, change-in",0.2,0,0,0,,,-1.2,0.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adolescent, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,13,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adolescent, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,5,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adults, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,50,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adults, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Child, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Child, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,11,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Non-head of household, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,15,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Non-head of household, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adolescent, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,13,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adolescent, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,5,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adults, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,50,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Adults, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Child, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Child, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,11,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,35,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Non-head of household, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,15,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,"Non-head of household, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,17,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,3,months,12,18,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,3,months,12,28,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Adolescent,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,6,months,24,18,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,High avocado allotment,Child,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,6,months,24,28,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,14,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,74,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,28,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,14,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,74,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,28,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,14,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,74,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,28,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,14,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,74,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,28,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,37,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,95%CI,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,74,Mean,"kg/m^2, change-in",0.3,,,-0.2,0.8,95%CI,"kg/m^2, change-in",0.3,0,0,0,,,-0.2,0.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,37,Mean,"kg/m^2, change-in",-0.1,,,-0.4,0.3,95%CI,"kg/m^2, change-in",-0.1,-1,-5,-10,,,-0.4,0.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,37,Mean,"kg/m^2, change-in",0.7,,,-0.3,1.6,95%CI,"kg/m^2, change-in",0.7,0,0,0,,,-0.3,1.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adults,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,74,Mean,"kg/m^2, change-in",-0.1,,,-0.4,0.2,95%CI,"kg/m^2, change-in",-0.1,-1,-5,-10,,,-0.4,0.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,37,Mean,"kg/m^2, change-in",-0.4,,,-0.9,0.1,95%CI,"kg/m^2, change-in",-0.4,-1,-5,-10,,,-0.9,0.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,37,Mean,"kg/m^2, change-in",0.1,,,-0.3,0.5,95%CI,"kg/m^2, change-in",0.1,0,0,0,,,-0.3,0.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adolescent, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,9,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adolescent, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,4,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adults, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,49,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adults, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,25,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Child, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,12,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Child, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,8,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Non-head of household, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,13,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Non-head of household, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,3,months,12,24,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adolescent, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,9,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adolescent, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,4,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adults, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,49,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Adults, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,25,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Child, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,12,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Child, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,8,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Head of household,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,37,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Non-head of household, female",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,13,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,"Non-head of household, male",ITT,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,6,months,24,24,Mean,"cm, change-in",NA,NA,NA,NA,NA,95%CI,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,3,months,12,14,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,3,months,12,30,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Adolescent,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,6,months,24,14,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 5,Low avocado allotment,Child,ITT,Within,Outcome,Anthropometry,Body size,Waist circumference:Height,Waist-to-height ratio,NA,6,months,24,30,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,95%CI,"ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,53,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,18,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,53,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,35,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,18,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,53,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,35,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,18,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,53,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,35,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,18,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,53,Mean,"mg/dl, change-in",-1.5,,,-3.4,0.5,95%CI,"mg/dl, change-in",-1.5,-2,-5,-10,,,-3.4,0.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,35,Mean,"mg/dl, change-in",-1.2,,,-3.8,1.4,95%CI,"mg/dl, change-in",-1.2,-2,-5,-10,,,-3.8,1.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,18,Mean,"mg/dl, change-in",-2,,,-4.9,0.9,95%CI,"mg/dl, change-in",-2,-2,-5,-10,,,-4.9,0.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,53,Mean,"mg/dl, change-in",-2.3,,,-4,-0.5,95%CI,"mg/dl, change-in",-2.3,-3,-5,-10,,,-4,-0.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,35,Mean,"mg/dl, change-in",-1.1,,,-2.7,0.6,95%CI,"mg/dl, change-in",-1.1,-2,-5,-10,,,-2.7,0.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,18,Mean,"mg/dl, change-in",-4.6,,,-8.7,-0.5,95%CI,"mg/dl, change-in",-4.6,-5,-5,-10,,,-8.7,-0.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,53,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,18,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,53,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,18,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,53,Mean,"mg/dl, change-in",-2.9,,,-9.2,3.4,95%CI,"mg/dl, change-in",-2.9,-3,-5,-10,,,-9.2,3.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,35,Mean,"mg/dl, change-in",-3.2,,,-11.4,5,95%CI,"mg/dl, change-in",-3.2,-4,-5,-10,,,-11.4,5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,18,Mean,"mg/dl, change-in",-2.4,,,-13.1,8.2,95%CI,"mg/dl, change-in",-2.4,-3,-5,-10,,,-13.1,8.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,53,Mean,"mg/dl, change-in",-6.3,,,-11.7,-1,95%CI,"mg/dl, change-in",-6.3,-7,-10,-10,,,-11.7,-1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,35,Mean,"mg/dl, change-in",-5.2,,,-12.1,1.6,95%CI,"mg/dl, change-in",-5.2,-6,-10,-10,,,-12.1,1.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,18,Mean,"mg/dl, change-in",-8.4,,,-17.9,1,95%CI,"mg/dl, change-in",-8.4,-9,-10,-10,,,-17.9,1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,53,Mean,"mg/dl, change-in",-3.6,,,-11.3,4.1,95%CI,"mg/dl, change-in",-3.6,-4,-5,-10,,,-11.3,4.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,35,Mean,"mg/dl, change-in",-3.5,,,-14.3,7.3,95%CI,"mg/dl, change-in",-3.5,-4,-5,-10,,,-14.3,7.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,18,Mean,"mg/dl, change-in",-3.7,,,-4.9,20.6,95%CI,"mg/dl, change-in",-3.7,-4,-5,-10,,,-4.9,20.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,53,Mean,"mg/dl, change-in",-9,,,-16.1,-1.8,95%CI,"mg/dl, change-in",-9,-9,-10,-10,,,-16.1,-1.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,35,Mean,"mg/dl, change-in",-6.3,,,-15.9,3.4,95%CI,"mg/dl, change-in",-6.3,-7,-10,-10,,,-15.9,3.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,18,Mean,"mg/dl, change-in",-14.2,,,-24.6,-3.8,95%CI,"mg/dl, change-in",-14.2,-15,-15,-20,,,-24.6,-3.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,53,Mean,"mg/dl, change-in",3.1,,,-13.6,19.8,95%CI,"mg/dl, change-in",3.1,3,0,0,,,-13.6,19.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,35,Mean,"mg/dl, change-in",2.5,,,-20.7,25.6,95%CI,"mg/dl, change-in",2.5,2,0,0,,,-20.7,25.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,18,Mean,"mg/dl, change-in",4.4,,,-18.7,27.5,95%CI,"mg/dl, change-in",4.4,4,0,0,,,-18.7,27.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,53,Mean,"mg/dl, change-in",-3,,,-25.1,19.2,95%CI,"mg/dl, change-in",-3,-3,-5,-10,,,-25.1,19.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,35,Mean,"mg/dl, change-in",-1.5,,,-34.3,31.2,95%CI,"mg/dl, change-in",-1.5,-2,-5,-10,,,-34.3,31.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,18,Mean,"mg/dl, change-in",-5.7,,,-25.6,14.1,95%CI,"mg/dl, change-in",-5.7,-6,-10,-10,,,-25.6,14.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Adults,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,53,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,35,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,High avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,18,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,60,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,3,months,12,23,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,60,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,37,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Immune,CRP,CRP,C-reactive protein,Blood,6,months,24,23,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,95%CI,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,3,months,12,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Free fatty acids,Free fatty acids,Free fatty acids,Blood,6,months,24,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,3,months,12,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,6,months,24,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,60,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,37,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,3,months,12,23,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,60,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,37,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HbA1c,HbA1c,Hemoglobin A1c,Blood,6,months,24,23,Mean,"%, change-in",NA,NA,NA,NA,NA,95%CI,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,60,Mean,"mg/dl, change-in",0.9,,,-1,2.7,95%CI,"mg/dl, change-in",0.9,0,0,0,,,-1,2.7,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,37,Mean,"mg/dl, change-in",-0.1,,,-2.2,2.1,95%CI,"mg/dl, change-in",-0.1,-1,-5,-10,,,-2.2,2.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,3,months,12,23,Mean,"mg/dl, change-in",2.3,,,-1.3,5.9,95%CI,"mg/dl, change-in",2.3,2,0,0,,,-1.3,5.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,60,Mean,"mg/dl, change-in",-0.3,,,-2,1.4,95%CI,"mg/dl, change-in",-0.3,-1,-5,-10,,,-2,1.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,37,Mean,"mg/dl, change-in",-1.2,,,-3.4,1.1,95%CI,"mg/dl, change-in",-1.2,-2,-5,-10,,,-3.4,1.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,6,months,24,23,Mean,"mg/dl, change-in",1,,,-1.8,3.8,95%CI,"mg/dl, change-in",1,1,0,0,,,-1.8,3.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,60,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,3,months,12,23,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,60,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,37,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,HOMA,HOMA-IR,HOMA-IR,Blood,6,months,24,23,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,3,months,12,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,6,months,24,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,60,Mean,"mg/dl, change-in",-1.5,,,-7.4,4.4,95%CI,"mg/dl, change-in",-1.5,-2,-5,-10,,,-7.4,4.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,37,Mean,"mg/dl, change-in",-1.8,,,-11,7.5,95%CI,"mg/dl, change-in",-1.8,-2,-5,-10,,,-11,7.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,3,months,12,23,Mean,"mg/dl, change-in",-1,,,-4.6,2.6,95%CI,"mg/dl, change-in",-1,-1,-5,-10,,,-4.6,2.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,60,Mean,"mg/dl, change-in",-8,,,-14.5,-1.4,95%CI,"mg/dl, change-in",-8,-8,-10,-10,,,-14.5,-1.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,37,Mean,"mg/dl, change-in",-9.9,,,-18.9,-0.8,95%CI,"mg/dl, change-in",-9.9,-10,-10,-10,,,-18.9,-0.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,6,months,24,23,Mean,"mg/dl, change-in",-4.8,,,-14.3,4.8,95%CI,"mg/dl, change-in",-4.8,-5,-5,-10,,,-14.3,4.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,3,months,12,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Nutrient bioavailability,Red blood cell magnesium,Red blood cell magnesium,Red blood cell magnesium,Blood,6,months,24,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,60,Mean,"mg/dl, change-in",-1.6,,,-8.5,5.2,95%CI,"mg/dl, change-in",-1.6,-2,-5,-10,,,-8.5,5.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,37,Mean,"mg/dl, change-in",-1.2,,,-11.1,8.8,95%CI,"mg/dl, change-in",-1.2,-2,-5,-10,,,-11.1,8.8,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,3,months,12,23,Mean,"mg/dl, change-in",-2.4,,,-11.4,6.6,95%CI,"mg/dl, change-in",-2.4,-3,-5,-10,,,-11.4,6.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,60,Mean,"mg/dl, change-in",-7.5,,,-14.7,-0.03,95%CI,"mg/dl, change-in",-7.5,-8,-10,-10,,,-14.7,-0.03,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,37,Mean,"mg/dl, change-in",-9.6,,,-19.3,0.1,95%CI,"mg/dl, change-in",-9.6,-10,-10,-10,,,-19.3,0.1,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,6,months,24,23,Mean,"mg/dl, change-in",-4,,,-15.2,7.2,95%CI,"mg/dl, change-in",-4,-4,-5,-10,,,-15.2,7.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,60,Mean,"mg/dl, change-in",3.4,,,-16.7,23.4,95%CI,"mg/dl, change-in",3.4,3,0,0,,,-16.7,23.4,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,37,Mean,"mg/dl, change-in",9.7,,,-7.1,26.5,95%CI,"mg/dl, change-in",9.7,9,5,0,,,-7.1,26.5,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,3,months,12,23,Mean,"mg/dl, change-in",-6.8,,,-53.9,40.3,95%CI,"mg/dl, change-in",-6.8,-7,-10,-10,,,-53.9,40.3,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,60,Mean,"mg/dl, change-in",1.2,,,-11.1,13.6,95%CI,"mg/dl, change-in",1.2,1,0,0,,,-11.1,13.6,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,37,Mean,"mg/dl, change-in",5.5,,,-8.8,19.9,95%CI,"mg/dl, change-in",5.5,5,5,0,,,-8.8,19.9,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,6,months,24,23,Mean,"mg/dl, change-in",-5.7,,,-29.6,18.2,95%CI,"mg/dl, change-in",-5.7,-6,-10,-10,,,-29.6,18.2,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,3,months,12,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Adults,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,60,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,37,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 6,Low avocado allotment,Non-head of household,ITT,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,6,months,24,23,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,95%CI,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,3,months,12,35,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,6,months,24,35,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,High avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,35,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,3,months,12,34,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Energy,Energy,Energy,Total energy intake,NA,6,months,24,31,Mean,"kcal, change-in",NA,NA,NA,NA,NA,95%CI,"kcal, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,31,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,34,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,31,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,34,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,31,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,34,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,31,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,34,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,31,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,34,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,31,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,34,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,31,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,34,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,31,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,34,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,31,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,3,months,12,34,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,31,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 7,Low avocado allotment,Family,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,6,months,24,34,Mean,"score, change-in",NA,NA,NA,NA,NA,95%CI,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,35,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,35,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,35,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,35,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,High avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,35,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Calcium,Calcium,Calcium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Fat,Fat,Fat,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Iron,Iron,Iron,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Potassium,Potassium,Potassium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Animal protein,Animal origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,3,months,12,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Macronutrients,Protein,Protein,Protein,NA,6,months,24,37,Mean,"%kcal, change-in",NA,NA,NA,NA,NA,95%CI,"%E, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Other,Protein,Vegetable protein,Vegetable origin,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,3,months,12,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,6,months,24,37,Mean,"g, change-in",NA,NA,NA,NA,NA,95%CI,"g/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Minerals,Sodium,Sodium,Sodium,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin B,Vitamin B9,Folate,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,3,months,12,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin C,VItamin C,Vitamin C,NA,6,months,24,37,Mean,"mg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,3,months,12,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin D,Vitamin D,Vitamin D,NA,6,months,24,37,Mean,"mcg, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,3,months,12,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
57,Pacheco 2021,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table S4,Low avocado allotment,Family,ITT,Within,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,6,months,24,37,Mean,"IU, change-in",NA,NA,NA,NA,NA,95%CI,"mg/d, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,5794,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,5794,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,5794,Mean,years,62.25,0.13,10.26,51.99,72.51,SD,years,62.25,62,60,60,0.13479,10.26,51.99,72.51,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 45-54","Age, 45-54",NA,,NA,,5794,Percentage,%,28.29,,,,,NA,%,28.29,28,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 55-64","Age, 55-64",NA,,NA,,5794,Percentage,%,27.58,,,,,NA,%,27.58,27,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 65-74","Age, 65-74",NA,,NA,,5794,Percentage,%,29.65,,,,,NA,%,29.65,29,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 75-84","Age, 75-84",NA,,NA,,5794,Percentage,%,14.48,,,,,NA,%,14.48,14,10,10,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,5794,Mean,kg/m^2,28.28,0.07,5.41,22.87,33.69,SD,kg/m^2,28.28,28,25,20,0.0710736,5.41,22.87,33.69,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,CRP,CRP,C-reactive protein,NA,,NA,,5794,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,No diabetes,No diabetes,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated diabetes,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated diabetes,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,>=4 years of college,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Less than high school,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,< 4 years of college,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen antigen,NA,,NA,,5794,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,5794,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","$25,000-<$50,000",NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","<$25,000",NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000",">=50,000",NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,IL-2,IL-2,IL-2,Blood,,NA,,5794,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,NA,,NA,,5794,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Health status,Medication use,Medications,Medications,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,5794,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese-American,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,5794,Percentage,%,52,,,,,NA,%,52,52,50,50,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,5794,Percentage,%,48,,,,,NA,%,48,48,45,40,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,TNF-a,TNF-a,Tumer necrosis factor-A soluble receptors,NA,,NA,,5794,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Diet quality,Diet quality,NA,,NA,,5794,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I/II,Obese I/II,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,Obese III,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,Oveweight,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,Underweight,NA,,NA,,5794,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,547,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,547,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,547,Mean,years,62.14,0.45,10.49,51.65,72.63,SD,years,62.14,62,60,60,0.44852,10.49,51.65,72.63,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 45-54","Age, 45-54",NA,,NA,,547,Percentage,%,28.7,,,,,NA,%,28.7,28,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 55-64","Age, 55-64",NA,,NA,,547,Percentage,%,27.24,,,,,NA,%,27.24,27,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 65-74","Age, 65-74",NA,,NA,,547,Percentage,%,28.52,,,,,NA,%,28.52,28,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 75-84","Age, 75-84",NA,,NA,,547,Percentage,%,15.54,,,,,NA,%,15.54,15,15,10,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,547,Mean,kg/m^2,28.41,0.22,5.2,23.21,33.61,SD,kg/m^2,28.41,28,25,20,0.222336,5.2,23.21,33.61,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Immune,CRP,CRP,C-reactive protein,NA,,NA,,547,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,No diabetes,No diabetes,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated diabetes,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated diabetes,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,>=4 years of college,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Less than high school,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,< 4 years of college,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen antigen,NA,,NA,,547,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,547,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","$25,000-<$50,000",NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","<$25,000",NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000",">=50,000",NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Immune,IL-2,IL-2,IL-2,Blood,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Health status,Medication use,Medications,Medications,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,547,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese-American,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,547,Percentage,%,49.54,,,,,NA,%,49.54,49,45,40,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,547,Percentage,%,50.46,,,,,NA,%,50.46,50,50,50,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Immune,TNF-a,TNF-a,Tumer necrosis factor-A soluble receptors,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Diet quality,Diet quality,NA,,NA,,547,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I/II,Obese I/II,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,Obese III,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,Oveweight,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Heavy,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,Underweight,NA,,NA,,547,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,683,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,683,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,683,Mean,years,60.25,0.39,10.28,49.97,70.53,SD,years,60.25,60,60,60,0.393353,10.28,49.97,70.53,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 45-54","Age, 45-54",NA,,NA,,683,Percentage,%,35.72,,,,,NA,%,35.72,35,35,30,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 55-64","Age, 55-64",NA,,NA,,683,Percentage,%,28.99,,,,,NA,%,28.99,28,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 65-74","Age, 65-74",NA,,NA,,683,Percentage,%,23.43,,,,,NA,%,23.43,23,20,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 75-84","Age, 75-84",NA,,NA,,683,Percentage,%,11.86,,,,,NA,%,11.86,11,10,10,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,683,Mean,kg/m^2,28.55,0.21,5.37,23.18,33.92,SD,kg/m^2,28.55,28,25,20,0.205477,5.37,23.18,33.92,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Immune,CRP,CRP,C-reactive protein,NA,,NA,,683,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,No diabetes,No diabetes,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated diabetes,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated diabetes,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,>=4 years of college,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Less than high school,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,< 4 years of college,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen antigen,NA,,NA,,683,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,683,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","$25,000-<$50,000",NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","<$25,000",NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000",">=50,000",NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Immune,IL-2,IL-2,IL-2,Blood,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Health status,Medication use,Medications,Medications,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,683,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese-American,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,683,Percentage,%,54.17,,,,,NA,%,54.17,54,50,50,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,683,Percentage,%,45.83,,,,,NA,%,45.83,45,45,40,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Immune,TNF-a,TNF-a,Tumer necrosis factor-A soluble receptors,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Diet quality,Diet quality,NA,,NA,,683,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I/II,Obese I/II,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,Obese III,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,Oveweight,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Medium,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,Underweight,NA,,NA,,683,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol consumption,NA,,NA,,4564,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,4564,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,4564,Mean,years,62.56,0.15,10.2,52.36,72.76,SD,years,62.56,62,60,60,0.150983,10.2,52.36,72.76,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 45-54","Age, 45-54",NA,,NA,,4564,Percentage,%,27.13,,,,,NA,%,27.13,27,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 55-64","Age, 55-64",NA,,NA,,4564,Percentage,%,27.41,,,,,NA,%,27.41,27,25,20,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 65-74","Age, 65-74",NA,,NA,,4564,Percentage,%,30.72,,,,,NA,%,30.72,30,30,30,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Age,Age group,"Age, 75-84","Age, 75-84",NA,,NA,,4564,Percentage,%,14.75,,,,,NA,%,14.75,14,10,10,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,4564,Mean,kg/m^2,28.23,0.08,5.44,22.79,33.67,SD,kg/m^2,28.23,28,25,20,0.0805241,5.44,22.79,33.67,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Immune,CRP,CRP,C-reactive protein,NA,,NA,,4564,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Impaired fasting glucose,Impaired fasting glucose,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,No diabetes,No diabetes,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Treated diabetes,Treated diabetes,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Health status,Diabetes,Untreated diabetes,Untreated diabetes,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,College or higher,>=4 years of college,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,High school,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,Less than high school,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,< 4 years of college,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen antigen,NA,,NA,,4564,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,4564,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"$25,000-<$50,000","$25,000-<$50,000",NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,"<$25,000","<$25,000",NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Household income,">=50,000",">=50,000",NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Immune,IL-2,IL-2,IL-2,Blood,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Immune,IL-6,IL-6,IL-6,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Health status,Medication use,Medications,Medications,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,4564,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese-American,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,4564,Percentage,%,51.97,,,,,NA,%,51.97,51,50,50,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,4564,Percentage,%,48.03,,,,,NA,%,48.03,48,45,40,,,,,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Immune,TNF-a,TNF-a,Tumer necrosis factor-A soluble receptors,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Diet quality,Diet quality,NA,,NA,,4564,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese I/II,Obese I/II,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese III,Obese III,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,Oveweight,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,Rare or never,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,Underweight,NA,,NA,,4564,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,547,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,547,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,547,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,547,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,547,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,547,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,547,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,547,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,547,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 1,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 2,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Heavy,Model 3,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,547,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,683,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,683,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,683,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,683,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,683,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,683,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,683,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,683,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,683,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 1,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 2,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Medium,Model 3,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,683,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,4564,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,4564,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,Immune,CRP,CRP,CRP,NA,,NA,,4564,Mean,mg/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,4564,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,4564,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,4564,Mean,mg/dL,NA,NA,NA,NA,NA,95%CI,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,4564,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,4564,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Total homocysteine,NA,,NA,,4564,Mean,umol/L,NA,NA,NA,NA,NA,95%CI,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 1,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 2,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Rare or never,Model 3,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a soluble receptors,NA,,NA,,4564,Mean,pg/mL,NA,NA,NA,NA,NA,95%CI,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table1,All,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,5794,Mean,serving/d,0.04,0.18,13.7,,,SD,g/d,2,2,0,0,9,685.065,0,687.065,1 serving=50 g
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table1,Heavy,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,547,Mean,serving/d,0.31,0.26,6.08,,,SD,g/d,15.5,15,15,10,13,304.044,0,319.544,1 serving=50 g
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table1,Medium,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,683,Mean,serving/d,0.06,0.02,0.52,,,SD,g/d,3,3,0,0,1,26.1343,0,29.1343,1 serving=50 g
60,Cheng 2023,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table1,Rare or never,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,4564,Mean,serving/d,0.003,0.01,0.68,,,SD,g/d,0.15,0,0,0,0.5,33.7787,0,33.9287,1 serving=50 g
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,2,weeks,2,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,4,weeks,4,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,6,weeks,6,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,8,weeks,8,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,10,weeks,10,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,12,weeks,12,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,2,weeks,2,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,4,weeks,4,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,6,weeks,6,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,8,weeks,8,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,10,weeks,10,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Fig 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,12,weeks,12,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Methods section,AVO,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,24,Absolute value,avocado/d,1,,,,,NA,g/d,150,150,150,150,,,,,150g/avo
61,Henning 2019,Intervention,NCT02953158,Methods section,CTRL,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,27,Absolute value,avocado/d,0,,,,,NA,g/d,0,0,0,0,,,,,150g/avo
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1200 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1400 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1600 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,AVO,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,CHO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1200 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1400 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1600 kcal plan,PP,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1200 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1400 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplemental Table 1,CTRL,1600 kcal plan,PP,Summary,Dietary,Macronutrients,Protein,Protein,PRO,NA,,NA,,,Absolute value,g,NA,NA,NA,NA,NA,NA,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Arachidonic acid,arachidonic acid,arachidonic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Docosapentaenoic acid,Docosapentaenoic acid,Docosapentaenoic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,a-linolenic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,AVO,NA,PP,Within,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Plasma,12,weeks,12,24,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Arachidonic acid,arachidonic acid,arachidonic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Docosahexaenoic acid,Docosahexaenoic acid,Docosahexaenoic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Docosapentaenoic acid,Docosapentaenoic acid,Docosapentaenoic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Eicosapentaenoic acid,Eicosapentaenoic acid,Eicosapentaenoic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Linoleic acid,Linoleic acid,Linoleic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Linolenic acid,α-Linolenic,a-linolenic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Myristic acid,Myristic acid,Myristic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Oleic acid,Oleic acid,Oleic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Palmitic acid,Palmitic acid,Palmitic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Supplementary Table 2,CTRL,NA,PP,Within,Outcome,Nutrient bioavailability,Stearic acid,Stearic acid,Stearic acid,Plasma,12,weeks,12,27,Mean,"concentration, change-in",NA,NA,NA,NA,NA,SD,"concentration, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,24,Mean,years,42.5,2.59,12.7,29.8,55.2,SD,years,42.5,42,40,40,2.59238,12.7,29.8,55.2,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,24,Mean,kg/m^2,30.1,0.65,3.2,26.9,33.3,SD,kg/m^2,30.1,30,30,30,0.653197,3.2,26.9,33.3,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,Total body fat,NA,,NA,,24,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,24,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,24,Mean,%,83,,,,,NA,%,83,83,80,80,,,,,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,AVO,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,24,Percentage,%,17,,,,,NA,%,17,17,15,10,,,,,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,27,Mean,years,36.4,2.08,10.8,25.6,47.2,SD,years,36.4,36,35,30,2.07846,10.8,25.6,47.2,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,27,Mean,kg/m^2,30,0.71,3.7,26.3,33.7,SD,kg/m^2,30,30,30,30,0.712065,3.7,26.3,33.7,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Anthropometry,Body fat,Body fat,Total body fat,NA,,NA,,27,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,27,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,27,Mean,%,74,,,,,NA,%,74,74,70,70,,,,,NA
61,Henning 2019,Intervention,NCT02953158,Table 1,CTRL,NA,PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,27,Percentage,%,26,,,,,NA,%,26,26,25,20,,,,,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,AVO,NA,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,24,Mean,"kg/m^2, change-in",-0.84,0.16,0.76,-1.6,-0.08,SD,"kg/m^2, change-in",-0.84,-1,-5,-10,0.155134,0.76,-1.6,-0.08,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,AVO,NA,PP,Within,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,12,weeks,12,24,Mean,"%, change-in",NA,NA,NA,NA,NA,SD,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,AVO,NA,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,12,weeks,12,24,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,AVO,NA,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,12,weeks,12,24,Mean,"kg, change-in",NA,NA,NA,NA,NA,SD,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,AVO,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,12,weeks,12,24,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,CTRL,NA,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,12,weeks,12,27,Mean,"kg/m^2, change-in",-0.93,0.24,1.26,-2.19,0.33,SD,"kg/m^2, change-in",-0.93,-1,-5,-10,0.242487,1.26,-2.19,0.33,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,CTRL,NA,PP,Within,Outcome,Anthropometry,Body fat,Body fat,Body fat,NA,12,weeks,12,27,Mean,"%, change-in",NA,NA,NA,NA,NA,SD,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,CTRL,NA,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,12,weeks,12,27,Mean,"g, change-in",NA,NA,NA,NA,NA,SD,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,CTRL,NA,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,12,weeks,12,27,Mean,"kg, change-in",NA,NA,NA,NA,NA,SD,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 2,CTRL,NA,PP,Within,Outcome,Satiety,Satiety score,Satiety score,Satiety score,NA,12,weeks,12,27,Mean,"score, change-in",NA,NA,NA,NA,NA,SD,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Metabolic,Adiponectin,Adiponectin,Adiponectin,Serum,12,weeks,12,24,Mean,"ug/mL, change-in",NA,NA,NA,NA,NA,SD,"μg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,CRP,CRP,CRP,Serum,12,weeks,12,24,Mean,"ug/mL, change-in",NA,NA,NA,NA,NA,SD,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Serum,12,weeks,12,24,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,SD,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Serum,12,weeks,12,24,Mean,"mg/dl, change-in",-1.5,1.25,6.1,-7.6,4.6,SD,"mg/dl, change-in",-1.5,-2,-5,-10,1.24516,6.1,-7.6,4.6,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Metabolic,Hepatic growth factor,Hepatic growth factor,Hepatic growth factor,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,IL-1b,IL-1b,IL-1b,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,IL-6,IL-6,IL-6,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Serum,12,weeks,12,24,Mean,"mg/dl, change-in",-1.1,5.61,27.5,-28.6,26.4,SD,"mg/dl, change-in",-1.1,-2,-5,-10,5.61341,27.5,-28.6,26.4,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,Leptin,Leptin,Leptin,Serum,12,weeks,12,24,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,MCP-1,MCP-1,MCP-1,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,NGF,Nerve growth factor,NGF,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,PAI,Plasminogen activator inhibitor-1,PAI,Serum,12,weeks,12,24,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Metabolic,Resistin,Resistin,Resistin,Serum,12,weeks,12,24,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Immune,TNF-a,TNF-a,TNF-a,Serum,12,weeks,12,24,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Serum,12,weeks,12,24,Mean,"mg/dl, change-in",-4.73,4.78,23.4,-28.13,18.67,SD,"mg/dl, change-in",-4.73,-5,-5,-10,4.7765,23.4,-28.13,18.67,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,AVO,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglyceride,Serum,12,weeks,12,24,Mean,"mg/dl, change-in",-25.5,7.63,37.4,-62.9,11.9,SD,"mg/dl, change-in",-25.5,-26,-30,-30,7.63424,37.4,-62.9,11.9,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Metabolic,Adiponectin,Adiponectin,Adiponectin,Serum,12,weeks,12,27,Mean,"ug/mL, change-in",NA,NA,NA,NA,NA,SD,"μg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,CRP,CRP,CRP,Serum,12,weeks,12,27,Mean,"ug/mL, change-in",NA,NA,NA,NA,NA,SD,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Serum,12,weeks,12,27,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,SD,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Serum,12,weeks,12,27,Mean,"mg/dl, change-in",-1.4,1.73,9,-10.4,7.6,SD,"mg/dl, change-in",-1.4,-2,-5,-10,1.73205,9,-10.4,7.6,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Metabolic,Hepatic growth factor,Hepatic growth factor,Hepatic growth factor,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,IL-1b,IL-1b,IL-1b,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,IL-6,IL-6,IL-6,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Serum,12,weeks,12,27,Mean,"mg/dl, change-in",-10.4,6.25,32.5,-42.9,22.1,SD,"mg/dl, change-in",-10.4,-11,-15,-20,6.25463,32.5,-42.9,22.1,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,Leptin,Leptin,Leptin,Serum,12,weeks,12,27,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,MCP-1,MCP-1,MCP-1,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,NGF,Nerve growth factor,NGF,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,PAI,Plasminogen activator inhibitor-1,PAI,Serum,12,weeks,12,27,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Metabolic,Resistin,Resistin,Resistin,Serum,12,weeks,12,27,Mean,"ng/mL, change-in",NA,NA,NA,NA,NA,SD,"ng/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Immune,TNF-a,TNF-a,TNF-a,Serum,12,weeks,12,27,Mean,"pg/mL, change-in",NA,NA,NA,NA,NA,SD,"pg/mL, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Serum,12,weeks,12,27,Mean,"mg/dl, change-in",-11.1,6.04,31.4,-42.5,20.3,SD,"mg/dl, change-in",-11.1,-12,-15,-20,6.04293,31.4,-42.5,20.3,NA
61,Henning 2019,Intervention,NCT02953158,Table 3,CTRL,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglyceride,Serum,12,weeks,12,27,Mean,"mg/dl, change-in",-10.9,7.62,39.6,-50.5,28.7,SD,"mg/dl, change-in",-10.9,-11,-15,-20,7.62102,39.6,-50.5,28.7,NA
61,Henning 2019,Intervention,NCT02953158,Table 4-6,AVO,NA,PP,Within,Outcome,Microbiome,Gut microbiota,Gut microbiota,Gut microbiota,Fecal,0,weeks,0,24,NA,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 4-6,AVO,NA,PP,Within,Outcome,Microbiome,Gut microbiota,Gut microbiota,Gut microbiota,Fecal,12,weeks,12,24,NA,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 4-6,CTRL,NA,PP,Within,Outcome,Microbiome,Gut microbiota,Gut microbiota,Gut microbiota,Fecal,0,weeks,0,27,NA,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
61,Henning 2019,Intervention,NCT02953158,Table 4-6,CTRL,NA,PP,Within,Outcome,Microbiome,Gut microbiota,Gut microbiota,Gut microbiota,Fecal,12,weeks,12,27,NA,Count,NA,NA,NA,NA,NA,NA,Count,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,Planned,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,21,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,Planned,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,21,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,Planned,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,21,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,Planned,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,21,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,21,Mean,years,56.9,1.77,8.1,40,72,"min,max",years,56.9,56,55,50,1.76756,8.1,40,72,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,21,Mean,kg/m^2,30.19,1.05,4.8,22.7,40.8,"min,max",kg/m^2,30.19,30,30,30,1.04745,4.8,22.7,40.8,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,21,Mean,m,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Body weight,NA,,NA,,21,Mean,kg,NA,NA,NA,NA,NA,"min,max",kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section,All,NA,ITT,Summary,Subject Characteristics,Health status,Diabetes,Diabetes progression,Diabetes progression,NA,,NA,,21,Mean,years,NA,NA,NA,NA,NA,"min,max",years,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,"Methods section, estimated",All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,21,Percentage,%,52.381,,,,,NA,%,52.381,52,50,50,,,,,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,"Methods section, estimated",All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Men,NA,,NA,,21,Percentage,%,47.619,,,,,NA,%,47.619,47,45,40,,,,,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section;Estimated,Control,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,21,Absolute value,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section;Estimated,Group 1,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,21,Absolute value,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Methods section;Estimated,Group 2,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,21,Absolute value,% fat from avo,75,,,,,NA,g/d,289.116,289,285,280,,,,,"1700 kcal/d, 30% E from fat, 75% fat E from avo, 14.7g avo fat in 100 g avo, 9kcal/g fat"
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Health status,Dyslipidemia,Castelli index,Castelli index,NA,,NA,,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Health status,Dyslipidemia,Kannel index,Kannel index,NA,,NA,,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Health status,Dyslipidemia,Rouffy index,Rouffy index,NA,,NA,,21,Mean,index,NA,NA,NA,NA,NA,SD,index,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Fasting glucose,Fasting glucose,NA,,NA,,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,Glucose,Postprandial glucose,Postprandial glucose,NA,,NA,,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,HbA1c,HbA1c,Glycosylated hemoglobin,NA,,NA,,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,HDL-C,HDL-C,HDL-C,Blood,,NA,,21,Mean,mmol/L,0.8,0.04,0.19,0.61,0.99,SD,mg/dL,30.936,30,30,30,1.60331,7.3473,23.5887,38.2833,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,HOMA,HOMA,Fasting Homeostasis Model Assessment,NA,,NA,,21,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Fasting insulin,Fasting insulin,NA,,NA,,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Metabolic,Insulin,Postprandial insulin,Postprandial insulin,NA,,NA,,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,LDL-C,LDL-C,LDL-C,Blood,,NA,,21,Mean,mmol/L,3.1,0.06,0.29,2.81,3.39,SD,mg/dL,119.877,119,115,110,2.44716,11.2143,108.663,131.091,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Antioxidation,Lipoperoxidation,Lipoperoxidation,Serum lipoperoxidation,NA,,NA,,21,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,,NA,,21,Mean,mmol/L,5.5,0.24,1.1,4.4,6.6,SD,mg/dL,212.685,212,210,210,9.28233,42.537,170.148,255.222,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 1,All,NA,ITT,Summary,Subject Characteristics,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,21,Mean,mmol/L,3.8,0.63,2.9,0.9,6.7,SD,mg/dL,336.566,336,335,330,56.0499,256.853,79.713,593.419,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,21,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,4,weeks,4,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose 2h,Postprandial glucose,Blood,4,weeks,4,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,HbA1c,HbA1c,Glycosylated hemoglobin,Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,HOMA,HOMA-IR,Fasting Homeostasis Model Assessment,Blood,4,weeks,4,21,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,4,weeks,4,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 1,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin 2h,Postprandial insulin,Blood,4,weeks,4,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,4,weeks,4,21,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,Glucose,Fasting glucose,Fasting glucose,Blood,4,weeks,4,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,Glucose,Glucose 2h,Postprandial glucose,Blood,4,weeks,4,21,Mean,mmol/L,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,HbA1c,HbA1c,Glycosylated hemoglobin,Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,HOMA,HOMA-IR,Fasting Homeostasis Model Assessment,Blood,4,weeks,4,21,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,Insulin,Fasting insulin,Fasting insulin,Blood,4,weeks,4,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 2,Group 2,NA,ITT,Summary,Outcome,Glycemia,Insulin,Insulin 2h,Postprandial insulin,Blood,4,weeks,4,21,Mean,mU/mL,NA,NA,NA,NA,NA,SD,pmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL/LDL + VLDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL/HDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol/HDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,21,Mean,mmol/L,0.88,0.04,0.2,0.68,1.08,SD,mg/dL,34.0296,34,30,30,1.6877,7.734,26.2956,41.7636,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,21,Mean,mmol/L,2.6,0.13,0.6,2,3.2,SD,mg/dL,100.542,100,100,100,5.06309,23.202,77.34,123.744,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation,Lipoperoxidation,Blood,4,weeks,4,21,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,4,weeks,4,21,Mean,mmol/L,4.6,0.18,0.81,3.79,5.41,SD,mg/dL,177.882,177,175,170,6.83517,31.3227,146.559,209.205,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 1,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,21,Mean,mmol/L,2.5,0.24,1.1,1.4,3.6,SD,mg/dL,221.425,221,220,220,21.2603,97.427,123.998,318.852,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,HDL:LDL+VLDL,HDL/LDL + VLDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,LDL-C:HDL-C,LDL/HDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,Total cholesterol/HDL,Blood,4,weeks,4,21,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,4,weeks,4,21,Mean,mmol/L,0.84,0.03,0.16,0.68,1,SD,mg/dL,32.4828,32,30,30,1.35016,6.1872,26.2956,38.67,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,4,weeks,4,21,Mean,mmol/L,2.5,0.15,0.7,1.8,3.2,SD,mg/dL,96.675,96,95,90,5.90694,27.069,69.606,123.744,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Antioxidation,Lipoperoxidation,Lipoperoxidation,Lipoperoxidation,Blood,4,weeks,4,21,Mean,nmol/L,NA,NA,NA,NA,NA,SD,nmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,4,weeks,4,21,Mean,mmol/L,4.6,0.22,0.99,3.61,5.59,SD,mg/dL,177.882,177,175,170,8.3541,38.2833,139.599,216.165,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 3,Group 2,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,4,weeks,4,21,Mean,mmol/L,2.7,0.46,2.1,0.6,4.8,SD,mg/dL,239.139,239,235,230,40.5879,185.997,53.142,425.136,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 40%),Osmotic fragility of erythrocytes (NaCl 40%),Blood,0,weeks,0,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 50%),Osmotic fragility of erythrocytes (NaCl 50%),Blood,0,weeks,0,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec","Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Blood,0,weeks,0,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec","Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Blood,0,weeks,0,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec","Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Blood,0,weeks,0,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Control,NA,ITT,Summary,Outcome,CVD risk factors,Serum viscosity,Serum viscosity,Serum viscosity,Blood,0,weeks,0,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 40%),Osmotic fragility of erythrocytes (NaCl 40%),Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 50%),Osmotic fragility of erythrocytes (NaCl 50%),Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec","Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec","Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec","Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 1,NA,ITT,Summary,Outcome,CVD risk factors,Serum viscosity,Serum viscosity,Serum viscosity,Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 40%),Osmotic fragility of erythrocytes (NaCl 40%),Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Erythrocytes,Osmotic fragility of erythrocytes (NaCl 50%),Osmotic fragility of erythrocytes (NaCl 50%),Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 30 sec","Platelet aggregation as a reaction to adenosine diphosphate, 30 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 60 sec","Platelet aggregation as a reaction to adenosine diphosphate, 60 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Platelet aggregation,"Platelet aggregation as a reaction to adenosine diphosphate, 90 sec","Platelet aggregation as a reaction to adenosine diphosphate, 90 sec",Blood,4,weeks,4,21,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
62,Carranza-Madrigal 2008,Intervention,Carranza-Madrigal 2008,Table 4,Group 2,NA,ITT,Summary,Outcome,CVD risk factors,Serum viscosity,Serum viscosity,Serum viscosity,Blood,4,weeks,4,21,Mean,NA,NA,NA,NA,NA,NA,SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Abstract,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,14,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Abstract,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,14,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Estimated,Control group,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,6,Absolute value,% fat from avo,0,,,,,NA,g/d,0,0,0,0,,,,,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Estimated,Experimental group,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,8,Absolute value,% fat from avo,50,,,,,NA,g/d,200,200,200,200,,,,,From paper
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,14,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Energy,Energy,Energy,Energy,NA,,NA,,14,Absolute value,kcal,NA,NA,NA,NA,NA,NA,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,14,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,14,Average,%E,NA,NA,NA,NA,NA,"min,max",%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,14,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,14,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods,All,NA,ITT,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,14,Absolute value,%E,NA,NA,NA,NA,NA,NA,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods section,Control group,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,6,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Methods section,Experimental group,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,8,Absolute value,g/d,200,,,,,NA,g/d,200,200,200,200,,,,,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6,Mean,years,45.2,3.72,9.12,37,54,"min,max",years,45.2,45,45,40,3.72322,9.12,37,54,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6,Mean,kg/m^2,28.26,1.38,3.39,24.7,32,"min,max",kg/m^2,28.26,28,25,20,1.38396,3.39,24.7,32,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,6,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip perimeter,NA,,NA,,6,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Abdominal perimeter,NA,,NA,,6,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip ratio,NA,,NA,,6,Mean,ratio,NA,NA,NA,NA,NA,"min,max",ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Control group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,6,Mean,kg,NA,NA,NA,NA,NA,"min,max",kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,8,Mean,years,39.9,3.22,9.12,34,48,"min,max",years,39.9,39,35,30,3.22441,9.12,34,48,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,8,Mean,kg/m^2,28.78,1.24,3.52,25.2,32,"min,max",kg/m^2,28.78,28,25,20,1.24451,3.52,25.2,32,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,8,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Hip circumference,Hip perimeter,NA,,NA,,8,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Abdominal perimeter,NA,,NA,,8,Mean,cm,NA,NA,NA,NA,NA,"min,max",cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist:hip circumference,Waist:hip ratio,NA,,NA,,8,Mean,ratio,NA,NA,NA,NA,NA,"min,max",ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 1,Experimental group,NA,ITT,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,8,Mean,kg,NA,NA,NA,NA,NA,"min,max",kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,6,Mean,mg/dL,38,1.59,3.9,34.1,41.9,SD,mg/dL,38,38,35,30,1.59217,3.9,34.1,41.9,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,15,days,2.142857143,6,Mean,mg/dL,37.3,2.12,5.2,32.1,42.5,SD,mg/dL,37.3,37,35,30,2.12289,5.2,32.1,42.5,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,30,days,4.285714286,6,Mean,mg/dL,36.8,2.37,5.8,31,42.6,SD,mg/dL,36.8,36,35,30,2.36784,5.8,30,42.6,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,6,Mean,mg/dL,124.4,10.17,24.9,99.5,149.3,SD,mg/dL,124.4,124,120,120,10.1654,24.9,99.5,149.3,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,15,days,2.142857143,6,Mean,mg/dL,125.9,11.06,27.1,98.8,153,SD,mg/dL,125.9,125,125,120,11.0635,27.1,98.8,153,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,30,days,4.285714286,6,Mean,mg/dL,116.8,10,24.5,92.3,141.3,SD,mg/dL,116.8,116,115,110,10.0021,24.5,92.3,141.3,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,0,weeks,0,6,Mean,mg/dL,232.6,15.15,37.1,195.5,269.7,SD,mg/dL,232.6,232,230,230,15.146,37.1,195.5,269.7,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,15,days,2.142857143,6,Mean,mg/dL,206.7,14.21,34.8,171.9,241.5,SD,mg/dL,206.7,206,205,200,14.207,34.8,171.9,241.5,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,30,days,4.285714286,6,Mean,mg/dL,202.5,9.68,23.7,178.8,226.2,SD,mg/dL,202.5,202,200,200,9.67548,23.7,178.8,226.2,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,6,Mean,mg/dL,215.8,33.72,82.6,133.2,298.4,SD,mg/dL,215.8,215,215,210,33.7213,82.6,133.2,298.4,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,15,days,2.142857143,6,Mean,mg/dL,195,26.33,64.5,130.5,259.5,SD,mg/dL,195,195,195,190,26.332,64.5,130.5,259.5,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,30,days,4.285714286,6,Mean,mg/dL,210,30.21,74,136,284,SD,mg/dL,210,210,210,210,30.2104,74,136,284,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,0,weeks,0,6,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,15,days,2.142857143,6,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Control group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,30,days,4.285714286,6,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,0,weeks,0,8,Mean,mg/dL,31.5,4.1,11.6,19.9,43.1,SD,mg/dL,31.5,31,30,30,4.10122,11.6,19.9,43.1,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,15,days,2.142857143,8,Mean,mg/dL,32.2,3.01,8.5,23.7,40.7,SD,mg/dL,32.2,32,30,30,3.0052,8.5,23.7,40.7,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,30,days,4.285714286,8,Mean,mg/dL,33.5,2.4,6.8,26.7,40.3,SD,mg/dL,33.5,33,30,30,2.40416,6.8,26.7,40.3,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,0,weeks,0,8,Mean,mg/dL,146.8,12.59,35.6,111.2,182.4,SD,mg/dL,146.8,146,145,140,12.5865,35.6,111.2,182.4,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,15,days,2.142857143,8,Mean,mg/dL,143.8,11.56,32.7,111.1,176.5,SD,mg/dL,143.8,143,140,140,11.5612,32.7,111.1,176.5,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,30,days,4.285714286,8,Mean,mg/dL,135.7,9.02,25.5,110.2,161.2,SD,mg/dL,135.7,135,135,130,9.01561,25.5,110.2,161.2,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,0,weeks,0,8,Mean,mg/dL,226.8,14.92,42.2,184.6,269,SD,mg/dL,226.8,226,225,220,14.92,42.2,184.6,269,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,15,days,2.142857143,8,Mean,mg/dL,222.9,5.37,15.2,207.7,238.1,SD,mg/dL,222.9,222,220,220,5.37401,15.2,207.7,238.1,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,30,days,4.285714286,8,Mean,mg/dL,206.3,6.08,17.2,189.1,223.5,SD,mg/dL,206.3,206,205,200,6.08112,17.2,189.1,223.5,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,0,weeks,0,8,Mean,mg/dL,215,25.46,72,143,287,SD,mg/dL,215,215,215,210,25.4558,72,143,287,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,15,days,2.142857143,8,Mean,mg/dL,208.4,28.96,81.9,126.5,290.3,SD,mg/dL,208.4,208,205,200,28.956,81.9,126.5,290.3,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,30,days,4.285714286,8,Mean,mg/dL,193,28.6,80.9,112.1,273.9,SD,mg/dL,193,193,190,190,28.6025,80.9,112.1,273.9,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,0,weeks,0,8,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,15,days,2.142857143,8,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
67,Anderson-Vazquez 2009,Intervention,Anderson-Vazquez 2009,Table 2,Experimental group,NA,ITT,Summary,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,30,days,4.285714286,8,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,98,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,98,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,98,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Insoluble NSP,Insoluble NSP,NA,,NA,,98,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,NSP,Nonstarch polysaccharides,NA,,NA,,98,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Soluble NSP,Soluble NSP,NA,,NA,,98,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at blood draw,Age at blood draw,NA,,NA,,98,Mean,years,64.2,0.59,5.8,58.4,70,SD,years,64.2,64,60,60,0.585888,5.8,58.4,70,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at natural menopause,Age at natural menopause,NA,,NA,,98,Mean,years,48.7,0.37,3.7,45,52.4,SD,years,48.7,48,45,40,0.373756,3.7,45,52.4,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Lifestyle,Years of education,Years of education,Years of education,NA,,NA,,98,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,102,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,102,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,102,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Insoluble NSP,Insoluble NSP,NA,,NA,,102,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,NSP,Nonstarch polysaccharides,NA,,NA,,102,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Soluble NSP,Soluble NSP,NA,,NA,,102,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at blood draw,Age at blood draw,NA,,NA,,102,Mean,years,64.6,0.52,5.3,59.3,69.9,SD,years,64.6,64,60,60,0.524778,5.3,59.3,69.9,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at natural menopause,Age at natural menopause,NA,,NA,,102,Mean,years,49.5,0.37,3.7,45.8,53.2,SD,years,49.5,49,45,40,0.366355,3.7,45.8,53.2,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Lifestyle,Years of education,Years of education,Years of education,NA,,NA,,102,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,42,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,42,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,42,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Insoluble NSP,Insoluble NSP,NA,,NA,,42,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,NSP,Nonstarch polysaccharides,NA,,NA,,42,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Dietary,Fiber,Fiber,Soluble NSP,Soluble NSP,NA,,NA,,42,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at blood draw,Age at blood draw,NA,,NA,,42,Mean,years,64.6,0.86,5.6,59,70.2,SD,years,64.6,64,60,60,0.864099,5.6,58,70.2,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Age,Age,Age at natural menopause,Age at natural menopause,NA,,NA,,42,Mean,years,49.5,0.48,3.1,46.4,52.6,SD,years,49.5,49,45,40,0.47834,3.1,46.4,52.6,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 1,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Lifestyle,Years of education,Years of education,Years of education,NA,,NA,,42,Mean,years,NA,NA,NA,NA,NA,SD,years,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,98,Mean,kg/m^2,29,0.46,4.6,24.4,33.6,SD,kg/m^2,29,29,25,20,0.46467,4.6,24.4,33.6,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,98,Mean,m,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,<30%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,98,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,102,Mean,kg/m^2,28,0.41,4.1,23.9,32.1,SD,kg/m^2,28,28,25,20,0.40596,4.1,23.9,32.1,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,102,Mean,m,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,>70%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,102,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,42,Mean,kg/m^2,29.4,0.77,5,24.4,34.4,SD,kg/m^2,29.4,29,25,20,0.771517,5,24.4,34.4,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,42,Mean,m,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,45-55%ile dietary fiber,NA,NA,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,42,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 2,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,242,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q1,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,49,Geometric mean,g/1000kcal,0,,,,,NA,g/d,0,0,0,0,,0,,,Avg kcal 1995;kcal SD 1211.17
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q1,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q1,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q1,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q1,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q2,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,48,Geometric mean,g/1000kcal,1.7,,,,,NA,g/d,3.3915,3,0,0,,2.05899,,,Avg kcal 1995;kcal SD 1211.17
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q2,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q2,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q2,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q2,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q3,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,49,Geometric mean,g/1000kcal,4.1,,,,,NA,g/d,8.1795,8,5,0,,4.9658,,,Avg kcal 1995;kcal SD 1211.17
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q3,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q3,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q3,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q3,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,49,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q4,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,48,Geometric mean,g/1000kcal,7.6,,,,,NA,g/d,15.162,15,15,10,,9.20489,,,Avg kcal 1995;kcal SD 1211.17
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q4,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q4,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q4,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q4,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q5,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,48,Geometric mean,g/1000kcal,16.7,,,,,NA,g/d,33.3165,33,30,30,,20.2265,,,Avg kcal 1995;kcal SD 1211.17
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q5,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q5,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estradiol,Estradiol,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q5,Adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
70,Monroe 2007,Observation,Multiethnic Cohort Study (MEC),Table 5,Avocado Q5,Further adjusted,NA,Summary,Outcome,Hormone,Hormone,Estrone,Estrone,NA,,NA,,48,Mean,pg/ml,NA,NA,NA,NA,NA,NA,pg/ml,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Methods section,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,234,Mean,years,37,,,21,74,"min,max",years,37,37,35,30,,,21,74,NA
72,Ballot 1987,Intervention,Ballot 1987,Methods section,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Women,NA,,NA,,234,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal alone,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Haemoglobin,Blood,2,weeks,2,129,Mean,g/l,NA,NA,NA,NA,NA,SD,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal alone,NA,ITT,Summary,Outcome,Nutrient bioavailability,Serum ferritin,Serum ferritin,Serum ferritin,Serum,2,weeks,2,129,Mean,ug/l,NA,NA,NA,NA,NA,+-1 SD,μg/l,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal alone,NA,ITT,Summary,Outcome,Nutrient bioavailability,Transferrin saturation,Transferrin saturation,Transferrin saturation,Blood,2,weeks,2,129,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal with avocado pear,NA,ITT,Summary,Outcome,Nutrient bioavailability,Hemoglobin,Hemoglobin,Haemoglobin,Blood,2,weeks,2,14,Mean,g/l,NA,NA,NA,NA,NA,SD,g/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal with avocado pear,NA,ITT,Summary,Outcome,Nutrient bioavailability,Serum ferritin,Serum ferritin,Serum ferritin,Serum,2,weeks,2,14,Mean,ug/l,NA,NA,NA,NA,NA,+-1 SD,μg/l,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 4,Rice meal with avocado pear,NA,ITT,Summary,Outcome,Nutrient bioavailability,Transferrin saturation,Transferrin saturation,Transferrin saturation,Blood,2,weeks,2,14,Mean,%,NA,NA,NA,NA,NA,SD,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 5,Rice meal alone,NA,ITT,Summary,Outcome,Nutrient bioavailability,Fe absorption,"Fe absorption, corrected","Fe absorption, corrected",Blood,2,weeks,2,129,Mean,NA,NA,NA,NA,NA,NA,+-1 SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 5,Rice meal alone,NA,ITT,Summary,Outcome,Nutrient bioavailability,Fe absorption,"Fe absorption, uncorrected","Fe absorption, uncorrected",Blood,2,weeks,2,129,Mean,NA,NA,NA,NA,NA,NA,+-1 SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 5,Rice meal with avocado pear,NA,ITT,Summary,Outcome,Nutrient bioavailability,Fe absorption,"Fe absorption, corrected","Fe absorption, corrected",Blood,2,weeks,2,14,Mean,NA,NA,NA,NA,NA,NA,+-1 SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table 5,Rice meal with avocado pear,NA,ITT,Summary,Outcome,Nutrient bioavailability,Fe absorption,"Fe absorption, uncorrected","Fe absorption, uncorrected",Blood,2,weeks,2,14,Mean,NA,NA,NA,NA,NA,NA,+-1 SD,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
72,Ballot 1987,Intervention,Ballot 1987,Table4 header;Table5 header,Rice meal alone,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,129,Absolute value,g/test meal,0,,,,,NA,g/test meal,0,0,0,0,,,,,NA
72,Ballot 1987,Intervention,Ballot 1987,Table4 header;Table5 header,Rice meal with avocado pear,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,14,Absolute value,g/test meal,100,,,,,NA,g/test meal,100,100,100,100,,,,,NA
73,Kim 2023,Intervention,MANE project,Methods section,Albendazole with avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,112,Absolute value,g/d,200,,,,,NA,g/d,200,200,200,200,,,,,NA
73,Kim 2023,Intervention,MANE project,Methods section,Albendazole without avocado,NA,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,110,Absolute value,g/d,0,,,,,NA,g/d,0,0,0,0,,,,,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,60,Mean,years,12.5,0.2,1.56,10.94,14.06,SD,years,12.5,12,10,10,0.201395,1.56,10.94,14.06,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,52,Mean,years,12.2,0.22,1.61,10.59,13.81,SD,years,12.2,12,10,10,0.223267,1.61,10.59,13.81,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI-for-age z-score,BMI-for-age z-score,NA,,NA,,60,Mean,z-score,-0.63,0.19,1.44,-2.07,0.81,SD,z-score,-0.63,-1,-5,-10,0.185903,1.44,-2.07,0.81,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI-for-age z-score,BMI-for-age z-score,NA,,NA,,52,Mean,z-score,-0.88,0.2,1.45,-2.33,0.57,SD,z-score,-0.88,-1,-5,-10,0.201079,1.45,-2.33,0.57,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,60,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,52,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height-for-age z-score,Height-for-age z-score,NA,,NA,,60,Mean,z-score,NA,NA,NA,NA,NA,SD,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height-for-age z-score,Height-for-age z-score,NA,,NA,,52,Mean,z-score,NA,NA,NA,NA,NA,SD,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,60,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,52,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Heavy hookworm infection,Heavy hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Heavy hookworm infection,Heavy hookworm infection,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Light hookworm infection,Light hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Light hookworm infection,Light hookworm infection,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Moderate hookworm infection,Moderate hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Moderate hookworm infection,Moderate hookworm infection,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,S. mansoni co-infection,S. mansoni co-infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,S. mansoni co-infection,S. mansoni co-infection,NA,,NA,,52,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,60,Percentage,%,41.7,,,,,NA,%,41.7,41,40,40,,,,,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,52,Percentage,%,59.6,,,,,NA,%,59.6,59,55,50,,,,,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,50,Mean,years,11.9,0.21,1.47,10.43,13.37,SD,years,11.9,11,10,10,0.207889,1.47,10.43,13.37,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,60,Mean,years,12.2,0.24,1.88,10.32,14.08,SD,years,12.2,12,10,10,0.242707,1.88,10.32,14.08,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI-for-age z-score,BMI-for-age z-score,NA,,NA,,50,Mean,z-score,-0.94,0.21,1.51,-2.45,0.57,SD,z-score,-0.94,-1,-5,-10,0.213546,1.51,-2.45,0.57,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,BMI,BMI-for-age z-score,BMI-for-age z-score,NA,,NA,,60,Mean,z-score,-0.85,0.28,2.19,-3.04,1.34,SD,z-score,-0.85,-1,-5,-10,0.282728,2.19,-3.04,1.34,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,50,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height,Height,NA,,NA,,60,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height-for-age z-score,Height-for-age z-score,NA,,NA,,50,Mean,z-score,NA,NA,NA,NA,NA,SD,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body size,Height-for-age z-score,Height-for-age z-score,NA,,NA,,60,Mean,z-score,NA,NA,NA,NA,NA,SD,z-score,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,50,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,60,Mean,kg,NA,NA,NA,NA,NA,SD,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Heavy hookworm infection,Heavy hookworm infection,NA,,NA,,50,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Heavy hookworm infection,Heavy hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Light hookworm infection,Light hookworm infection,NA,,NA,,50,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Light hookworm infection,Light hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,Moderate hookworm infection,Moderate hookworm infection,NA,,NA,,50,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,Moderate hookworm infection,Moderate hookworm infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Health status,Infection,S. mansoni co-infection,S. mansoni co-infection,NA,,NA,,50,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Health status,Infection,S. mansoni co-infection,S. mansoni co-infection,NA,,NA,,60,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,50,Percentage,%,58,,,,,NA,%,58,58,55,50,,,,,NA
73,Kim 2023,Intervention,MANE project,Table 1,Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,60,Percentage,%,46.7,,,,,NA,%,46.7,46,45,40,,,,,NA
73,Kim 2023,Intervention,MANE project,"Table 1, Estimate",Albendazole with avocado,Dual-dose, PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,60,Percentage,%,58.3,,,,,NA,%,58.3,58,55,50,,,,,NA
73,Kim 2023,Intervention,MANE project,"Table 1, Estimate",Albendazole with avocado,Single-dose, PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,52,Percentage,%,40.4,,,,,NA,%,40.4,40,40,40,,,,,NA
73,Kim 2023,Intervention,MANE project,"Table 1, Estimate",Albendazole without avocado,Dual-dose, PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,50,Percentage,%,42,,,,,NA,%,42,42,40,40,,,,,NA
73,Kim 2023,Intervention,MANE project,"Table 1, Estimate",Albendazole without avocado,Single-dose, PP,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,60,Percentage,%,53.3,,,,,NA,%,53.3,53,50,50,,,,,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Cure rate,Cure rate,NA,3,weeks,3,112,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Egg reduction rate,"Egg reduction rate, arithmetic",Fecal,3,weeks,3,112,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Egg reduction rate,"Egg reduction rate, geometric",Fecal,3,weeks,3,112,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram after treatment, arithmetic",Fecal,3,weeks,3,112,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram after treatment, geometric",Fecal,3,weeks,3,112,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram before treatment, arithmetic",Fecal,0,weeks,0,112,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole with avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram before treatment, geometric",Fecal,0,weeks,0,112,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Cure rate,Cure rate,NA,3,weeks,3,110,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Egg reduction rate,"Egg reduction rate, arithmetic",Fecal,3,weeks,3,110,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Egg reduction rate,"Egg reduction rate, geometric",Fecal,3,weeks,3,110,Mean,%,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram after treatment, arithmetic",Fecal,3,weeks,3,110,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram after treatment, geometric",Fecal,3,weeks,3,110,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram before treatment, arithmetic",Fecal,0,weeks,0,110,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
73,Kim 2023,Intervention,MANE project,Table 3,Albendazole without avocado,NA, PP,Summary,Outcome,Infection,Hookworm,Eggs per gram,"Eggs per gram before treatment, geometric",Fecal,0,weeks,0,110,Mean,eggs/g,NA,NA,NA,NA,NA,95%CI,eggs/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Results section,Avocado tertile 1,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,163,Categorical,g/d,12.8,,,0,12.8,"min,max",g/d,12.8,12,10,10,,,0,12.8,NA
75,Jackson 2012,Observation,Jackson 2012,Results section,Avocado tertile 2,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,130,Categorical,g/d,36.4,,,12.8,60,"min,max",g/d,36.4,36,35,30,,,12.8,60,NA
75,Jackson 2012,Observation,Jackson 2012,Results section,Avocado tertile 3,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,142,Categorical,g/d,60,,,60,,"min,max",g/d,60,60,60,60,,,60,,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,435,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,435,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,209,Mean,years,67.5,0.55,7.9,59.6,75.4,SD,years,67.5,67,65,60,0.546454,7.9,59.6,75.4,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,209,Mean,kg/m^2,25.1,0.32,4.6,20.5,29.7,SD,kg/m^2,25.1,25,25,20,0.318189,4.6,20.5,29.7,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,209,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Cancer,High-grade prostate cancer,High-grade prostate cancer,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Cancer,Low-grade prostate cancer,Low-grade prostate cancer,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Cancer,"Prostate cancer, unknown","Prostate cancer, unknown",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Cancer,Prostate-specific antigen,Prostate-specific antigen,NA,,NA,,209,Median,ug/L,NA,NA,NA,NA,NA,IQR,μg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,"Education, secondary",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,"Education, primary or less",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, tertiary",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of prostate cancer,Family history of prostate cancer,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Supplement use,Supplement use,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Screening,Previous digital rectal examination,Previous digital rectal examination,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,Previous PSA screens,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <=24.99",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Cases,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.99",NA,,NA,,209,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,226,Mean,years,62.6,0.7,10.5,52.1,73.1,SD,years,62.6,62,60,60,0.69845,10.5,52.1,73.1,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,226,Mean,kg/m^2,25.1,0.29,4.3,20.8,29.4,SD,kg/m^2,25.1,25,25,20,0.286032,4.3,20.8,29.4,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,226,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Cancer,High-grade prostate cancer,High-grade prostate cancer,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Cancer,Low-grade prostate cancer,Low-grade prostate cancer,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Cancer,"Prostate cancer, unknown","Prostate cancer, unknown",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Cancer,Prostate-specific antigen,Prostate-specific antigen,NA,,NA,,226,Median,ug/L,NA,NA,NA,NA,NA,IQR,μg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,High school,"Education, secondary",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Less than high school,"Education, primary or less",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,Some college,"Education, tertiary",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of prostate cancer,Family history of prostate cancer,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Supplement use,Supplement use,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Screening,Previous digital rectal examination,Previous digital rectal examination,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Health status,Screening,PSA screening,Previous PSA screens,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <=24.99",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 1,Controls,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.99",NA,,NA,,226,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 3,Avocado Tertile 2,NA,NA,Avocado Tertile 1,Outcome,Cancer incidence,Prostate cancer,Prostate cancer risk,Prostate cancer risk,NA,,NA,,130,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 3,Avocado Tertile 3,NA,NA,Avocado Tertile 1,Outcome,Cancer incidence,Prostate cancer,Prostate cancer risk,Prostate cancer risk,NA,,NA,,142,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,193,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,193,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Fatty acids,Linoleic acid,Linoleic acid,Linoleic acid (n-6),NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Fatty acids,Linolenic acid,Linolenic acid,Linolenic acid (n-3),NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Cases,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,193,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrate,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,244,Mean,kcal,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Fat,NA,,NA,,244,Mean,%E,NA,NA,NA,NA,NA,SD,%E,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Fatty acids,Linoleic acid,Linoleic acid,Linoleic acid (n-6),NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Fatty acids,Linolenic acid,Linolenic acid,Linolenic acid (n-3),NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table 4,Controls,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,244,Mean,g,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
75,Jackson 2012,Observation,Jackson 2012,Table3,Cases,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,243,Median,g/d,25.6,,,,,NA,g/d,25.6,25,25,20,,,,,NA
75,Jackson 2012,Observation,Jackson 2012,Table3,Cases,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,243,Mean,g/d,36.9,,40.5,,,SD,g/d,36.9,36,35,30,,40.5,0,77.4,NA
75,Jackson 2012,Observation,Jackson 2012,Table3,Controls,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,192,Median,g/d,30.2,,,,,NA,g/d,30.2,30,30,30,,,,,NA
75,Jackson 2012,Observation,Jackson 2012,Table3,Controls,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,192,Mean,g/d,56.2,,70.8,,,SD,g/d,56.2,56,55,50,,70.8,0,127,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Adherence analyses section,Control group,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,6,months,24,115,Average,avocado/wk/subject,1.48,,,,,NA,g/d,31.7143,31,30,30,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Adherence analyses section,Control group,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,3,months,12,115,Average,avocado/wk/subject,1.25,,,,,NA,g/d,26.7857,26,25,20,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Adherence analyses section,Intervention group,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,6,months,24,120,Average,avocado/wk/subject,4.03,,,,,NA,g/d,86.3571,86,85,80,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Adherence analyses section,Intervention group,NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,3,months,12,120,Average,avocado/wk/subject,4.1,,,,,NA,g/d,87.8571,87,85,80,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Figure 4,Control group,Adults,ITT,Summary,Outcome,Physical activity,Physical activity,Sedentary,Mean sedentary time,NA,6,months,24,74,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Figure 4,Control group,All,ITT,Summary,Outcome,Physical activity,Physical activity,Sedentary,Mean sedentary time,NA,6,months,24,116,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Figure 4,Intervention group,Adults,ITT,Summary,Outcome,Physical activity,Physical activity,Sedentary,Mean sedentary time,NA,6,months,24,67,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Figure 4,Intervention group,All,ITT,Summary,Outcome,Physical activity,Physical activity,Sedentary,Mean sedentary time,NA,6,months,24,110,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Control group,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,35,Absolute value,avocado/wk/family,3,,,,,NA,g/d,300,300,300,300,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Methods section,Intervention group,Family,Planned,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,31,Absolute value,avocado/wk/family,14,,,,,NA,g/d,64.2857,64,60,60,,,,,150g/avo;7d/wk
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,65,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,101,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,58,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,92,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,0,weeks,0,73,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,0,weeks,0,116,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,65,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,101,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,58,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,92,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,0,weeks,0,73,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,0,weeks,0,116,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,65,Mean,kg/m^2,30.6,0.79,6.39,24.21,36.99,SD,kg/m^2,30.6,30,30,30,0.792582,6.39,24.21,36.99,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,101,Mean,kg/m^2,26.7,0.78,7.85,18.85,34.55,SD,kg/m^2,26.7,26,25,20,0.781104,7.85,18.85,34.55,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,58,Mean,kg/m^2,30.2,0.84,6.38,23.82,36.58,SD,kg/m^2,30.2,30,30,30,0.837735,6.38,23.82,36.58,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,92,Mean,kg/m^2,26.5,0.79,7.53,18.97,34.03,SD,kg/m^2,26.5,26,25,20,0.785057,7.53,18.97,34.03,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,73,Mean,kg/m^2,30.9,0.75,6.4,24.5,37.3,SD,kg/m^2,30.9,30,30,30,0.749063,6.4,24.5,37.3,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Control group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,116,Mean,kg/m^2,26.9,0.74,7.95,18.95,34.85,SD,kg/m^2,26.9,26,25,20,0.738139,7.95,18.95,34.85,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,66,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,3,months,12,114,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,66,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,6,months,24,114,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,0,weeks,0,67,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic blood pressure,NA,0,weeks,0,110,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,66,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,3,months,12,114,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,66,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,6,months,24,114,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,0,weeks,0,67,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic blood pressure,NA,0,weeks,0,110,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,66,Mean,kg/m^2,29.5,0.8,6.46,23.04,35.96,SD,kg/m^2,29.5,29,25,20,0.795171,6.46,23.04,35.96,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,3,months,12,114,Mean,kg/m^2,26.6,0.66,7.09,19.51,33.69,SD,kg/m^2,26.6,26,25,20,0.664039,7.09,19.51,33.69,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,66,Mean,kg/m^2,29.4,0.77,6.25,23.15,35.65,SD,kg/m^2,29.4,29,25,20,0.769322,6.25,23.15,35.65,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,6,months,24,114,Mean,kg/m^2,26.7,0.65,6.89,19.81,33.59,SD,kg/m^2,26.7,26,25,20,0.645308,6.89,19.81,33.59,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,Adults,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,67,Mean,kg/m^2,29.6,0.8,6.55,23.05,36.15,SD,kg/m^2,29.6,29,25,20,0.80021,6.55,23.05,36.15,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Supplemental Table 4,Intervention group,All,ITT,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,0,weeks,0,110,Mean,kg/m^2,26.9,0.67,7.07,19.83,33.97,SD,kg/m^2,26.9,26,25,20,0.674098,7.07,19.83,33.97,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,14,Mean,years,16,0.27,1,15,17,SD,years,16,16,15,10,0.267261,1,15,17,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,74,Mean,years,45.4,1.85,15.9,29.5,61.3,SD,years,45.4,45,45,40,1.84834,15.9,29.5,61.3,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,120,Mean,years,32.3,1.92,21,11.3,53.3,SD,years,32.3,32,30,30,1.91703,21,11.3,53.3,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,32,Mean,years,8.9,0.37,2.1,6.8,11,SD,years,8.9,8,5,0,0.371231,2.1,6.8,11,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Age,Age group,Adolescents,Adolescents,NA,,NA,,120,Percentage,%,11.7,,,,,NA,%,11.7,11,10,10,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Age,Age group,Adults,Adults,NA,,NA,,120,Percentage,%,61.7,,,,,NA,%,61.7,61,60,60,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Age,Age group,Children,Children,NA,,NA,,120,Percentage,%,26.7,,,,,NA,%,26.7,26,25,20,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,74,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,32,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,14,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,74,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,32,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,74,Mean,kg/m^2,31,0.71,6.1,24.9,37.1,SD,kg/m^2,31,31,30,30,0.709111,6.1,24.9,37.1,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,14,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,32,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,120,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Family income <$30,000/yr",NA,,NA,,120,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, moderate","Physical activity, occupational, moderate",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, moderate","Physical activity, occupational, moderate",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, vigorous","Physical activity, occupational, vigorous",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, vigorous","Physical activity, occupational, vigorous",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,32,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,14,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,74,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,120,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,32,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,32,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,32,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,120,Percentage,%,58.3,,,,,NA,%,58.3,58,55,50,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,All,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,120,Percentage,%,41.7,,,,,NA,%,41.7,41,40,40,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,14,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,74,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Control group,Children,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,32,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,19,Mean,years,15.5,0.32,1.4,14.1,16.9,SD,years,15.5,15,15,10,0.321182,1.4,14.1,16.9,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,67,Mean,years,41.4,1.75,14.3,27.1,55.7,SD,years,41.4,41,40,40,1.74702,14.3,27.1,55.7,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,115,Mean,years,29.1,1.71,18.3,10.8,47.4,SD,years,29.1,29,25,20,1.70648,18.3,10.8,47.4,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,29,Mean,years,9.5,0.41,2.2,7.3,11.7,SD,years,9.5,9,5,0,0.40853,2.2,7.3,11.7,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Age,Age group,Adolescents,Adolescents,NA,,NA,,115,Percentage,%,16.5,,,,,NA,%,16.5,16,15,10,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Age,Age group,Adults,Adults,NA,,NA,,115,Percentage,%,58.3,,,,,NA,%,58.3,58,55,50,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Age,Age group,Children,Children,NA,,NA,,115,Percentage,%,25.2,,,,,NA,%,25.2,25,25,20,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,19,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,67,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,29,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,19,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,67,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,29,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,67,Mean,kg/m^2,29.9,0.81,6.6,23.3,36.5,SD,kg/m^2,29.9,29,25,20,0.806318,6.6,23.3,36.5,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,19,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference:Height,Waist:height,NA,,NA,,29,Mean,ratio,NA,NA,NA,NA,NA,SD,ratio,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Lifestyle,Family size,Family size,Family size,NA,,NA,,115,Mean,people,NA,NA,NA,NA,NA,SD,people,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Lifestyle,Household income,"<$30,000","Family income <$30,000/yr",NA,,NA,,115,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, moderate","Physical activity, occupational, moderate",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, vigorous","Physical activity, occupational, vigorous",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, vigorous","Physical activity, occupational, vigorous",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,"Physical activity, total activity",NA,,NA,,29,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,19,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,67,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,115,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,29,Mean,min/wk,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, moderate","Physical activity, recreational, moderate",NA,,NA,,29,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Physical activity,Recreational activity,"Recreational, vigorous","Physical activity, recreational, vigorous",NA,,NA,,29,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,All,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,115,Percentage,%,69.6,,,,,NA,%,69.6,69,65,60,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Adults,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,67,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 1,Intervention group,Children,ITT,Summary,Subject Characteristics,Physical activity,Transportation activity,Transportation-related,"Physical activity, transportation-related",NA,,NA,,29,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,"Table 1, estimate",Intervention group,All,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,115,Percentage,%,30.4,,,,,NA,%,30.4,30,30,30,,,,,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,"Table 1, estimate+",Intervention group,Adolescents,ITT,Summary,Subject Characteristics,Physical activity,Occupational activity,"Occupational, moderate","Physical activity, occupational, moderate",NA,,NA,,19,Mean,MET-min/wk,NA,NA,NA,NA,NA,SD,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Moderate physical activity,Total moderate activity,NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Moderate physical activity,Total moderate activity,NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,,Outcome,Physical activity,Physical activity,"Occupational, moderate","Occupational, moderate",NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, moderate","Occupational, moderate",NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, vigorous","Occupational, vigorous",NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, vigorous","Occupational, vigorous",NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Physical activity,Total physical activity,NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Physical activity,Total physical activity,NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, moderate","Recreational, moderate",NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, moderate","Recreational, moderate",NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, vigorous","Recreational, vigorous",NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, vigorous","Recreational, vigorous",NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Transportation-related,Transportation-related,NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Transportation-related,Transportation-related,NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Vigorous physical activity,Total vigorous activity,NA,3,months,12,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Control group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Vigorous physical activity,Total vigorous activity,NA,6,months,24,74,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Moderate physical activity,Total moderate activity,NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Moderate physical activity,Total moderate activity,NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, moderate","Occupational, moderate",NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, moderate","Occupational, moderate",NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, vigorous","Occupational, vigorous",NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Occupational, vigorous","Occupational, vigorous",NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Physical activity,Total physical activity,NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Physical activity,Total physical activity,NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, moderate","Recreational, moderate",NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, moderate","Recreational, moderate",NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, vigorous","Recreational, vigorous",NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,"Recreational, vigorous","Recreational, vigorous",NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Transportation-related,Transportation-related,NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Transportation-related,Transportation-related,NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Vigorous physical activity,Total vigorous activity,NA,3,months,12,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
76,Allen 2023,Intervention,Effects of Avocado Intake on the Nutritional Status of Families Trial,Table 2,Intervention group,Adults,ITT,Within,Outcome,Physical activity,Physical activity,Vigorous physical activity,Total vigorous activity,NA,6,months,24,67,Mean,"MET-min/wk, change-in",NA,NA,NA,NA,NA,SD,"MET-min/wk, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Methods,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,36803,Percentage,%,0,,,,,NA,%,0,0,0,0,,,,,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Methods,HPFS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,36803,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Methods,NHS,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,62175,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Methods,NHSII,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,88475,Percentage,%,100,,,,,NA,%,100,100,100,100,,,,,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, <1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, >=4/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, >=4/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, 1-3/mth",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, 1-3/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table 3,"Pooled, 1-3/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,49,,,43,57,IQR,years,49,49,45,40,,,43,57,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,25.1,,,23.3,26.9,IQR,kg/m^2,25.1,25,25,20,,,23.3,26.9,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,56,,,47,64,IQR,years,56,56,55,50,,,47,64,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,23,,,23,26.5,IQR,kg/m^2,23,23,20,20,,,23,26.5,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,52,,,44,61,IQR,years,52,52,50,50,,,44,61,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,25,,,23.3,26.6,IQR,kg/m^2,25,25,25,20,,,23.3,26.6,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"HPFS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,47,,,42,53,IQR,years,47,47,45,40,,,42,53,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,23.2,,,21.3,25.8,IQR,kg/m^2,23.2,23,20,20,,,21.3,25.8,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,53,,,47,58,IQR,years,53,53,50,50,,,47,58,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,23.4,,,21.3,26.4,IQR,kg/m^2,23.4,23,20,20,,,21.3,26.4,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,50,,,44,56,IQR,years,50,50,50,50,,,44,56,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,23.5,,,21.6,26.4,IQR,kg/m^2,23.5,23,20,20,,,21.6,26.4,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHS, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,42,,,37,47,IQR,years,42,42,40,40,,,37,47,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,24,,,21.5,27.9,IQR,kg/m^2,24,24,20,20,,,21.5,27.9,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit <=4/wk",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,42,,,37,48,IQR,years,42,42,40,40,,,37,48,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,23.2,,,21,26.6,IQR,kg/m^2,23.2,23,20,20,,,21,26.6,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit >=4/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,,Median,serving/d,NA,NA,NA,NA,NA,IQR,serving/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Dietary,Energy,Energy,Energy,Total kcal,NA,,NA,,,Median,kcal,NA,NA,NA,NA,NA,IQR,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,,Median,years,43,,,38,48,IQR,years,43,43,40,40,,,38,48,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,,Median,kg/m^2,24.1,,,21.7,27.8,IQR,kg/m^2,24.1,24,20,20,,,21.7,27.8,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of hypertension,Family history of hypertension,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,,Median,METs/w,NA,NA,NA,NA,NA,IQR,MET-min/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S1,"NHSII, total fruit 1/d",NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, <1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, >=4/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, >=4/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, 1-3/mth",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, 1-3/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"HPFS, 1-3/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, <1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, >=4/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, >=4/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, 1-3/mth",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, 1-3/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHS, 1-3/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, <1/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,0,,,0,1,"min,max",g/d,0,0,0,0,,,0,2.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, >=4/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, >=4/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, 1-3/mth",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/mth,2,,,1,3,"min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, 1-3/mth",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, 1-3/wk",NA,Actual,Summary,Dietary,Avocado intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving = 1/2 avo
77,Borgi 2016,Observation,Nurses' Health Study (NHS 1986-2014);Health Professionals Follow-up Study (HPFS 1986-2010);Nurses' Health Study II (NHSII 1991-2011),Table S3,"NHSII, 1-3/wk",NA,NA,<1/mth,Outcome,CVD incidence,Hypertension,Hypertension,Hypertension,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Estimated,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,192651,Percentage,%,54.9751,,,,,NA,%,54.9751,54,50,50,,,,,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Estimated,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,192651,Percentage,%,45.0249,,,,,NA,%,45.0249,45,45,40,,,,,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,53670,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,67233,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,53670,Categorical,1/2 avo/mth,1,,,0,1,"Min,max",g/d,2.5,2,0,0,,,0,2.5,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,67233,Categorical,1/2 avo/mth,1,,,0,1,"Min,max",g/d,2.5,2,0,0,,,0,2.5,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,53670,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,67233,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,53670,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,67233,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,53670,Mean,years,60.1,0.04,8.9,51.2,69,SD,years,60.1,60,60,60,0.0384171,8.9,51.2,69,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,67233,Mean,years,59.8,0.03,8.9,50.9,68.7,SD,years,59.8,59,55,50,0.0343241,8.9,50.9,68.7,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,53670,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,67233,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,53670,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,67233,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,53670,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,67233,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,53670,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,<1/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,67233,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,9523,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,10774,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,9523,Categorical,1/2 avo/wk,1,,,1,,"Min,max",g/d,10.7143,10,10,10,,,10.7143,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,10774,Categorical,1/2 avo/wk,1,,,1,,"Min,max",g/d,10.7143,10,10,10,,,10.7143,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,9523,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,10774,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,9523,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,10774,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,9523,Mean,years,60.5,0.09,8.6,51.9,69.1,SD,years,60.5,60,60,60,0.0881275,8.6,51.9,69.1,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,10774,Mean,years,60,0.08,8.6,51.4,68.6,SD,years,60,60,60,60,0.0828533,8.6,51.4,68.6,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,9523,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,10774,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,9523,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,10774,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,9523,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,10774,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,9523,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,>=1/wk,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,10774,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,23548,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol intake,NA,,NA,,27903,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,23548,Categorical,1/2 avo/mth,2,,,1,3,"Min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,51451,Categorical,1/2 avo/mth,2,,,1,3,"Min,max",g/d,5,5,5,0,,,2.5,7.5,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,23548,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Dietary,Energy,Energy,Energy,Energy intake,NA,,NA,,27903,Mean,kcal/d,NA,NA,NA,NA,NA,SD,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,23548,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Dietary,Fiber,Fiber,Fiber,Fiber intake,NA,,NA,,27903,Mean,g/d,NA,NA,NA,NA,NA,SD,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,23548,Mean,years,60.3,0.06,8.7,51.6,69,SD,years,60.3,60,60,60,0.0566947,8.7,51.6,69,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Age,Age,Age at cohort entry,Age at cohort entry,NA,,NA,,27903,Mean,years,59.5,0.05,8.7,50.8,68.2,SD,years,59.5,59,55,50,0.0520827,8.7,50.8,68.2,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Diabetes,History of diabetes,History of diabetes,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Family history,Family history of colorectal cancer,Family history of colorectal cancer,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Intestinal polyps,History of intestinal polyps,History of intestinal polyps,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, current","MHT use, current",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, never","MHT use, never",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,"Menopausal hormone, past","MHT use, past",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Health status,Medication use,NSAID use,NSAID use,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Multivitamin,Multivitamin intake,Multivitamin use,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,23548,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,27903,Mean,h/day,NA,NA,NA,NA,NA,SD,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Latino,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Japanese-American,Japanese-American,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Race,Race,Native Hawaiian,Native Hawaiian,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Current smoker,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Former smoker,Former smoker,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,23548,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years among every smokers,NA,,NA,,27903,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,23548,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,"HEI, Total score",HEI-2015,NA,,NA,,27903,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,"BMI, <25",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,"BMI, >=30",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Men,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,23548,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 1,1-3/mth,Women,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,"BMI, 25-29.9",NA,,NA,,27903,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,9523,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,10774,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,9523,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,10774,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,9523,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,10774,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,9523,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,10774,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,23548,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,27903,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in colorectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,23548,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,27903,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in left colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,23548,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,27903,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in rectum,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,23548,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,27903,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 2,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk in right colon,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Men, African-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Men, Japanese-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Men, Latino",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Men, Native Hawaiian",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Men, White",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Women, African-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Women, Japanese-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Women, Latino",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Women, Native Hawaiian",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,>=1/wk,"Women, White",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Men, African-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Men, Japanese-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Men, Latino",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Men, Native Hawaiian",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Men, White",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Women, African-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Women, Japanese-American",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Women, Latino",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Women, Native Hawaiian",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 3,1-3/mth,"Women, White",NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,>=1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,>=1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table 4,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/day,1,,,1,,"Min,max",g/d,75,75,75,70,,,75,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/day,1,,,1,,"Min,max",g/d,75,75,75,70,,,75,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=1/day,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,2,,"Min,max",g/d,21.4286,21,20,20,,,21.4286,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,2,,"Min,max",g/d,21.4286,21,20,20,,,21.4286,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=2/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"Min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,4,,,4,,"Min,max",g/d,42.8571,42,40,40,,,42.8571,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,>=4/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,1,,,1,1,"Min,max",g/d,10.7143,10,10,10,,,10.7143,,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,1,,,1,1,"Min,max",g/d,10.7143,10,10,10,,,10.7143,10.7143,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/mth,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/mth,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"Min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,2,,,1,3,"Min,max",g/d,21.4286,21,20,20,,,10.7143,32.1429,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-3/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Men,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,3.5,,,1,6,"Min,max",g/d,37.5,37,35,30,,,10.7143,64.2857,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Women,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,1/2 avo/wk,3.5,,,1,6,"Min,max",g/d,37.5,37,35,30,,,10.7143,64.2857,1 serving=1/2 avo
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Men,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78,Cheng 2024a,Observation,Multiethnic Cohort Study (MEC),Table S1,1-6/wk,Women,NA,<1/mth,Outcome,Cancer incidence,Colorectal cancer,Colorectal cancer,Colorectal cancer risk,NA,,NA,,,Hazard ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Methods,Avocado-supplemented diet,NA,Actual,Summary,Dietary,Avocado Intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,505,Absolute value,avo/day,1,,,,,NA,g/d,168,168,165,160,,,,,168 g=1 avo
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Methods,Habitual diet,NA,Actual,Summary,Dietary,Avocado Intake,Avocado intake,Avocado intake,Avocado intake,NA,,NA,,503,Absolute value,avo/day,0,,,,,NA,g/d,0,0,0,0,,,,,168 g=1 avo
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,1008,Mean,years,50,0.44,14,36,64,SD,years,50,50,50,50,0.440959,14,36,64,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,1008,Mean,kg/m^2,33,0.17,5.5,27.5,38.5,SD,kg/m^2,33,33,30,30,0.173234,5.5,27.5,38.5,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,Female,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,726,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,Male,ITT,Summary,Subject Characteristics,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,282,Mean,cm,NA,NA,NA,NA,NA,SD,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Race,Heritage,Hispanic,Hispanic,NA,,NA,,1008,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Race,Race,African-American,Black,NA,,NA,,1008,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Asian,Asian,NA,,NA,,1008,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Caucasian,White,NA,,NA,,1008,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Race,Race,Other and Multi-racial,"American Indian, did not answer, other, or multiple races",NA,,NA,,1008,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,1008,Percentage,%,72,,,,,NA,%,72,72,70,70,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Results,All,NA,ITT,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,1008,Percentage,%,28,,,,,NA,%,28,28,25,20,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 1,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 2,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,25-30 years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,31-59 years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,60+ years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Asian,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, <45 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 45-54 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 55-64 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Black,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Female,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Healthy/overweight,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Hispanic/Latino,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,LLU site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Male,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Not hispanic/latino,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class I,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class II,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class III,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Other,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-Hershey site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-UP site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Tufts site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,UCLA site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,White,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,505,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Avocado-supplemented diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,25-30 years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,31-59 years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,60+ years,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Asian,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, <45 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 45-54 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 55-64 points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 65+ points",ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Black,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Female,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Healthy/overweight,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Hispanic/Latino,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,LLU site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Male,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Not hispanic/latino,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class I,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class II,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class III,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Other,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-Hershey site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-UP site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Tufts site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,UCLA site,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,White,ITT,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,0,weeks,0,503,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,25-30 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,31-59 years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,60+ years,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Asian,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, <45 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 45-54 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 55-64 points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,"Baseline HEI, 65+ points",PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Black,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Female,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Healthy/overweight,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Hispanic/Latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,LLU site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Male,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Not hispanic/latino,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class I,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class II,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Obesity class III,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Other,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-Hershey site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Penn State-UP site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,Tufts site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,UCLA site,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 3,Habitual diet,White,PP,Summary,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,score,NA,NA,NA,NA,NA,SD,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,25-30 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,96,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,31-59 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,644,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,60+ years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,268,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Asian,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,58,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Black,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,149,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Female,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,730,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Healthy/overweight,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,317,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Hispanic/Latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,207,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,LLU site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Male,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,278,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Not hispanic/latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,797,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Obesity class I,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,386,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Obesity class II,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,192,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Obesity class III,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,112,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Other,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,104,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Penn State-Hershey site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,119,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Penn State-UP site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,134,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,Tufts site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,253,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,UCLA site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Avocado-supplemented diet,White,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,694,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,25-30 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,96,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,31-59 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,644,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,60+ years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,268,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Asian,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,58,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Black,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,149,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Female,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,730,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Healthy/overweight,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,317,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Hispanic/Latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,207,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,LLU site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Male,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,278,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Not hispanic/latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,797,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Obesity class I,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,386,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Obesity class II,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,192,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Obesity class III,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,112,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Other,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,104,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Penn State-Hershey site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,119,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Penn State-UP site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,134,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,Tufts site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,253,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,UCLA site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 4,Habitual diet,White,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,694,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,112,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,985,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,261,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,112,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,985,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,261,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,295,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,283,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,104,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,922,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,240,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,293,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,284,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,105,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,921,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,239,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,299,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,303,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,111,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,972,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,259,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,292,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,303,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,109,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,963,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,259,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,295,Mean,"mg/dl, change-in",-0.18,,,,,NA,"mg/dl, change-in",-0.18,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,301,Mean,"mg/dl, change-in",-0.53,,,,,NA,"mg/dl, change-in",-0.53,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,110,Mean,"mg/dl, change-in",0.71,,,,,NA,"mg/dl, change-in",0.71,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,964,Mean,"mg/dl, change-in",-0.28,,,,,NA,"mg/dl, change-in",-0.28,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,258,Mean,"mg/dl, change-in",-0.5,,,,,NA,"mg/dl, change-in",-0.5,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",2.11,,,,,NA,"mg/dl, change-in",2.11,2,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",6.67,,,,,NA,"mg/dl, change-in",6.67,6,5,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",-5.62,,,,,NA,"mg/dl, change-in",-5.62,-6,-10,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",2.96,,,,,NA,"mg/dl, change-in",2.96,2,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",2.43,,,,,NA,"mg/dl, change-in",2.43,2,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,112,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,985,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,26,weeks,26,261,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,306,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,112,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,985,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,26,weeks,26,261,Mean,"mmHg, change-in",NA,NA,NA,NA,NA,NA,"mmHg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,295,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,283,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,104,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,922,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Anthropometry,Body fat,Hepatic fat fraction,Hepatic fat fraction,NA,26,weeks,26,240,Mean,"%, change-in",NA,NA,NA,NA,NA,NA,"%, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,293,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,284,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,105,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,921,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Anthropometry,Body fat,Visceral adipose tissue,Visceral adipose tissue,NA,26,weeks,26,239,Mean,"L, change-in",NA,NA,NA,NA,NA,NA,"g, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,299,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,303,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,111,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,972,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,26,weeks,26,259,Mean,"cm, change-in",NA,NA,NA,NA,NA,NA,"cm, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,292,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,303,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,109,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,963,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Immune,CRP,CRP,CRP,Blood,26,weeks,26,259,Mean,"mg/L, change-in",NA,NA,NA,NA,NA,NA,"mg/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Glycemia,Glucose,Glucose,Glucose,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,295,Mean,"mg/dl, change-in",0.02,,,,,NA,"mg/dl, change-in",0.02,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,301,Mean,"mg/dl, change-in",-1.1,,,,,NA,"mg/dl, change-in",-1.1,-2,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,110,Mean,"mg/dl, change-in",-0.79,,,,,NA,"mg/dl, change-in",-0.79,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,964,Mean,"mg/dl, change-in",-0.18,,,,,NA,"mg/dl, change-in",-0.18,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,26,weeks,26,258,Mean,"mg/dl, change-in",0.61,,,,,NA,"mg/dl, change-in",0.61,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",2.17,,,,,NA,"mg/dl, change-in",2.17,2,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",6.84,,,,,NA,"mg/dl, change-in",6.84,6,5,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",1.06,,,,,NA,"mg/dl, change-in",1.06,1,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,NA,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",4.07,,,,,NA,"mg/dl, change-in",4.07,4,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 5,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",5.6,,,,,NA,"mg/dl, change-in",5.6,5,5,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,299,Mean,"kg/m^2, change-in",0.23,,,,,NA,"kg/m^2, change-in",0.23,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,302,Mean,"kg/m^2, change-in",0.09,,,,,NA,"kg/m^2, change-in",0.09,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,111,Mean,"kg/m^2, change-in",0.11,,,,,NA,"kg/m^2, change-in",0.11,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,972,Mean,"kg/m^2, change-in",0.14,,,,,NA,"kg/m^2, change-in",0.14,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,260,Mean,"kg/m^2, change-in",0.15,,,,,NA,"kg/m^2, change-in",0.15,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,299,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,302,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,111,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,972,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,260,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,295,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,301,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,110,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,964,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,258,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,296,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,301,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,108,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,963,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,258,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,295,Mean,"mg/dl, change-in",-5.49,,,,,NA,"mg/dl, change-in",-5.49,-6,-10,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,301,Mean,"mg/dl, change-in",-5.97,,,,,NA,"mg/dl, change-in",-5.97,-6,-10,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,110,Mean,"mg/dl, change-in",-2.45,,,,,NA,"mg/dl, change-in",-2.45,-3,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,964,Mean,"mg/dl, change-in",-4.95,,,,,NA,"mg/dl, change-in",-4.95,-5,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,258,Mean,"mg/dl, change-in",-4.05,,,,,NA,"mg/dl, change-in",-4.05,-5,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",-5.38,,,,,NA,"mg/dl, change-in",-5.38,-6,-10,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",-5.36,,,,,NA,"mg/dl, change-in",-5.36,-6,-10,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",-3.31,,,,,NA,"mg/dl, change-in",-3.31,-4,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",-4.91,,,,,NA,"mg/dl, change-in",-4.91,-5,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",-4.56,,,,,NA,"mg/dl, change-in",-4.56,-5,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,NA,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Avocado-supplemented diet,No change HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,299,Mean,"kg/m^2, change-in",0.2,,,,,NA,"kg/m^2, change-in",0.2,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,302,Mean,"kg/m^2, change-in",-0.09,,,,,NA,"kg/m^2, change-in",-0.09,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,111,Mean,"kg/m^2, change-in",0.13,,,,,NA,"kg/m^2, change-in",0.13,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,972,Mean,"kg/m^2, change-in",0.13,,,,,NA,"kg/m^2, change-in",0.13,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Anthropometry,BMI,BMI,BMI,NA,26,weeks,26,260,Mean,"kg/m^2, change-in",0.23,,,,,NA,"kg/m^2, change-in",0.23,0,0,0,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,299,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,302,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,111,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,972,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Anthropometry,Body weight,Body weight,Body weight,NA,26,weeks,26,260,Mean,"kg, change-in",NA,NA,NA,NA,NA,NA,"kg, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,295,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,301,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,110,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,964,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,Cholesterol ratios,Total cholesterol:HDL-C,TC:HDL-C,Blood,26,weeks,26,258,Mean,"Ratio, change-in",NA,NA,NA,NA,NA,NA,"Ratio, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,296,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,301,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,108,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,963,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Glycemia,Insulin,Insulin,Insulin,Blood,26,weeks,26,258,Mean,"uIU/mL, change-in",NA,NA,NA,NA,NA,NA,"pmol/L, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,295,Mean,"mg/dl, change-in",-1.48,,,,,NA,"mg/dl, change-in",-1.48,-2,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,301,Mean,"mg/dl, change-in",-0.62,,,,,NA,"mg/dl, change-in",-0.62,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,110,Mean,"mg/dl, change-in",-3.58,,,,,NA,"mg/dl, change-in",-3.58,-4,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,964,Mean,"mg/dl, change-in",-2.48,,,,,NA,"mg/dl, change-in",-2.48,-3,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,26,weeks,26,258,Mean,"mg/dl, change-in",-4.93,,,,,NA,"mg/dl, change-in",-4.93,-5,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",-1.11,,,,,NA,"mg/dl, change-in",-1.11,-2,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",-0.92,,,,,NA,"mg/dl, change-in",-0.92,-1,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",-3.61,,,,,NA,"mg/dl, change-in",-3.61,-4,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",-1.97,,,,,NA,"mg/dl, change-in",-1.97,-2,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",-3.26,,,,,NA,"mg/dl, change-in",-3.26,-4,-5,-10,,,,,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Decrease >5 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,299,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase >10 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,302,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,Increase 5-10 points HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,111,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,NA,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,971,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table 6,Habitual diet,No change HEI,PP,Within,Outcome,Lipids,VLDL-C,VLDL-C,VLDL-C,Blood,26,weeks,26,259,Mean,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,"mg/dl, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,490,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,479,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Avocado-supplemented diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,472,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Added sugars",Added sugars,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Dairy",Dairy,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Fatty acid ratio",Fatty acid ratio,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Greens and beans",Greens and beans,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Refined grains",Refined grains,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Saturated fats",Saturated fats,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Seafood and plant protein",Seafood and plant protein,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Sodium",Sodium,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total fruit",Total fruit,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total protein foods",Total protein foods,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Total vegetables",Total vegetables,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole fruit",Whole fruit,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Food groups,"HEI, Whole grains",Whole grains,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,8,weeks,8,486,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,16,weeks,16,487,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S1,Habitual diet,NA,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,480,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,25-30 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,96,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,31-59 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,644,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,60+ years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,268,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Asian,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,58,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Black,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,149,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Female,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,730,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Healthy/overweight,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,317,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Hispanic/Latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,207,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,LLU site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Male,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,278,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Not hispanic/latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,797,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Obesity class I,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,386,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Obesity class II,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,192,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Obesity class III,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,112,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Other,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,104,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Penn State-Hershey site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,119,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Penn State-UP site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,134,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,Tufts site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,253,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,UCLA site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Avocado-supplemented diet,White,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,694,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,25-30 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,96,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,31-59 years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,644,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,60+ years,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,268,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Asian,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,58,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Black,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,149,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Female,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,730,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Healthy/overweight,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,317,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Hispanic/Latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,207,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,LLU site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Male,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,278,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Not hispanic/latino,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,797,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Obesity class I,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,386,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Obesity class II,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,192,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Obesity class III,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,112,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Other,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,104,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Penn State-Hershey site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,119,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Penn State-UP site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,134,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,Tufts site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,253,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,UCLA site,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,251,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S2,Habitual diet,White,PP,Within,Outcome,Dietary patterns,Total diet,"HEI, Total score",HEI-2015 score,NA,26,weeks,26,694,Mean,"score, change-in",NA,NA,NA,NA,NA,NA,"score, change-in",NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,1+/day,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,NA,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,Some,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,505,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,490,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,490,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,490,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,479,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,479,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,479,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,472,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,472,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Avocado-supplemented diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,472,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,1+/day,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,NA,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,Some,ITT,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,0,weeks,0,503,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,486,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,486,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,8,weeks,8,486,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,487,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,487,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,16,weeks,16,487,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,1+/day,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,480,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,NA,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,480,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
79,Petersen 2024,Intervention,Habitual Diet and Avocado Trial,Table S3,Habitual diet,Some,PP,Summary,Outcome,Dietary patterns,Avocado consumption behavior,Avocado consumption behavior,Avocado consumption behavior,NA,26,weeks,26,480,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Results,Avocado consumers,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,403,Mean,g/d,24.63,,,20.11,29.15,95%CI,g/d,24.63,24,20,20,,,20.11,29.15,None
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Results,Avocado consumers,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,403,Median,g/d,10.4,,,4.49,26,IQR,g/d,10.4,10,10,10,,,4.49,26,None
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Results,High consumers,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,199,Mean,g/d,44.11,,,35.89,52.33,95%CI,g/d,44.11,44,40,40,,,35.89,52.33,None
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Results,Low consumers,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,204,Mean,g/d,5.21,,,4.63,5.79,95%CI,g/d,5.21,5,5,0,,,4.63,5.79,None
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Results,Non-consumers,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,2333,Mean,g/d,0,,,0,0,95%CI,g/d,0,0,0,0,,,0,0,None
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Lipids,Apolipoprotein,ApoB,ApoB,Blood,,NA,,403,Mean,g/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,403,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,403,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,403,Mean,kg/m^2,26.29,,,25.65,26.93,95%CI,kg/m^2,26.29,26,25,20,,,25.65,26.93,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Height,Height,NA,,NA,,403,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,403,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,403,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,Plasma glucose,NA,,NA,,403,Mean,mmol/L,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,403,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,,NA,,403,Mean,mmol/L,1.44,,,1.4,1.48,95%CI,mg/dL,55.6848,55,55,50,,,54.138,57.2316,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,,NA,,403,Mean,mmol/L,3.16,,,3.05,3.27,95%CI,mg/dL,122.197,122,120,120,,,117.944,126.451,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,,NA,,403,Mean,mmol/L,5.17,,,5.03,5.3,95%CI,mg/dL,199.924,199,195,190,,,194.51,204.951,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,403,Mean,mmol/L,1.23,,,1.12,1.34,95%CI,mg/dL,108.941,108,105,100,,,99.1984,118.684,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,403,Mean,years,48.8,,,46.71,50.89,95%CI,years,48.8,48,45,40,,,46.71,50.89,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Metabolic,Basal metabolic rate,Basal metabolic rate,Basal metabolic rate,NA,,NA,,403,Mean,MJ,NA,NA,NA,NA,NA,95%CI,MJ,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, high","Highest level of education, high",NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, low","Highest level of education, low",NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, medium","Highest level of education, medium",NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of diabetes,Family history of diabetes,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Meeting physical activity recommedations,Meeting physical activity recommedations,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Low physical activity,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Moderate physical activity,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,403,Mean,min/d,NA,NA,NA,NA,NA,95%CI,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,High physical activity,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,403,Percentage,%,66.26,,,,,NA,%,66.26,66,65,60,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,403,Percentage,%,33.74,,,,,NA,%,33.74,33,30,30,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Avocado consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,403,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Lipids,Apolipoprotein,ApoB,ApoB,Blood,,NA,,199,Mean,g/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,199,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,199,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,199,Mean,kg/m^2,26.12,,,25.13,27.12,95%CI,kg/m^2,26.12,26,25,20,,,25.13,27.12,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Height,Height,NA,,NA,,199,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,199,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,199,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,Plasma glucose,NA,,NA,,199,Mean,mmol/L,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,199,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,,NA,,199,Mean,mmol/L,1.4,,,1.34,1.47,95%CI,mg/dL,54.138,54,50,50,,,51.8178,56.8449,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,,NA,,199,Mean,mmol/L,3.16,,,2.98,3.34,95%CI,mg/dL,122.197,122,120,120,,,115.237,129.158,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,,NA,,199,Mean,mmol/L,5.16,,,4.95,5.36,95%CI,mg/dL,199.537,199,195,190,,,191.417,207.271,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,199,Mean,mmol/L,1.29,,,1.11,1.46,95%CI,mg/dL,114.255,114,110,110,,,98.3127,129.312,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,199,Mean,years,48.5,,,45.21,51.79,95%CI,years,48.5,48,45,40,,,45.21,51.79,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Metabolic,Basal metabolic rate,Basal metabolic rate,Basal metabolic rate,NA,,NA,,199,Mean,MJ,NA,NA,NA,NA,NA,95%CI,MJ,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, high","Highest level of education, high",NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, low","Highest level of education, low",NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, medium","Highest level of education, medium",NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of diabetes,Family history of diabetes,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Meeting physical activity recommedations,Meeting physical activity recommedations,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Low physical activity,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Moderate physical activity,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,199,Mean,min/d,NA,NA,NA,NA,NA,95%CI,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,High physical activity,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,199,Percentage,%,69.02,,,,,NA,%,69.02,69,65,60,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,199,Percentage,%,30.98,,,,,NA,%,30.98,30,30,30,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,High consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,199,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Lipids,Apolipoprotein,ApoB,ApoB,Blood,,NA,,204,Mean,g/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,204,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,204,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,204,Mean,kg/m^2,26.45,,,25.55,27.35,95%CI,kg/m^2,26.45,26,25,20,,,25.55,27.35,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Height,Height,NA,,NA,,204,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,204,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,204,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,Plasma glucose,NA,,NA,,204,Mean,mmol/L,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,204,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,,NA,,204,Mean,mmol/L,1.48,,,1.41,1.54,95%CI,mg/dL,57.2316,57,55,50,,,54.5247,59.5518,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,,NA,,204,Mean,mmol/L,3.16,,,3.02,3.3,95%CI,mg/dL,122.197,122,120,120,,,116.783,127.611,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,,NA,,204,Mean,mmol/L,5.18,,,5.01,5.34,95%CI,mg/dL,200.311,200,200,200,,,193.737,206.498,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,204,Mean,mmol/L,1.17,,,1.07,1.28,95%CI,mg/dL,103.627,103,100,100,,,94.7699,113.37,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,204,Mean,years,49.09,,,45.31,52.88,95%CI,years,49.09,49,45,40,,,45.31,52.88,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Metabolic,Basal metabolic rate,Basal metabolic rate,Basal metabolic rate,NA,,NA,,204,Mean,MJ,NA,NA,NA,NA,NA,95%CI,MJ,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, high","Highest level of education, high",NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, low","Highest level of education, low",NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, medium","Highest level of education, medium",NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of diabetes,Family history of diabetes,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Meeting physical activity recommedations,Meeting physical activity recommedations,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Low physical activity,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Moderate physical activity,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,204,Mean,min/d,NA,NA,NA,NA,NA,95%CI,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,High physical activity,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,204,Percentage,%,52.84,,,,,NA,%,52.84,52,50,50,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,204,Percentage,%,47.16,,,,,NA,%,47.16,47,45,40,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Low consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,204,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Lipids,Apolipoprotein,ApoB,ApoB,Blood,,NA,,2333,Mean,g/L,NA,NA,NA,NA,NA,95%CI,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Diastolic blood pressure,Diastolic BP,NA,,NA,,2333,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,2333,Mean,mmHg,NA,NA,NA,NA,NA,95%CI,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,BMI,BMI,BMI,NA,,NA,,2333,Mean,kg/m^2,27.49,,,27.21,27.77,95%CI,kg/m^2,27.49,27,25,20,,,27.21,27.77,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Height,Height,NA,,NA,,2333,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body size,Waist circumference,Waist circumference,NA,,NA,,2333,Mean,cm,NA,NA,NA,NA,NA,95%CI,cm,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Anthropometry,Body weight,Body weight,Weight,NA,,NA,,2333,Mean,kg,NA,NA,NA,NA,NA,95%CI,kg,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Glycemia,Glucose,Glucose,Plasma glucose,NA,,NA,,2333,Mean,mmol/L,NA,NA,NA,NA,NA,95%CI,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Glycemia,HbA1c,HbA1c,HbA1c,NA,,NA,,2333,Mean,mmol/mol,NA,NA,NA,NA,NA,95%CI,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Lipids,HDL-C,HDL-C,HDL-C,Blood,,NA,,2333,Mean,mmol/L,1.33,,,1.31,1.35,95%CI,mg/dL,51.4311,51,50,50,,,50.6577,52.2045,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Lipids,LDL-C,LDL-C,LDL-C,Blood,,NA,,2333,Mean,mmol/L,3.15,,,3.11,3.19,95%CI,mg/dL,121.811,121,120,120,,,120.264,123.357,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Lipids,Total cholesterol,Total cholesterol,Total cholesterol,Blood,,NA,,2333,Mean,mmol/L,5.08,,,5.03,5.13,95%CI,mg/dL,196.444,196,195,190,,,194.51,198.377,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Outcome,Lipids,Triglycerides,Triglycerides,Triglycerides,Blood,,NA,,2333,Mean,mmol/L,1.29,,,1.26,1.33,95%CI,mg/dL,114.255,114,110,110,,,111.598,117.798,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,2333,Mean,years,49.12,,,48.16,50.08,95%CI,years,49.12,49,45,40,,,48.16,50.08,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Metabolic,Basal metabolic rate,Basal metabolic rate,Basal metabolic rate,NA,,NA,,2333,Mean,MJ,NA,NA,NA,NA,NA,95%CI,MJ,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, high","Highest level of education, high",NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, low","Highest level of education, low",NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Education,"Highest level of education, medium","Highest level of education, medium",NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Health status,Family history,Family history of diabetes,Family history of diabetes,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Meeting physical activity recommedations,Meeting physical activity recommedations,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Low physical activity,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Moderate physical activity,Moderate physical activity,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary time,NA,,NA,,2333,Mean,min/d,NA,NA,NA,NA,NA,95%CI,hr/wk,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Vigorous physical activity,High physical activity,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,2333,Percentage,%,47.05,,,,,NA,%,47.05,47,45,40,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,2333,Percentage,%,52.95,,,,,NA,%,52.95,52,50,50,,,,,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Current smoker,Smoker,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 1,Non-consumers,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,Never smoker,NA,,NA,,2333,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,403,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,403,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,403,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,403,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,403,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Avocado consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,403,Mean,g,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,199,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,199,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,199,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,199,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,High consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,199,Mean,g,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,204,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,204,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,204,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,204,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,204,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Low consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,204,Mean,g,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Other,Alcohol,Alcohol intake,Alcohol,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Calcium,Calcium,Calcium,NA,,NA,,2333,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Carbohydrates,Carbohydrates,Carbohydrates,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Energy,Energy,Energy,Total energy,NA,,NA,,2333,Mean,MJ,NA,NA,NA,NA,NA,95%CI,kcal/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Fat,Fat,Total fat,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fiber,Fiber,Fiber,Dietary fiber,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Magnesium,Magnesium,Magnesium,NA,,NA,,2333,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,MUFA,MUFA,MUFA,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,2333,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Macronutrients,Protein,Protein,Protein,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,PUFA,PUFA,PUFA,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Fatty acids,SFA,SFA,Saturated fat,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,g/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Minerals,Sodium,Sodium,Sodium,NA,,NA,,2333,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),Table 2,Non-consumers,NA,NA,Summary,Dietary,Vitamins,Vitamin E,Vitamin E,Vitamin E,NA,,NA,,2333,Mean,g,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
80,Probst 2024,Observation,Australia Health Survey (AHS 2011-2013);National Health Survey (NHS);National Health Measures Survey (NHMS);National Nutrition and Physical Activity Survey (NNPAS),"Table 2, estimate",High consumers,NA,NA,Summary,Dietary,Minerals,Potassium,Potassium,Potassium,NA,,NA,,199,Mean,mg,NA,NA,NA,NA,NA,95%CI,mg/d,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Methods,High consumer,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,782,Categorical,servings/wk,1,,,1,7,"Min,max",g/d,7.14286,7,5,0,,,7.14286,50,1/2avo=1 serving = 50 g
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Methods,Low consumer,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,1405,Categorical,servings/mth,2,,,1,3,"Min,max",g/d,3.33333,3,0,0,,,1.66667,5,1/2avo=1 serving = 50 g
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Methods,Nonconsumer,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,4013,Categorical,servings/mth,0,,,0,0,"Min,max",g/d,0,0,0,0,,,0,0,1/2avo=1 serving = 50 g
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,6814,Mean,years,62.15,0.12,10.23,51.92,72.38,SD,years,62.15,62,60,60,0.123929,10.23,51.92,72.38,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,CVD risk factors,Blood pressure,Systolic blood pressure,Systolic BP,NA,,NA,,6814,Mean,mmHg,NA,NA,NA,NA,NA,SD,mmHg,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,BMI,BMI,BMI,NA,,NA,,6814,Mean,kg/m^2,28.33,0.07,5.43,22.9,33.76,SD,kg/m^2,28.33,28,25,20,0.0657807,5.43,22.9,33.76,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,CRP,CRP,CRP,NA,,NA,,6814,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,CVD risk factors,D-dimer,D-dimer,D-dimer,NA,,NA,,6814,Mean,ug/mL,NA,NA,NA,NA,NA,SD,ug/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Metabolic,eGFR,eGFR using CKD-EPI equation,eGFR using CKD-EPI equation,NA,,NA,,6814,Mean,mL/min/1.73m^2,NA,NA,NA,NA,NA,SD,mL/min/1.73m^2,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,NA,,NA,,6814,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Metabolic,Homocysteine,Homocysteine,Homocysteine,NA,,NA,,6814,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,IL-2,IL-2,Il-2,Blood,,NA,,6814,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,IL-6,IL-6,Il-6,NA,,NA,,6814,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Metabolic,MMP3,MMP3,MMP3,NA,,NA,,6814,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Antioxidation,ox-LDL,ox-LDL,OxLDL,NA,,NA,,6814,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,African-American,African-American,NA,,NA,,6814,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Caucasian,Caucasian,NA,,NA,,6814,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Chinese-American,Chinese,NA,,NA,,6814,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Race,Race,Hispanic,Hispanic,NA,,NA,,6814,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,6814,Percentage,%,52.85,,,,,NA,%,52.85,52,50,50,,,,,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,6814,Percentage,%,47.15,,,,,NA,%,47.15,47,45,40,,,,,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Pack-years of cigarette smoking,Pack-years of cigarette smoking,NA,,NA,,6814,Mean,pack-years,NA,NA,NA,NA,NA,SD,pack-years,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Immune,TNF-a,TNF-a,TNF-a,NA,,NA,,6814,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 1,All,NA,NA,Summary,Subject Characteristics,Metabolic,Urinary albumin/creatine,Urinary albumin/creatine,Urinary albumin/creatine,NA,,NA,,6814,Mean,mg/g,NA,NA,NA,NA,NA,SD,mg/g,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,782,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,782,Mean,ug/mL,NA,NA,NA,NA,NA,SD,ug/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,782,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,782,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,782,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,782,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,782,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,782,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,High consumer,NA,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,782,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,1405,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,1405,Mean,ug/mL,NA,NA,NA,NA,NA,SD,ug/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,1405,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,1405,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,1405,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,1405,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,1405,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,1405,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Low consumer,NA,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,1405,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,4013,Mean,mg/L,NA,NA,NA,NA,NA,SD,mg/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,4013,Mean,ug/mL,NA,NA,NA,NA,NA,SD,ug/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,4013,Mean,mg/dL,NA,NA,NA,NA,NA,SD,g/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,4013,Mean,umol/L,NA,NA,NA,NA,NA,SD,μmol/L,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,4013,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,4013,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,4013,Mean,ng/mL,NA,NA,NA,NA,NA,SD,ng/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,4013,Mean,mg/dL,NA,NA,NA,NA,NA,SD,mg/dL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 2,Nonconsumer,NA,NA,Summary,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,4013,Mean,pg/mL,NA,NA,NA,NA,NA,SD,pg/mL,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,High consumer,NA,NA,Nonconsumer,Outcome,Mortality,Mortality,Mortality,Mortality,NA,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 3,Low consumer,NA,NA,Nonconsumer,Outcome,Mortality,Mortality,Mortality,Mortality,NA,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,High consumer,NA,NA,Nonconsumer,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table 5,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,High consumer,NA,NA,Nonconsumer,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,782,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,CRP,CRP,CRP,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,D-dimer,D-dimer,D-dimer,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,CVD risk factors,Fibrinogen,Fibrinogen,Fibrinogen,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Metabolic,Homocysteine,Homocysteine,Homocysteine,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-2,IL-2,IL-2,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,IL-6,IL-6,IL-6,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Metabolic,MMP3,MMP3,MMP3,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Antioxidation,ox-LDL,ox-LDL,OxLDL,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81,Carris 2024,Observation,Multi-Ethnic Study of Atherosclerosis (MESA),Table S2,Low consumer,NA,NA,Nonconsumer,Outcome,Immune,TNF-a,TNF-a,TNF-a,Blood,,NA,,1405,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Adherence,"Adherence to Mediterranean diet, high/moderate","Adherence to Mediterranean diet, high/moderate",NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Adherence,"Adherence to Mediterranean diet, low","Adherence to Mediterranean diet, low",NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Age,Age,Age,Age,NA,,NA,,934,Median,years,19,,,18,19,IQR,years,19,19,15,10,,,18,19,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,No alcohol,No alcohol,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,Occasional alcohol,Occasional alcohol,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Alcohol,Weekly/daily alcohol,Weekly/daily alcohol,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Maternal schooling level, Higher education","Maternal schooling level, Higher education",NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Family education,"Maternal schooling level, Secondary or lower","Maternal schooling level, Secondary or lower",NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Anxiety,Anxiety DASS-21 score,NA,,NA,,934,Median,score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Anxiety,Anxiety DASS-21 symptoms,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Depression,Depression DASS-21 score,NA,,NA,,934,Median,score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Depression,Depression DASS-21 symptoms,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Stress,Stress DASS-21 score,NA,,NA,,934,Median,score,NA,NA,NA,NA,NA,IQR,score,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Other,Mood,Stress,Stress DASS-21 symptoms,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,No sedentary lifestyle,No sedentary lifestyle,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Physical activity,Physical activity,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,No physical activity,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Physical activity,Physical activity,Sedentary,Sedentary lifestyle,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Female,Female,NA,,NA,,934,Percentage,%,52.9,,,,,NA,%,52.9,52,50,50,,,,,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Sex,Sex,Male,Male,NA,,NA,,934,Percentage,%,47.1,,,,,NA,%,47.1,47,45,40,,,,,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Never smoker,No tobacco use,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Occasional smoker,Occasional tobacco use,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Lifestyle,Smoking,Weekly/daily smoker,Weekly/daily tobacco use,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Dietary patterns,Total diet,Mediterranean Diet Score,Mediterranean diet score,NA,,NA,,934,Mean,score,NA,NA,NA,NA,NA,SD,Score,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Normal weight,Normal weight,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Obese,Obese,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Overweight,Overweight,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 1,All,NA,NA,Summary,Subject Characteristics,Anthropometry,Weight groups,Underweight,Underweight,NA,,NA,,934,Percentage,%,NA,NA,NA,NA,NA,NA,%,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 4,.5-3 unit/wk,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,units/wk,1.75,,,0.5,3,"Min,max",g/d,37.5,37,35,30,,,10.7143,64.2857,unit=avo;150g
83,Morales 2023,Observation,Morales 2023,Table 4,.5-3 unit/wk,NA,NA,0-.5 unit/wk,Outcome,Mood,Mood,Depression,Depression symptoms,NA,,NA,,,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 4,>3 unit/wk,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,units/wk,3,,,3,,"Min,max",g/d,64.2857,64,60,60,,,64.2857,,unit=avo;150g
83,Morales 2023,Observation,Morales 2023,Table 4,>3 unit/wk,NA,NA,0-.5 unit/wk,Outcome,Mood,Mood,Depression,Depression symptoms,NA,,NA,,,Odds ratio,NA,NA,NA,NA,NA,NA,95%CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
83,Morales 2023,Observation,Morales 2023,Table 4,0-.5 unit/wk,NA,Actual,Summary,Dietary,Avocado Intake,Avocado Intake,Avocado Intake,Avocado Intake,NA,,NA,,,Categorical,units/wk,0.25,,,0,0.5,"Min,max",g/d,5.35714,5,5,0,,,0,10.7143,unit=avo;150g
